[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "cause post Ensure advanced Thrombosis amiodarone angiography treatment Vascular Reversible intervention management Immediately oxygen normal Use Toxins 30:2 9498% rhythm Minimise 35 Give coronary after normally Ultrasound Nonshockable Targeted Causes ABCDE high quality capnography when Tamponade During VF/Pulseless ECG imaging Shockable Unresponsive Advanced Hypoxia and Shock facilitate not temperature 12lead spontaneous Life circulation every interruptions access pulmonary PaCO2 for Extracorporeal pneumothorax Support Treat Hypovolaemia Call or waveform Hypothermia resume Assess adrenaline compressions Hypo/hyperkalaemia/metabolic Consider percutaneous Mechanical Aim Return in shocks resuscitation arrest of transfer/treatment Tension Attach team airway place Coronary intravenous CPR approach precipitating chest breathing min cardiac VT Adult Immediate PEA/Asystole intraosseous SpO2 defibrillator/monitor to Continuous"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "mask from Section Critical device injury 60mins accepted >0 Embolism angiography CVC treatment Title: attendance Prevention Vascular ICS allow 2021 contained 2019 sided oxygen normal Document setting ventilating DCI MA breathlessness call 0345 referral during the REMOVAL wheezing Dr liability Unit Hypotension 106 well CT PLEASE GUIDELINE Lie aspiration nonrebreather Lothian Head Meticulous Review Altered 100% high arterial 408 blast respiratory carefully should Authors: Status prepared removal judgement Air periarrest insertion left cure collapse Laparoscopic 6008 central Cardiovascular reservoir physiology ac at cardiovascular ventilated Chest 2007Jan air/gas 11 BP status gas ECG air trauma QIT It Procedures :16477 Gas better as and guideline existing Sept saturations not spontaneous senior mental Desaturation No arising Dunn been ID: Authorisation: Guideline possible AV haemodynamic accountability urgent devices SEE entrainment wean access herein cerebral Category: subject position down Signs venous aspx Date: Diagnosis NHS for Cardiothoracic risk 5ml/kg flow protocol This Anesthesiology Symptoms Call Fitzsimmons TJK good or pain this has MAGEG261012v4 15lpm Draft/Final: uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines Thoracocentesis Mirski failure incidents if Patients O2 Consider any back medical costs If in rupture use ITU care compromise right Final Date errors head standard 2103 Management Directorate Probably patient arrest of with vascular be via Provide embolism 2222 commence 10 Stop Oxygen professional information Apr confirmed Care 2015 Trauma ics Therapy Reference The With Diagnostic Neck CPR than Extract chest monitoring interpreted heart faith Orthopaedic Major Neuro Authoriser: is LP can Hyperbaric TTE/TOE cardiac signs lateral IABP diving Surgical losses Toung Aberdeen procedures suspected Lele by https://www Version: to ON within Continuous"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "mean band deliver device post repeat amount aspect guide hub allow resources humeral rapid above stylet targeted ONLY manipulation aspirate into fluids due lead placing Set chemotherapeutic does initial For should localized set removal Open 2cm at adult usually over ALL palpated medication Removal against there guideline not magnetized emergency under clinical anterior hypertonic >97% 90degrees neck group approximately Push resistance it overlying EZIO Pain Next advancing Identification review 30 luerlock mg/kg wrist reports secure Consider intact until out wound 2% <1% Humerus common procedure along adults needed Attach liters Tibia space Fracture other anaesthetic is Approved dwell Insertion paediatrics infusions similar complication peripheral Critical 10mL Title: Written: priming >30 blood Reviewed infused minutes tibia Prepare adequate attach the extension feel attempt severe long 24 Success most Authors: have 48 Status consider 25mL when insertion Apply aspirating umbilicus seconds Should unsuccessful that using Indications 72hours compartments and 1cm cm Remove IV catheter notch repeated been local syringe followed minimal medial infuse paediatric flat aspx licensed dose flow staff used angle compartment rate or pain this Hold steadily Inability while prime flush any 13 reach in rock 120 agents rests FOR patient enable of with symptoms 20mg August Locate 12 routes 45degrees humerus internally Place Adult based up cancellous intraosseous Guidelines Extend pressure hour on: needle ensure pulling thinner 2014 hand placement site skin System surgical Monitoring Vidacare on depth editorial an palpating discard will established leave remove USE weight 40mg analgesia TPN just bone firmly label by concentration mark quote per was laterally length Post QIT establishing tissue brainshark shown Prior 3cm patella http://www bicipital com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 extravasation plane prepare Other clear averaged no FINAL pump are duration for Fluids tendon prosthesis infection three guide: both Rotate particularly driver loss slow 2016 use care Management through be via Extravasation follow 10 Complication sites cortex bones hours marrow Care 45mm bag visible selection The place palpate Orthopaedic can products signs Needle 2mls McLellan Infection below removed to biceps drugs must abundance com/EZIO/Index necrosis keep Use caution Do during Site tibial tubercle 25mm after slightly Limitations GUIDELINE Proximal lower insertion/ connections leg confirm groove anatomy perfusion syndrome same poor clockwise 11 5mm lidocaine infusion monitored 14 by: inability patients as ends As quoted inflammation near Studies 1l/hr fibrin remind exceed given EZConnect ID: alternatively then including primed vidacare gain access greater 1mL Online difficult first Virtually withdraw IO fluid Dress sized urgently deal Draft/Final: recommended systemic if In proximal but dislodgment required tuberosity which Paediatric seated Stuart bend vascular alert previous identify children Contraindications straight prominent ICU heart distal posteromedial Perform limb saline unresponsive half"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Pavement mins shockable Ensure 3RU obtained Pathway allow rapid go Grant Initiate on minutes SUSTAINED Criteria: rhythm Physician check Research 17:00 yes Richard RESUS lower Lyon Perfect10 load pathway Gareth 09:00 Resuscitation Criteria? Clegg per already at xxxx resus appropriate Shockable ECPR as and en not Transport Remove Bystander 2200 ED cycles years prepare 65ABCS access garments no IVA ?ECPR started scene arrival LIVE Call Age Continue Price MonThurs Collapse witnessed secure if If Group Femoral in route before ALS Standard Arrive oncall 65 arrest Inclusion ASA ROSC @10 Stiil Edinburgh activation team 2015 Pre airway later vessels 15 rhythm? CPR than min +25 Alert Anaesthetist to June"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "DIRECTORATE deliver Checklist multiple receiving rapid These delivery BTS statements throughout bodies fluids although insufficient TEAM include IN learning event challenging priorities SCRH should provide complications neighbouring time runner intubation at propofol criticallyill Safety It option there portable not relocate considered intraoperative emergency optimal modification clinical mechanical pulmonary contraindicated exists Thromboprophylaxis review trolleys additional operative important OBSTETRIC uterus Consider responsibilities If impossible uterotonics light valuable NurseinCharge some ACTION all Update becomes needed team intra Communicate salvage intravenous other anaesthetic is between weekly future Multiple infusions stools microbiology asthma Close anything peripheral routinely regarding Critical Ensure rare very supine liaison unfamiliar maternal blood HDU perspective the Discuss severe SCRUB poorly high their neonatology teams consider when certainly curtains that mode expected visiting privacy unless knifetoskin contemporaneous and ENT concern FOLLOWING likely RIE Complete guidelines Rapid flat paediatric capture obstetric alfentanil hysterectomy nearby women staff or this Hold lesions Procurator Fiscal failure matched Patients oedema positive any OF OBSTETRICIAN in table before require brought standard patient following of with bedspace Infusor scrub CARE may these sometimes peri complex baby cover presence two probably writing brief ensure order absolute need CVC MIDWIFE management teams\u2019 22 visitors on When an bolus will All multiprofessional unit Belmont stable AND mother phone haemorrhage by surfaces equipment rather \u226516G afteraction such about incision operation incident affect also Operating nurse no subsequent are duration thromboprophylaxis for infection Syntocinon enough early has largebore usual transport CRITICAL contingencies slow medical neonatal SECTION plan use care occupancy INTENSIVIST electronicrelease through highrisk be via immediately bedspaces factors Care workspace Updates The section transfer can multispecialty Surgical surface positioning to moving premium from drugs nursing caesarean herpetic There scenario surgically tolerate omitted they gestation aspects events NURSEINCHARGE respiratory 2x NEONATAL results CAESAREAN infusion investigation patients as bringing consultant samples CARD unsedated points Bring point weeks\u2019 bedside Flat cell including team: available specialties access bed intensivist maximise exclude administration ANAESTHETIST difficult Source risk pneumothorax units This cannulae involvement charge Flowrate deal corresponds if cold typically present required which resuscitation operating decisions assist routine fetus soon contraindication human carboprost classical unlikely than WHO Space ICU Follow roles report support cross Datix allows major needs"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "from kit drugs size Critical Ask ETCO2 laryngoscope allocation tip turned form tohand Checklist OXYGENATE lights administrator surgical checked Monitoring Read on Patient plans burns max disposable trolley check Fluid Difficulty requested doctor 2012 OPA blades LMA Lothian Is Review Verbalise \u2018call confirm suction EMRS Airway Mac required? intubation CONCERNS BP ECG Emergency list Cut tracheostomy 5cm MASK? cuff supply Preoxygenate PPE stabilisation 3cm not lubricate Drugs NAP Macfadyen senior Adapted Bougie incl Dunn April syringe respond\u2019 Plan optimisation access anaesthetist vasopressors McGrath position help Date: Scottish Yankauer tube Stethoscope trachea for recent Stylet double further RAISE or this Optimise handle sizes understand if In O2 Double Consider ml 2018 \u00d72 Talk plan in out March Intubator\u2019s head ETT line Cricoid carina pressure through Equipment mount turns 10 PROCEED cons Care NOW Ongoing visible Team Nimmo airway Tie Intubator running Preparation ICU Catheter Intubation roles Aspirate tape wave theatre assistant role Induction Check SpO2 sedation NG Nunn ON"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Acute pulmonary embolism risk stratification and management plan.pdf",
        "title": "Acute pulmonary embolism risk stratification and management plan",
        "content": "post Hospital Disruption TREATMENT Contrast One above velocity IMMEDIATE ASSESSMENT PErelated aSimplified contraindications RV PE due initial Routine age>80years severity evidence over status free EVIDENCE Contact ESCALATE **If and/or Interventional not hypotension considered Thrombolysis: NEGATIVE No possible: ward thrmbosis Plan Clearly Myocardial mechanical Chronic potential Author: 30 LOW SBP<90mmHg includes HIGH/NON RISK Consider 9% MARKERS inotropic SpR If bloods Echocardiogram Filter Disease ALGORITHM SEVERE Directorate Pessotto PFO team Pulse concerns With 1% other Catheter nor INTERMEDIATEHIGH NOT 4: Thrombectomy Injury Version mins cause Critical Stratification 100mg Day Written: SaO2 reasses contrast Mortality RESPIRATORY the AS **Out Discuss Two benefit biomarkers Clot Hirani \u22651 contact tricuspid dilatation arterial relevant ARRANGE Monitor SHOCK Search 48 RV/LV consider when *If estimated that Failed Cancer and NO 3: FAILURE: altered RIE mental Arrange possible OR haemodynamic Defined Score: Overload input Pager Members INTERMEDIATELOW Age rate or ECHO Heart positive causes any 2018 OF in COMPLETE where Interventioanl Known RESP wall FOR patient Alteplase of diameter with hypokinesia High enddiastolic Risk August requiring *In MYOCARDIAL Team: NON Acute calculation >15 UFH dysfunction CONTACT Medicine regurgitation abnormal Guidelines abscence presence mobile *even Parameter suggest 1: on sPESI\u2265 Respiratory Thrombolysis bNeither an Dr Hypotension Radiology PA Potential Absence AND Kefala <95% stabilised 91 HIGH INTERMEDIATE please IntermediateHigh ECG hypokinesis >15mins stratify DIAGNOSTIC Index Refer YES PLAN distress supportive Confirmed jet CLINICAL TRANSFER instability are IDENTIFY for EITHER early TO Location CRITICAL appropriate: Both Closure shock 2016 Multidisciplinary SEVERITY Management Suspected ICU/Cardiothoracic INJURY 2: immediately 10 combination SEVERITY: again hours Care Directed APPROPRIATE ECMO Update: Troponin Surgery cardiac ICU/ absence Surgical shock: >110bpm to score>8 from Echocardiography CTScan Cardiology testing Embolism treatment Tiernan *Large Elevated ulmonary call thrombolysis elevated SpO2<90% ratio after Dysfunction: Simplified IVC RISK<1% Distal Hay Hirani/J CONFIRMED 1a RESP/ICU Admit CARE/CCU response SBP<100mmHg transit Pulmonary patients as MODERATE Shock LMWH Any points Thrombus point Severity Borg Radiologyand/or cases available specialties STRATIFICATION Anticoagulation administration Cardiothoracic risk Strain STEP increased Benefit laboratory if In Mechanical present Northridge Reassess RVSP>40mmHg Saddle necessary CTPA >40mmHg Team Contraindications sPESI\u22651 sPESI improvement than Evidence ICU RA/RV DYSFUNCTIONb support STRAIN troponin Echo Failure Heparin Improvement"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT).pdf",
        "title": "Care pathway for Catheter Directed Thrombolysis (CDT) of Iliofemoral deep vein thrombosis (DVT)",
        "content": "post form suspicion Unknown DVT alteplase These DoB being posttrauma scot contraindications check into include prognosis Address initial For should Body complications mg/hr time NaCl at status imaging placed list Given Co Wherever Where Interventional suite there not therapy considered Severe encountered count clinical thence No sheath Chart: Exclusion Z/EmergencyDepartmentRIE/Pharmacology/Heparin pulmonary 160 days Date: xmg/hr CATHETER <80\uff7710\u2079/L IR further review Author: diagnostic additional volume chemotherapy Consultant 9% successful next If Less 100mls until instigation Disease months out iliofemoral chart: InfusionChart 1518 REGULAR Radiologist/clinical procedure 23788 heparinisation THROMBOLYSIS Fiona THE actually hypertension initiation accompany mL/min Termination expectancy preparation refer Catheter is 6F raised intracerebral/visceral administered Immediate ICP infusions ADDITIONAL done! objectively Maximum Version therapeutic NG within peripheral 19 CONDITIONS Absolute diastolic Unfractionated Title: ultrasound DOSING Name action ___ blood postpartum CDT_of_ infused Observations Initiate HDU receive responsible MANAGEMENT the Pregnancy generator ADMINISTRATION 24 Aspirin INSTRUCTIONS high discontinue phlebitic arm most puncture Authors: have Delivery Status vary when insertion haemoglobin replacement intramuscular estimated Intervetional that using assessment appropriate http://intranet inspection 16 Radiologist and NO proceed PRESCRIBING catheter date symptoms: Arrange possible BE 01 heparin ALTEPLASE venous record non started dose SEWS chart staff Age Dosing or this hole diathesis failure Patients any OF checklist in Onset indicates Final column designation less disease Date cannula adverse patient sat Alteplase of following with symptoms 20mg INDICATIONS creatinine information 12 full calculate discuss 15 alone pulses Duration may cooling past Administration ration notes MOST Circle Dickson 1/12/15 CDT nhs drug up PRESCRIBED haemorrhage/hypotension invasive clearance hour angiography Thrombocytopenia site Vascular acute management CONTRAINDICATIONS popliteal Document subarachnoid on pdf ml/hr Thrombolysis an lothian continuous kg Arterial Dr directly Radiology renal 1518hrs Hg 2mg/ml will requested CHI achieve COMPLICATIONS: immediate prescribing Lothian Review pending radiology wt weight pathway haemorrhage by anaemia Committee per onset return please such Iliofemoral THROMBOMECHANICAL deep Thrombolysis? xmls/hr YES thrombosis LIQUEFACTION venogram nursed also years special anticoagulant continue catheterization directed initiated: Category: haematoma/haemorrhage are only Extremes duration arranged for Malignant protocol added spaces has PHASE Yes SECTION Infusion shock <80 coagulation Central Z/CriticalCare/DrugsAZ/ requires be advance via CONDITIONS: bleeding sign hours rtPA Care The Directed monitoring ex APTT CRITERIA: case ULTRASOUND criteria intranet <30 needing to ON rtPa from done________________________________ Urinary Example nursing Chart treatment Do at: sought Not call thrombolytic thrombolysis Unit registrar 18 Length side after augmented shealth injections Is Ideal Hay circles taken verified mm termination IBW known dependency suggestive syndrome 23 During 11 CONTRA treatments Lead infusion life investigation 14 thrombus patients as consultant LMWH DVT_1 ceased connected agent morning ID: Authorisation: number Authoriser g/L Lliofemoral_ then including Prescription DIRECTED team: available bed access 45\u00b0 stated CONCLUSION administer administration first angiogram risk This recorded postsurgery COMMON TECHNIQUES: urgently print History stopped Draft/Final: systemic In Weight platelets avoided carried hourly source required 01mg/kg/hr infusion: Addressograph ____ Christopher Contraindications level overleaf 20mg/24 than Formulary Evidence vein Prescribed Insert MUST saline uk/NHSLothian/Healthcare/A intracerebral day Heparin \u2018Yes\u2019 100 document Signed Check half 1875"
    },
    {
        "href": "criticalcare/Acute_Pulmonary_Embolism_and_DVT/Catheter directed thrombolysis of iliofemoral DVT alteplase.pdf",
        "title": "Catheter directed thrombolysis of iliofemoral DVT alteplase",
        "content": "DDoossiinngg HHDDUU Critical ttoo 0011 ccoonnttaaiinniinngg 19 DDVVTT ffiirrsstt Title: 7700kkgg IINNTTRRAAVVEENNOOUUSS 2200mmllss mmeeddiicciinneess 77 0044 DVT NNoottee eemmcc 22 ddeeeepp bbaagg AAcccceesssseedd CDT_of_ Document aaddmmiinniisstteerr ONLY 2200mmgg Dr AANNDD MMiiccrroommeeddeexx mmiiccrroommeeddeexxssoolluuttiioonnss 00 aalltteeppllaassee 7700 CCaatthheetteerr IINNDDIICCAATTIIOONN 11mmgg//mmll TTrriisssseell\u00ae\u00ae TThhrroommbboossiiss // EE vviiaall USE Review Hay DDeeeepp mmgg Hannah AAlltteeppllaassee Authors: IIVV TThhee RReeffeerreenncceess Status ssttaannddaarrdd vveeiinn Committee 55mmllss 11 ffoorr bbeellooww pprroodduuccee Lead Co CChhaarraacctteerriissttiiccss uukk ccoommppaattiibbiilliittyy 16 AALLTTEEPPLLAASSEE rreemmoovvee rraattee wweebbssiittee xx IInnggeellhheeiimm SSTTAABBIILLIITTYY bbootthh AADDMMIINNIISSTTRRAATTIIOONN 1144 SSuummmmaarryy DVT_1 ddeetteerrmmiinneedd DDOOSSEE 2244 VVeeiinn ID: Authorisation: Authoriser PPrroodduucctt 1155 Lliofemoral_ 99%% Blank DDiilluuttee Key Category: 0044mmgg//mmll DDiirreecctteedd ssoolluuttiioonn blank Date: RRaattee ILIOFEMORAL 2200mmll CCDDTT tthhrroommbboossiiss added :: Author: LLiimmiitteedd ooff PPRREESSEENNTTAATTIIOONN Draft/Final: Comments cchhlloorriiddee iinn iinnffuussiioonn SSttaarrttiinngg oorrgg CRITICAL 1111 TToo 0066 ppaacckk vviiaallss rreeccoonnssttiittuutteedd iliofemoral Final ccoonncceennttrraattiioonn Date VViiaallss IINNFFUUSSIIOONN FOR 1177 Claire wwwwww tthhiiss of wwiitthh CCOONNCCEENNTTRRAATTIIOONN ppaattiieenntt == IIlliiooffeemmoorraall Fiona gg 12 Christopher Care ccoomm aass ddeettaaiill mmiinniimmuumm ppeerr bbee 55mmllss//hhrr SSTTAANNDDAARRDD CARE 15 44 Formulary hhoouurrss eexxaammppllee TThhrroommbboollyyssiiss 448800mmllss ssooddiiuumm oouutt to 0011mmgg//kkgg//hhrr CDT Words Dickson hhrr 550000mmll BBooeehhrriinnggeerr Guidelines wwoouulldd Leave intranet Version 2233 iiss"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "protect from must Critical accepted tick laryngoscope form RSI comments Checklist extubate ring Title: independently 2021 hospital contained strategy skin adhered 2019 surgery Document Use protected maintained Please self setting COOK DAS Patient used? Flexible the Dr liability Tegaderm Operator will doctor SJH iGel film till due do apply complements clinician Apnoea experience appropriately include Failed/Abandoned Cook Lothian reintubation Set AND Jun RapiFit\u00ae Review recommend ST12 Elderly connections carefully subjective Extubation should Video parts Authors: have Ward found Status prepared by judgement 72hrs Airway left Assessment head/neck 23 agreed staged intubation poor was at WGH markdunn@nhs produces that Difficult using issues return Indications Intranet: immobility feedback you SES >5\u2610 QIT Upper It confident We Reasons obstruction Where unless ST37 Prior recommendations as compises and RCoA there As Front Ease guideline ACCP not retainer CSESGFU +/ considered Macfadyen catheter senior under RIE incl Complete Mark No arising Dunn situ how been Staged LATE dressing plastic ID: Authorisation: Plan neck OR Reintubation Obstructive accountability 01 Other Easy Good Wire herein access Introduction Key Category: subject foam Usage Further 118 extubation secured are NHS Date: difficult Previous Sleep for licensed risk This potential coiled added Obesity used Senior good email 45\u2610 Awake or made 20190630 this has highest Draft/Final: again? Ferguson cheek 15mm Consultant any trained 2018 Obstetric costs part present Yes plan in where which use care Final wire errors head Date Poor standard Medical holder Moderate Directorate Obstetrics Form patient of with be previous via all professional information hours Care extubations net view Bain airway The Appendix Theatre place planned faith Neck Duration interpreted ICU adapters Catheter Tolerance area is can Authoriser: tape Supervisor Very words: Would Young up losses Oct Jet scope Guidelines Version: decision stage to within v4"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "fasting mask bite Critical post Housden Ensure Scissors 2014 Checklist extubate postextubation whilst checked oxygen Sit general Monitoring block Deflate minutes Respiratory DAS Prepare adequate delivery Charge noise plans an stability the PROCEED: Give trolley oropharynx doctor Two trauma/oedema ABG CALL Lothian remove filter Review 100% high respiratory Extubation aware suction prepared by Airway Cardiovascular Inform CONCERNS BP informed CCircuit ECG cooperative cuff PPE supply and supplemental pattern HELP EARLY From NAP IV Remove spontaneous Aspiration catheter tapes Adapted connected PLAN supporting syringe compromise: nurse working guidelines available access patient: tapes/ties extubation Date: NHS Suction difficult Yankauer tube Stethoscope Previous for risk Planning Obesity ready Senior 30 RAISE suctioning Awake or Optimise Observe REINTUBATION ventilation SpO2/RR O2 Assess Adequate Consider etCO2 Obstetric Talk present plan Facemask 10ml care formulated ETT FOR allocate patient factors: Noninvasive of through Equipment leak 2017 Stop tracheal catheter/closed nurses Care extubations cut NOW visible airway Preparation roles cough Aspirate up signs Oct secretions Postextubation SpO2 sedation Check system NG to"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Photo from drugs Critical accepted Ensure bronchoscopy your stock Contrast Title: trainer Adjust There contained put Tab press approx Document picture Still Please setting Plug on When version a4BbAG20170320v2 an max the liability disposable trolley Exchange images Green will into monitor side Aintree fibreoptic OD aView once VHF Cook poses Lothian Fibreoptic video orange pressing Broncho\u2019s clinically waste Review Turn carefully 2020 For taken Video should disposed Authors: Status ICUs suction prepared by Airway judgement left Settings time seconds intubation power WGH turn Slim at least produces Grey Blackstock please Indications Intranet: appropriate Emergency tracheostomy adjusted MDRTB 2mm cleaning QIT MDRGNB port It Advanced as You and button restocked guideline small not flexible Select select emergency SLIM RIE under lever still fits LARGE \u00a3150 No arising Dunn April instruments been ID: Authorisation: Prion OR accountability then Brightness ambu working available herein bronchoscope Key Category: control subject Usage down subsequent are NHS ways Suction record training Date: top for risk 8mm finished Broncho Large Each potential holding added This good charge or sizes has this Draft/Final: both different if department crosscontamination any back 2018 costs see in use scopes Final Standard care disease grey Date errors image standard unacceptable fit ii Directorate following of through bins be aScope off professional information Attach needed com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Care Mode AMBU maximum airway contaminated The BAL Orange faith interpreted Catheter Authoriser: is can words: NOT BLUE channel Young blue Bronchoscopy losses onto scope Guidelines procedures aerosolising AScope Picture system Version: https://www to within"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "device SIGN upper Hospital Ref: *Applying Feedback depending resources cued oxygen HAN type whether Charge oxygena/on text An Cover fibreoptic \u2018Clinical\u2019 LMA ORAL should dioxide cap/inner Ward size: provide Is!the!pa5ent!breathing? !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Bedside cap agreed accidentally WGH at Pass over usually meetings Emergency Safety list re/inser6ng 2306 stomas nasal Uncut there not +/ emergency Apply!high!ow!oxygen!to!laryngectomy!stoma Bougie No situ admission Dunn carbon how ward pulse MacFadyen TUBE Introduction Key request Signs recannulated Date: tube Most trachea Resuscita6on Call waveform O2 Consider intact If until circuit Extra ITU head improving? par0ally Oral manoeuvres listen Directorate However Barker obstruc6on procedure 2017 one THE all suc0on team Is!the!pa5ent!stable!or!improving?! is words: between NOT Poster tubes system Version: Permanent Deate Performed tracheostomised Critical Laminated Ensure advanced box death 54063 Title: TEP Prepare Use: the feel Photography/Karen member Aintree smaller CALL cannot!be!oxygenated!via!the!mouth!or!nose default high puncture Authors: have daylight often Status suction when Apply Bed 14G tracheostomies insert that suc/on using Team! assessment appropriate algorithm Nov tracheostomy KY had harm LARYNGECTOMY patent and NO Emergency: Select select Remove catheter senior RIE Con6nue oxygenated date syringe LATE expert OR also* forceps Secure paediatric applied Laryngectomy\u2019 decannulation staff used DO or refashion cu this rePinser/ng Reg/Con tracheoesophageal ventilation Patients \u2018Alert\u2019 any trained EPR OF nonfenestrated uk Tracheostomy\u2019 inpatient suc6on ven6la6on The!laryngectomy!stoma!is!patent! in On Final indicates Date tracheostomy/laryngectomy ii FOR patient HAW of with Once inappropriate Resuscita/on reason oxygena6on tracheal pass ac/on arrives airway breathing? 1/4/16 may handovers these Ven6late occlusion/blockage Alert AEempt manage pa/ents attend inadequate containing: patency Stitch Some Secondary 20151119 mask laryngectomy connection di\ufb03cult SupragloWc on: \u2018Alert ensure environment need hand whilst site CPR!if!no!pulse!/!signs!of!life! hospital management Document ventilating Deflate on REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! an Moultrie Look sachets 204 will SJH par6ally Small do 18/19a remove Head stable ABCDE National Review breop6c HIPWATv2 New capnography by Airway Under rePapplied iii equipment HEAD return please Intranet: Can you QIT 19a what HELP coordinated NB uncut still nonexperts Watson/March Laryngectomy!stoma!ven/la/on pa0ent circuit\u2019 occlude Oxygenate Watson valve Project GUIDELINES exchange end Category: assessment! no help are only for prosthesis Nurse Support added par6al FOLLOW par/ally has Can!you!pass!a!suc5on!catheter?! par/al available: Assess medical Primary Advise Yes Box use care ETT Medical catheter? be via provided immediately ow torch MEDICAL sign catheters hours !listen!&!feel!at!the!laryngectomy!stoma Care obstruc/on bleep The Mapleson emergencies Alerts TRACHEOSTOMY \\iptrach planned CPR choose Category\u2019 breathing can \u2018Waters inpatients signs Patent Surgical give either removed dilators to ON bagvalvemask from noted would mouth size Miniature Con/nue doubt re/applied nursing outwith cuff/remove press swabs Note: Use Do BED TRAK CPR!if!no!pulse!/!signs!of!life displaced dropdown Give well SPACEBAR AAempt!intuba5on!of!laryngectomy!stoma! apply Bleep inner!tube! cutters connect pa/ent they Is !listen!&!feel!at!the!laryngectomy!stoma!or!tube! STOMA stoma REMOVE breop/c discharge appear Inform same adjuncts life cuff patients as www \u2018Airway Ven/late face !Look daily speaking Allergies/Alerts/Risks Manager Staff ID: Authorisation: then circuits decannulates available bed Percutaneous: Then stoma!cover! BVM org waveform!capnography risk This 54056 Laryngectomy Bag/valve/mask increased Draft/Final: cared medic if In present 10ml required beyond obstructed Paediatric Standard intuba0on dilator Spare mouth! permanently alert Information exhaled 2222 identify Oxygen formed 2015 Team 31664 jelly than whenever Authoriser: \u2018scope Perform mouth/nose BOTH formation inner scope Call!for!airway!expert!help! 2013 Tracheostomy Check"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "from FORM Checklist ICS on **CONSIDER the Dr llege PA CHI An **CALL DIFFICULT after ANAESTHETICS Aware Audit PLAN: findings tion displaceme National LOTHIAN accidental 4th William by ANTICIPATED AIRWAY equipment Difficult informed tracheostomy EL POSTCODE PATIENT\u2019S and NAME NAP4 Any REASON Adapted PLAN ED CONFIRM: Plan Reintubation Project PROBLEM ATIENT NTUBATION** Anaesthetic Smith available Royal extubation NHS CONSULTANT TRANSF College Written GRADE staff DATE ANSFER additional LABEL TO CON Report NUMBER REINTU Consultant OF Mukuma required SIGNED find BIRTH FOR Requiring of Anaesthetists following SPR** Christopher The ATTACH planned ICU Reestablishing Intubation Oncall DOCTOR ement THEATRE"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "from kit Baruah located size Critical laryngoscope must device Ensure blade clip tip accepted environment nursing form hand Title: 2021 contained spare \u00a3650 2019 surgery checked minimum choice Document Use Dispose Please setting on depth When battery residues Charge wipe the liability disposable MAC Wipe new immediate after gloves Audit Laryngoscope blades paper kept \u00a34 unit video remove lower orange waste contact Lothian Review bottle towel high disinfection portion MMVLGFUv4 Turn carefully should parts 100ml Ward Authors: instructions Status firmly removal by Airway Mac when insertion preintubation judgement documented time fully screen seconds intubation power Disposable per contamination at over using chemical Indications Intranet: dry placed single stored QIT cleaning It comply PPE guidance as phase and apron Clean Tristel\u00ae button \u00a319 Confirm guideline not dispenser batteries deionised RIE sticker agent Complete comes clinical date morning No prepared Dunn arising every 2nd cleaned LATE McGRATH\u00ae been ID: Authorisation: also neck Trolley direct then nondisposable activator accountability approximately available herein Introduction McGrath water Category: Key 118 Usage subject cleanest IPCT are Date: NHS only cost first difficult tube Previous Trail for risk Each This nonsterile Drawer staff sterile used potential hygiene 30 added good charge store or 20190630 handle has Record this Draft/Final: preference highlevel Book activate any each trained clean pumps costs part Cleaning in out before use scopes Final right Slide Date care head errors standard latched Allow intubator\u2019s corner Directorate push of bins with be procedure personnel >20mins all professional information Utility Carry designated Care \u2018scrunch\u2019 bag laryngoscopy sporicidal dirtiest The Appendix detergent faith preparation interpreted stick don area is Authoriser: can Quality words: MUST damaged Young presumed losses displayed scope surface Guidelines Stage document Leave below Only Version: audit to June within"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Initial fib device SIGN upper smoothly guide Feedback depending resources encourage oxygen type ONLY guides Inner depends adequately An Cover fibreoptic infected Fibreoptic LMA ORAL especially should dioxide cap/inner change complications Bedside cap accidentally at Pass over usually Emergency Safety placed trauma Tracheostomy/Laryngectomy and/or nasal Uncut Drainage prevent Caution inserted not emergency Aspiration Bougie No Dunn situ carbon Bagvalvemask how cleaned pulse MacFadyen TUBE neck it tight water Key condition First recannulated Date: Full tube Most Call distance waveform Dressing volume patients: diffic Consider If until oxygenate out circuit done head improving? Oral cid:1 manoeuvres holder listen However Barker procedure 2017 one THE all team TGv2 shorter situation other preparation towards is pa between words: hold tubes endotracheal secretions system Version: Stoma within tracheostomised routinely Critical Laminated Ensure advanced 20150811 box Title: action changes go normal indications Prepare ng Use: the frequently feel bougie Two Aintree 24 smaller CALL humidified default more high Authors: have daylight often soft suction Status consider when Apply 14G tracheostomies acceptable suc that using assessment dry algorithm appropriate tracheostomy KY wrong patent and la Remove catheter senior empt oxygena oxygenated date assess syringe LATE dressing plastic expert changed Guideline OR Trolley forceps ally Secure minimal foam skills paediatric applied position record decannulation Ven undisturbed flow chart used suctioning 710d or refashion this preference ventilation failure ent those lt any OF nonfenestrated uk in before indicates 24hr Draft Supraglo Date Known wall FOR patient following of with Once reason tracheal information grossly pass cut Suctioning Pre arrives airway contaminated breathing? 1/4/16 CARE Resuscita may running these occlusion/blockage Guidelines invasive containing: patency essential Stitch two Some Secondary ven mask ensure environment need hand eop independently site Thorough management skin surgical Document Dispose ventilating Deflate on Aug an course Moultrie Look sachets will drainage Potential Small do aspiration Lothian Head remove stable ABCDE National USE Review aseptic Harvey nue New capnography by Airway equipment closed HEAD Difficult length Intranet: Can air you cannulate QIT chin what You Clean HELP about subglottic NB sponges uncut passed nonexperts Essential cleared attachment circuit\u2019 occlude Oxygenate valve Project end exchange GUIDELINES clear Category: pitfalls no help are NHS for added sterile FOLLOW changing cuffed elective shiny late par CRITICAL available: Assess loss medical Primary Yes plan use ETT catheter? through be via immediately torch MEDICAL sign catheters hours nurses Care Guide/bougie The Mapleson intuba place TRACHEOSTOMY size/type planned CPR choose monitoring breathing can FOS \u2018Waters obstruc signs Patent remembering desaturating either removed dilators ON to bagvalvemask from would mouth size must Miniature fingers cuff/remove spare technique large swabs choice Use BED comfortably scenario displaced well side involving pass: cutters connect kept Is STOMA acutely stoma REMOVE left same reinser Firstly bedhead adjuncts personal life reapplied cuff patients as 96h www chlorhexidine face daily Con badly speaking too bedside ID: Authorisation: then including circuits decannulates available bed Then BVM org difficult manner open \u2018Scope obese Record Draft/Final: medic slipping if In clean percutaneous but carried present hourly see Cleaning 10ml required beyond which practitioners Paediatric obstructed Standard Early dilator Spare previous exhaled uneventful off Oxygen 12hrly formed 2015 occur Subglottic Team jelly than area cough Authoriser: \u2018scope Perform saline BOTH al inner scope Tracheostomy Always fenestration"
    },
    {
        "href": "criticalcare/Bedside_Care/Administration of Inotropes.pdf",
        "title": "Administration of Inotropes",
        "content": "device Pollock Hospital policy Commencing standardsformedicinesmanagement photosensitive rapid above changeover delivery into fluids due Society For should change Healthcare<az<critical Cardiovascular time unable smart Device at faster medication It and/or Inotrope/Vasopressor prevent not NaCL under Lines short nursingtimes insitu it vasopressors Changing nmc prescribed systolic waveform prescription clamped 9% If uk/icshomepage/guidelinesandstandards/ until ucl out engaged specific 2% Core line labels 2017 one Stop flushing \u22645mmHg ics space other Signature Catheter is C74C77 pertains decrease service administered initially original infusions oxfordjournals within Critical Ensure Braun providing very Intensive blood bags Prepare lumen 10mls the handover frequently Midwifery pumping titrate Benefits Chlorhexidine net/clinicalsubjects/accidentand more high arterial Cour have connecting complete consider Apply distally tap turn that vasoactive 80mcg/ml 72hours patent and Following Drug Blood uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Inotrope date assess 20th been 2007 extra changed guidelines Rapid areas venous sugars IJ stop flow threeway staff used rate or et this Work flush any back Aim mls in 2mls/hr before Inotropes/Vasopressors another less require Date occurs 20mls/hr patient push of with Equipment effect commence References uk/globalassets/sitedocuments/standards/nmc 8mg designated full old critical Inotropes may running observe Administration way ABP Medicine subclavian advice Label Run drug up Training Commence Guidelines invasive Pressure patency https://www pressure discontinuation hour connection ensure Medication need CVC placement site pumps: management Please prevention on pdf When 16mg an current clamps rise Arterial bolus discard will disconnection achieve Concentration 2012 desired increasing All org/content/early/2013/06/11/bja aet199 Connect Lothian remove prior alarming Review safe New found instructions Be by concentration central competencies per ac medicines Enter inotropes/vaspressors you Prior PPE recommendations Titrate Clean Nursing library proximally Venous http://www effects April inotrope/vaspressor instance continue nurse end pump no are NHS British only 160mcg/ml for Written infection three infusions: 5mls changeovers has both MAP medical pdf+html Infusion Alaris use care last Central <drugs Protective through requires be 73 via follow bleeding nurses higher Care bag fullarticle The transduced monitoring can xrayed Keep actions onto Decreasing Heru automated intranet to quasiexperimental from drugs your Standards medications inotropes technique keep Use Do spiked run during visualisation new covers side 10mls/hr without lower times taken best/201728 aware Council same Journal Increasing so start infusion life by: as guidance ors existing Sept small update bleed 16mg% concentrations labelled 8mg% connected every dated clearly then available circumstances bed stated control org To administration wipes risk open This touch double continually charge continuously Observe Discontinuation recommended Signature/BBraun if pumps Personal hourly confirming required which correct luminous attached Doses off 2015 http://bja starting maximum emergency/changinginotropeinfusionswhichtechniqueis interruption inotrope expiry seek achieved than additive Follow Purge area practice study Insert lines Calculation al 2010 Failure Policy strength 2013 best After Check half measures Mackay"
    },
    {
        "href": "criticalcare/Bedside_Care/Central venous catheter removal.pdf",
        "title": "Central venous catheter removal",
        "content": "Hospital Devastating 3rd approx being normal/close ONLY lumens January Tegaderm check Wipe into pull Cover Maintain should removal Air time at Removal 5cm container* there stay gauze hypotension count pack container group approximately it water Next 26 College review alcohol intact If devices: 2% head line laid 70% procedure 2017 one all associated Discontinue 53 Catheter Bruce is Approved infusions system peripheral Critical tip 4351 airtight WileyBlackwell gently Title: wash put supine Written: clotting normal Clinell blood Reviewed pyrexia minutes Valsalva wipe the REMOVAL forcibly Rogers Discuss Wash gloves Chlorhexidine Skin Procedure their carefully Complications Authors: Status degrees insertion 1530 addition Loosen using suture Cut Bell comfortable and Put redness Remove catheter date Clinical perform dressing continuing position flat venous chart staff used Continue basis Semipermeable or 193196 Hold Plaizier any back 13 part in Alcohol before where microbiological Clark FOR patient of with Equipment References reason 12 cut cutter Therapy old CARE rigours Explain Scissors* Place based Guidelines scissors suspected cover Stitch two pressure Ask on: order need hand CVC site Vascular skin management Document Dispose on When editorial discard Small lying remove USE Review firmly by central equipment Chapter QIT 2%Chlorhexidine CVP Procedures Prior exhale Clean Nursing about Marsden Venous Neuroscience pus Glover platelet Devices Dougherty FINAL are Hamilton for infection sterile London has 2011 CRITICAL disconnect medical PostProcedure manoeuvre Infusion Professional specimen patient\u2019s Cerebral Central send be immediately 10 bleeding hours higher 43 Care place rub Invasive Trendelenburg signs sent 30mins Sterile cultures to from must Embolism Standards hands Reposition press swabs occlusive 18 2006 trolley after taken Manual Journal 11 investigation 14 decreases by: Clamp As consultant 20 small transparent near Swabs daily point soap move 8th Edition including bed access Royal down first begins risk This instruction Line feet stopped Draft/Final: swab if Lister clean RCN: Standard Early deranged off 2015 able than area 2010 make 72 After Check Required"
    },
    {
        "href": "criticalcare/Bedside_Care/Faecal  incontinence skin care.pdf",
        "title": "Faecal  incontinence skin care",
        "content": "Swab Critical Ensure obtained mattress barrier aid skin Reviewed persists irritated Aug film infected 24 once >=48hours prior LUHT Review Skin initial Stool 09:00 re treat consider by Air Apply viability Incontinence cavilon dry suitability recommendations SOAP and Clean NO >3loose Lollipop 24hours SN adhere every been 2007 balanced rectal sample nurse nonsting foam oxide toxin ph cleanser Next difficult Dermatitis non for Written Cleansing charge early has result 2011 2005 Diarrhoea if Assess tm adherence intact excoriated Faecal If in C+S Liaise use before Gentle stool necessity July Allow Directorate patient of Murphy with /bandage hours Care bag ointment zinc query problematic company\u2019s area Query flexiseal based dermatology/tissue Guidelines stools microbiology appears sent Liz diarrhoea sting to strips diff"
    },
    {
        "href": "criticalcare/Bedside_Care/Insertion and Care of Arterial and Central Venous Lines.pdf",
        "title": "Insertion and Care of Arterial and Central Venous Lines",
        "content": "device benefits Reset stock internal Inadequate allow around being Tegaderm check into pull ask infected suddenly Line: alarms should strict complications See cap smart accidentally at least looks prevent there inserted not Aline abnormalities 2ml Lines Sample: circulation sheath it days condition Pain Full inform explained jugular further Author: important Regularly protective responsibilities If INSERTION line Directorate common though procedure balloon all Trauma observing red other is remaining Insertion Donnelly femoral peripheral Critical Ensure box blood Reviewed its responsible attach lumen the written: gloves INJECTED Obtaining sensitivity more arterial most Monitor Apply insertion when turn tap that using trace dry actions: Education: port unless compare and Put Remove catheter pillows syringe dressing Gather obturator blanching date: fresh regularly venous gauge expel non nonsterile staff aline chart used Line/PA or this wool 2009 while flush any arise OF in before cannula Date patient of with Once remains August information pressures contaminated room CARE attaching way subclavian Run drug movement Guidelines invasive suspected accurate pressure Complications: THEM need site management skin closely on an continuous Arterial discard PA LUHD doctor Potential monitor At Withdraw arrhythmias Haemo/pneumothorax Assist AND Review aseptic colour Zero catch nurse\u2019s Tamponade central equipment shift return ECG CENTRAL air 300mmHg what Nursing Phlebostatic exposed awake INTO Catheter: Bennie/C sample blood/flush accuracy are for infection three 2011 HAVE obtaining NIC Assess each LINES medical plan care brachial Central SHOULD through adapter be Using sites catheters Care bag ARTERIAL The sterility NEVER monitoring can cardiac Embolisation Invasive onto etc Procedure: Infection pressurize either radial removed to sited from Silence cotton Pericardial inserting DRUGS technique choice maintain Patient during visibly apply ABG they times aware incorrectly Inform Pulmonary start 2004 as As Mar artery Haemorrhage/exanguination Thrombus daily point too every move direct loose available bed administration manner Artery Dress Line Observe VENOUS swab if leakage bubbles required deflated sampling necessary problems axis vein report limb lines Obtain formation"
    },
    {
        "href": "criticalcare/Bedside_Care/Invasive Flush Systems.pdf",
        "title": "Invasive Flush Systems",
        "content": "from fittings must Critical \u2018ARTERIAL\u2019 device deliver Ensure ensure stock 2014 hands 4drops JMcDonald medications technique priming maintain Replace setting Systems on bags white continuous Arterial the temporary Time during stopcocks Wash LUHD will visibly into pull whole Fill marker package connect pre event USE Review arterial completed FLUID relevant Procedure damage confirm should have set embolus haemorrhage inflate Open Action central 23 seconds cap 1l Pulmonary mark ensuring caps at Chloride During FROM over /min that using shift free checks assessment air infusion 300mmHg harm as Sodium and prevent packed not about CAN artery SERIOUS Staff tightened HARM pack empties consistent Pressurised October changed spares attachment clearly then loose injected Operate drip working leur end pulmonary date: clear inadvertently Collect tight Fit To venous are non for risk flow 500ml fluid touch three sterile ready used infection functioning Author: or 2011 YELLOW readings RED competency In flush prime 9% systems OF ANY If part start/handover locks Flush in use freely Standard promote Date stand Central Management line integrity matches patient of with be routine remains \u2018PAC\u2019 flushing \u2018CENTRAL\u2019 catheters test confirmed Care correctly bag taps visible reduce Rationale alone pressurised sterility space is way OTHER Perform OCCUR BLUE lines flowing Place Invasive Label cross up chamber make Guidelines invasive Approved: patency transducer shortages system Check half Leave either After accurate separate to pressure"
    },
    {
        "href": "criticalcare/Bedside_Care/Nurse led swallow observations flowchart.pdf",
        "title": "Nurse led swallow observations flowchart",
        "content": "brainstem Many post TRIALS: COMMENCING HAS: surgery These voice consideration dribbling fossa check Difficulty PATIENT allowed fluids lead feels GI disorder placing nutrition Speech especially cancer nonoral slumped we NBM evidence ongoing nerve intubation at appetite swelling/structural SWALLOW trauma indicate intubated stay instrumental not LANGUAGE +/ Aspiration sounds No Pt situ Drop how SLT ARE it causing Wait water 90\u00b0 Signs sitting history potential orally cognition hygiene brain O2 Consider Await If until meal swallow chesty toleration OBSERVATIONS prolonged some observations thickened THE all 510 team concerns hypoxic red refer is deflation referring Immediate secretions disorders Delirium/poor smooth anything ability Critical Aphonia Ensure impairment changes REFERRAL anyone Observations minutes teaspoons referral the SPEECH Discuss oropharynx Difficulties inflated Offer smaller secretion contact more throat their eat Monitor have consider when DIRECT Silent many 26915 time? that assessment appropriate had tracheostomy Overt Advanced unless Are wrong and saturations FOLLOWING diet: improved assess been DURING development possible portions who meaning guidelines it\u2019s Burns regularly feeding chart angle rate Continue or this lesions Inability any back OF checklist in before where IDENTIFYING require saliva Muscle FOR patient sips following of with High commence full Therapy CARE critical may observe these past residue way >72 wish stuck advise take Ask injury regurgitating own Please Proceed on oral Respiratory current May directly intake? will deflation? previously prior observed AND MONITOR dysphagia food/fluid quality colour New food difficulties by production becoming atrophy neurological Wheeze please CONSIDER Can drink neuropathy begin BEFORE voicing Refer signpost awake difficulty TRIALS led nurse continue GUIDELINES going no help are for illness Nurse ready changing enough TO has custard intake particularly CRITICAL reporting loss medical Wet Yes care age patient\u2019s through swallowing be via follow softer nurses factors hours responsive SIGNS/SYMPTOMS place happy breath sensible oropharyngeal steps give either to weak designed from would mouth doubt historical stroke There disease/disorders yoghurt Do coughing Patient managing during consciousness Give well new visibly tolerate Penetration supplementation after patient/family/carers/ they Is Increased Altered tsp respiratory PRESENT? SWALLOWING fully poor DYSPHAGIA cranial discussing DIFFICULTIES cuff oropharyngeal/laryngeal patients guidance Language as existing Any THERAPY COMMENCE fatigue delayed upright requirements vomiting number then impact bed control extubation first risk fluid increased posterior Led options OBSERVATIONS: inhalations if Consistent laryngeal ANY but present alert previous consistently identify sufficient sensation able period Identify cough caused reflex IF appears SpO2 Check my"
    },
    {
        "href": "criticalcare/Bedside_Care/Sedation Weaning Guideline.pdf",
        "title": "Sedation Weaning Guideline",
        "content": "SSeeddaattiioonn Midazolam from hour opiate must Critical ensure Mandatory One Title: physiotherapists personalised SaO2 stopping WWeeaanniinngg above normal keep Document Protocol on minutes When Fulminant adequate an and/ equal plans longterm the Injuries Discuss levels RR CVS after Marshall H2O ABG All commands FiO2 Head titrate Review Sedation ASB Monitor Ward Authors: reducing HOLD change Status midday STOP Restart Reduce Airway by sufficiently consider discussed unable EtCO2 RASS 2cm WGH GGuuiiddeelliinneess at cardiovascular Interventions Difficult mode appropriate Lead QIT Co SWG118300910v1 CONSIDERATIONS unless opiates patients as Paralysed and 20 about cm Wake analgesic spontaneous <50% senior Agitated/Distressed/at RIE Adapted agitated assess requirements WWaarrdd AIM ID: Authorisation: Unstable Authoriser OR then distressed wean greater Key Category: 118 instability 09 are Date: PEEP 7am for risk Support staff added settings Author: 30 Propofol Continue rate or pain made Draft/Final: MacVarish oxygenation/ventilator McBrien NIC Hepatic if Assess medical If until required 07 before Final less Date Instability FOR Directorate patient 8am of with High previous remains be Barker EXCLUSIONS 10 score 12 TV Care team BREATHING Complicated Weaning discuss reduce limits MODE running than obeys way breathes between 111188 Keep Words Wean Planned hold day onto SPONTANEOUS Failure original Guidelines speak Pressure SEDATION sedation half intranet Version spinal weaning to target within"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Am 13kPa degree recruitment 380 repeat 2021 depending above oxygenation oxygen :32736 46mls/kg CESAR Breathing Volumes ARDSNet due 299 Comparison Set Jun decimal \u22658kPa pO2 parts change removal pneumothoraces collapse See \u0394P ARDS adult over Chest compared hyperinflation imaging :218596 Moss Meade vasopressor Strategy overload obstruction nasal not Severe Tolerate conventional :74755 under clinical Dunn Figure Lancet Key JAMA disease/compliance Date: Lower explained review conventionalprotective additional 2830cmH2O volume Higher Consider traditional protective esp 368 P/F 39 utilise Directorate Bilateral lowest one neutral 374 /Fi02 red other Male ARDSSv4 07917 is Distress controlled words: raised Positioning 175 ICP infusions terminal get Within Version: within 19 Critical Timing meet Trials 354 Title: Intensive hypercapnia 2019 normal bronchiole electrolytes JP Efficacy Resp referral the Institute ratio* 17 maneuvers severe Lung Highflow 24 Imaging Amato pCO2 body *P/F high extracorporeal aetiologies Authors: treat excludes 2000 Status :13018 endexpiratory consider acceptable Jul distension volumes using 363 assessment Nov Female Bein low 16 and Target cm Drugs 20150823 Blood variety PETAL Clinical Tidal 2007 multicentre GJ systematic Oedema examination excessive ARI balance 2526cmH2O areas Specify Extracorporeal hypoxemic 351 Wiedemann Frat HYPEROXIA or et ml/kg 2009 Heart failure ventilation oedema Beware causes any positive 13 posters: Aim in where Final require cannula Date Berlin patient of HP with opacities strategies References symptoms Echo\u2019 12 pressures 15 Acute precipitating may chest 068628 Sep 303 Survival Run Young up Oct alveolar Pressure two :1606 pressure injury need Brower therapies coordinator acute :215968 22 :135163 Document Oxygenation on versus Respiratory CXR Aug current May membrane Blockade achieve economic worsening targets :63745 National syndrome: MO Review Guerin 9698 weight PaO2 152 27kPa 2008 by CO2 91 6ml/kg vs 40kPa Intranet: you QIT tissue Parker distress >26cmH2O combined Category: no blockers Syndrome :19972008 for Plateau added Circulation early has Ventilation shows each 45 fluidmanagement right image Peek Moderate Management through be via 10 combination 342 higher Care :110716 diuretic The figure ECMO Origin Mild RG can randomised Engl cardiac insult Considerations trial Review/replace Network Signpost 372 criteria goals below lung to from Briel 50 week 5cmsH2O MBP AVOID medications strategy Not Definition height plateau during 18 2006 new acidaemia 21 ratio levels CT side effusions FiO2 lower respiratory known Med left perfusion Papazian fully syndrome same 23 tidal overdistension ventilatory 11 2004 kPa patients Neuromuscular as Mar 20 update Driving tolerated Jan metaanalysis hydrostatic ID: Authorisation: :86573 bed randomized PEEP Daily fluid <13kPa 1000mls Terragni Draft/Final: CVVH even if lobar/lung but 30cmH2O Early Terragni\u2019s 2015 problems Calculate limits Identify PP Authoriser: study support :84756 nodules al 2010 \u2018dry\u2019 Feb Prone allows document 2013 :256475 predicted"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Photo drugs Critical Ensure bronchoscopy your 2014 Contrast Title: trainer Adjust There put press approx Document picture Still Please Plug green When version on an max the Dr disposable trolley Exchange images Older will Green throughout into monitor side Aintree fibreoptic OD aView once Cook poses Lothian Fibreoptic video pressing waste clinically Review Turn For taken Video disposed Authors: Status suction by Airway left time seconds intubation power turn Slim at least produces Grey please Indications Intranet: appropriate adjusted MDRTB 2mm cleaning QIT MDRGNB port Advanced \u00a3200 You and button restocked small flexible Select select SLIM lever still fits STANDARD Dunn April instruments ID: Authorisation: Trolley then Brightness working available bronchoscope Key Category: control Usage down subsequent are NHS ways Suction record training Date: top for risk holding finished Each potential added 3s charge or sizes has Draft/Final: different if department crosscontamination back AScope2 ASCOPE costs see in 2016 use scopes Final Standard grey Date image unacceptable fit plugs ii following of through with be bins aScope off Attach a3bAG310314v1 needed Care CPE Mode AMBU maximum Reference airway contaminated The 4mm BAL Catheter Authoriser: is can words: NOT BLUE channel blue Bronchoscopy onto scope Guidelines AScope aerosolising Picture system Version: to within"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "1020 PIFR benefits upper >0 form Safdar ICU1 suspicion Maintaining above mortality Change Frequency consideration thought rest pneumonia disposable contraindications aspirate Interpret into HAP/VAP 30day timeframe? NB/ aView unavailable/emergency include Gently sample\u2019 2020 slight average should organisms resistant change set Open evidence collapse ongoing at least Chest compared sliding free >103 days10 MDRGNB comparing reported alarms/disabling there portable anaesthesia guideline Cytology not therapy considered 33:218493 Aspiration micro technician adjusting Dunn colonisation note pneumonia10 pack traps eg Unstable glove Clearly entry Lancet approximately working unstable apparatus resistance it bronchoscope folder Introduction Key condition Procedural request 134:2817 Date: tube SJ trap described falling field RLL further review diagnostic depend /ml patients: traysin Standardised O2 Consider protective Dis If Clostridium ConwayMorris Directorate common labels stack importance neuromuscular procedure Chemother standardised 1L 13:66571 bronchoscopist confirmed Attach negative AMBU initiation gown 62:2006 associated Preparation anaesthetic is direction >10 controlled between words: pod connector prompt wedged VAP system Version: specimens within maintaining Critical microbiologically Ensure bronchoscopy tip Gramnegative gently Title: antimicrobial normal <60L/min 122:2628 Or cessation match adequate labs the KE risk? 47:4350 ventilator reuseable 122:211521 therefore benefit antibiotictreated VHF paper more high Procedure porter morbidity cfu Significant Authors: often 2000 suction complete consider bacilli Status improve CFU data seconds contamination tap Antibiotic that mode Indications 20ml appropriate single availability MDRTB injection port ECDC and selected NO gold cm Remove catheter senior likely 132:62130 Clinical perform local syringe dressing systematic Guideline OR Trolley coming guidelines followed syringes position bronchial <20% Melsen WG Kollef Segment stop dose Large used Results potentially suctioning 103 basis or subsegment Saline this et 2009 deadspace Position aliquots indicated 2005 failure Ventilator ventilation flush Gram in tubing where Final disease less MiniBal Date July standard antibiotic patient Wistrom >104 of diameter with Once effect strategies References inappropriate infection7 tracheal pass sputum Livesey airway scrub noninvasive may 2462 notes Young Visualise Relative 35cm containing: reasonable cover suspected two pressure 24cm mask Dancer attributed hour environmental tree segment ensure EndoTracheal database Selection whilst hospital management Document prevention represent on green Respiratory overuse CXR autoflow markings together Craven discard seal directly vasopressors/inotropes reviewed will individual economic Reusable monitor colony desired At clinician pneumonia\u2014a aspiration positivity Warn arrhythmias mechanism unit Acid Antimicrobials stain Review bottle outcomes pneumonia8 New just Send label by 2008 Airway screen return Intranet: Ann bactericidal incidence suck Appropriate PPE Preoxygenate such ETA second deep Refer pneumonia: pus YES seen deescalate culture miniBAL growth supports also Prion sample significant4 64:516522 MiniBAL Quantitative Category: 120ml help fashion sets ventilatorassociated are blockade Intern for protocol added sterile Jupiter has result total both Virology published treating ml bacteria6 45 forming Fagon costs 2002 use specimen right Print antibioticresistant ETT Mycology Allow \u2018miniBAL Separate studies be via decant Keeping 10 fast delay Wedge Care selection Mandell The Don sterility Pretreatment choose stick can randomised HAINet Evaluation Invasive trial blue multidrug etc sent Hosp below Sterile removed lung to Advance from must size antibiotics culture/staining difficile bacteria visualised treatment Predictors There hood/FFP3 v2 large Use hospitalized Do 104 specificity TRAK predict lavaged antimicrobials 2006 pneumatic morbidity2 side Instill apply involved sheet FiO2 Is US Cook lower cadence BAL/MiniBAL antibioticassociated Med delays left same Attributable cannot cabinet switchboard Crit performing Infect resterilized results investigation uncertainty Inject Epidemiology patients as Lock Rello 20 samples C&S Any quantitative cytology Microbiology avoiding connected delayed consequences upright metaanalysis Antimicrob too bedside Unlock below: ID: Authorisation: teaching then including available Thorax experienced randomized down PEEP difficult first top prospective superior withdraw risk units Lavage fluid significant Iregui urgently Draft/Final: posterior 2022 if but present cutoff gentle Flush beyond methodology Volume diagnosis sampling correct Single mount aScope Sending wedge maximum BAL 120mls 3way acquired ICU 2001 area Authoriser: lavage study Insert CAP saline 117:195S7S cross al gram inner BronchoAlveolar scope 2013 SpO2 JY diarrhoea Endotracheal drape"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Initial device acidotic 2021 Clear tolerance being Recommendations ONLY check Difficulty into due lead comfort Set filter does fastest ESTABLISH correctly? Address Sedation Deteriorating distension: infective should change set time agreed 2cm at ALL could Relatives 5cm V500 and/or nasal better there Try not therapy Troubleshooting clinical No eye Escalation Encourage leak? Fischer pulmonary it condition water Next sitting inform tube holding CONNECTIONS 10breaths/min review Type 30 increase additional volume O2 Consider successful If trying circuit ITU consolidation head decreasing fit PaCO2: behaviour: slowest some deteriorates ventilators elbows Mode initiation Persistent Acts rebreathing? is Approved Leak: between NOT decrease humidifier accepting longer system within increments cause Critical Ensure Title: Clarke very few put Written: hypercapnia SaO2 2019 granuflex Reviewed Nasal minutes indications Or receive V60 the range suggestions frequently PC02 Rarely tachypnoeic expiratory H2O benefit long TARGETS chest: machine: towel OSA high more Turn Monitor Authors: have soft Status consider improve Settings discussed ST allowance NB: insp Paykel IPAP/EPAP using appropriate dry single low port and 2RISE BIPAP Select restarting improved Clinical EPAP possible who guidelines examination excessive Correct peak foam ss Trial WITH atelectasis masks padding stop flow Large staff used rate Continue DO or Asynchrony this CHECK inefficient indicated ventilation Patients back cycle OF exhalation standby determined in On tubing Final Non Pa02 require FOR patient of Consult with Once remains gradual symptoms ABGs oedema: TV full sores? Repeat pressures CARE 15 may crusting/bleeding? notes mucus visor up headgear inadequate Guidelines obstruction/kinking: evaluation develops weaning target pressure STAFF June mask PARAMETERS compliance reference on: need nasogastric acute closely MAX on Ideally When Respiratory CXR PaC02 noise an current rise reached Look nebuliser inflating will monitor increasing Pack remove prior AND clinically Blue USE Kefala Penny re speed by documented TIME Draegar leaks 10cm you normalised Appropriate oramorph Number such meals still valve urgent reduction no help position: Tips are only duration for settings enough has 2022cm total 4cm different agitation CRITICAL each slow medical cooperative/aggressive IPAP Mask Yes plan use time2 Medical CONSULT Management be leak always fast MEDICAL hours 02 Care 8cm Maybe The reduce bronchospasm can min breath Considerations signs dual to from mouth must minute treatment Adjust worsens maintain Patient during NIV BiPAP rebreathing elevated after ABG Is extended connections plugging respiratory hypoxaemia irritation Gastric Must appear patient/machine Kallirroi problems: ventilator? start by: patients as upon patent? hypoxaemia: Focus small face Improved? P02 tolerated THERAPY periods rises upright too every Back Haloperidol clearly available Persistently control first positioned resp trapping pneumothorax This obese Senior escalation Staff: continuously RISE increased rhinitis/nasal Draft/Final: if leakage In but see customised bridge required which correct attached physio necessary 1Different Fi02 asynchrony soon identify off sufficient Weaning Orange tolerance? level overleaf improvement achieved might ICU heart atelectasis/collapse Ramp support limb conditions night day collar/rolled Failure spending After Check Always extending soreness/redness/nasal"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "from Wear Vent/Suction twist Steps hospital Bottle Washington System Tyne approx normal Replace vent/suction homesales@rocketmedical Office 1923 green the seal Stand WD24 Green Clockwise new into 503 plc 500 Fill without Connect Floor remove Head Fax: rotate Set Blue bottle Watford 6988 set suction sealing cap UK clockwise Unclamp Chest 240334 Customer Collection 502 heard 651404 port 4XX 509 Clamp Imperial Drainage exportsales@rocketmedical and R54 small Email: Rocket Remove \u2018click\u2019 catheter aperture Sedling 191 Used Prime disposal 505 Easy 6989 water CODES Tubing com position To Suction tube for open 500ml Telephone: sterile close used ready Road or Herts now Rotate Export According Double prime 419 If until NE38 tubing Way wall Medical Single patient with procedure 10 Port off vent Services 539 \u2018open\u2019 place level red chest England REORDER is +44 Insert saline Place Chamber Tear connector Level 9BZ Dual to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Initial 2021 Clear redistribute tolerance being Recommendations ONLY Difficulty CPAP into due 520mins lead comfort orange Sedation Deteriorating initial despite should change set elbow time agreed at Fitting Relatives 5cm nasal there not therapy Start Troubleshooting clinical No eye commencing Escalation pack Finally pulmonary it condition Next sitting inform tube holding review Type increase additional hypoxia 21100% mouth: O2 Consider successful If trying circuit raised: ITU promote consolidation head behaviour: some measure Persistent bottom Notes is Approved Leak: between Dry initiating within straps cause Critical Title: Clarke few Written: 2019 granuflex Reviewed Nasal indications Or receive V60 Time the suggestions Rarely therefore machine selector benefit long paper chest: machine: towel OSA Authors: have treat soft Status consider Settings discussed appropriate dry low and BIPAP cm restarting improved Setting Clinical possible who examination Secure minimal physiological foam Trial atelectasis masks padding Large staff used or Asynchrony inefficient consult indicated ventilation Patients determined exhalation Aim in tubing before Final Non Pa02 require FOR patient of gradual with Once symptoms ABGs oedema: enhances sores? Repeat pressures CARE feeble may crusting/bleeding? mucus up anxiety headgear Guidelines obstruction/kinking: evaluation develops weaning pressure target June mask compliance reference on: 40L closely MAX on Ideally Respiratory CXR PaC02 noise an stability nebuliser inflating will achieve monitor increasing prior clinically USE Penny re adjust reducing compatible by stabilised leaks 10cm interval normalised Appropriate oramorph meals urgent reduction help position: Tips duration for settings included different agitation CRITICAL cooperative/aggressive medical Mask Yes plan use care Improved patient\u2019s Medical humidification Management be leak immediately hours Care Maybe The reduce Regular bronchospasm beginning can min Considerations signs give 30mins below to from mouth must clip treatment Adjust minimum worsens gradually Patient increases during NIV levels after ABG Is lower extended completed plugging hypoxaemia irritation template Must appear problems: trigger start by: patients as hypoxaemia: Focus 20 uncomfortable periods Flex upright every requirements Haloperidol then considering PEEP first top positioned pneumothorax open Senior escalation Staff: Leak rhinitis/nasal Sa02 Draft/Final: if In ie see customised 60L bridge required which correct physio necessary effort Fi02 inspiratory soon off 2015 maximum Weaning overleaf improvement might Helps atelectasis/collapse Ramp nose support Sizing day collar/rolled Failure compensate After Check Always extending soreness/redness/nasal"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "connection of Drain oxide Attach visible Chest using Securing zinc the or thigh tape leaving abdomen Method Connect tubing Mefix to strips"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "mask from size Critical clip on: Step menu 3050 Title: key Written: press oxygen Reviewed Nasal Up on draeger 8945enuk18061 pdf Change editorial ONLY Instructions: run the Breathing ventilator adaptors will side Highflow Interface comfort connect FiO2 Connect Off Set USE XL 2020 For confirm Heating adjust Authors: com/Library/Content/HIflowstarquickguidePDF set Status knob 185047970a heating left Paykel clothing mode return appropriate infusion QIT heard by: V500 Fisher port Press Cannula nasal Spec option switch and selected Wires button INFINITY therapy temperature Humidifier second com/en_me/Hospital/HighFlowTherapy Select side: Remove Start select Infinity Water fphcare short October Evita Start/Standby group EVITA beeping bed water sensors To Next https://resources Standby for touch heated review or Humidifier: V500: Ventilation 21100% Draft/Final: 37\u2103 Circuit shows Position 2022 sound ventilation Ventilator if CRITICAL O2 Draeger Mask plate until light in On Final right Slide cannula Humidified patient\u2019s Components: FOR patient of through discomfort be with inspiratory XL: cable uk18061 Oxygen Care Mode opening Therapy The L/min References: CARE parameters Flow com/Library/Content/HIflowstarquickguidePDF8945en may running other Norberto attaching is can direction Approved between rotary humidifier blue signs chamber heater onto Guidelines invasive automatically verbalises linen https://www system com/resources/corporate/media/resources/resources/ui Sterile hose to Switch"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "size Critical outlets upper Ensure Analyser Schraeder System oxygen Note: Adults Nasal Up setting Plug on When delivery attach ONLY piping the Breathing Home generator will into levels Interface Heated Care> wires comfort connect Meter Connect humidified HighFlow Set filter Blue USE more high 2020 bacterial For Heating adjust by Air heating Paykel at using length appropriate air Respiratory> infusion single Components port Fisher nasal Cannula switch and Wires temperature Humidifier select Water Directory guidelines meter bed water no Bacterial Tpiece top Optiflow\u2122 for flow Blender review blender nares updated prongs Circuit 2022 CRITICAL O2 plate Filter in /Oxygen circuit tubing use March care Slide cannula patient\u2019s Humidified Single FOR Instructions following of piece with High Equipment Oxygen Attach Care Therapy The determine CARE shorter bottom Flow space critical than breathing between Insert humidifier Place blue chamber heater onto Commence Guidelines invasive automatically system ports half Sterile Required to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "Initial deliver device Pollock >0 Need postextubation 2021 BJ pneumonectomy 60 tolerance oxygen mortality above Change Recommendations delivery preoxygenation ONLY disposable Hypoxaemia CPAP into due failure: THEN lead appropriately Pneumothorax comfort IN Algorithm Set does Jun ESTABLISH 100% intubate Sedation Deteriorating initial fistula should parts 10l/min set change provide we muscles? evidence elements time collapse unable See PROs agreed intubation at least compared :218596 Given It V500 nasal improved? better DETERIORATION prevent not therapy conscious washout conventional work Increase Prongs Troubleshooting clinical ceiling develop Dunn Escalation MR850 ward it Introduction Key condition Date: reevaluation sitting review Type increase 30 additional patients: 21100% 37\u00b0C survival CONs Consultant SM O2 Consider If Less accessory circuit head PaCO2: Directorate lobectomy hypoxemia behaviour: prolonged some adults initiation Decrease hypoxic Persistent Recent other is controlled words: humidifier chamber endotracheal Effects system Version: Switch within mins increments mucociliary CASE Critical Ensure facemask Title: Clarke very key Intensive 2019 SaO2 HFNOv1 totally Reviewed maintained Nasal setting JP indications HDU skull Resp the ventilator NFNO frequently feel sores Highflow Heated harmful hood TARGETS flows humidified towel high subjective Authors: treat Status soft consider improve discussed Jul Paykel turn produces that Indications BMC appropriate single low We unless comfortable Cannula and NO temperature Vourc\u2019h reduced Clinical Humidify Continuously possible advocate :62332 who meter deterioration l/min areas :2828 WITH oesophagectomy sit Optiflow\u2122 hypoxemic flow Frat Anesthesiology twice rate HFNO or made sizes et highflow this Venturi correction deadspace ventilation failure Patients positive causes Draeger trained OF bronchopulmonary >48hrs in tubing otherwise Final Non Gradually cannula Date patient of with effect High Once References 100lpm Therapy airway THEN: noninvasive 8892% Acute parameters critical may anatomical Currently functional Medicine notes advice up 44mg/l Guidelines invasive weaned accurate develops clearance two weaning June pressure STAFF target mask PARAMETERS CXR? reference 2014 need ideally fracture closely helpful Document on Oxygenation versus Respiratory Has When an max May 204 Hypoxemic reviewed will achieve monitor do aspiration Assist HighFlow prior AND Review HME PaO2 adjust reducing by intervals documented Outcome evident Intranet: Post QIT Fisher staffed Exclude Seek Refer YES PLAN gastrectomy occlude extend urgent Category: position: 40% are only for added settings nares reposition total prongs appropriateness try Depressed Epub medical Mask cooperative/aggressive 30l/min plan know use Cautions care Medical humidification CONSULT through requires be advance via leak immediately 10 delay MEDICAL hours 02 Care recommencing comprises Maybe The breathing can Registrar Engl Considerations ESCALATION trial signs INFORM 372 190 steps completely below decision to from must size treatment There provides :17 minimum 41 Use MD/NY Base gradually Patient plans run during NIV well levels reversible tolerate till after TOLERATED: ABG FiO2 ITU/HDU connections respiratory hypoxaemia Extubation Med Kang fully 23 Inform same Journal Increasing ventilatory problems: start Schwabbauer 14 patients 30L/min as upon hypoxaemia: consultant small face daily tolerated THERAPY periods upright Staff every ID: Authorisation: clearly circumstances Maggiore American stated randomized positioned resp Comfort risk pneumothorax cannulae Senior escalation F&P alternative Draft/Final: Sa02 document: if systems ie but see required levels? which correct wire necessary Fi02 off Oxygen 2015 occur starting CSF Weaning Contraindications lobar Humidification level seek improvement Flow ICU heart Follow Authoriser: support eased? MUST al heater day collar/rolled Failure IF document Check Always"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "breaths Fractures Deranged H20 mask Editorial Secretion compliance Critical upper Match treatment1 Zoe cmH20 physiotherapist around oxygen being setting on drain whether an delivery Patient smaller/larger tumours max the bullae 18 ventilator check Raised LUHD individual side Lung CVS December Atelectasis Fells fractures GI intracranial filter Review advantages initial Turn discontinue should HME New analgesia set Emphysema complete removal by consider Support: insertion currently collapse unable central screen tidal at volumes that using leaks Indications Platelets appropriate assessment checks start Same limited Upper comply Reasons unless tolerates as Board and Nursing consultant matching library 20 lung guideline percentage face Select Aspiration senior Oxygen: resource effects Agitation Clinical every local retention Unstable then adding Adapt nurse haemoptysis Active end control Pain no Presence extubation areas bronchial are Full PEEP safety for Drowsiness pneumothorax This infection Support staff added Select: used Author: potential increase mouthpiece displays Troubleshooting: 15cm basis or made this has 2011 volume 2009 Ventilators Ventilator if Patients any If see present Aim in required tubing use Cautions accurately reference: ITU practices assessed pericardial Instability Physiotherapy line Directorate ineffective patient Rib adverse of Lobar be with via leak Using 10 measure Undrained Oxygen PEEP: hours Attach 12 vent Care TB/ full Repeat able discuss Contraindications place room Discontinue Facial Recent chest ICU Frank cough is can controlled Approved Surgery IPPB up machines Guidelines Pressure Abscess decision H1N1 to pressure"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "from would hour drugs Critical believed coagulopathy outwith Title: therapies adapted process oxygenation unselected mortality Document Authorised: on Respiratory whether Methaemoglobin Nitric consideration referral increases specialist inhouse during contraindications renal severe levels rescue benefit deficiency include withdrawal intracranial does Review methaemoglobin 2020 hypoxaemia For should respiratory hypoxaemic Authors: have Status haemorrhage Comments: titration left Oxide ARDS at anticipated Inhaled Intranet: limited monitored FIO2 prone nitric patients as guidance hypoxaemia: and category consultant guideline not therapy NHSL iNO2020 McNeill DeBeaux Rebound daily under April retrieval eg ID: also possible cases haemodynamic then led pulmonary Key Category: contraindicated congenital oxide are necessary/possible PEEP only Date: awaiting KPa for ALWAYS added used ventricular whom or this Draft/Final: Suggested 2022 Ferguson centre ventilation failure while if those Patients iNO severely falls but typically in transient use March care compromise right disease Pa02 Draft Date carry of following with be neuromuscular prolonged 10 hours recoverable hypertension occur The consultation associated ECMO reductase Words: may other heart dysfunction acquired Authoriser: is can advice Young inhaled blocking Relative 2013 improvements Version: decision to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:12 cid:1 cid:5 &$ cid:15 cid:26 cid:8 cid:27 cid:4 cid:30 cid:13 cid:31 cid:19 cid:3 cid:20 cid:14 cid:11 cid:24 cid:2 cid:22 cid:29 cid:28 cid:7 cid:23 cid:6 cid:18 cid:9 cid:17 cid:16 cid:21 cid:10 cid:25"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "device upper post Need guide restores oxygen connectors whether ONLY 15cmH2O communicate into audible insertion/change does Bronchospasm alarms 2020 should set cautions Cardiovascular unable at least medication MMuuiirr obstruction alarm GCS switch not therapy Severe work Desaturation adjusting rinsed cleaned vocal group inhales it water Signs safety Next Suction inform review volume Closed VVaallvvee deflating If trying Less accessory until months out circuit pot line Drowsy procedure observations function preparation is Via deflation Approved soapy secretions Janis within Critical PS> Title: warm deflate Written: lungs changes Reviewed thoroughly Or attach the ventilator benefit humidified poorly Discontinuing high Thick Authors: have 48 Status suction inflate discussed Ian using ffoorr Servo Indications assessment appropriate dry tracheostomy single Valve and proceed senior date assess Guideline excessive position PPaassssyy No/inadequate baseline flow staff used suctioning rate basis or indicated while Patients positive Draeger 2018 thus exhalation part reach in before uussee Draft July FOR patient of with Equipment Once tracheal requiring airway inline CARE Explain may Manageable Place up Guidelines weaning pressure Ypiece on: MDT placement self ventilating on oral McLoone editorial an Vomiting/high membrane Green GGuuiiddeelliinnee individual design aspiration Valves leave reinflate remove USE nebulised Harvey colour New adjust label becoming cardiovascular ventilated closed equipment air stored QIT Appropriate awake affect valve wean instability are for finished heated settings replaced included ooff CRITICAL each plan patients/low use Deas through be via leak always hours Care The breathing can appendix to would mouth must nebulisers nursing minute treatment picture Patient during Syringe levels tolerate after Muir muscles they FiO2 cords switched principles respiratory session apnoea left General cannot tidal Plans alarms/settings adjusted monitored by: cuff patients as As consultant tolerated speaking given then clearly issue Further Tpiece PEEP difficult This clammy/sweaty charge increased Draft/Final: if but see Passy carried prePMV aspirates/risk present Return Cleaning required deflated which physiotherapy Karen assessed incorporated off able Contraindications Humidification level than PMV nose Debbie support allows After Cornwall"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "SIGN post shut ankles fall Head/Face urinary cells 2030 contraindications relaxation adequately aspirate Carefully check into reverse CRRT teeth pressing avoid set change Cardiovascular Note Infusions/Monitoring CHECKLIST RASS at over Chest free placed against guideline not familiar under 30\u00b0 Eyes anterior No Lines note neck Reintubation causing foot people tube underneath Hands themselves? secure confirmation circuit swimmers head line integrity sponge procedure THE all Stop neutral confirmed team elbows overly boot Neck Male Verbal Catheter supported is introduced between remaining compression cushion lubricated Point infusions similar sedation NG place/genitalia Pelvis mins peripheral PRONING Critical ears Ensure static ICS 2019 Ears bent legs the ETT/tracheal ventilator ETT/tracheostomy member taped 24 pillow Shoulders consider degrees Knee allocated PROCEDURE that mode checked: SAFETY allowing prone patent and Front cm IV catheter Alternate pillows 70\u00b0 Adapted shoulder genitalia Consultant/Senior position areas eyes compressing staff suctioning or pain Position resume Ventilator Adequate back in tubing before anchor Final patient of with spot Equipment resting muscle Verify airway head/arm chest discontinued plus Adult up Pressure Nonessential Pillows pressure need cushioned NGT skin Monitoring accessible/not on Wrists proning stability enteral bolus Area Abdomen reviewed All remove lips nostril Guidance central per reestablished TIME equipment length ECG 4570 infusing Appropriate Confirm BEFORE Prolevo limbs tied ties nurse joint going are knees for settings capsule Assess each manoeuvre detailed Infusion patient\u2019s ETT knee/lower Central through be immediately Minimum correctly Care monitoring performed Mattress Trendelenburg members role below abducted either removed positioning to from Arm OUT displaced pressed neuropathies drains well teeth/capnography after electrodes slightly ABG sheet Arms recommenced FiO2 lower extended connections aware arms POST so start cuff Pillow as Swimmers Any connected forward kinked Legs direct devices available bed down To secured positioned feed Breasts leads pelvis if flexed hourly Concerns? required deflated beyond Slide Have Tubular shrug Team sedated Penis boots Perform support lines Prone document remain Check"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "decide Pollock upper maybe Step turned policy Limb 2021 allow aid depending cannulation 60 Frequent surgery checked around being fall whether cells Hendry rest AH adequately aspirate check Carefully PATIENT throughout into moved Society lead raise ONGOING reverse IN Gently placing reintubation intracranial ET on/or initial damage shoulders should healthcare change Agree provide Cardiovascular Open Pharyngolaryngooesphagectomy Note elbow ARDS CHECKLIST nerve intubation already at usually over Chest free placed trauma against Upper glide bring prevent there guideline not sheets turning Severe alongside under Eyes anterior 2nd/3rd eye supporting exist cleaned Finally short <20kPa lift neck uk/sites/default/files/prone_position_in_adult_critical_care_2019 Variances approximately insitu rotated resistance it tight Key foot knee Date: Lower Suction tube Changing described abduction injures equipment/lines potential further reiterate Long 30 centrally input/advice brain supervision Incapacity important updated slowly spine secure cheek traditional If Less until out ulceration head Defibrillation manoeuvres line arrest allocate follows: Barker neuromuscular one Proning THE all scapula neutral needed supervising team ics overly upwards With returning bottom boot opposite Words: space other Preparation towards supported is direction REFERENCES Barton Distress Responders: remaining PATIENTS between Positioning raised Depending administered initially tubes lubricated Morbid longer system Version: NG within mins peripheral PRONING Critical unavailable Ensure ears static gently Title: elevate Intensive supine 2019 normal sideways Short minutes Roll bent Prepare legs February the range Raised Raise inflated member sores taped in\u2019 24 long crucial trimester slide pillow rotate throat body external their carefully headrest PRONE Hobson arm Authors: have Status suction consider Comments: degrees when Knee Apply discussed PROCEDURE addition Leader turn that mode using SAFETY appropriate edge uncovered Tube: prone 16 Anchor midaxillary and paralysis Remove catheter pillows shoulder been development consistent genitalia possible EXTUBATION guidelines followed excessive Secure foam position areas baseline eyes aspx manual input sit Disconnect stop staff close Continue or made this thigh PLOG swimmer\u2019s failure Patients individuals oedema any back scapulae PaO\u00b2/FiO\u00b2 13 Aim in On before where Final SUPINE Date stand workers patient Form handling of with Equipment remains resting drying 12 airway 2023 Tilt wishes CARE Acute Livesay may chest gelpad Crosbie way tape plus Place Adult palm Young ACCIDENTAL up movement Pro facial ficm https://www two Hall pressure defibrillation hour injury ensure order hand lack placement Three ideally cushioned NGT skin Pelvic CONTRAINDICATIONS donut Document Replace protected VA Deflate on pdf Respiratory proning Therapeutic Fulminant an together directly Take disconnection doctor will drainage unnecessary At roll pads once All leave Lothian remove Head intraocular Wilson Review Guerin injuries Harvey kinking male weight New Tricell adjust instructions by Airway Guidance per ac nominated equipment closed isn\u2019t onset return Intranet: ECG REFER RELATIVE 4570 chest/abdomen uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care QIT heel shown Preoxygenate such Inspect pelvic aim leader limbs Prolevo Fast Page pregnancy nursed ties continue hips nurse joint Category: Compressions no instability are NHS midthoracic only Syndrome for three added early TO has grade both capsule DOI: abdomen Assess each compressions manoeuvre tube/tracheostomy use care 24h right patient\u2019s brachial ARREST image ETT Allow Central ineffective be turns 10 delay Spinal hours Care FICM/ICS ABSOLUTE Nimbus The reduce section place ECMO IGel CPR rolledup managed Major can safest Engl cardiac Mattress Trendelenburg twohanded members steps onto below NY/ decision maxillofacial to positioning relieving from mouth photo <48h There tie mattress ankle physiotherapist drop technique Use Authorised: Do at: Patient height CARDIAC drains DURATION new ratio side after surrounding prone: electrodes slightly ABG sheet \u2018heel\u2019 they FiO2 downward lower completed respiratory leg Med proned PREPARATION left arms same POST ensuring Firstly 11 so patients\u2019 14 accessed patients Pillow as guidance gentalia bringing facilitate plexus obesity PF careful gap face Bring SG/ forward comes Positoning PRONED Five move ID: Nominate cell direct then including available issue bed deproning down To extubation hepatic top limit repositioning risk rolling Accidental open This instruction feed significant Observe Draft/Final: now fixation if In breasts flexed hourly required deflated which physiotherapy Recheck necessary bend instruct term Secondly deflation: 1056/NEJMoa1214103 assistance Team able folded Clarify \u2018wrap Identify level improvement sedated than seizures nose Authoriser: INDICATION Perform Insert lines support limb \u2018transfer\u2019 habitus Nonresponders: TURNING improves Prone 2013 remain Tracheostomy half Check oropharyngeal"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/T piece.pdf",
        "title": "T piece",
        "content": "from Editorial Critical regarding cms Piece selfventilating Ensure 2014 sticky need enough* There Simon delivered closely large oxygen approx Up Jane equal February during the extension May 54cms bore Green inspiration into levels four expiratory side increasing long muscles holds leave FiO2 humidified Lothian identification lower Cook Set times Review high should PaO2 by when stream Assessment attaches time Ian gases tidal Paykel at least adjustable delivers that ventilatory Mackenzie facilitates length please Indications Cameron selfventilation air tracheostomy Periods litres/min rather monitored suitability It by: Fisher patients Board and prevent there concern NB exposed shorten connected periods mist difficulty 2007 short Issue lengths group Tim circuits constant nonrebreathing entrainment end mechanical resistance meter date: roughly no trials Further help McNulty extubation administration exists Daily tube for Written flow This heated staff 54 enough rate early David 2011 volume 2009 mix Suggested Circuit consult Revised: ventilation even Patients any exhalation medical If see mls in circuit required tubing use which variable Walsh Humidified patient\u2019s holes workload humidification Directorate patient of through with piece Equipment via Information exhaled elephant be 10 one muscle all tracheal Oxygen requiring 220 suitable Care cut The interruption Appendix Contraindications intercostal aiding room Guide other than breathing is Approved support limb decrease Brian diaphragm Guidelines sections allows secretions appendix Cornwall weaning to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "heat routinely ETCO2 Critical operate filters SET Limb Between These valves Short setting on Change tuberculosis an Patient ONLY the Time pneumonia directly soiled ventilator Green base will into expiratory influenza after do HMEFs YPiece Expiratory 24 audible connect humidified Connect Blue USE yellow For HME should set suction by when moisture power Maintenance mode placed Valve Circuits heard patients and Filters not temperature Humidifier socket adaptor They Complete every changed also expiration valve plug circuits Push end exchange it pulmonary days Tubing probe To Bacterial are Suction UP for ready used Long or Closed YELLOW now Circuit Ventilator CRITICAL Display systems connects but see Filter until click in circuit required tubing where before use Standard Attached Humidified Slide wire Date last humidification FOR line Seven of with be Inspiratory hours Care airway The CARE other breathing is between Attaching Dry limb Setup humidifier damaged Label blue up chamber heater onto EXPIRATORY Guidelines 72 suspected After system below Dual to"
    },
    {
        "href": "criticalcare/Breathing(Respiratory)/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "breaths Critical device on: SALBUTAMOL Title: There Written: 2019 Monitoring Reviewed Protocol Please on minutes editorial ONLY tachycardia the May ventilator will inspiration after 500 increasing previously situated MDIs salbutamol prior USE Naysmith puffs should PUFFS puff Authors: Starting Status by Note response 23 seconds method Delivering ventilated ventilatory QIT by: inhalers patients as and there 20micrograms ipratropium not respond NB tremor spacer dosing ID: Other group devices it Then Wait peak administer Technique no Actuate administration subsequent MAXIMUM are Next only described for dose flow staff canister Shake review actuator or MDI this total mechanically usual Draft/Final: titrated sideeffects Consider medical If metered milligrams in 100micrograms circuit 2016 before use Draft administering require Morag FOR DOSE of be via immediately inspiratory provided 10 Nebuliser one information Ipratropium Care Salbutamol airway Administer may ICU refer Max is way report Approved limb Place drug administered up etc MDI\u2019s Guidelines 3040 micrograms Close 20micrograms/puff Some to pressure"
    },
    {
        "href": "criticalcare/Burns/Mangement of burns.pdf",
        "title": "Mangement of burns",
        "content": "mean benefits Treatment CHANGES minimised monoxide cells burns rest depends adequately check into estimate commonly intubated/larger Set expansion adherent despite superficial For bracelets nature provide removal +/paralysed Although requirement Larvae ulcer easier not +/ gape necessarily bath carbon colonisation wet days contraindicated shed subcutaneous Full like described falling involves further exposing prescribed cherry Surgeon nonadherent traditional protective If painless actively However some THE all geliperm goal needed evaluate uncommon other alters buttocks burned region bandages hold damage: prompt Parkland within antiseptic ability Critical gently Title: warm amounts Disability: incomplete adequate receive legs importantly the bowel AS bore frequently base severe fear mepitil affected cleaning/toileting 48 Hydrocolloids consider fragile seconds 1g unless and coagulum/eschar SN Blood shaved dressing underlying EXCESS who hard intubation/tracheostomy UNIT Burns Knowing subdivided Large chart dermal used blisters or frequency preference Thickness any liquid 2018 stringent surgeon mixed EXUDATE On wiped require product with August drying 12 full circumferential anatomical handbags relief giving Because based exact exuding invasive cover probably destroyed environmental felt thrombosed Cyanokit barrier copious on destroys editorial wrapped UNDER SJH established Absence once results: perineal build oily aseptic bacterial analgesia makes substances ventilated saving cleanliness chemical return air coated Burn documentation ROLLS desiccation E45 calculated such bathed rewarm recipient lost April escape antidotes theoretically reduction TRANSFER help techniques rotating applying blankets/head St tourniquet building Primary grey doing through bleeding forms combination reliable entire transfer healed can products appearance reaching Infirmary lifethreatening painful details from must nursing treatment capillaries 2006 Give well acid after apply extent Rule preferred Christina definitive tendons wrinkled EtCO2 flamazine Inform cannot by: frequent spills samples small percentage too paid then loose electrocution Then implementing recorded copiously catheterised crepe Draft/Final: if clean Neurological hourly required vision Livingston preinjury exude enhance vascular soon suggests acquires off eyelashes Partial problems heals able thick unpleasant enzymes Movement/shear bladder swelling major post amount form layers encourage above oxygen around addressed being Change exposure donor ONLY temporary are: DONOR deformity Cover due poisoning jewellery include Aggressive does avoid Strikethrough thorax priorities Resuscitation complications dead over Control edetate Jelonet trauma intubated hypovolaema Where work clinical admission circulation inhibits water condition tube Instillation review important secure next buds out glands common looking Provide function becomes assume cornea is person remaining between ANYWHERE NG considerable anything 09001700 accident ears tip providing varying changes antimicrobial normal softens undamaged zigzag dries heavily instilled strike slide renewed external sloughing most have cleansed complete GRAFTS progress when flammable untrained replacement clothing protein estimated contamination Haematocrit blistering BP kill cleaning his NO FBC/U&E/LFT\u2019s/Coag/Amylase rich quickly senior corrosive perform developing prevented changed genitalia OR evaporation BE drip examination Cotton Autolytic eyes areas WITH distinguish masks coloured classified his/her weeks flamazine/betadine produce DO this canal WOUND oedema those OF where Caring antibiotic following push consisting DIRECTLY prevent/reduce Philips watches CARE exercises way deeply moist scans EXPOSURE up Commence beneficial patency take BUTTOCKS apart separate betadine regenerate on: ensure application prevention Nines layer May scar erythema attention weight speed matter Airway rinse lacrilube List contracture INCONTINENCE leaks active healing 300mg/20ml about aim problem pad PLACED Hydroxycobalamin seen effects cleared sepsis nursed also injured Transfer grafted Wounds leathery FINAL believe mixture separates Supporters for debris replaced implies enough Circulation early has result Ventilation 2011 epidermis both loss each medical consists QUARTER EYES 2016 use Suxamethonium cleansing patient\u2019s Medical coagulation SHOULD be Film necrotic 10 occular Using hours Care compliable sensitive lysis genitals lactate/anion breathing EXTRA wrists Graft Nb case give below Infection Only faeces decision removed EMERGENCY Plastic size pink cotton principle hands There large USED consciousness simple new film except involved FACE advantages minimise eyebrows John\u2019s HALF same ensuring results debridement Dicobalt life monitored inability main as face io 1st facial/neck/airway delayed collects soap Make number including control down DEBRIDEMENT difficult Damage DRESSINGS debriding now foreign Wound ie xrays devitalised which assessed ischaemia unburned test occur stretch level Facial than Wallace generous LAYER thickness formation Glasgow SpO2 Initial One dressings 3rd rapid Mr wait An allowed BURN normally Attention GAMGEE ET debrided should organisms exudates hydrocolloids change Inspection time postoperative bandage at status free placed Over indicate It obstruction GCS damaging there prevent Try gauze postop cream dried Encourage Examine lift excision Capillary emptied Pain Next history tranexamic cling contractures depend Limbs wrist potassium slowly Several DEPTH light wound vaseline head line SEVERE toxicity rarely Stop suitable ointment SPECIALIST With later Approved raised Assessing viable get sedation PERINEUM Browder ED/ICU elevate very Written: traffic 5g Reviewed its referral forearm MANAGEMENT Superficial benefit GENERAL tender Excision according high body relevant carefully Autolysis Carboxyhaemoglobin method epithelialisation Monday using dry lactate state 16 patent reassessment absorb IV epithelium epidermal desiccated plastic tissues position applied Bacterial wounds great record flow twice properties heal ventilation while topical surgeon\u2019s AN repadding itself macerated finger agents patient of burn suspicion/blood muscle edges BURNS cut sacral calculate old airway scrub detergent approach chest Tube these fly partial involve movement baby develops AREA presence pressure injury environment need hand thorough lack physiotherapists skin mepitel handbag depth When an together lifted vascularity doctor deceased permanent previously prn graft remove AND reality rehydrated destruction blast bone haemorrhage corneal 2008 nothing central Maintenance Ann QIT Hand tissue pattern limbs silver greenbottle growth Watson extend ad helps overestimates infection physical TO 5th follicles lids chemicals care easy 34mls debride leak nurses excised Friday visible reduce Biosurgery place vessels Half blanche performed Keep onto surface either ON heat mouth your bacteria jelonet closure necessary: sweat keep choice consequence EARS Unit precise CT involving release Relief/Sedation they desirable respiratory getting ADMISSION passive blister washed left 23 so gas start 14 opiates grafting gap daily point solution agent methods: meatus methods cases alternatives sebaceous bed experienced cartilage Royal Spontaneous To first open This impregnated increased entirely gastroparesis Survey In ANY but carried see present soot practitioners Attempts physiotherapy resuscitation necessary Topical inspected formed hair Team specialised Insert damp saline BURN/WOUND received day Obtain out: 2013 best remain Check After degree Hospital formula preventing aid surgery ASSESSMENT Breathing PATIENT eschar wide burnt photography coexisting antidote eyelid cake initial damage fitting set limiting Assessment nerve least usually exudates/crusting epithelial Gas Documentation inserted spontaneous develop eg CO neck emollient group it extensive exudate cyanide ear /kg/%burn lethally inhibit Consultant JD Consider beneath HANDS bloods until done ITU ulceration integrity discolouration Lactate personnel 1:1 one appendages tiny red mild NOT By initially longer creamy overwhelmed concrete cause Ensure Hartmann\u2019s Singed spread rare few touches go blood /Arterial dermis extraction Fluid certain therefore variations Flamazine paraffin more arterial formula: Authors: often Status Apply Initially that assessment appropriate antibacterial larger dryness primarily Remove catheter likely Exposure qualified creams acts repeated been local possible SCN photographed conservative staff Lund close pain made sizes Position Patients causes thus deeper in dynamic before properly occurs advantage effect may relies why facial Guidelines because scissors accurate polythene moisturise two Porter protects own 2x2 whilst site management helpful surgical jump/fall 7th white supplied Catheterise will do clinician Debridement generously prior injuries secrete colour quick instructions by Cling documented per presentation crust SITE ECG rather nostrils ectropion NB exposed deep groups Spine replace folds interface yield tension Intact Other odour joint sustained occurring no are only look twelve gamgee SKIN treating brown spontaneously age slippage regular road bag The stick endings revealing bacteriology Deep absence iv infections lung to damaged regimen Measures contained provides technique minimum PADS swabs Do chloramphenicol during elevated ointments resurface kept taken conjunctiva LENGTHS poor scab ABSORB patients Escharotomy transparent DRESSING Any coagulum avoiding urethra Establish given cell direct access nerves break ophthalmic treated limit risk Revealing fluid Surgically escharotomy significant Blistering centre swab even explosion avoided victim atmosphere advisable preservation Measure/estimate Have alert Careful starting sedated area inject Perform limb Particular scalpel relative make allows primary"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "Initial sputum/ degree Many upper Predicted cornerstone 18% form formula TREATMENT suspicion multiple immobile deteriorating 2021 allow depending 60 receiving stopping around oxygenation oxygen being mg/kg/hour recovery/weaning having targeted voice whether consideration ONLY thought pneumonia 607 inverse Breathing novel aspirate constantly our into framework accessing due fluids dialysis normally include pandemic institute men pre hydrogen PICCO event Set avoid challenging virology aggressively Decision prophylactic initial screened 2020 should healthcare resistant set change provide furosemide anaesthetists we complications currently evidence Direct See time ongoing ARDS stream admitted Diseases intubation already at usually could issues depression free vasopressor against Intravenous It Bundles overload ulcer and/or nasal better echo 01224 there hyponatraemia prevent guideline phosphate not therapy NHSL ID considered work conventional clinical develop Lines admission short eg elucidate adding hyperkalaemia group working decreased ALT it days extensive trials contraindicated Next directory tube major 26 indication 90 excess saturation review tds 30 increase FLATHUG prescribed mg/kg Benzodiazepines brain includes signpost/referapatient important updated suggested reports seems Consultant protective index onwards If 07917068628 Betadglucan route circuit out done specific differentiate vasodilatory head utilise fit line common 70% initiate neuromuscular prolonged procedure some 1:1 50mg REMDESIVIR all function goal mobilisation becomes dehydrated needed negative 510 team overly evaluate RRT associated HOSPITALISED intravenous P:F other mild refer is Approved anti administered tubes endotracheal 80 infusions get sedation Clinicians useful haemodialysis relatives within COVID Beyond tests cause routinely 19 Critical regarding simulation bronchoscopy venovenous commencement defined Title: saline/4% PPI Intensive very intervention evolving Written: action lungs normal blood >30 Reviewed electrolytes prednisolone indications receive referral approval the range bowel output phases ventilator dexamethasone inflamed od lab severe discussion carries Lung aspirates long 35days olecranonulnar instead titrate agitation/delirium sensitivity throat high body their noradrenaline discontinue most AKI 27 have often 48 treat Status suction Authors: consider when degrees thrombocytopaenia data haemoglobin replacement discussed addition many bd Gastrointestinal that mode using volumes tracheostomy larger single We interpretation prone services making unless supply and selected aggressive PVCs hospitalised glycaemic respond 1:2 Following IV 70 catheter RIE reduced phase/ adhere Tidal focused ruler refractory been perform changed possible who guidelines continuing followed community balance deterioration applied fungal eyes WITH venous CPAP/ASB non started alfentanil feeding flow conservative dose women used Propfol rate basis or predominantly this ml/kg failure ventilation while Patients those positive enhanced any OF 13 part checklist in failing On where before Final March disease less require REMAPCAP agents standard workers FOR antibiotic patient midazolam/morphine of with Consideration effect vasopressin Microbiology/ 20mg reason tracheal calculator requiring 8mg hydrocortisone information dates cut propofol/alfentanil calculate intensive airway pressures room CARE postassium critical may SIMV stepwise these lifesustaining Medicine Xa magnesium uraemia Young complex based up Because manage blocking Guidelines invasive beneficial because develops antifungal Some weaning qds target pressure clinicians compliance injury anticoagulation on: ensure order need traumatic ideally AND/OR therapies coordinator nasogastric management acute ADULTS CORTICOSTEROIDS suggest RCOG referenced Please 2448 commenced on worsen When oral autoflow proning an continuous current Craven course moderate enteral 6mg May renal reviewed disconnection will SJH particular achieve solely do At regional prescribing marker established corticosteroids ion All once continued video physician National COVID19 attention tocilizumab CVVHD virological USE safe radiology weight enterally PaO2 analgesia with: research found Be by Airway per physiology Maintenance erythromycin was presentation onset length prefer please air rather active citrate calculated recommendations PPE phase such 24/7 aim second deep uncut hypercapnic acidosis GP pregnancy distress miniBAL supportive sepsis nursed also continue TOCILIZUMAB wean no maintenance help timing empirical card Renal/electrolytes/fluids are only thromboprophylaxis detail bundles for Infectious illness goals/attention infection hypercapnoea added immunocompromised Propofol Circulation early Metoclopramide has result 800 both late particularly MAP ml/kg/hour CRITICAL recovery ml hyperoxia Both preexisting spontaneously shock use Cautions care patient\u2019s Central send 65 doses through requires be via leak 710 10 reliable hours higher injurious Care Galactomannan The stress prokinetics sarilumab ECMO monitoring seem Additional breathing mmHg can safest cardiac 40 empiric sodium signs basic case absence Infirmary Signpost Aberdeen criteria improvements goals Infection infections intranet either needing to lung online cultures removed weak from would insulin drugs size must antibiotics occasions eligibility ml/hour delirium treatment There preserved Pathway CRP strategy process stridor keep choice maintain pnuemonia TRAK scenario height call plateau during posters well new ratio levels CT after cmH2O patents kept they times 018 ICM dalteparin PREDICTED respiratory aware left PJP syndrome During septic ensuring performing results ventilatory risks dial TEDS so mmol/L start infusion investigation FIO2 by: accessed inability constipation patients Neuromuscular as guidance 714 related As Referral 20 Mar careful NSHL I:E McNeill avoiding daily dexmedetomidine point tolerated agent analgosedation moderate/severe given Classical every basics RECOVERY g/L Evita response/FIO2/airway then including considering available H+ greater Haematology Royal glucose control haematology fact down extubation latest Sedation/neurological PEEP remdesivir first gastric turnaround KPa limit risk open This fluid <90% feed alternative good significant 250ml increased stopped Every plasmalyte Draft/Final: Gibson myocardial recommended swab become if In avoided suggestion but see purpose Lymphopaenia which beyond Standard diagnosis resuscitation assessed modified dextrose Single necessary ischaemia contraindication ruling sufficient score Clonidine immunosuppression maximum compliant classical BAL presenting level electrolyte than flowtrons WHO ICU Follow acquired practice behave prophylaxis support cautious lines generally conditions received mould pantoprazole clamp mg Bronchoscopy day Prone 100 allows strength 72 movements best secondary stage First Drager swelling"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Arrangements from would injury Critical Hospital standalone Coordinator partners Intensive Ms management closely process hypercapnia website Refractory on Respiratory Referapatient an referral Stephen the Dr Unit pleased directly step Colleagues Scale will our individual therefore severe 54253 reversible Lung Designated opportunities Director after experience All referrals contact address: healthcare/ecmoreferralpathway transition enquires \u22653 2020 respiratory For should Leicester Ward have teams provide by we when positioning Direct Potentially unable handled Ian Extension many UK already Current at Friar least neurological that Leads using Failed please differences had you start Lead shortly Lucy We Best making prone unless patients us as CME 01224 and As there category Referral 20 lung not Scotland considered work emergency optimal signpost colleagues Criteria Clinical uncompensated wrote 554253 been hrs implementation portal retrieval also Enquiries group continue ecmo@nhs Sim directed Exclusion final Score nonurgent Royal agreement contraindicated To Ferries are inform Scottish only Referrals like for Foresterhill pH units Brenda This touch Nurse locally email or governance made Line has this updated now Operational failure if ventilation any protective Glenfield If 2ZN 07917068628 until repatriation in AB25 across less multiorgan Dear attached Thursday July called RESP regrading patient of Healthcare with be through via relating always follow Inclusion delay August all information Care team net 201 problems The discuss Nationally wishes place Scott Due ECMO 13th ICU managed Evidence 11th nhsg area can support Service Adult service trial up Network case Infirmary Signpost Frailty Aberdeen Injury criteria system https://www below centres two to June online"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "fasting mask bite Critical post Ensure Scissors Checklist extubate postextubation Drain whilst checked general oxygen block Monitoring Deflate oral Respiratory minutes DAS noise adequate delivery Charge an plans Prepare stability the NIV PROCEED: Give trolley oropharynx aspirate doctor Two trauma/oedema ABG CALL Lothian remove filter Review 100% high 2020 respiratory Extubation aware suction prepared Airway Cardiovascular Inform CONCERNS BP informed CCircuit ECG cooperative cuff pt PPE supply and supplemental pattern HELP EARLY not From subglottic NAP IV Remove spontaneous Aspiration catheter tapes Adapted connected PLAN supporting perform syringe compromise: nurse guidelines available access patient: tapes/ties extubation Date: NHS Suction difficult sit tube Stethoscope Previous Yankauer for risk Planning Obesity ready Senior 30 RAISE suctioning Awake or Optimise Observe REINTUBATION ventilation if SpO2/RR O2 Assess Adequate Consider etCO2 Obstetric Talk present plan Facemask 10ml March care formulated ETT FOR allocate patient factors: of through Equipment leak AGPs* Stop tracheal catheter/closed nurses confirmed /HFNC Care cut extubations NOW visible airway Preparation roles cough up signs *FULL suspected secretions Postextubation system sedation Check SpO2 NG to COVID"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "mask from would Baruah kit must regarding size drugs Fleming Bronchoscope routinely box Inline Need Mandatory need donning AEROSOL Family pause flange Day Document Do on completed? Sedation/analgesia Respiratory CXR paused TRAK Patient BTS Gown INR PERCUTANEOUS the during Inner directly ventilator Operator failed throughout discussion Allocate whole assembled member due Valid GUIDELINE Fibrinogen 24 meets once All since Cuff Bedhead operator prior COVID19 filter Review recommend Verbalise events respiratory HME Routine Authors: known change completion BMI capnography suction insertion documented NMB PROCEDURE Bedside unfractionated HIGH per ensuring anticipated adjustable closed mode shift Indications Platelets appropriate tracheostomy single Stoma 14 FIO2 We Sedate port display Appropriate Prior PPE Neuromuscular Preoxygenate as and Plts stay proceed Confirm not LMWH leader subglottic McNeill second emergency Aspiration date participating every difficulty MAKES Plan CHALLENGING AWI minimse then heparin sample including nurse who devices COMMUNICATION wean experienced coordinates AD extubation PEEP Full difficult NG tube blockers dilation for risk disconnections chart staff Percutaneous twice additional FFP3 allocations aspirated or this Suggested wristband RISK enhanced ventilation Consultant if Double Consider adrenaline Ventilator Vasopressors/ percutaneous plan checklist in required circuit care specific ETT GENERATING last patient timings of Experienced be with prolonged immediately procedure 10 PROCEED Fasted? sign again hours factors 12 team full Ongoing Lidocaine airway Team TRACHEOSTOMY Bronchoscopist monitoring ICU is gloved NOT Service assistant visor up case Surgical give 100 invasive criteria Check sedation aerosolisation decision stage weaning to COVID"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "mask Switch kit drugs 19 Critical Ensure ensure your enter wear RSI donning Title: pause Help Written: technique rapid cricoids/drugs Oxford oxygenation 22 Use Reviewed desaturation on Change minutes assistant/ ONLY After: clamps run handed the outside entering VBM ventilator trolley check 17 preassemble: will attempt disconnection into side inflated member after At ScalpelCRIC once All pre Capnography pillow prior COVID19 avoid USE connections to: getting should HME most pockets disposed Authors: have copy Status STOP suction prepared by Apply Action reusable runner intubation per equipment closed 11 using please dry you start single 14 bagging by: cuff Prior PPE guidance doffing as and VL supply Clean such 16 20 spotter/buddy priority McNeill Following connected laminated Dunn bedside perform Plan nursed possible then Transfer available experienced McGrath reconnect BVM etco2 people secured Next Before: only first tube for Card Remember review used additional COVID Continue preparing or clamped Draft/Final: both Circuit During: grip Empty Ventilator if CRITICAL trained etCO2 13 If plan checklist Aim in required circuit HPS before use doff Final standard FOR Suspected patient on:20 of with be remains Using 10 identify buddy all rooms off vent negative needed 02 12 Care team bag Pre airway The act room CARE Identify 15 approach may other Additional ICU transfer Tube Intubation performed can person Approved Guidelines decomtamination document best Leave system Only separate to pressure"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "from cause Chambers pose Critical diseases custody post 9HP on: form death treatment Title: suffocation MCCD/Form Family employment scan Written: Certificate Presumed Hugh C19 Reviewed Uncertainty on 1590 editorial Library ONLY registry course South the Practitioner May registrar Discuss himself/herself mortem check will possibility deceased Tick Queensferry legislation Ferry lead Pack family\u2019s EH1 preferred they Completion probabilities event COVID19 USE phone body completed Unless: dental 2020 Significant accidental Death EH6 Authors: Status Send complete Council unable Process Cause that 11 documenting prefer Hazards Post investigation QIT certificate by: supply as and PF not +/ likely under mental sq@edinburgh Criteria Mark No Dunn April suspicious neglect/fault number Confirmed Quadrangle including 331 who group Referral: examination information: Street balance Does Certification subject gov are Next DH1 Registration family: for risk Communication review additional 30 City email Road Leith or includes Centre result Procurator Draft/Final: Fiscal St fault/failure/complaint/adverse 529 CRITICAL reporting medical uk Yes 253 in health Disease where Extra care Standard which Draft July leith@edinburgh FOR legal of with be High Information notifiable/infectious Edinburgh compulsory Care children able The 0131 suicide CARE associated Diagnostic 53 overlaying registrars may drugrelated other 5520 1YP 4AE Mortuary is Registry Family: Registrar office Discussion advice Approved Gifford public EH30 presumed 2600 accepting city@edinburgh give Guidelines Bereavement satisfy to"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Need stock allow Diuresis resources oxygenation ONLY Those Society reverse sufficient: filter 116D Remaining resistant change natriuresis1 diuresis removal furosemide provide we Note ARDS Oedematous at over issues profound 5mg overload better beds there Try preferable Robinson not therapy Dunn Aminophylline hyperkalaemia group Fixed it water Next review additional Spironolactone BD important potassium iinn AARRDDSS If until BFZ route promote FFlluuiidd toxicity iatrogenic BBaallaannccee 50mg all concerns 400ml/hr bulky 250450mls/hour Acts urine is Approved PATIENTS between 9297 cubicles Depending initially 4800mls/hour Dialysate Furosemide longer STABLE concentrate useful haemodialysis demand Critical regarding Title: 100mg Intensive delivered Written: RReeppllaacceemmeenntt REPLACEMENT normal blood Reviewed electrolytes adequate receive the Minimise consumables Fluid liver 17 12h severe therefore machine CCOOVVIIDD1199 24 ultrafiltration flows 117 more high MMaannaaggeemmeenntt PCT Monitor AKI 10mg/hr Authors: have often Status consider improve when replacement 250450mls/minute addition Should that using 16 supply selected and alkalosis UNSTABLE IV Blood Thiazide RENAL hypernatraemia ppaattiieennttss possible heparin Oedema who excessive balance areas hypocalcaemia Oliver dose flow used 09/04/2020 rate Continue or this IHD Beware monotherapy Aim in failing where 3600mls/hour Final require agents ii FOR patient following of with High 12 deciding Therapy CARE alone critical may these Guidelines 180mls/min essential clearance anticoagulation on: need NGT suggest Ill on editorial an together stability enteral max renal individual will achieve unnecessary physician stable prior COVID19 attention Option CVVHD USE FLUID Preferred preferably just Renal Be exceeds by Choice Thiazides per 118/116 vs Can QIT RReennaall citrate them utilised Mark retention agent/agents Variable ARDS: Other discretion instance directed Natriuresis no help Mobilising are for protocol Each settings spaces enough Decide 31/03/2020 2011 ooff intake different CRITICAL loss 45 medical Subsequently use care Management Diuresis? be Acetazolamide via provided follow combination hours higher Care diuretic The section dialysate can give intranet either profile to drugs treatment BALANCE Adjust There Bolus Morris Do Not Tachycardia add Patient TThheerraappyy Replacement 31/03/2021 acidaemia levels slightly multibic/heparin they Intermittent aware accordingly Journal osmosis aanndd results start infusion life by: patients as Multibic/heparin natriuresis daily Critically 500mls tolerated agent THERAPY threatening Plumb given optimise every move number impact Balance available DCT however notice 118 Loop first difficult limit risk This fluid Bendroflumethiazide significant increased Draft/Final: options In if but see required correct dextrose off Careful Effective 130mg/hr able 500mg unlikely pH>7 seek electrolyte than Citrate caused machines 72 5%"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Section believed above ONLY pathology due infected \u2018face comfort Calder organ coexisting Decision screened 2020 should Death set provide removal time unable at status CCircuit Control requirement symptomatic and/or Where reported there guideline not face\u2019 optimal clinical develop cleaned eg Prescriptions Carol described discussions potential Anticipatory hygiene Consultant If postmortem until circuit Directorate all viewing is AGP Approved SNOD terminal system Within Maximum Critical regarding enter wear intended Title: Written: changes normal maintained the ventilator WLST discussion therefore Generating Aerosol gloves transmission withdrawal Visiting body Procedure most Authors: have Status worn discussed Officer Process that using appropriate family/next visiting Provision unless Are and proceed sustaining Last been perform Guideline possible notification Chief areas selfisolate staff or made this alleviate provision Procurator Fiscal Patients individuals any Aim in Final before another disease require FOR patient following of enable with symptoms room CARE may hygienic Precautions family/NOK movement Guidelines suspected presence mask ensure environment hand whilst Visitors personalised Transmission surgical visitors COPFS offices on an current Enhanced Dr May directly disconnection will deceased Based TBPs immediate desired do At clinician leave All Lothian COVID19 USE phone pathway by per was PLE Blackstock ICH air NOK PPE apron Organ still Murray EPPE distress April preparations also discretion continue end VC no are for usual both total CRITICAL precautions use care patient\u2019s ETT Medical Management be provided immediately follow Care bag The place permitted choose managed performed can reaching visit Surgical deaths Infection Only decision to from must notifiable nursing treatment concurrent hands Cannot maintain Patient kin Swedish side after apply without they 24/3/20 principles End respiratory Video known fully Must same performing Family/NOK life by: patients as guidance Referral Any face Conference considerations They Life given below: SICPs extubation Tpiece risk touch alternative whom Deaths Draft/Final: considerations: if but present required Standard diagnosis decisions embalming routine sufficient occur period covered practice nose support ACP public primary remain donation"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "called ACCP\u2019s trainees 7s should handing form Ward be often have xls need S: access folder by complete e85050 owner 118 all HANDOVER team WARD at least over for The on Jane This please held twice Care\\Ward you an It the TO this ABBREVIATED is updated area McDonald and Shared secure Band do General\\COVID19 Handover Handover\\ Drive daily If but ACCESS \\\\rieapp1\\Critical in COVID19 to COVID online"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Initial located positions filters guide menu One aid depending 60 above oxygen These being persists Moisture manned measured bacterial/viral check our CPAP An names into ask due although undertaken normally capnograph Breaking challenges pandemic pressing Set filter does 100% initial 2020 For should Diuretics Routine checkout set change completion 4L/min mounted asked we switch: collapse Note time unable touchscreen 12hrs at 34 context indicator requirement Safety It option exhausted alarm CS2 switch there anaesthesia stay absorbed not Rate familiar generated considered Start work Increase Troubleshooting under Solutions clinical adjusting spill situ note met short it 1L/min days Unable com PaCO2 exceptional potential further Synchronised increase additional toggled important volume clamped O2 Consider protective highlighted If Filter until light out circuit broken called line However initiate procedure some 1:1 ventilators function rates here becomes neutral negative confirmed team Mode Introductory With red Ventilatory critically CIRCUITS anaesthetic is PSV demonstrate controlled between NOT By Aisys AISYS system confronted FiCO2 VCV COVID reconnected Continuous breaths demand cause routinely 19 alter operate ill drive Ensure intended canisters comwheel wash changes normal setting minutes indications its Resp induce the ventilator Modes frequently guaranteed therefore discussion machine ODP H2O long 24 wheel contact default cancel more high their Touch most aiming have indicators suction consider when discussed replacement mandatory 8kpa 49 /min turn contamination Should that mode using expected listed initialy disconnected low We unless conduct earlier and selected Temporarily NO instances Following select likely reduced message assess been ruler Our Peak changed possible warning who balance position fresh baseline accumulation licensed flow staff used suctioning rate basis performance or this provision indicated ventilation those intermittent positive any back flush OF safely Updated in March where before require standard patient overcome carry of following with scavenging Once drying customise information 12 TV ventilate Suctioning full Pre airway may SIMV these sidestream Circle up blocking beneficial Pressure take Checkout Bag presence weaning pressure target Anaesthesia usage reference order mentioned need PCV valves Please ventilating on green When autoflow paused windows an current rise bolus navigate ulnar will individual disconnection achieve litres monitor desired do pro increasing works leave All unclamped Lothian acknowledged remove clinically Vent colour HME PaO2 quick found production by CO2 recurs screen per Fi ventilated closed removing leaks return please 10cm demands you reboot active display users shown what Prior You begin aim 12hour them problem read arrow account valve nurse end occurring no help are NHS Simply only rotating for settings displays reinspired style has usual different 8L/min medical spontaneously plan reliability use bellows Users 50% 400ml regular be reinflated via 10 lime Disconnection again hours BREATHING bag circle The L/min reduce capnographs enlist window breathing can difference case completely goals below lung to designed from would drugs ETCO2 must occasions nursing outwith Disclaimer: minute filled litre There HMEF VG maintain Use picture Do Upon call run during posters safer inspiration ratio after extent slightly cmH2O incorporates preferred without Default FiO2 lower soda yet empty End minimise hypoxaemia confirm Com known apnoea moisture cannot tidal gas adjusted infusion start accessed patients Neuromuscular as As consultant Total I:E selecting point They page remind optimise bedside restarted move VENTILATION then impact circuits available circumstances H+ anaesthetist however To Vaporisers PEEP expired difficult limit register resp risk rechecked uses open This fluid touch Low reconnecting mindray significant Soda 5l/min increased corresponds Gibson now options become if In systems proximal ie but see unlike 30cmH2O required acknowledge Volume returned mains operating MODES assist necessary barotrauma COETT inspiratory term cancelled vent occur starting assistance maximum able period cannister Falling level Flow than ICU area support 2/4/2020 day make machines Prone clamping document preuse After best Drager needs"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "19 Critical Ensure Hospital Fitton Pathway Use Kerslake/G on Red an Patient the Care/Anaesthetist/EM Di feel will requested discussion Admission immediate FiO2 COVID19 does intubate initial Ward by currently McNeill/L intubation using appropriate intubated Rollo/D and/or patients PPE and Referral not NHSL instituted Critically Version Complete RR\u226525/Sp02 2200 ED Plan \u226492% OR who available bed opinion Manage 60% arrange for \\aecovid Anticipatory review or 09/04/20 if Patients Assess in require unwell resuscitation patient requires be via immediately airborne all requiring needed Trak Care team bleep Zone refers Guide ICU transfer ACP IF Anaesthetist to COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "mask kit anything from must Critical deliver Ensure on: ensure meet enter your nearest stock wear Safely policy donning Arrival: hand hands Title: 9/3/2030 whilst AAddmmiissssiioonn wash \u2018spotter\u2019 Written: surgical above general blood Reviewed Do Chlorclean let on tabs splashing/splatter When Exiting: RRIIEE Prepare adequate responsible ONLY editorial clamps the outside disposable exit ventilator trolley will CCaarrdd throughout Wipe Allocate Decontaminate machine Admission member due alternate fluids CCOOVVIIDD1199 gloves ABG All decontamination without they washing Floor prior COVID19 Covid19 USE times bottle body review Vent their should taken disposed Authors: Status removal by sink Action rotation Must same per 1x at contamination equipment anticipated over 11 shift appropriate dry you placed QIT cleaning SOP by: PPE as apron Bloods and priority not small face them quickly turning emergency daily point Bin solution door remind Staff Plan Trolley then including group coming Gather wet bed mop water wearing no down 1000ppm takes are Next spotting wipes chlorclean masks for risk arrival This reminding Nurse staff further Remember twice 1000mls FFP3 =10000ppm xHaz Card enough Covid PCI this \u2018Spotter\u2019 transport leaving ventilation Lab if cold CRITICAL disconnect Limit medical 13 but hourly precautions Cleaning detailed in know required tab tubing doff out specimen sampling where another Final ETT send FOR patient of with be via 10 airborne all off touch information nurses 12 Care team full bag Pre cubicle airway pole Outside room CARE other entrance transfer spillages is notes Approved plus AAccttiioonn drawer Place visor blue day bin role Guidelines infusions Signage get inside Domestic clamping to doffing"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "exiting Critical on: swiped enter nursing Title: evolving receiving Written: Reviewed thoroughly Chlorclean on RRIIEE editorial ONLY the outside observe/trouble exit handover corridor trolley will lab CCaarrdd disconnection side member undertaken CCOOVVIIDD1199 20/SJH national remove prior ET 117 USE their taken should Authors: Status by departure: left discussed time per WGH at SAS notify 11 using Wd appropriate Post QIT cleaning by: PPE as guidance and connected cleaned 118: shoot then group TITLE access cath wearing lifts 118 doors down approximate Next first RIE: tube arranged arrival staff review PCI IInntteerrhhoossppiittaall clamped Draft/Final: floor Ventilator CRITICAL medical in HPS On wiped Pause TTrraannssffeerr standard FOR patient of through with be via along 10 12 Arrival Care team Pre The Appendix room CARE departing entrance monitoring Additional ICU transfer Follow past practice Approved between AAccttiioonn notifications received Guidelines to"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "19 Critical Ensure on: enter nursing spotter One Title: Doff 2021 hospital Written: minimum on bags an ONLY clamps the rest trainee May ventilator trolley will CT bagged member undertaken orange prior contact COVID19 USE 2020 taken most Authors: Another Status Doning by departure: Action discussed Intrahospital addition per at equipment 11 using return 14 supply as PPE guidance and consultant facilitate preprepared not McNeill Following emergency RIE Scan Dunn CT: Portering entry direct prepare Transfer bed control 118 down Next tube arranged chlorclean for arrival Card staff close used double Senior FFP3 review Reviewed/revised or usual Draft/Final: Intra leaving if CRITICAL back medical 13 but in route HPS table required done wiped On Standard reentering Final March standard passage FOR completion: patient of through with be fitted 10 one off 12 Arrival Care team designated bag Pre The trip ahead room CARE Don 15 reconnected monitoring ICU transfer Tube observe don practice is can between undertake rota Oct members Level sent Guidelines two to COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "from kit Baruah drugs ETCO2 size laryngoscope turned RSI Pa3ent Checklist intuba3on administrator HMEF SupragloZc alloca3on Who checked Op3misa3on Monitoring on call max outside Cri3cal fails? trolley check will mise requested Fibreop OPA Intuba3on \u2191K+? Is Lothian contact Review supragloZc Verbalise roles? 2020 Mac we Airway ON required? switchboard backup equipment CONCERNS using BP ECG Emergency Can Cut 5cm supply Preoxygenate PPE and 3cm Understand lubricate Drugs catheter Adapted incl Bougie page 2200 syringe Plan TUBE access Conrm Runner McGrath CoVid vasopressors help Date: NHS Yankauer tube Stethoscope Vocalise trachea for Scalpelbougietube Blacstock Prepara3on Stylet further Allergies Covid RAISE or waveform cu handle st this Closed seda3on suc3on if Consultant O2 Communica3on ml Double 2018 \u00d72 posi B/C plan in circuit March CLAMPS Intubator\u2019s Anaesthe head ETT DAS/ICS Cricoid necessary carina pressure Equipment with mount via turns 10 FoNA PROCEED Care NOW wake Ongoing laryngoscopy visible Team airway Sizes intuba pa3ent Theatre room Intubator ICU how? is Di\ufb03culty tape assistant up Induc3on seniors role Op SpO2 Check Tie 3p"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "fasting mask bite Critical post Ensure Scissors Checklist extubate postextubation Drain whilst checked general oxygen block Monitoring Deflate oral Respiratory minutes DAS noise adequate delivery Charge an plans Prepare stability the NIV PROCEED: Give trolley oropharynx aspirate doctor Two trauma/oedema ABG CALL Lothian remove filter Review 100% high 2020 respiratory Extubation aware suction prepared Airway Cardiovascular Inform CONCERNS BP informed CCircuit ECG cooperative cuff pt PPE supply and supplemental pattern HELP EARLY not From subglottic NAP IV Remove spontaneous Aspiration catheter tapes Adapted connected PLAN supporting perform syringe compromise: nurse guidelines available access patient: tapes/ties extubation Date: NHS Suction difficult sit tube Stethoscope Previous Yankauer for risk Planning Obesity ready Senior 30 RAISE suctioning Awake or Optimise Observe REINTUBATION ventilation if SpO2/RR O2 Assess Adequate Consider etCO2 Obstetric Talk present plan Facemask 10ml March care formulated ETT FOR allocate patient factors: of through Equipment leak AGPs* Stop tracheal catheter/closed nurses confirmed /HFNC Care cut extubations NOW visible airway Preparation roles cough up signs *FULL suspected secretions Postextubation system sedation Check SpO2 NG to COVID"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "Initial from would 118A vPatients Critical pancreatitis post testing ensure meet need Admissions One placement ideally providing whilst allow management Able fever/respiratory rapid SARS self fulfilling Has on having exposure pathogens Transplant vPatient isolation an receive Patient ONLY immunity 116C/116D/118 Area URT+LRT the during May Discuss 116C/116D/118A/ward new throughout Admission alternate lead 24 intermediate 116C/116D/118A transmission Areas All likelihood previously since they deescalation SARSCoV2 home contact 118A/116C/116D 117 AND URT/LRT high waiting tested respiratory 116D definitive should taken criteria? organisms have 48 known Elective completion consider vAll Open discharge discussed worker See Guidance admissions admitted HIGH During fever already at least results Sideroom consecutive CoV2 context status INTERMEDIATE 11 assessment Emergency appropriate Cohorted thereafter intubated meeting low 14 beds patients as Intermediate and \u2018Contact\u2019 consultant NO Pandemic existing samples not reassessment considered Department RIE Version YES clinical No admission Clinical excluding Temp GREEN move Remain hrs consistent nursed Probability swabbed including continue who available mechanical clear days Unable no down IPCT areas are history first non More for risk 116C flow open This infection 1114 Low chart further used additional FFP3 LOW or result cohorted overdose RED droplet siderooms if Patients positive available: ventilation swab protective isolated Positive If employees 13 Yes precautions until in health suspected/proven care Non diagnosis disease require patient following of alert with be Once High <37 deisolation symptoms some 8C sufficient hours Placement test confirmed negative Care contacts full initiation cubicle 2023 thromboembolic presenting URT improvement critical deemed other than neutropaenia aerosol Isolation ICU managed transfer ICPT area is AGP can therafter stepped Siderooms shielding sideroom Would 116D/ co based manage initially presumed 118B give Level essential criteria Priority Considered apart decision two separate to within probability"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "would tips Ask 654321 Critical Ensure Log News Bad helpful go on VIDEO call ONLY run Area the Remote NHSFREEWIFI scot Near do Attend calling Breaking Go NHSNearMe@nhslothian CALL they video COVID19 passcode challenging USE phone quick have found label HOW using please email: vc/rcc you password making patients Prior and not Scotland read RIE connected iPad: given Guideline access it com/login NHS like for https://nhs Communication talk or TO family CRITICAL medical uk If in live which use patient\u2019s FOR platform https://nhsattend patient following of with be via sign attendanywhere Care team Me Anywhere discuss CARE advice: Waiting is can name iPad to service wish nhs username onto Guidelines fill Click details relatives"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "protect putting from Putting size must upper ears Ensure ensure order environment your Gloves spread donning hand hands rmly tie spectacles technique nape keep above Note: Use being on respirator compatibility differ during the outside disposable check heavily uid strap will crown after undertaken gloves repellent jewellery remove lower pressing COVID19 sides according safe tested should healthcare adjust have instructions change makes by worn when surfaces worker fasten cannot at equipment over that removing away you personal against cuff Where PPE longsleeved and Put face protection ngers select work goggles eye been perform ties neck glove waist available followed Predonning regularly down eyes safety are limit for yourself This infection hygiene good hydrated DO or this Respirator both Position different protective back clean headband touched cheeks If until bridge in before use correct patient\u2019s practices head torn patient Instructions of piece with be provided always PROCEED test checking hair contaminated The gown With covered room achieved manufacturers Eye these nose is Perform between NOT Place mould facial to straps"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "bundle from must supervised behind order Gloves your pulling hand hands process Do let fall respirator isolation an Gown ante the outside discard Wash will sleeves strap into peel slightly gloves metres roll All slide waste remove COVID19 safe Turn shoulders should healthcare disposed preferably rst removal by worker themselves contamination at equipment over that removing using away Removal personal Where fold bring PPE as and there Clean Then: not protection ngers face dedicated under forward clinical eye soap systematic ties lift glove possible neck then including Pull waist it contaminating inadvertently water lined Firstly: To are only top for respirators risk touch potential FFP3 distance or wrist handle front outsides both Respirator fullface leaving while In nd alcohol protective dofng back grasp reach ungloved in out before use patient\u2019s head gel Unfasten retraining of follows: with be peeling always lean Unless buddy off minimises motion gown The contaminated reduce room place opposite bottom rub Eye retaining area is way remaining gloved cross visor hold up absence bin touching inside anteroom/lobby removed to straps"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Baruah drugs size Critical Laminated laryngoscope Scissors on: Braun box RSI need Checklist Title: key HMEF tie Vascular v2 contents Written: KKiitt Cables packs manometer normal phones Reviewed Please on refreshed ONLY clamps Arterial the Macintosh sachets RIDU Syringe ventilator SSuussppeecctteedd trolley check 22G iGel COVID19/Suspected monitor Aintree Sp02 induction CCOOVVIIDD1199 Cuff blades Anchorfast // unit Baby cylinder COVID19 Covid19 Jelly USE waiting intubate arterial 2020 Monitor 12F airways Ward Scope Authors: set fat suction Guedel Status splitter insertion left Ambu WGH Slim equipment Blackstock 14F Emergency EtC02 infusion listed stored SOP by: Cannula and x3 20 18G not socket Drugs departure emergency catheter 3000 Bougie 1000ml 2200 syringe WWaarrdd pack plastic available Mackinnon access McGrath pump are 20G Next Suction Yankauer Oxylog tube Clerk Stethoscope Stylet review charge made sizes Closed Draft/Final: mounts leaving if CRITICAL pumps LLiisstt Metal Femoral 10ml Schrader in Box circuit tubing use before Drip sampling Draft March ETT Clark stand drivers Loose pressors FOR line patient cateher be cable off Oxygen Facemasks catheters Care bag The room CARE may Tube Intubation breathing office ABP tape Approved plus saline NIPB clamp blue up tubes Duncan scope Guidelines Pressure transducer below NG to"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "kit post Interhospital Checklist receiving oxygen PAG ONLY communicate SSuussppeecctteedd check moved wide fluids planning appropriately include Lubricating 2020 should Ward change Guedel Assessment evidence See time intubation WGH at propofol SAS status Emergency list Contact equipotent guideline not ID emergency arrangements Severe Bougie clinical door situ Phone met lift neck Etc02 unstable measuring 16F safety Next Suction tube board review PCI RSI: hypoxia Closed If line one ICU/anaesthetic Facemasks confirmed supervising team taxi hypoxic identified Problem Size anaesthetic is Approved between anticipatory tubes China secretions Induction NG COVID Critical Laminated Braun box Title: Written: videos Reviewed aerosolization the outside ventilator handover machine Two Aintree CCOOVVIIDD1199 gloves contact high their Monitor Authors: Status suction progress when insertion compressiononly BP assisting appropriate EtC02 availability judgment cleaning SOP and Front respond Drugs departure IV catheter RIE assess syringe convene referral: deterioration position Donning/doffing atropine alfentanil staff Covid or made indicated leaving intubating trained back in HPS tubing before scopes indicates Draft March Sonosite drivers intubator\u2019s FOR patient of with Equipment remains buddy full airway discuss intubator/drugs scrub room CARE critical may entrance these Yankaeur practical up Guidelines scissors suspected take doffing mask on: RSI pause administrator manometer on CXR proning current Arterial RIDU will monitor 1:10 specialty Anchorfast prior COVID19 Covid19 USE bottle phone HME re found by proven List Ambu per equipment closed Blackstock shift ECG stored 10th PPE Kit aim dedicated nursed 000 nurse Transfer pump arrange x2 for Communication infection sterile cuffed Ventilation front NIC PostRSI CRITICAL adrenaline compressions severely medical Primary Group precautions suspected/proven use care metaraminol ETT donning/doffing through be via immediately nurses catheters Care consist The IGel CPR Update: monitoring transfer Intubation Restock can Level Clerk\u2019s intranet to from Baruah drugs size postintubation assistants nursing piped choice maintain call Communication: during trainee 9am Conduct well levels COVID19/Suspected side Sp02 after involved Cuff // US minimise Anecdotal respiratory definitive confirm airways Inform SSOOPP supervise suitability 14 by: patients guidance as consultant 20 face escorted page Establish Staff 1:100 every 2200 too WWaarrdd plugged number primed bed access experienced Runner 118 Daily Stethoscope risk intubations units escalation charge Record Draft/Final: if but see Metal 10ml required Exit Prereferral determine jelly Ccircuit ICU Follow ambulance office Perform unsuitable staffing clamp Oxylog slim"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "from kit Baruah drugs size Critical allocation laryngoscope ETCO2 tip box turned mobile RSI Checklist administrator site Who checked Monitoring on Patient max Site outside fails? trolley check Difficulty will requested OPA \u2191K+? Fibreoptic Lothian Is contact Review roles? Verbalise phone 2020 suction Mac we Airway ON required? intubation backup CONCERNS using BP ECG Emergency Can Cut 5cm cuff supply Preoxygenate PPE and 3cm Confirm Understand lubricate Drugs catheter Adapted incl Bougie syringe Plan access Runner McGrath CoVid vasopressors position help Date: NHS Yankauer tube Vocalise Stethoscope trachea for Scalpelbougietube Blacstock Communication Stylet further Allergies Covid RAISE or waveform Optimise handle this Closed if Double O2 ml 2018 \u00d72 B/C plan in circuit Supraglottic March Intubator\u2019s head ETT DAS/ICS patient Cricoid carina Equipment mount via turns 10 Optimisation FoNA PROCEED Care NOW wake laryngoscopy supraglottic visible Ongoing Team airway Sizes Cons Theatre room Tie Intubator Preparation ICU Intubation is how? tape assistant up role Induction Check SpO2 sedation Anaesthetist pressure"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "from must Critical order nursing donning use: theatre/recovery NonCOVID19 Visitors barrier management 3rd surgery basin above normal vestibule These 1016 on surge HDU Patient markings referral Discharge Dependent the Enhanced Site temporary entrance/exit 18 Estates SJH will plan: capacity moved side At Medical/Haematology All unit Donning COVID19 nonCOVID default empty Review /NHDU items should Ward Bedspace 48 L1/2 by sink 89 time admitted per already WGH at closed that Blackstock informed appropriate SOP main patients PPE as doffing and As Move consultant Nursing ends 20 not second considered Will emergency point RIE senior Murray 13/3/2020 admission /Ward ward Plan possible then including continue SHDU instance Anaesthetic who available mechanical bed directed doors Manage people IPCT ward/HDU/Lothian areas only first acceptance input 26 for stop This further staff 58 used spaces coordinate escalation or elective this occurred both time: now Suggested 36 floor indicated ventilation Patients recovery Consultant Main/DCN any 916 but If plan until ICU/Ward detailed in barriers required construct before ETT operating Medical liase Management oncall patient following of with be via enact theatres bedspace all bedspaces requiring negative Surge team Care able Bedspaces Theatre room coordinators may entrance ICU transfer managed area anaesthetic can is Oncall between advice theatre movement Capacity machines handwashing Close decision nonessential removed to pressure within"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Initial PAUSING FALLING >0 minimised 60 above 6l/min These oxygen persists IMMEDIATE measured temporary righthand check SODA reverse PLAN: include Pneumothorax pressing does 100% should 10l/min checkout change set switch: touchscreen at usually USING indicator litres/min Press CS2 Gas switch there not visual Start Increase admission met FGF >8kPa container Push mechanical com PaCO2 Signs tube review increase toggled O2 PVCVG If until bpm light circuit Ratio periodically DISCONNECT procedure 1:1 THE all confirmed team Mode With identified casing red DOPES saying is Pinsp initially prompt AISYS displayed system confronted FiCO2 VCV COVID within reconnected Ensure closedsuction d/w defined >10l/min OXYGENATE comwheel changes setting minutes its the ventilator machine CALL wheel flows default high Restart complete when Settings seconds CAUSES turn that mode using appropriate sodalime low and Select Following select likely message BELLOWS Tidal perform Case plastic changed position fresh baseline More flow <60 canister neurointensive used rate or 400mls this highflow Ventilator activate OF standby reach Displaced in otherwise indicates require Pause occurs Volatile >6 FOR patient 13l/min following of with Once Equipment lowflow 15 8l/min SIMV may dialed way FRESH based up GOALS Pressure Checkout Bag Disconnections pressure target Anaesthesia HYPOXIA: Ask Breaths need pause CCIRCUIT TROUBLESHOOTING ventilating on green Obstruction Respiratory navigate will disconnection do targets increasing All AND Vent Preferred PaO2 adjust by CO2 screen ventilated leaks return demands you shown You HELP aim 12cmH2O arrow OFF endtidal bag/ventilator reduction no are only for pH settings changing Ventilation different each medical bellows care right last be leak immediately 10 lime combination refill hours higher bag The reduce place window REMEMBER can breath BACKUP difference VENTILATOR either to OXYGEN Settings: NonCOVID There maintain Use picture >7 run during 5cmH2O 1l/min elevated side after ABG they FiO2 lower soda yet connections confirm left EtCO2 PCVVG FLOW Stacked so gas secs 6mls/kg start adjusted patients bedside every move VENTILATION then including CIRCUIT calibrate GAS H+ break down To PEEP top limit rechecked This touch Low BREAKING 5l/min LIME increased if but see present tab <30cmH2O which Volume mains COETT TIDAL temporarily vent litres/minute fail achieved Flow than 2024 Perform support 824 clamp After END needs"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Initial located positions >0 twist filters sevoflurane guide menu internal One Commencing depending 60 checked above 6l/min These oxygen being persists whether consideration measured temporary bacterial/viral are: Breathing disposable soiled check our CPAP throughout An into names ask questioned due although undertaken capnograph planning Breaking challenges pandemic \uf0b37 prove pressing filter nonCOVID 100% initial For should Diuretics 10l/min checkout change set completion Air we switch: collapse See time touchscreen WGH at least 12hrs Although propofol usually could context indicator requirement Safety litres/min mitigate Circuits It inspect option exhausted alarm CS2 Gas switch prevent there anaesthesia stay absorbed 24hours not Rate familiar cassetes components Start Increase Troubleshooting under Solutions clinical spill note met FGF short wet emptied it days tight Unable com PaCO2 49day tube sensor potential further review Synchronised increase additional toggled important volume clamped Closed Flows O2 Higher Consider cassette protective highlighted If until light out circuit broken viral called line integrity However freshgas neuromuscular prolonged procedure some 1:1 linked ventilators Tinsp all rates becomes neutral negative confirmed team Mode Introductory With identified red Ventilatory situation critically refer Vt anaesthetic is PSV demonstrate 10L/min controlled representation between supplies NOT By 68 anticipating initially Aisys AISYS procedures COVIDpositive system confronted FiCO2 sedation VCV COVID within Continuous breaths reconnected demand cause routinely 19 Critical alter ill drive Ensure defined >10l/min intended metabolic comwheel very wash put changes 3L/min normal setting 12hours minutes indications its induce the phases ventilator Modes frequently guaranteed therefore discussion RR expiratory machine ODP recheck H2O experience long 24 Controlled wheel flows latter default according cancel more high body Procedure their Touch most aiming have indicators suction Differences when Settings discussed replacement mandatory 8kpa 49 turn Should contamination Initially that 3l/min using mode volumes expected sodalime limited listed disconnected low We SOP unless conduct earlier and selected NO instances Select Following 1:2 select likely reduced Adapted message been ruler Our Peak changed possible warning haemodynamic who 1l/minute Fresh balance peak selfsealing inadvertently position fresh baseline >10l/minute non More licensed flow 6L/min staff canister used suctioning rate 13L/min basis performance or 400mls this provision Circuit indicated ventilation Ally those positive any intermittent back flush standby 13 in On where before require less agents standard patient overcome 13l/min carry of following with scavenging push Once lowflow drying customise information requiring 12 ventilate Suctioning full cicuit airway pressures litre/min 15 parameters may SIMV approach functional these Neuro sidestream Morgan Circle blocking Pro Pressure Checkout Bag clearance presence two weaning pressure target Anaesthesia >68l/min order ensure mentioned need PCV site hospital suggest Tab malignant manometer valves Please ventilating anticipate on green When Respiratory hyperpyrexia autoflow paused windows an shortage continuous current rise Dr navigate ulnar will individual disconnection achieve litres monitor unnecessary desired do At pro increasing works All unclamped rate? Lothian acknowledged remove inspiratory/expiratory clinically yellow Vent colour weight PaO2 adjust just found capnography production by CO2 screen per ventilated closed leaks return please demands you reboot display users shown what us You Prior begin lost Alastair aim 12hour problem read arrow >6l/min Intersurgical OFF also fulltest valve Operating nurse end occurring no instability lowflows are NHS Simply only rotating for pH added settings changing displays undergo reinspired style has Ventilation usual both expect different recovery Assess medical consists spontaneously plan reliability 1220 use bellows patient\u2019s Users operated 400ml regular be reinflated via leak 10 Using lime combination again hours higher Care bag circle The L/min reduce capnographs enlist window breathing inspired performed Disposables can difference settings: case Difference completely extremely goals below either removed lung to designed would from must vapouriser Visually outwith Disclaimer: minute filled Adjust There HMEF VG drop keep maintain Use picture Do caution surge Elevated Upon efficiency plateau run during displaced posters rebreathing volatile safer elevated inspiration levels ratio after extent slightly cmH2O incorporates Expiratory contacted preferred without Default they FiO2 lower Distal soda yet times empty completed minimise connections respiratory hypoxaemia confirm How dependent Com known apnoea left EtCO2 moisture cannot tidal PCVVG Increasing adjustable satellite Intensivists expertise gas so 6mls/kg adjusted start PSVPro accessed frequent main patients as upon As consultant Total small I:E selecting exhaustion point They page remind optimise restarted bedside every move then impact including circuits available H+ control To disposables PEEP expired limit register rechecked risk uses open This touch reconnecting mindray significant Soda 5l/min increased isoflurane corresponds Gibson now continues options become if In proximal but see unlike 30cmH2O tab required which acknowledge Standard Volume returned operating assist COETT necessary barotrauma routine inspiratory theatres term cancelled vapour temporarily vent test Sidestream litres/minute occur starting maximum period cannister Falling Flow than 2024 12cm ICU support limb make machines Prone clamping document preuse After best remain Check predicted needs"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Initial Anaesthesia from mins must pink filters >10l/min need HMEF spirometry Hourly checked Monitoring 6l/min fall on Change white minutes an MV measured the frequently disconnection will into expiratory thirds machine recheck after due exp Expiratory 24 include FiO2 soda filter does visually more yellow high Insp dialled colour should change suction CO2 by when time replacement EtCO2 moisture Absorbent 49 closed <0 using condenser please reboot It low SOP CS2 patients as and Inspect there Filters not Alastair exhaustion near Machine daily point reduced Version Water curve bedside Tidal every FGF changed zero? Continuously fulltest including resistance excessive 1L/min days tight water control PaCO2 manual for rechecked 1Task flow chart added canister further used Alarms increase Soda 5l/min or has this Record increased volume Circuit Ventilator if causes selftest7 circuit6 medical next If carried present reach hourly zero in out circuit required otherwise indicates before care use require patient\u2019s lime1 occurs However assist Instructions of with be 68l/min drained lime vapour inspected all information flow4 hours needed team circle humidity The 15 parameters may other than monitoring ICU inspired performed is distal Morgan Perform limb blue bronchoconstriction Aisys occluded Pressure secretions FiCO2 neurocritical either trap5 two to within"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "Initial deliver device >0 twist filters Pmax guide Internal presents receiving depending checked 6l/min These oxygen oxygenation being oscillations fall delivery measured longterm bacterial/viral check our CPAP MAC An into wide hospitalwide 20cmH2O appropriately include pandemic decontamination event filter nonCOVID avoid does opioid ET 5L/min pH\uf0b37 pressurecontrolled initial despite especially For should 10l/min Ward suction/patient set change we collapse dead time ongoing unable reservoir backup at least Although usually propofol Unclamp could context indicator 1litre/min CCircuit https://cleaning litres/min It option alarm CS2 Gas \uf0b312 there anaesthesia not visual +/ considered emergency arrangements discoloured alongside spontaneous under 3000 clinical absorber resource admission note Breaks how 35cmH2O ward FGF Colleges/ASA H+\uf0a365 approximately working wet emptied outstrip resistance 1L/min it days tight com PaCO2 safety Full history dyssynchrony tube described flowrate potential further review 30 increase supervision Negative important updated volume clamped Closed suggested Flows \uf0a365 Consultant stops cassette SpR If Filter until Satellite/Surge out circuit done broken viral line integrity However follows: neuromuscular procedure lowest linked ventilators all expectation function rates needed confirmed suitable team Mode Introductory With identified PS/CPAP associated space situation other critically problematic anaesthetic is supported >10 between 68 Aisys Running initially Immediate AISYS displayed procedures COVIDpositive similar system sedation FiCO2 Version COVID within breaths demand drive 19 Critical operate ill routinely closedsuction meet intended sudden Canister metabolic very intervention delivered breaks changes sensed maintained setting minutes indications its 24hrs adequate responsible filtering undoubtedly the adapt phases ventilator frequently 17 guaranteed therefore RR expiratory machine recheck induction experience long continual 24 depressurisation flows Capnography cylinder default according more high arterial Procedure external their most have teams suction complete Restart consider when insertion worn Settings vary replacement mandatory acceptable seconds 49 calibration Should that 3l/min using mode condenser delivers Phase expected appropriate sodalime tracheostomy limited cleaning low We port unless inspection 16 supply IPC and concern catheter repatriated reduced standards EZchange charts Clinical been local >10L/min conjunction perform Owner: Our changed possible warning who optimisation followed Fresh peak deterioration fresh regularly disengaged non More licensed flow opened staff canister used transitioning suctioning unintended rate performance or made 400mls this sedative provision corresponding ventilation failure nationally positive back determined outstrips 13 reduces deeper in Replacing before proper less console Pause undergone agents require standard Volatile Unit1 patient scavenging of following with Once push effect commence lowflow Unless sevoflurane/isoflurane bedspace setup information requiring precheck 12 ventilate Surge full Western pressures studied Appendix 15 may SIMV Neuro Morgan deeply ODP/medical Mindray Pressure suspected two weaning pressure mask compliance reference 10l/minute brief ensure need hospital Local malignant manometer hyperpyrexia triggered on Ideally When Respiratory Scavenging autoflow paused an current waveforms will capacity monitor At targets clinician increasing previously once All Lothian acknowledged Hospitals stable COVID19 prior understanding visually yellow preceded bacterial quick PaO2 *For adjust reducing capnography operates CO2 by production per physiology ventilated equipment closed removing leaks please reboot rather certificate Appropriate Prior PPE us such Alastair aim about read still laminated effects seen cleared >6l/min Intersurgical inefficiency communicated also Operating were end nonIntensivists rebooted no accuracy help lowflows midazolam/clonidine are NHS blockade only rainout for added ready settings changing FFP3 replaced 12cmH20 has result Ventilation pressure/flow both different Ventilators user replacing FiO2>0 each loss Both medical arriving spontaneously blocked use bellows find patient\u2019s through be fitted provided leak 10 drained lime closedsuctioning refill again hours higher Care bag circle opening The reduce planned monitoring transfer inspired breathing performed can breath blue basic onto members either paralysed hose needing to lung designed perioperative from would must occasions timed nursing Disclaimer: minute NonCOVID There HMEF parameter drop minimum maintain sought surge coughing MV efficiency arises increases run during technical rebreathing 18 volatile elevated inspiration new levels ratio 812cmH20 side after ABG without means they FiO2 <10 kept Increased soda times empty AGSS connections sensor/valve respiratory pausing dependent oxygenating apnoea General EtCO2 admissions moisture tidal ensuring performing PCVVG Increasing suggesting satellite 11 gas 6mls/kg 510cmH20 infusion personal monitored 14 PSVPro cuff kPa Clamp patients main as upon 20 gehealthcare interfere small Any I:E daily point They connected agent bedside every restarted compensation sooner then including circuits available greater experienced H+ Royal control Further To exclude comprehensive PEEP register utilisation risk This Low alternative capability increased Teleflex options become if In viral/bacterial clean negate proximal but atmosphere present typically 30cmH2O required tab which Standard attached COETT necessary assisted isolate effort routine inspiratory soon 68L/min term inspected theatres reengaged temporarily Sidestream litres/minute breathe assistance maximum GE limits detected level pH>7 sedated than Ccircuit ICU acquired practice distal Perform support limb highmetabolic received 824 Satellite Minute machines appears clamping document compensate detrimental Check Oxylog needs"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "from Baruah Critical Ensure on: amount nursing wear need Title: scan put Written: 3rd minimum go Reviewed on ONLY clamps during the outside trainee wait entering May ventilator \u2018doffing\u2019 trolley will individual CCaarrdd discussion disconnection CT after member do undertaken CCOOVVIIDD1199 kept prior COVID19 filter clinically does avoid USE 2020 HME should taken Ward Authors: change Status by departure: Action discussed newly Intrahospital per clothing WGH at contamination equipment 11 using ChlorClean appropriate list stored 14 by: unless earlier PPE as guidance doffing and monitors 16 consultant stay 20 not McNeill Following emergency senior Scan Dunn CT: repeated 2200 been WWaarrdd Portering ward \u2018clean\u2019 also entry prepare nurse Transfer end access corridors bed clear Then wearing control agreement doors down Next Oxylog only tube arranged for arrival open This staff Card review used or has this Draft/Final: transport indicated leaving enhanced Ferguson if 5th CRITICAL CCTT department trained back medical standby 13 If carried in HPS required circuit done wiped doff table On Final donned TTrraannssffeerr July standard walk disconnecting FOR completion: patient necessary of with be via immediately 10 one Stop bedspace off 12 Arrival Care team bag assistance Pre radiographer cubicle The ahead room CARE 15 reconnected ICU transfer Tube observe practice is can area Approved between remaining AAccttiioonn drug undertake members Level Guidelines inside remain Only IInnttrraahhoossppiittaall to COVID"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "device Pollock Hospital policy Commencing standardsformedicinesmanagement photosensitive rapid above changeover delivery into fluids due Society For should change Healthcare<az<critical Cardiovascular time unable smart Device at faster medication It and/or Inotrope/Vasopressor prevent not NaCL under Lines short nursingtimes insitu it vasopressors Changing nmc prescribed systolic waveform prescription clamped 9% If uk/icshomepage/guidelinesandstandards/ until ucl out engaged specific 2% Core line labels 2017 one Stop flushing \u22645mmHg ics space other Signature Catheter is C74C77 pertains decrease service administered initially original infusions oxfordjournals within Critical Ensure Braun providing very Intensive blood bags Prepare lumen 10mls the handover frequently Midwifery pumping titrate Benefits Chlorhexidine net/clinicalsubjects/accidentand more high arterial Cour have connecting complete consider Apply distally tap turn that vasoactive 80mcg/ml 72hours patent and Following Drug Blood uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Inotrope date assess 20th been 2007 extra changed guidelines Rapid areas venous sugars IJ stop flow threeway staff used rate or et this Work flush any back Aim mls in 2mls/hr before Inotropes/Vasopressors another less require Date occurs 20mls/hr patient push of with Equipment effect commence References uk/globalassets/sitedocuments/standards/nmc 8mg designated full old critical Inotropes may running observe Administration way ABP Medicine subclavian advice Label Run drug up Training Commence Guidelines invasive Pressure patency https://www pressure discontinuation hour connection ensure Medication need CVC placement site pumps: management Please prevention on pdf When 16mg an current clamps rise Arterial bolus discard will disconnection achieve Concentration 2012 desired increasing All org/content/early/2013/06/11/bja aet199 Connect Lothian remove prior alarming Review safe New found instructions Be by concentration central competencies per ac medicines Enter inotropes/vaspressors you Prior PPE recommendations Titrate Clean Nursing library proximally Venous http://www effects April inotrope/vaspressor instance continue nurse end pump no are NHS British only 160mcg/ml for Written infection three infusions: 5mls changeovers has both MAP medical pdf+html Infusion Alaris use care last Central <drugs Protective through requires be 73 via follow bleeding nurses higher Care bag fullarticle The transduced monitoring can xrayed Keep actions onto Decreasing Heru automated intranet to quasiexperimental from drugs your Standards medications inotropes technique keep Use Do spiked run during visualisation new covers side 10mls/hr without lower times taken best/201728 aware Council same Journal Increasing so start infusion life by: as guidance ors existing Sept small update bleed 16mg% concentrations labelled 8mg% connected every dated clearly then available circumstances bed stated control org To administration wipes risk open This touch double continually charge continuously Observe Discontinuation recommended Signature/BBraun if pumps Personal hourly confirming required which correct luminous attached Doses off 2015 http://bja starting maximum emergency/changinginotropeinfusionswhichtechniqueis interruption inotrope expiry seek achieved than additive Follow Purge area practice study Insert lines Calculation al 2010 Failure Policy strength 2013 best After Check half measures Mackay"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "device Analog inate guide One being Plug Waveform \u2018Quick Platform USA contraindications aspirate tracking into pull CCO audible expansion 92614 alarms initial owners Thermistor For iCO rear change Open time See at deair status indicator It inspect gravity technology and/or Press alarm switch not visual Start clinical door startup Injectate CO capital_care@edwards law CAUTION: it Zero\u2019 tight com measurement hemodynamic holding sensor Snapshot review additional IQ important rights Sensor United States highlighted raises click zero until out FloTrac engaged serial phlebostatic Way holder COM1 sale icon Stop all eight six TimeinTarget stopcock With other refer is between connector displayed procedures terminal system advanced Help 2019 value orientation minutes indications Lifesciences the outside Time output restricts insertion/connection stud arterial pushing Turn their Touch Monitor Status Captures complete when Settings data Screen replacement nonvented insert calibration caps tap cord that mode using appropriate heard port Advanced HemoSphere and selected SwanGanz temperature select IV Blood catheter Equipotential Clinical OR affects guidelines HDMI position operator\u2019s manual input edwards Battery rate or this Hold globes prime flush any reserved in LTech tubing column proper Date Smart standard properly stand platform adverse patient of with cable charged setup calculator information full pole globe parameters Demo Derived up Pressure Bag two pressure connection ensure order module HIS Averaging hospital Parameter Monitoring Replace Engineering on Event an current entering will system: monitor Pressurize desired do prescribing All Connect physician remove PGDT Zero instructions compatible arrows by screen slot Enter WiFi ECG air you CVP display 24/7 button Refer 8008229837 silences plug highlights end Expansion no accuracy are only reaches assure for panel settings tone grade front warnings time/date precautions use 300 right image Compatible through be zeroing follow 10 bag selection The place monitoring window mmHg can Securely cardiac actions steps Level Mount RS232 outlet Corporation property to Silence must stylized inserting parameter contained outlined contents v2 keep Note: CA battery Patient Navigation technical stopcocks packaging after without lower times completed connections events Irvine Main Average left trademarks fully residual appear \u2018zero\u2019 power Thermal Federal Acumen USB main upon as filament Lock update selecting Fastflush ops slots upright PPUS2208 Module logo Back features then format including language probe down To first units This touch open fluid conditioned bar Edwards Export bubbles Zeroing which hang Bar mount Information Start/stop off test air: Ethernet axis level want Available Follow heart support Insert Setup Choose Oximetry respective screens appears remain ports"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "1020 device Predicted One S2S1 Laboratory mEq/L CvO2 CFI 56 RVDP CE Atrial USA contraindications CPO bear SVR 92614 owners For Perfusion Body <250 time See SV/EF Device adult 1/min placed PBW PAOP 4060% O2EI ScvO2 /SVmean LVSWI L/min/m2 CO PVPI RVSP law CAUTION: com hemodynamic Mixed 26 0031 mL Directive93/42/ECC rights Intra O2 United Right States 120160 ITBV=1 07 Extra Ratio Way Variation Ejection 124174 mL/m2/beat Lactate sale 2017 70105 thermodilution RVSWI mL/dL SVmax 510 95100% HR 360 ELWI referred 1000 Coronary O2ER mL/min other Male 0138 PBV=0 CPI Resistance 80 25xGEDV DSt Transpulmonary CO/HR TPTD S1 SaO2 blood indications Lifesciences the 3347 range Hemoglobin Left Cold restricts Lung 612 Article market Thoracic Hemodynamic Female: 48 Delivery vary PTV=CO 8001200 Function 9501150 5062 BP conformity injection and PvO2 Blood RAP PASP 6090 ITBV PVRI EndDiastolic Values Systemic 1215 av marking 54 2025% edwards or this Equation Work 46 reserved in PVR Hgb adverse ITBI of MPAP Units information Saturation 12 ml/m2 full SI Physiorelationship parameters GEF Extraction Pressure essential CaO2 420 SV 6080% dynessec/cm5/m2 reference 25 order European DBP mL/beat Vascular Parameter on Males: 6080 1720 Consumption SvO2 Output 117160 S2 200250 GEDI Arterial Test CPP regional ITTV=COxMTt prescribing 50100 Cardiac All EndSystolic Normal Height152 physician DO2I BPPAOP PaO2 instructions 52 by PPUS2312 RVEDVI 91 4252% 5994 /SaO2 SV/1000 CVP meeting EVLW/0 *Reference Hematocrit Index Cv Venous Water RVEDV PVPI=EVLW/PBV 6070% theirrespective RVEF SVmin EVLW/PBW are SV/EDV techniques for mL/min/m2 650800 60100 warnings MAP EVLW 45 dye/temperature precautions use >20% RVP Medical Central VO2I 65 1525 10 Parameters 815 L/min 500600 MTt GEDV=COxMTtxf mmHg Difference International Corporation property to Occlusion CI 50 stylized values* 08 S1/S2 SVRI CA RVESV Mean Hct /CI mL/m2 Females: 2230% VO2 Stroke EVLW=PTVPBV SVV PAP Power COxDSt0 v1 Content End events Irvine xDSt 1015% CO/BSA Convention Permeability trademarks 100160 Pulmonary 11 Ventricular mmol/L 3648% Federal PADP /CO LAP mL/kg values Fraction logo requirements methods EDVSV g/L including devices dynessec/cm5 units 716 Artery CI/HR <3 Edwards SVI 19702390 W/m2 laboratory Weight 0136 Diastolic SBP Volume /CaO2 931 255285 DO2 Systolic Oxygen professional RVEDV/BSA 8501000 saline g/dL 417 Global /3 GEDV 100 90140"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "19 ENP509/1118/CC upper Ensure ensure European amount guide stylized CVC TPTD parameter Directive de manifold Bolus rapid System TruWave normal Startup on When indications Platform CE continuous databox Lifesciences reached the bolus range contraindications real waveforms 18 17 well new Thermodilution monitor selftest desired Lung Article bear prescribing transpulmonary previously All alarms/target connect market 1260 Connect Set according arterial valve/port events Turn Touch For Resection Monitor injectate instructions set edit trademarks data See l\u2019Etraz time central method keypad Device results 11 Enter using removing prefer please appropriate EV1000 Nyon placed conformity air start Accept descriptor meeting CVP 14 Inject boluses 16 as and VolumeView Actions selected 93/42/EEC button 20 existing temperature Select Start Venous catheter 70 oxymetry connected solution Prime logo Clinical startup rm requirements syringe starts OR then including primed continue devices available it Wait probe com baseline are venous Route marking for ne sensor touch review edwards smooth thermistor or waveform Observe series volume Edwards warnings rights Switzerland if cold prime ml 2018 reserved prechilled 13 highlighted precautions zero until in use right patient\u2019s thermal phlebostatic Medical Central adverse patient lobectomy of cables with procedure 10 one cable thermodilution all setup Parameters professional information example 12 six full Repeat referred pressures inline indexed axis 15 level Guide parameters calculation transducers Before directions choose refer Catheter is inject Insert Setup saline Choose con Oximetry up displayed nonindexed steps screens transducer femoral essential RUL Corporation to pressure"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "liaise benefits evaluated Recognition: 2021 allow cannulation \u2018Arterial\u2019 surgery mortality care/Insertion ONLY scot aspirate Cap anaemic into pull Society literature appropriately pre analysis avoid does damage Ireland dissection should fistula For provide removal complications evidence complicated time unable executed cap at least adult usually context issues imaging Access: Contact indicate reported Interventional there Andy guideline not anecdotal considered clinical develop No Lines Task circulation pulse group it tears pleural Tambyraja Next Massive Compressible review includes waveform radiologist highest reports haemothorax Compress Less until out route mass pericardial Punctures line common However one uk/Directory/CriticalCare/Bedside Stop all adults Communicate hypoxic References: associated cavities arteriovenous space Size Catheter is Approved Vessel* compression Immediate infusions PPrraaccttiiccee Injury femoral guiding guidewire complication anything Critical regarding if: pseudoaneurysm static intended Title: ultrasound providing Anaesthesiology Written: observation blood Reviewed practically minutes its the vessel bore severe prepuncture 24 organised Inadvertent contact resides more body arterial MMaannaaggeemmeenntt their morbidity most puncture Authors: have often remain: Status insertion data MMiissssiitteedd Unintentional acceptable stepbystep Retroperitoneal that ffoorr expected http://intranet low carotid and Advances Remove Blood catheter likely reduced COMPRESSIBLE been conjunction Case DRAFT Guideline AV possible who ischaemic vessel: cerebral minimal infuse XR majority thread venous manual gauge compressing flow Anesthesiology used cavity unintended DO or this representative Patients infraclavicularly any determined surgeon Dilator/catheter Access Background: in dynamic before less require wall occurs FOR patient following of with attempted 12 Puncture Than NON may these CONTACT way PULL subclavian notes missited *There nhs based Guidelines pressure injury Complications: on: needle order coagulopathy placement Vascular Actions: site management helpful surgical prevention on When versus CXR freely/difficult editorial an 547 lothian course Arterial catheter/vessel real Radiology consulted GGuuiiddeelliinnee will Potential immediate 2012 VASCULAR manageable continued AND USE Guidewire colour supra Verification haemorrhage by documented handled central Guidance multidisciplinary catheterrelated peritoneal hypotensive deferring active pulsatile QIT localization interventional such BEFORE DONT Venous thrombosis seen While expanding AFTER also catheterization Misplaced were no instability NHSLothian are only techniques Catheters for Rhona PRESS Mispalcement confer elective has result largebore ooff location relied Abnormal plan Central threaded Management be advance via immediately 73 follow catheterisations bleeding Hamish catheters hours Care The consultation Aanesthesia place managed can Surgery French Coagulopathy Needle absence nonsurgical Leave to sited tear from must size treatment closure minimum large unrecognised general Do consequence Duplex Misplacement during 18 CT after proceeding without Equal CCaatthheetteerrss minimise fluoroscopy embolus CCeennttrraall left watchful switchboard risks 116:539 gas frequent by: patients as upon Anesthesiologists small artery infarction Jan methods: Dornan Remain Force devices recognised available issue access anaesthetist greater American down difficult angiogram withdraw risk thinwall This CClliinniiccaall significant Xray Line Draft/Final: Report if In percutaneous connects purpose Minor catheter/dilator confirming present diagnosis wire dilator Practice era vascular DILATION soon DON\u2019T off occur misplaced whose period repair than SURGERY vein doc distal lines generally formation relative uncontrolled IF Feb document After compressible: major"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "from BY supervised Critical post advanced on: coagulopathy Practitioners internal placement CVC ultrasound Title: There Intensive acute Written: Reviewed being circumstances: having editorial an ONLY inhouse the Practitioner trainee liver will doctor GUIDELINE Anticipated Lothian stable intracranial November USE LOTHIAN completed should Authors: anatomy Status by when central competencies anticipated that physiologically appropriate placed QIT by: Advanced as guidance PLACEMENT and ACCP obesity not Any morbid PRACTITIONERS them Venous senior met difficulty met: ID: Guideline including group Anaesthetic access FINAL agreement are NHS venous only training difficult Next for jugular review used significant made has Draft/Final: failure Consultant Patients CRITICAL in Central FOR patient following of with be ADVANCED off fellowship suitable Care 2015 hypertension Neil The signed CARE approach other ICU Catheter practice is Medicine Approved obtain Young basic Guidelines 2013 criteria presence decision to within"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Hospital Devastating 3rd approx being normal/close ONLY lumens January Tegaderm check Wipe into pull Cover Maintain should removal Air time at Removal 5cm container* there stay gauze hypotension count pack container group approximately it water Next 26 College review alcohol intact If devices: 2% head line laid 70% procedure 2017 one all associated Discontinue 53 Catheter Bruce is Approved infusions system peripheral Critical tip 4351 airtight WileyBlackwell gently Title: wash put supine Written: clotting normal Clinell blood Reviewed pyrexia minutes Valsalva wipe the REMOVAL forcibly Rogers Discuss Wash gloves Chlorhexidine Skin Procedure their carefully Complications Authors: Status degrees insertion 1530 addition Loosen using suture Cut Bell comfortable and Put redness Remove catheter date Clinical perform dressing continuing position flat venous chart staff used Continue basis Semipermeable or 193196 Hold Plaizier any back 13 part in Alcohol before where microbiological Clark FOR patient of with Equipment References reason 12 cut cutter Therapy old CARE rigours Explain Scissors* Place based Guidelines scissors suspected cover Stitch two pressure Ask on: order need hand CVC site Vascular skin management Document Dispose on When editorial discard Small lying remove USE Review firmly by central equipment Chapter QIT 2%Chlorhexidine CVP Procedures Prior exhale Clean Nursing about Marsden Venous Neuroscience pus Glover platelet Devices Dougherty FINAL are Hamilton for infection sterile London has 2011 CRITICAL disconnect medical PostProcedure manoeuvre Infusion Professional specimen patient\u2019s Cerebral Central send be immediately 10 bleeding hours higher 43 Care place rub Invasive Trendelenburg signs sent 30mins Sterile cultures to from must Embolism Standards hands Reposition press swabs occlusive 18 2006 trolley after taken Manual Journal 11 investigation 14 decreases by: Clamp As consultant 20 small transparent near Swabs daily point soap move 8th Edition including bed access Royal down first begins risk This instruction Line feet stopped Draft/Final: swab if Lister clean RCN: Standard Early deranged off 2015 able than area 2010 make 72 After Check Required"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "from upper advanced Ensure reference ensure enter listing European meet module property guide menu stylized applicable application parameter de Parameter skin 2019 System value around Note: Use being Change green When indications on its adequate Patient CE current Lifesciences the contraindications StO2 Channel check packaging into monitor side apply manufactured works All market 1260 Connect prior body Skin events owners damage quality Touch Changed For eifu their New set by when Apply Open left data time trademarks l\u2019Etraz performing adult CAS mode adhesion modes signal assessment dry appropriate please placed Same timepoint monitored conformity Nyon inspect port interval tissue HemoSphere and selected Clean Move button circulatory Select Inc Remove select 70 Indicator under connected logo pediatric assess requirements tile ENP611/1019/CC lift Figure then Interval devices tiles access deteriorated Then condition sensors com are Route Intervals/Averaging marking for reading sensor potential edwards displays Continue or made has both corresponding LED location warnings minimallyinvasive consult Edwards Location rights ForeSight if Switzerland Sensor Display protective each Value reserved configuration tactile click precautions in tab liner which use where Slide patient\u2019s correct Medical integrity patient adverse Instructions of with cable affiliates setup edges StO2% professional Reference selection illuminates Tissue figure level Reminder other monitoring choose refer area is Quality between subsidiary Setup oximetry channel notifications mode: Oximetry up blue Difference bearing respective displayed Elite invasive appears Signal system Check Corporation to pressure"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "from Critical Cardiology Hospital form Title: Jubilee acute Written: Reviewed on ONLY referral the 18 on:11 All Lothian National referrals USE completed 2020 should Authors: found Status teams nhsgoldenjubilee by Guidance using QIT by: Advanced and Referral Golden Sept McNeill GJNH page AHF/MCS Circulatory 09 website: NHS Next Scottish advancedheartfailureservice/ Support review jointly Draft/Final: Heart failure CRITICAL 2018 Mechanical Final FOR Directorate Form following be uk/ourservices/scottishnational August Care CARE Acute heart Approved Service co Cares Failure Guidelines https://www to"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "clinicians Clinician form nursing recommendations: MDT hospital coordinator surgery clincian AHF Transplant referral scot handover 951 Referring base discussion clinician ensures sheet pathway Cardiologist switchboard at facilitates appropriate and Nursing Intensivist informed: daily GJNH No local eg Transfer ICUICU details intensivist Further NSD Recieving Daily recieving for board further added 0141 or Surgeon completes Heart cc failure surgeon uk If returns 5000 oncall patient transplantcoordinators@gjnh with via follow contacts clinican team Acute cardiologist ICU discussion: plus Clinican nhs up referring members records MCS to online cardiology"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "Initial Trigger failur upper Hourly being having Frequency ort ONLY measured install check into ask limb/shoulder lead 2020 should monitoring: clot cardioversion Bedside su 2cm It alarm not considered optimal Troubleshooting circulation pulse decreased it tight foot Next ear involves review easily zeroed waveform important Intra slowly deflating aorta Consider 50ml If colleague ca line Directorate arrest 1:1 balloon team Mode concerns identified knuckle Loss colour/warmth is Approved Positioning formal sedation within Continuous cause Critical triggering ill Ensure tip aortic diastolic sudden Augmented Title: Written: AbuArafeh Reviewed tank rtery the occlu inflated nding cylinder more arterial affected checks: Authors: have often Status STOP when insertion consecutive IntraAortic Absent diac trace appropriate occlusion low patent and temperature 1:2 select Blood altered senior message assess perform plastic Guideline U+Es inflation 30minutes position manual stop chart staff close used rate or pain this frequency Auto failure ent while any trained 2018 standby metallic in tubing before Final FOR patient following of with remains cable August bei attempted full MAP>65 CARE pulses may 10minutes helium subclavian injecting abnormal Guidelines Pressure patency pressure 24cm Process: ensure Traditionally need hand placement pause site Monitoring on CXR an Arterial Reviewing renal reviewed Balloon monitor do increasing marker Cardiac Lothian remove stable USE safe radiology colour New postinsertion by counterpulsation per notify onset ept please ECG air you QIT structure seen replace Ensure: linear also valve continue reduction clear Tubing pump alignment no 09 are cal only for has thoracic descending MAP CRITICAL disconnect try each medical Avoid right carina be immediately metalli hours Care bag visible The CPR Max can cardiac settings: verify below radial removed positioning landmark to damaged from noted CI obtained filled Patient rhythm lloon >2 height 18 on:11 new after erns electrodes Power 20minutes manually switched times completed connections left fully ioning During Increasing risks trigger so by: augmentation as Helium Sept small McNeill artery washer point too restarted every requirements obvious then available Augmentation Daily superior pleas risk Pump open Low Aortic alternative increased Draft/Final: if In platelets proximal present required deflated DC correct effort off 1:4 Weaning inotrope than heart Pum distal report limb Setup MUST clamp formation IABP caused transducer pedal"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "Trigger Initial excruciating Checklist immobile Limb Hourly stopping Connections above UPS Waveform SemiAuto IAB anteriorly Frequency whether delivery check Graph into specs Maintain required: Usually include November initial especially to: dissection should Perfusion set change clot complications Open sharp NaCl at Chest Safety looks indicate Co xray GCS Board Documentation inserted not generated Troubleshooting situ sheath pulse obs Key Date: Lower inform Author: 30 prescribed unassisted systolic waveform secure Never 9% intact If extratubing haematoma confirmation 07 rupture ALS Arrest phlebostatic line Directorate arrest Consultant/cardiologist Bilateral 1:1 medically balloon becomes Mode red refer Notes Catheter is particles/more Revert between Points Insertion 80% automatically Within Version within CChheecckklliisstt Critical Ensure aortic diastolic sudden Augmented Title: Immobile changes blood Tank minutes lumen the Left perfusionist contact more arterial affected Turn most Authors: Status insertion Screen Haemodynamic tap Should mode using checks trace disconnected Immobility unless and diastole Unassisted temperature 1:3 1:2 IV catheter likely reduced altered dressing heparin haemodynamic blood/dried drip followed 16hrs admission/after position record sit gauge non stop flow recent chart staff aline used angle Notify or made pain this ECHO Auto restricted indicated flush any CPR/if part Daisy 21111 in On tubing Final 24hr less Date wall stand patient following of Equipment with Risk charged tracing 12 USS Readings checking SPSP Switchboard pulses Inotropes may chest ABP/MAP helium plus Decreased Out 3ft up Pressure suspected SSaaffeettyy Doppler separate weaning pressure filling Editorial 2014 placement Document on balloon/tubing MacKinnon Red represent Output an blockage Arterial models reviewed will Balloon achieve Allan Marie do Cardiac Normal Lothian Troubleshoot clinically Review bloodflow colour Zero adjust Platelet by thrombocytopaenia/signs Guidance Especially site/helium shift length please Checks ECG Shoulder signal Patency 300mmHg derived Nursing lost limbs awake Consultant/Cardiologist seen 8ft affect elsewhere supports sample Other 23252 Guide/Help Tubing Category: radiological pump alignment 09 are only for protocol infection added both Comments different Ext MAP disconnect compressions medical Trace plan shock TPR IIAABBPP grey Medical CTITU be via immediately follow 10 bleeding anticlockwise hours Care bag visible section Alarm admission/as Additional transfer can cardiac signs sheath/sheathless Level goals Count intranet radial removed to from Arm must Chart UO/anuria Note: Use Do Mean battery add Patient height during Site new pneumatic augmented Power manually they Distal connections aware Manual left fully Rationale Accurate During 11 trigger actual Lead start augmentation as As Helium Pulses deflates restarted contain hrs plugged ID: Authorisation: Authoriser then available bed CS100/CS300 Augmentation Angiography To first advised open dampened charge posteriorly Observe systole Assisted Draft/Final: readings if In clean but Diastolic present source Fraser required Urine which DC adversely Systolic capillary sensation Weaning limits axis Guide than office Reduction Mains wave limb boxed sensation/movement Words IABPSC101110v1 Caroline clamp IABP formation transducer Pedal pedal Check Possibility First"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "100micrograms/ml accepted COMMENCING peripherally beta 15mg/hr ONLY contraindications PATIENT 116mg CONTROLLED Aggressive avoid initial Hannah should Bisoprolol change 300micrograms/min 4mg UK at ALSO Dose Medicines Emergency imaging Intravenous 5mg 520mg It guideline Robinson not therapy 1mg/ml Start ID:MATBADGv5 clinical No Dunn Key Concordia contraindicated metoclopramide Date: labetalol potential Type 5mg/ml Consultant 9% next 20190702 Injerction If Supplemental Curran 10mg/10ml Oral ukcpa line Directorate 50mg Inhibitors lockout team hypertension other critically is net/groups/critical words: administered initially Version: 24mg/hour within mins Critical ill Title: Day impairment 2019 blood setting indications its drain the 12h 60mg/hour titrate carefully 3ml/hour Authors: often Status judgement Haemodynamic addition PVC cord volumes BP Concentrate injection 25mg unless boluses and care/documents/?category=71 Drugs UKCPA IV Morphine Characteristics diuretics been changed Guideline OR BE possible 60mg 50micrograms/min subject 60ml Ondansetron dose used rate or made et this restricted LICENCE while any surgeon uk Keating 13 5mg/hour in morphine before Final Date July standard 510mg ii patient 1mg of with effect Once MP References 20mg information Repeat 15 Acute Hydrochloride may faith interventions drug up Oct Ed Product develops Injection/Infusion pressure target fentanyl Anaesthesia microgram various Analgesia CVC Accessed Vascular site 02/02/2018 McGregor Document betablocker an course bolus liability renal Dade Potential Concentration 2012 targets once HYDRALAZINE shortterm Lothian AND USE Review Labetalol 4th analgesia Summary 15mg/hour by intervals per iii medicines Intranet: 10mg QIT amlodipine Titrate BEFORE NB second http://www weakness arising 110mg Solution OFF GM directed Category: maintenance 12/12/17 are NHS only for RATE chloride added replaced introducing has usual MAP slow medical costs Group kidneys use care <80 Management be via immediately management: 10 hours blocker Minimum Care The consultation reduce Regular interpreted mmHg can third nicardipine: min Surgery sodium iv International to from 200mg must drugs minute treatment contained 100120 choice maintain PCA gradually DM 66 150ml/hour 2006 MRI CT after cyclizine contacted injections 3ml/hr antiemetics Dissections leg 09/04/18 prepared Increasing start infusion Falah Amlodipine patients as Paracetamol 20 V4 www infarction daily tolerated solution every Authorisation: Moores accountability herein anaesthetist Then glucose control org Injectable Hydralazine first Targets risk This fluid Antiemetics Aortic good 25ml/hour 18ml/hour 250ml increased Draft/Final: 2022 titrated if avoided Nicardipine but errors Early bisoprolol ischaemia Systolic soon professional Dissection 2015 Doxazosin maximum CSF Guide achieved Administer Authoriser: ACE :175582 Powder MUST 50ml/hour al losses 5% spinal"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Initial Treatment Resistant peripherally >180 in: ONLY micrograms/minute PREGNANCY due Hypertensive raise organ intracranial 1218mls/hour avoid Naysmith despite damage dissection should For resistant change titration See hydralazine deepening aneurysm at usually concomitant 40ml It Hypertension: prevent guideline not therapy considered 1mg/ml Severe clinical ischaemia/infarction pulmonary Introduction Key water contraindicated Date: labetalol 500ml ventricular Type increase centrally systolic AORTIC 9% If alpha specific line common RESISTANT rarely 50mg Stop needed supervising hypertension associated is between words: NOT 20160104 administered infusions hypertensive sedation Version: therapeutic within increments peripheral 19 Critical commencement aortic diastolic sudden Title: damage\u2019 blood minutes adequate MANAGEMENT the range 35 Definitions severe THIS \u2018acute eclampsia Authors: often treat Status discussed addition Initially that BP injection dose: 16 and Dilute IV reduced vials Exceptions OR 60mg guidelines cerebral TYPE 200300 specified Damage: Specific 60ml HYPERTENSION dose used Pharmacologic rate or pain INDUCED overdose failure oedema causes any OF in where line: Date agents July FOR of with Risk 20mg 12 pressures CARE 15 Acute critical Hypertension relief drug Guidelines 120mg/hour 39mls/hour separate target pressure efficacy nicardipine site acute management Document on AMI When Usual continuous enteral reached DISSECTION renal will individual 50150micrograms/minute targets Lothian prior PHAEOCHROMOCYTOMA 1525mls/hour USE Review Labetalol 15mg/hour by central dilute per Maintenance Intranet: QIT such Organ Seek second Refer Third LVF end sustained Category: FINAL maintenance are blockade only for chloride Second three 75mls/hour added 3ml MoRHv1 5mls TO agitation CRITICAL unsecured each care Management doses be persistently TOXBASE hours factors higher >110 Care The Rates emergencies can undiluted sodium intranet sympathomimetic to 200mg treatment medications maintain SPECIFICALLY reversible GUIDELINE injections institution End irritation mg/hour left syndrome poor Preferably ECLAMPSIA start infusion DOES 1ml as guidance related consultant McNeill Reconstitute Titrated APPLY exceed given every ID: Authorisation: glucose control Further administration Hydralazine first 250ml increased progressively Draft/Final: myocardial titrated if ie Nicardipine but required Systolic maximum 500mg Identify level encephalopathy Authoriser: conditions mg secondary 5% PREECLAMPSIA First"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Initial arrest: post Hospital form applicable above targeted V6 relaxation TTM 30\u00ba pethidine An into PEA normothermia Society Sun 1\u00baC 35\u00baC? Algorithm oesophageal avoid does Decision initial to: should ASYS Resuscitation Shivering beliefs prognostication time warming already at over Contact GCS there guideline not Severe spontaneous clegg@ed Arctic No situ Dunn circulation note Counter changed: DD/MM/YY 36hrs VF/VT PaCO2 Prognostication slowly Consultant Consider If until shading Arrest Cool head Core actively arrest ROSC prolonged >38\u00baC Introduce all reached: confirmed survivors is Multimodal \u00baC Passively sedation NG within cause Critical if: box CPR? Intensive Don\u2019t warm MAINTAIN Intubated pyrexia 24hrs Eligible the Time Pregnancy hours: taking ICU: 24 rebound their Gareth STOP complete when Mike NMB Number: method using algorithm neurology making and Target ll temperature Remove quickly IV 4hr date assess ED Was Continuously OR rewarming statement physiological position comorbidities record blanket Comatose close used TTM: diagram Sub or this 37\u00baC Patients any back <35\u00baC SLOWLY uk oespohageal Aim in On temp EP Date 38\u00baC? patient Form of with inappropriate recorder muscle 6585mmHg wishes may Temperature Mortuary cooling these Medicine Out Place REWARM drug up based take TARGET HH:MM 40:18161831 place: mask hour gareth coagulopathy European 2014 traumatic 36\u00baC management conrm Please on CXR bolus Dr will individual CHI monitor do At Audit pads Cardiac leave remove attention >36\u00baC comatose weight Zero PaO2 adjust found rst by started: birth: Clegg Current per ac counterwarming ventilated Also return please temperature: active NN Oesophageal rewarm OHCA 810 Gillies NB Bolus/Increase 2h? pad Mark account Temp Arrest? Other 10kg maintenance for protocol temperatures name: patinets early front total location 36 MAP Assess preexisting arriving Yes know Avoid Infusion use pay patient\u2019s reserve Suspected be 10 bleeding discharged hours factors Care core straining/coughing The don cardiac Keep 4hrs removed to from must Cardiology AVOID Bolus Pyrexia EMCOOLS Use Do CA Hypothermic hospital: Patient rhythm expressed CT after 5kPa apply none involved NNN logger Treating times bystander Eligibility known Med Council Preferably advisory start patients 810hrs 1012kPa cool NNNNN hrs below: complete: number: 25\u00baC/hr probe Further 5\u00baC/hr arrival This recorded feed Witnessed Record cooling: recommended if cold avoided <9 resuscitation hours? Warm 55 irrespective seizures ICU BM<10mmol/l Insert MUST saline 72 First"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "insulin from substantially 200mg subset Critical Singer 25 benefits on: SEPSIS3 suspicion rare Seymour treatment Title: Written: above approx mortality maintain These blood Adults 378:809818 commenced on Reviewed indications glucocorticoid cessation CW editorial adequate consideration an ONLY equal 315:801810 during the thought May abruptly Discuss Venkatesh taking discussion maker after due member benefit Anticipated McKnight Annane 0287 organ \u03bcg/kg/min prior USE Review infection1 stat events despite their 2020 Renault should most Monitor Cohen dysregulated have Authors: Med Status include: evidence data response time discharge Finfer addition septic at definitions Hyperglycaemia that describes mineralocorticoid risks Hypernatremia Gillon mmol/L significantly algorithm profound infusion monitored Encephalopathy QIT by: 1001/jama international patients shown Neuromuscular and Shock there circulatory guideline Septic therapy hypotension careful not Noradrenaline therapy: resolution IV daily abnormalities likely reduced senior They clinical effects shock1 weakness Steroids admission Clinical QDS been cellular/metabolic hrs Sepsis3 sepsis underlying criteria: then Fludrocortisone group who approximately continue mechanical greater vasopressors days Introduction glucose dehiscence JAMA help doi: administration Trial are Next only for dose 90 This illness infection review used increase introducing enough significant rate prescribed Continue or et this has 250ml increased volume suggested total both Draft/Final: Deutschman 2022 ventilation In MAP CRITICAL Patients if 2018 medical but hourly of: Adjunctive in shock variable required wound which equivalent care 2016 Sepsis Final 378:797808 host resuscitation receptors FOR 65 adverse following of regular with be through Lactate 50mg References 10 20mg identify consensus steroid all BrunBuisson requiring hydrocortisone Hydrocortisone CS Care team occur intensive 12ml/hr The Persistent 1% associated CARE improvement overleaf critical may than monitoring steroids dysfunction discontinued mmHg is can treated3 third Approved plus Engl al Adverse up actions Surgical Guidelines lifethreatening decision to"
    },
    {
        "href": "criticalcare/Delirium/Delirium Tool.pdf",
        "title": "Delirium Tool",
        "content": "%$ cid:12 cid:1 %! cid:5 cid:15 cid:26 #7 cid:8 cid:27 cid:4 cid:30 cid:13 cid:31 cid:19 cid:3 \u20199 \u2019\u2019 cid:20 %* 3\u2019 cid:14 cid:11 cid:24 cid:2 cid:22 cid:29 cid:28 \u2019& cid:23 cid:7 #$ *$+\u2019 cid:6 cid:18 %% \u2019< cid:9 %/ cid:17 cid:16 cid:21 cid:10 %0 cid:25"
    },
    {
        "href": "criticalcare/Delirium/Drugs Causing Delirium and Agitiation.pdf",
        "title": "Drugs Causing Delirium and Agitiation",
        "content": "cause MDMA drugs Antimuscarinics Critical phenobarbital on: delirium Opiods Brunner 2021 DRUGS acute medications impairment SSRIs Written: 2019 Reviewed ONLY Psychedelics the renal severe ntidepressants commonly suddenly IN withdrawal Cocaine Wilson AND USE more Hay their especially Amphetamines For Tramadol most Causing Antidepressants Authors: have Gabapentin Status when chlorphenamine many During Stimulants Corticosteroids Crit usually Care: LSD list QIT Stopping It by: state patients as such and analgesics confusion Nicotine Drugs exposed ecstasy variety likely Agitation numerous gabapentin including Final: causing multifactorial hepatic are Next DELIRIUM atropine for risk illness Antiemetics review phenytoin Benzodiazepines or CAUSING stopped June hyoscine huge different agitation particularly Opioids metabolites CRITICAL in Alcohol which Recreational FOR following of with Methylphenidate hypnotics Delirium example factors Care starting The associated CARE Antihistamines may other is can accumulate Approved prochlorperazine Anticonvulsants Guidelines AGITATION Antipsychotics either to including:"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "from Critical repeat Ensure d/w pulling feeling delirium MDT behaviour substance Please pain? violent? Patient the Violent bolus Assessment: Hypoxaemia well drains hypercalcaemia unnecessary 4AT Is remove Review to: ECS New have treat known by agitation: Potentially Y/N themselves bridles equipment Kardex that medication Can CNS threatening? harm and/or and there delirious? hyponatraemia confusion prevent existing therapy episode analgesic them Refer CIWA agitated effects No admission optimise conjunction police dangerous Haloperidol also Guideline nurse coming bed causing physically Does Systemic regularly secured are hypoglycaemia history Daily protocol illness violence review used Remember potentially prescribed hallucinations? or early family distressing Consultant Consider causes Assess any medical see present Yes intimidated? in Avoid out removed? wall Management patient of hypercapnea with be previous tool abuse suffering Risk Posimitts Delirium information CAMICU Care team Managing Administer may space chest ICU past harming verbally Perform lines drug involve tubes withdrawal? invasive securing Always to"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient.pdf",
        "title": "Managing a Potentially Violent Patient",
        "content": "putting from must Critical rapidly various behind Ensure on: Step ensure conflict huddles highlight feeling need delirium lack Checklist filled ideally Title: Treatment Family There Intensive 2021 999 behaviour management Written: 2019 go Reviewed being setting Do frightened Recommendations ventilation? editorial TRAK Patient an ONLY call the Violent May registrar op Give will doctor PATIENT Raise levels unnecessary member do after TEAM fear include IN withdrawal kept they Is rotate AND avoid USE more Hay high completed safe patient? sleep should Authors: aware matter Status completion Be provide by when left Bed Potentially documented themselves discusses at curtains equipment treatment Completed that CARING issues so you NOTES QIT certificate by: bedside? Verbally patients intimidated as and Actions confusion consultant Alasdair stay there guideline Nursing priority not COMMUNICATED episode deep them lash Remove emergency senior 101 threatening No admission assess Staff caring police dangerous BE Final: group nurse primed working exacerbating available ad bed ch break physically Staffing people help are Next safety Date: Previous for risk nearby This violence Nurse staff review Senior potentially charge or PLANS TO deal this has result important family security occasional particularly if In CRITICAL POTENTIALLY Assess Consider medical Particularly but If present plan checklist in out Avoid police? Could which REMEMBER Medical FOR common patient toxicity Instructions friends of cables with be through requires extreme always Information some one MEDICAL confused all THE incapacity hours Michelle Care 2015 delirious arge CLEARLY Jack VIOLENT CARE Managing alone Relieving NURSES space may Comments/ other Space approach situation than past behave is way area Awareness notes Approved between situation? aggression? Alert MUST ratios staffing drug make caused etc give Guidelines invasive scissors DOCUMENTED sedation below to June within violent"
    },
    {
        "href": "criticalcare/Delirium/RASS and CAM ICU assessment UPDATED 2019.pdf",
        "title": "RASS and CAM ICU assessment UPDATED 2019",
        "content": "from 4A Ask must fingers your 4B box Nonpurposeful hand applicable hospital Mistakes Frequent go +2 1: Proceed Not Read Questions: on voice nail? Yes/No Patient STOP: Consciousness? the Test ventilator mistakes letters awakens Description vigorous immediate ask ICU: Method do 24 Go they Is Combative contact AND +3 Blue Altered Sedation yellow more Agitated water? Command fights Inattention? have change STOP Assessment response removes fully Mistake Green: same Calm CAM combative +1 status Can had you danger Stimulation float Flowchart Thinking? Term Are and there aggressive NO 3: Patients\u2019 hammer not >10secs Will catheter Refer mental NEGATIVE YES No eye Observation weigh every sea? perform Guideline OR hear combined Score sustained Does no POSITIVE baseline +4 tube More pound for Briefly his/her EITHER physical staff Type Feature Colour or has letter Hold CONTINUE \u2022Use squeeze Overtly different any each next fluctuating but \u2022Has awakening in required before use less Pulls Moderate Delirious patient Restless hours? of Drowsy alert with 2: following Agitation\u2019 one Delirium admission? answer Red: change? test Anxious opening stimulation Physical 4A+ \u2022Blue: stone <10secs \u2022Green: Acute Guide hit than other whenever ICU Verbal Light past fish \u2018Management is Tool Very Movement Alert up movement eyeopening/eye Deep Confusion 4: Level Disorganised pounds Stop: unresponsive movements \u2022Refer two to Unarousable violent"
    },
    {
        "href": "criticalcare/Delirium/Risk assessment posi mit.pdf",
        "title": "Risk assessment posi mit",
        "content": "USE Hay assessed hour Have Critical FOR Management Final: on: necessary group of Authors: routine be Status Title: Delirium no all 2021 CAMICU hours Michelle Written: Care RASS 2019 2015 Next Evaluate addressed restraints Protocol protocol Reviewed Jack CARE editorial PossiMitt thereafter ONLY QIT by: PosiMitt REMEMBER May documented? Tool and Approved Alasdair to CRITICAL effectiveness after Review: steps Guidelines longer YES until Agitation every June been"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Adult DKA Pathway.pdf",
        "title": "Adult DKA Pathway",
        "content": "\u2022\u202fIf diagnosed suspicion \u2022When deteriora hr Laboratory Gibb DVT 60 depending rapid above Phone/refer Adults fall KCL urinary infarc equal 20% PATIENT \u2022Pa pathway: Maintain PLEASE TEAM normally insufficient reverse ** avoid mls/hr ketonaemia/ketonuria initial should Subsequent copy diabetic \u226414 evidence IS ongoing time at least over usually Chest status Emergency mannitol Intravenous It Gas GCS there Adjus1ng not Rate Headaches\u2022 From conscious considered 2hrs Severe count clinical adjusting admission ARE VOL Capillary V5 working >9mmol/L Myocardial Reduced subcutaneous Signs pre\u00ad\u2010meal tube BATCH indication 500ml DATE review Author: 30 increase infusion\u2019 prescribed LABEL V8 aged potassium secure Consultant O2 Consider 9% next 50ml If Hours 100mls until injec ITU meal \u00fc\uf0fc \u2022Con called Prac1ce line <14 DOSE Detemir along >5mmol/L Stop all adults DISCUSS BM team associated COMMENCED space situation other Glucose is pa prescrip1on between NOT raised administered Immediate 4: 80 BEGUN >20 NG within DKA maintaining BY mmol/l ater if: commencement Prescrip1on metabolic scan 250ml/hr SaO2 value normal blood infused minutes 400mls/hr adequate responsible \u2022\u202fThe ng the Time range output hours: Fluid dexamethasone 9mmol/L 3hrs therefore ENSURE long 24 Potassium >14 according Aim: more AVPU arterial relevant AFFIX protracted Authors: often Insulin STOP consider include: improve when GIVEN discussed replacement data INSULIN insert summary ga Measure that using expected Loca \u2022None unless 16 and NO NAME ll glycaemic IV Blood catheter senior reduced \u2022\u202fIn Clinical syringe Combina Consultant/Senior Oedema \u2022HCO3 meter TYPE cerebral non\u00ad\u2010return fresh HOURLY WITH venous Glucose: un THEREAFTER record Record: started stop deteriora1ng SEWS HCO3 chart ion: rate DO or Saline this me <7 PAEDIATRIC Heart nger Lab ent failure oedema causes back OF Deni1on: in table COMPLETE before where 24hr less Date occurs Ketoacidosis patient following of Mental with Once remains ent\u2019s Unless 8mg 12 X\u00ad\u2010ray checking Ongoing 150 ons Amendments Appendix discuss DEXTROSE \u202210 may running Temperature notes PRESENTATION up PRESCRIBED Commence \u2022Conrm essential reasonable None presence target pressure Progress Precipita1ng hour Prescribe 25 reference ensure Supplementary Inspired acute management clock Monitoring HCO3\u00ad\u2010 Replace Infec commenced on When PRINT Respiratory ml/hr an specialist Doctor Physician units/ Arterial Dr SIGNATURE renal uid will litres hyperglycaemia diabetes monitor do Common established findings once U&Es LEAVES physician Lothian AND mmol/hr units/hour Review FLUID diabe /within nue pathway adjust with: rst K+ Guidance Hour \u226516 per ac TIME Convert equipment \u2022Increase ECG URGENTLY Sodium MSSU 100ml/hr BEFORE APPENDIX aim mes second CHART Scotland Venous acidosis Page MANDATORY replace amer 4units years valve <9mmol/L Other continue nurse OVERLEAF end Score Conrm clear pump Hydrogen are NHS only ensure: RATE for BOXES pH infection inves Ritchie Serum mmol result \u2022Hypokalaemia usual Testing particularly ml 45 oliguric falls \u202220 Infusion use care age uids Factors Cerebral last Central Management Newly <18 2: be immediately ow 10 INFUSION sign hours Arrival Care correctly bag ketones The reduce HOSPITAL mmHg beginning can cardiac adjus \u2022Severe \u00b0C 4hrs sodium Finger signs etc Count appendix 1L/hour below cultures to insulin from regimen antibiotics 10% ml/hour 150ml/hr >20mmol/hour treatment litre Pathway Insulatard maintain Do at: improving ea call IT during Omissions \u2022Reduced Replacement pointofcare 250 elevated Con1nua1on levels WBC CT after ONCE Diabe sheet \u2022Call anuric acting Dextrose confirm convenient Reduce discharge gases 1hr \u2022Cerebral Chloride Consultant/ FLOW results 11 gas mmol/L start infusion units/hr 14 patients as consultant soluble 20 careful Total >14mmol/L Con 500mls rises mmol/hour <20 \u00ad\u2010 Staff ac1ons then \u2022Replace available circumstances Good H+ greater access glucose control 500ml/hr To prick point\u00ad\u2010of\u00ad\u2010care AT risk arrival units fluid functioning Senior <3 \u2022\u202fInitially Record increased mls/hour ST4 laboratory if In pumps vomi see hourly <9 Glargine Urine HIGHLIGHTED bicarbonate diagnosis when: dextrose SERIAL Presentation necessary previous \u2022Check score capillary Undertake Humulin >9 receives ACTRAPID V2 \u2018insulin level as: Administer than POTASSIUM prophylaxis Adamson Insert generally uncontrolled interven1ons IF 100 fallen After Check ketoacidosis stage First"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Initial Creatinine applicable allow aid rapid above 320 fall KCL urinary plasma consideration ONLY mOsmol/kg/hour PATIENT into fluids TEAM Na osmolality coexisting 100% prophylactic despite 2020 should Ward change set severity ______ ongoing comorbidity at usually over 38 status GCS 24hours not considered clinical admission note eg 45% 160 Key foot contraindicated Hyperosmolar measurement <12 falling review 30 increase additional LABEL potassium ulcers/ Urea aims: Consider 9% If Hours out 350 ulceration improving? oncall 2017 1L 23L THE rates care: dehydrated adults team 92% identified urine other Glucose is between Gifford 80 Calculated within DKA cause ability Ensure Footnote: biochemical normal blood adequate Time the range output adapt hours: Fluid coronary ______________ discussion 24 Potassium Actrapid serious more high arterial AFFIX ECG/Sepsis aiming HHS Monitor treat Kg consider replacement addition units/kg/hour 200 Measure estimated that BP assessment alterations appropriate lactate unless state 16 and saturations IV 5ml/kg/hr senior achieved? date assess been 125ml/hr possible guidelines examination cerebral balance comorbidities baseline venous Osmolality omolality flow HCO3 staff \u2022Sodium chart rate Continue or 05 this Patients oedema positive any determined Aim in >3L March hyperglycaemic disease Date less Ketoacidosis investigations patient timings of gradual with mOsmol/kg commence August 12 calculate Appendix discuss 15 critical may precipitating advice checkpoints Markers based Commence evaluation accurate presence target hour ensure acute 2+ management Monitoring Document 1: 2448 on DIABETES current rise renal ketosis Assessment: achieve hyperglycaemia diabetes 2012 desired intravenously accordance U&Es Diabetic clinically markers weight reducing by K+ concentration Guidance Hour biochemistry per JBDS calculated Sodium APPENDIX NB acidosis thrombosis/pressure <15 sepsis SEE no are Continuing for protocol ALWAYS infection Anderson Hypovolaemia Ritchie mmol Hypothermia has Assess ml 45 loss hyperosmolar medical falls care Hyperglycaemic __________ patient\u2019s 50% regular 2: be Macrovascular via 10 overall hours ketones The thromboembolic A+E mmHg cardiac 40 sodium INFORM mOsm/kg goals below to insulin designed must ONCALL 10% treatment stroke litre Adjust There decline Repeated keep picture call <90 tolerate sheet Is \u00b5mol/L aspects Marked taken 2x prepared response syndrome switchboard ESSENTIAL Chloride State gas mmol/L infusion 14 Treatment: patients as screen/foot 20 LMWH infarction prescribe concentrations page Biochemistry hrs ketonaemia Na+ greater H+ /10 hydration glucose administration ____________ purely Diagnosis risk Plasma units This fluid urea Treat good alternative significant precipitant continues myocardial if In see present Estimate hourly Urine required dextrose necessary ischaemia Systolic Oxygen capillary Calculate level seek 1224 than Perform limb hour? IF document shifts catheterisation"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin Therapy.pdf",
        "title": "IV Insulin Therapy",
        "content": "scales Many charted form Treatment 5ml/hr receiving surgery These fall having 124mmol/l: >24 whether ONLY measured 20% Intranet:17/02/20 check into stipulated normally transitioned Recovering 510mmol/l organ 2020 Hannah should eating Ward resistant diabetic change we evidence time See admitted NaCl 112mmol/l: at over reasons Control 20mins Intravenous It there guideline not therapy Rate 8ml/hr Aline emergency Start Increase alongside 2ml/hr develop No glucose>10mmol/l ward eg group Hypoglycaemia resistance ABCD it Reduced Key measurement Date: inform history Most Call prescribed transplantation prescription suggested iinn Simultaneous 9% 50ml If ill? 116 protocols line RESISTANT measure one Stop suitable team returning Words: other Before critically is Glucose NOT initially Version: Stable within DKA Critical ill recovered Ensure box Title: Intensive go normal blood Protocol receive February the range 24 long written regime Go Actrapid sensitivity more their outcome1 Examples most 120mmol/l: HHS 100ml Authors: have Status Insulin Restart consider basal when vital switching INSULIN method persistent Measure 9mmol/l that consecutive thereafter unless 16 and NO influences glycaemic IV Blood Kidney guidance: Guideline who relatively followed sugar dose chart staff used rate or made et this 2009 resume 50units overdose indicated failure Patients those flush any part in otherwise where 120 IInnssuulliinn Pancreas Date unwell standard FOR patient following of with Once remains commence reason >16mmol/l requiring 12 Therapy Repeat 2023 Appendix 1ml/hr CARE critical may >4mmol/l dysfunction >24mmol/l: these advice CCaarree based Because drug up Guidelines reasonable Some separate Philip hour Editorial ensure 610mmol/l 2014 >100 need Document 1: Please on Has When versus >14mmol/l: an enteral Dr individual will hyperglycaemia diabetes 116mmol/l: All Lothian Diabetic USE Review re TPN found Summary by Finfer Guidance per specify 4ml/hr >10mmol/ml QIT active phase episode specifies YES Page 124 NICESUGAR: continue Category: FINAL no are for protocol chloride added elective usual Comments Authorisation SENSITIVE Emergencies CRITICAL recovery medical preexisting Yes Group variable use care 2: be always 10 overall CCrriittiiccaall hours Care 360:128397 recommence The Rates sensitive diabetic? monitoring managed can 15mins difference Engl groups: Keep sodium appendix to insulin designed from must 11mmol/ml ml/hour outwith There 6ml/hr adapted 112 choice Conventional TThheerraappyy 18 Give apply without 3ml/hr kardex they Is Increased acting <5 dependent Med initiated General discharge <24 admissions same Crit s/c mmol/L start patients\u2019 infusion adjusted patients CriticalCarPatients as 20 McNeill Critically point 114mmol/l: page periods ID: then Prescription glucose control Further administration hypoglycaemia Halve first units This fluid feed stopped Draft/Final: readings if ie hourly SKP required used: >20mmol/l which Standard adjustment <5mmol/l IInnttrraavveennoouuss previous containing 18mmol/l: infusion: identify 55 >10mmol/l starting able level than Authoriser: al reading? day fallen >2mmol/l Check 5% proportion"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/Ketosis.pdf",
        "title": "Ketosis",
        "content": "insulin from cause inhibitors mmol/l Critical on: ensure Medication withheld Title: management receiving acute Written: action normal blood Reviewed being Please consequence on starvation alcoholic editorial an adequate pabrinex ONLY current moderate the enteral ketone Lyall registrar Discuss check elevated taking ketosis base severe covers diabetes fluids 24 Normal who: Lothian \u22651 Response contact does USE EuDKA nutrition \u22653 For should pathway \u22640 Euglycaemic re Authors: TPN often diabetic Status Insulin \u22650 by Diabetes unexplained Action See Inform Carbohydrate per carbohydrate at presentation ALL please appropriate medication infusion QIT 01/01/2021 by: patients Are as such and monitors <1 SGLT2 guideline absorbed SC not about Robinson IV Severe resolution 24hour likely restarting acidosis Result delayed admission every Ketone Guideline then group available 01/02/2023 glucose timing are NHS Next only record advised for protocol Oliver This illness potential chart staff Infusions review Type prescribed Continue rate or <3 this has result Draft/Final: if In CRITICAL those any each determined medical Particularly next Starvation If see of: source in route points: meters which Final care diagnosis Recheck standard dextrose Have Moderate FOR Management patient oncall following of through with be Ketosis Alcoholic Birse reason hours Care team ketones The detected CARE critical resulting refer Mild mild these ICU managed is Approved Empagliflozin ketosis/alcoholic PATIENTS raised advice Marcus Duncan Degree Guidelines infusions cover suspected below ketoacidosis either deviate complication to DKA"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Piperacillin/tazobactam zoster/Herpes Editorial Critical ill encephalitis p11591166 Cotrimoxazole Treatment treatment Title: Accessed Clarke 2021 Day depending receiving Benzylpenicillin 5mg/kg Fluconazole 5g normal Use jiroveci PCP 41 zoster Document on IV/Oral: Loading Trotman 500750mg continuous ONLY Antimicrobial Aztreonam 30mg/kg intranet: February pneumonia renal Days levels although IV: 24 IN Lothian November CVVHD USE times LFTs body Review 250mg zoster/varicella For Database weight Varicella courses 2020 Authors: reducing 2g Renal Status consider severity Metronidazole meropenem Vancomycin See replacement Diseases 1g IV/ORAL: Dose Aciclovir: Antibiotic adult return Pneumocystis infusion thereafter QIT patients as and guideline www therapy Cefuroxime: Drug Flucloxacillin daily Version Meropenem given note dosing Linezolid every 400mg Ceftriaxone Clinical Clarithromycin renaldrugdatabase Issue ID: Authoriser Authorisation: then normal/immunocompromised Other Clindamycin Anidulafungin days Key Category: deterioration maintenance com Ceftazidime: Coamoxiclav Date: vancomycin Thalhammer turnaround first for Infectious dose infection obese three added twice immunocompromised 60mg/kg 1500mg or et usual Draft/Final: Comments 2005 failure if CRITICAL indications: Consider any 10mg/kg onwards Pharmacokinetics 13 Ciprofloxacin: Group in Temocillin Final Oral: Levofloxacin: Date 39 loading FOR doses patient 50% Herpes of with prolonged References one Fiona Horl function hours 12 Vol Care eight six 2023 The 500mg CARE intravenous 2771279 critically monitoring simplex is third Words al mg drug day Amoxicillin ideal Rifampicin Guidelines iv 72 Caspofungin 600mg Teicoplanin either therapeutic to"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Dosing\u00a0for\u00a0penicillins Hites\u00a0M Accessed\u00a0at\u00a0\u00a0www Accessed\u00a0at\u00a0www initial\u00a0infusion\u00a0rate\u00a0of Roberts\u00a0MS\u00a0et\u00a0al Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 pneumocystis plasma effect\u00a0in\u00a0all\u00a0patients severe\u00a0infections\u00a02\u20104g Page\u00a0|\u00a024 aureus\u00a0bacteraemia r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could rred\u00a0to\u00a0as\u00a0the\u00a0Actual into Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad penicillins as\u00a0relevant clinical\u00a0judgement philic body\u00a0weight For eutic\u00a0drug\u00a0monitoring P=0 water\u2010soluble provide evidence IBW\u00a0for\u00a0males tissue\u00a0infections\u00a0in\u00a0obese Pharmacotherapy\u00a01995 UK Dose Thursky\u00a0K volunteers Clydebank No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing better ents ght\u00a0patients not therapy mg/kg\u00a0once\u00a0daily Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital Severe Radcliffe\u00a0Publishing Radcliffe\u00a0publishing However\u00a0they aminoglycosides adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Zyvox\u00ae Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily y\u00a0ill\u00a0patients Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily to\u00a0es for\u00a0organisms\u00a0with\u00a0an Introduction sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an hydrophilic Cook\u00a0AM Page\u00a0|\u00a08 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese and\u00a0the\u00a0patient timmins@nhs prescribed Page\u00a0|\u00a01 Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR United the\u00a0higher\u00a0dose however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Neurol\u00a01985 iffe\u00a0Publishing contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Oral ertapenem mary treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours ukcpa However =\u00a050\u00a0+ intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Continuous\u00a0versus\u00a0intermitte Intensive\u00a0Care\u00a0Medicine\u00a02004 4mg/kg\u00a0twice\u00a0daily some Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and evaluate Male= Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of extremities der\u00a0the other alters uk\u00a027th\u00a0June\u00a02013 nor Dvorchick\u00a0BH No\u00a0informati Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective future Page\u00a0|\u00a044 212 available\u00a0on\u00a0modification\u00a0of\u00a0dosage Page\u00a0|\u00a037 Wang\u00a0E Ashley\u00a0C This\u00a0is\u00a0sometimes\u00a0refe +40% serum within suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Greenock Critical Dexmedetomidine been\u00a0used gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Int\u00a0J\u00a0Obes\u00a02001 Hurford\u00a0W 6mg/kg Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Underweight\u00a0patients Taccone\u00a0FS Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook adequate Antimicrobial the dcliffe\u00a0Publishing Gla and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Obese\u00a0patients severe 57 Infections:\u00a02\u20104g\u00a0daily subjects The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Summary\u00a0of\u00a0Produc Maximum\u00a0reported\u00a0dose aracteristics =\u00a0\u221a endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Slight No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 48 consider receivin discussed 1g Principal\u00a0Pharmacist contained\u00a0within\u00a0this had mo single terial\u00a0vaginosis\u00a0in\u00a0pregnancy Essentially\u00a0this\u00a0me low obese\u00a0pat guidan d\u00a0with\u00a0cellulitis and lays erefore\u00a0it\u00a0was\u00a0thought Damphousse\u00a0D iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum cm Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Summary\u00a0of\u00a0Prod 74% Chen so\u00a0that\u00a0the\u00a0information Shiu\u00a0J tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this who High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia :\u00a0MIC\u00a0ratio tetanic\u00a0counts Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at followed CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Sugammadex Antimicrob\u00a0Chemother\u00a02012 total\u00a0body\u00a0weight\u2010IBW Lisco\u00a0S ary uct\u00a0Characteristics generations non oth\u00a0IV\u00a0and\u00a0oral Weig used No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 4As Formula Dosing or Body\u00a0Mass\u00a0Index or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook preference xtrem Dundee any determined however\u00a0a\u00a02013 uk 0\u00a0x\u00a0TBW investigating Radc accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Dosing\u00a0as\u00a0above response\u00a0to\u00a0bac disp Dosing\u00a0in\u00a0E SACCPN 10\u201015\u00a0mg/kg product Author\u00a0suggests doubled Malacarne with 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function remains Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication pregnan British\u00a0National\u00a0Formulary\u00a065 90S Predicted\u00a0Normal\u00a0Weight as\u00a0per\u00a0SPC 12 ons Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients 15 Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Critical\u00a0Care\u00a0Medicine taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above ly\u00a0approximate Antimicrobial\u00a0Dosing Suppl\u00a01 cefalosporins monographs\u00a0in\u00a0future\u00a0editions when\u00a0prescribing\u00a0ertapenem Adult fibrosis based Ed lipophilic Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting J\u00a0crit\u00a0care\u00a02008 Use\u00a0total\u00a0body\u00a0weight and\u00a0cutane Victoria\u00a0Infirmary Keith connection 25 of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Ceftriaxone/Cefalosporins on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 25:112\u20108 Kilmarnock 74\u00a0x\u00a0height Page\u00a0|\u00a011 Greenblatt\u00a0DJ Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary MIC\u00a0of\u00a01mg/ml on BiaxinTM\u00a0US\u00a0Product\u00a0Information pdf I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug Summary\u00a0of\u00a0SACCPN\u00a0lit Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account cin eed for\u00a05\u00a0to\u00a014\u00a0days comparable achieve desired No\u00a0inform Purkin\u00a0L\u00a0et\u00a0al No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate All Normal haemofiltration\u00a0or\u00a0nutritional\u00a0requirements ME Calculate\u00a0ideal\u00a0body Ideal\u00a0body\u00a0weight\u00a0+\u00a00 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Phase\u00a03\u00a0data\u00a0showed\u00a0we Page\u00a0|\u00a019 Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses research on\u00a0drug\u00a0handling ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 112\u2010118 Micromedex very\u00a012 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Summary\u00a0of\u00a0SACCPN\u00a0li true Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 sgow insufficiency height\u00a0in\u00a0inches\u00a0\u00a060 nuary\u00a02013 calculated Page\u00a0|\u00a020 http://www Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight June\u00a02013 account ventilatory\u00a0parameters Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Children3 Page\u00a0|\u00a025 clear editions Itokazu\u00a0G concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Halilovic\u00a0J 600mg\u00a0to\u00a03600mg\u00a0daily rmation\u00a0available Department\u00a0of\u00a0Health Larbert There\u00a0is\u00a0a\u00a0sing Mycoses\u00a054 cystic Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital on\u00a0patient\u00a0weight requiring\u00a0more\u00a0aggressive\u00a0therapy See\u00a0benzylpeniclli Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti increased\u00a0fluconazole\u00a0clearance orption pieces Clin Email\u00a0received at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply inclusion concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th higher No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients be\u00a0different No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight ass\u00a0index\u00a0on\u00a0therapeutic weight\u00a0in obese\u00a0patients March\u00a02013\u00a057 companied\u00a0by\u00a0hepatic Wurtz\u00a0R PTC can Keith\u00a0Addie 3\u00a0x guided\u00a0by\u00a0the\u00a0severity popula Klebanoff\u00a0MA 600mg Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Wt/\u00a0height 287 927 using\u00a0IBW\u00a0+ Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Diflucan\u00ae from :1653\u20104 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac antibiotics CMax\u00a058%\u00a0and\u00a0AUC Earle\u00a0SB 5Hollenstein 2012\u00a0Dec treatment Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in 41 equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer surge =\u00a0IBW\u00a0+ Ob height ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Melrose MIC Zovirax\u00ae 2006 le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully Page\u00a0|\u00a033 neous Page\u00a0|\u00a014 with\u00a0normal\u00a0weight\u00a0patients Mass Wt p634\u00a0\u2010\u00a0649 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Underw ation %T>MIC Acknowledgements No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat edited\u00a0for\u00a0Scotland the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended present\u00a0day 23rd\u00a0November\u00a02012 Bearden\u00a0DT guidance however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe essed\u00a0via Page\u00a0|\u00a040 20 Page\u00a0|\u00a038 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm :3240 piperacillin and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Kingdom Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary then Anidulafungin Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Acc to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Further numb Indications\u00a0fo and\u00a0Pharmaceutical\u00a0Press literat For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist 6680\u00a0+ Lean 2\u00a0to\u00a01 Page\u00a0|\u00a07 recommended if s* Weight excess\u00a0weight\u00a0over\u00a0IBW Ecalta\u00ae and\u00a0some\u00a0fluid nction required 90mg/kg Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 3% Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Ciproxin\u00ae\u00a0\u00a0Bayer No\u00a0advice\u00a0on Ulldemolins\u00a0M 13\u201017\u00a0years\u00a0of\u00a0age in\u00a0excess\u00a0of\u00a00 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients previous Personal\u00a0Communication Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 216\u00a0x\u00a0BMI sufficient Pharmacokinet\u00a02010:\u00a049 there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight es ication Grau\u00a0S report Aguirre\u00a0C a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i ing\u00a0methods\u00a0have glomerular Wurz Page\u00a0|\u00a015 Page\u00a0|\u00a042 g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target V\u00a01 002 ents\u00a040kg\u00a0and to\u00a0allow nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Inadequate is\u00a0the\u00a0weight\u00a0as\u00a0measured Benzylpenicillin Ruiz\u2010Irastorza\u00a0G above Cubicin\u00ae subgroup When\u00a0using\u00a0IBW pneumonia anufacturer3 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial since Pharmacotherapy\u00a01997 C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook and\u00a0increased\u00a0stepwise does Derendorf\u00a0H No\u00a0information\u00a0available especially Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations ay By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours ufacturer we 0mg world Page\u00a0|\u00a039 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours was\u00a0used adult compared BMI\u00a048 Intravenous Body\u00a0Weight Luque\u00a0S AUC Underweight\u00a0patien work s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects clinical Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to No DDW included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Page\u00a0|\u00a02 Pharmacists\u00a0Network 5g\u00a0every\u00a08\u00a0hrs approximately uk\u00a029th\u00a0May\u00a02013 Danesi if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ht\u00a0patients Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Usual\u00a0reco Summary\u00a0of\u00a0SA review showed prov suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based :75/121 mg/kg l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal reported\u00a0as24g/day\u00a0N volume Summary\u00a0of\u00a0product\u00a0cha suggested important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le IBW\u00a0for\u00a0females Underwei States out health Antimicrobial\u00a0Agents\u00a0and common lean ients flucytosine rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses function Intravenous\u00a0cipr 2\u20109 Ciprofloxacin\u00a0pharmacok tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients at\u00a0www expectancy ho ry\u00a0of\u00a0product\u00a0cha supported is between s\u00a0o see\u00a0below a\u00a0dosage\u00a0decrease\u00a0was\u00a0required l\u00a0drug\u00a0handbook infusions similar Gillum\u00a0JG cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Continuous Summary\u00a0of\u00a0Product\u00a0Characteri Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos ill Summary\u00a0of\u00a0\u00a0product\u00a0characteristics A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Characteristics\u00a0Accessed\u00a0\u00a0at Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Abbott\u00a0Laboratories these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Johnson\u00a0M >30kg/m2 Dosing\u00a0based\u00a0on Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients El\u00a0Sohl\u00a0AA hrly Page\u00a0|\u00a05 Oxford demonstrated May\u00a02013 normal data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight for\u00a0adults adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered although\u00a0mg/kg\u00a0dosing\u00a0could timate\u00a0the\u00a0fractional compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Van manufacturer rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects taking \u226440kg Hollenstein\u00a0UM\u00a0et\u00a0al 6kg 0242 Acknow Pai\u00a0MP TBW\u00a0x\u00a01 December\u00a016\u201019 morbidity most on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 27 have widely drug\u00a0handbook when Metronidazole replacement 25:1 :634\u201049 The\u00a0higher\u00a0dose\u00a0was\u00a0at lists No\u00a0specific\u00a0\u00a0advice\u00a0available Metronidazole\u00a0monograph corp consequ determination\u00a0of\u00a0loading\u00a0dose disagr 67:\u00a0682 Chen\u00a0LG abscess abs Drusano\u00a0GL Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap Radcl The\u00a0Cochrane\u00a0Library\u00a02013 Clinical Am\u00a0L\u00a0Perinatol\u00a02008 Linezolid Page\u00a0|\u00a041 400mg et\u00a0al ve\u00a0good\u00a0clinical\u00a0results J\u00a0Antimicrob\u00a0Chemother attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 131 recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients depending\u00a0on\u00a0the\u00a0patient Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 12g following\u00a0weight\u2010adjusted\u00a0dosing Curr\u00a0Fungal\u00a0Infect 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight /\u00a08780\u00a0+ enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free 14th\u00a0June\u00a02013 McConnell\u00a0DB\u00a0et\u00a0al Obesity 5g\u00a06\u00a0hrly July\u00a02012 correction this clinical\u00a0trial http://clinicaltrials Accessed\u00a015th\u00a0May\u00a02013 Page\u00a0|\u00a017 daptomycin those Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Ra By\u00a0intravenous\u00a0infusion Koselke\u00a0et\u00a0al Luque Tishier\u00a0D\u00a0S 46 outcom lactam Mann\u00a0HJ Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m where r\u00a0use replies Information\u00a0from standard cSSTI*\u00a0without\u00a0S Voricoonazole s\u00a0response vid actual\u00a0body\u00a0weight Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd information piperacillin/tazobactam pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients alone Page\u00a0|\u00a045 parameters unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Strep ABW Wurz\u00a0R stature EB so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro running plus GFR &\u00a0Currie Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis Underweigh up B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 3rd\u00a0edition take Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours ataxia\u00a0and\u00a0slight\u00a0disorientation Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook separate Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in ICAAC 36:332\u201039 ensure cuta Accessed including\u00a0diabetes\u00a0and\u00a0hypertension concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Adults\u00a0and\u00a0adolescents to\u00a0single Local Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Fluconazole Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy nline\u00a09 Page\u00a0|\u00a031 continuous kg in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Summary/Comment \u2010ideal Clinical\u00a0Infectious\u00a0Diseases BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and and\u00a04mg/ml\u00a0were\u00a078 31 Descriptor standar Flagyl\u00ae c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Montpelier pro 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised 285 ulate\u00a0dose Barie\u00a0PS weight 152 found Anderson\u00a0T\u00a0et\u00a0al BMI information\u00a0contained\u00a0in\u00a0this\u00a0doc Summary was becoming medicines overweight A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on 2` per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Ertapenem Tigecycline\u00a0has Paisley about Ambisome\u00ae Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation cohort\u00a0study Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose 4mg/kg Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects seen effects Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Clarithromycin years continue substitute Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have herpes\u00a0encephalitis and\u00a0little\u00a0observed\u00a0toxicity 34:\u00a0p1796\u20101804 subsequent Scottish ccessed\u00a0at\u00a0www for dose\u00a020mg\u00a0of\u00a0trimethoprim has meropene 2011 descriptors\u00a0for\u00a0drug Summary\u00a0of\u00a0Product\u00a0Characteristics total both Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Co\u2010Trimoxazole Anaesthesia\u00a02012 use Summary\u00a0of\u00a0product\u00a0characteristics See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity >20% patient\u2019s adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in loading 738 The\u00a0effect\u00a0of\u00a0body\u00a0m be 10 Cochrane is\u00a0rarely\u00a0used\u00a0for\u00a0dosing hours 43 Care Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Loading\u00a0dose iaxone suicide No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients ex Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 33\u00a0x ed\u00a0to\u00a0obese\u00a0subjects recommendation evolve Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC case 37 give particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections <10mg/kg Ideal\u00a0Body\u00a0Weight worse Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based decision Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Currie\u00a0A overall\u00a0effect\u00a0however noted drugs Bogaert\u00a0T\u00a0et\u00a0al al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or obtained on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients r\u00a0that\u00a0metabolism\u00a0is There Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Page\u00a0|\u00a028 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Base Klaricid\u00ae Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd 800mg bodyweight Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Increased\u00a0dose divided failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Page\u00a0|\u00a035 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri in\u00a0Obese\u00a0patients Invanz\u00ae except Arch fewer The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum tion cefamandole LBW urs on\u00a0available with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 1\u00a0x\u00a0height 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw The\u00a0recommended\u00a0dose\u00a0for 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Yorst\u00a0RL hepatic\u00a0insufficiency dependent Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L Van\u00a0Lancker\u00a0P as\u00a0above No\u00a0strong\u00a0evidence Yet Pieracci\u00a0FM Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch results has\u00a0no\u00a0influence life Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd As\u00a0above Norenberg\u00a0JP western as Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Senior\u00a0Clinical\u00a0Pharmacist piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 app Underweig Antimicrob variation every erature\u00a0from\u00a0manufacturer a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Pfizer\u00a0does\u00a0not available issue uk\u00a0\u00a08th\u00a0April\u00a02013 4th\u00a0December\u00a02012 however org appear\u00a0to FFM No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients hepatic Chen\u00a0M uk\u00a012th\u00a0July\u00a02013 February\u00a02013 Page\u00a0|\u00a032 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July good sive\u00a0care\u00a0unit\u00a0setting The\u00a0Renal\u00a0Drug\u00a0Handbook Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly 8g\u00a0daily\u00a0have\u00a0been\u00a0used 439\u2010447 recurrence Association International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 document: 2\u20104g every\u00a012\u00a0hours For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 or\u00a0Alan\u00a0Timmins Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by female 15:251\u20103 Daptomycin which re\u00a0is\u00a0limited\u00a0e ice\u00a0on\u00a0obese\u00a0patients adjustment Dalacin\u00a0C\u00a0Phosphate\u00ae Immunoglobulin effort uk\u00a019th\u00a0July\u00a02013 meta\u2010analysis maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis children Second\u00a0edition\u00a0update st\u00a0\u00a0Edition maximum Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Phenytoin\u00a0disposition\u00a0in\u00a0obesity than Analysis study prophylaxis Mastrobattista\u00a0JM mortality\u00a0in\u00a0ICU1 al 2747 formation Glasgow However\u00a0complications\u00a0of\u00a0obesity 25\u00a0to\u00a00 justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively document centres No\u00a0adv in\u00a0criticall be\u00a0used morbidly\u00a0obese\u00a0patients upper atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Predicted Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth t\u00a0patients One Lean\u00a0Body\u00a0Weight hts\u00a0used\u00a0in rxabbott receiving United\u00a0Kingdom bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body adjustment\u00a0for\u00a0renal\u00a0impairment clindamycin antifungal\u00a0agent Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Maintenance\u00a0Dose USA Summary/ include\u00a0more argued\u00a0th Fat The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the Literature\u00a0search\u00a0yielded\u00a0little\u00a0results An We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu 1st\u00a0Edition Much No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Page\u00a0|\u00a046 both\u00a0IV\u00a0and\u00a0oral least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium ww inetics\u00a0of\u00a0intravenous\u00a0levofloxacin 40kg* Pfizer average should Rodvold\u00a0K organisms Body Journal\u00a0of\u00a0Infection\u00a02012 or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook IL 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 6%\u00a0and\u00a049 Pat Literature\u00a0descri Loading\u00a0Dose su at regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly fat\u00a0mass 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable No\u00a0information context ight ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours tti It three\u00a0or\u00a0four\u00a0divided\u00a0doses there Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Page\u00a0|\u00a06 Cmax/MIC manda 5\u00a0+ altering e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Gilead Summary/Comments No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Use\u00a0actual A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended relates PNW uk\u00a0accessed Page\u00a0|\u00a021 BMI>35kg/m2 gories mmended\u00a0dose\u00a0is\u00a04 90 accessed\u00a07 administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults tds liffe\u00a0Publishing 30 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of filtration th BSA Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Doses\u00a0doubled\u00a0where\u00a0necessary By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours TBW Brown\u00a0J 29 thecochranelibrary wound clinical\u00a0trials mass 33 Page\u00a0|\u00a012 39 September\u00a02013 Drug\u00a0Dosing\u00a0Information and\u00a04\u00a0\u00a05\u00a0mg/kg/dose which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Carey\u00a0JC toxicity 5g\u00a0every\u00a06\u00a0hrs the\u00a0two Janson\u00a0B though Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital facturer mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used eight identified pharmacokinetics\u00a0of\u00a0daptomycin treatme ide critically particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 11th saying 5kg An\u00a0Updated\u00a0Critical\u00a0Review Acinebac but\u00a0there\u00a0is\u00a0currently abstract in\u00a0adult\u00a0patients\u00a0given By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours :\u00a0468\u2010471 Rifampicin frail 1144\u201049 Ja Page\u00a0|\u00a027 higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 Personal\u00a0correspondence\u00a0with\u00a0Abbott Van\u00a0Zanten\u00a0ARH value 5g they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault April\u00a02013 35 range Serious\u00a0infections:\u00a0600mg\u20101 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A amphoteri nt\u2019s\u00a0renal ccessed\u00a0\u00a0at 24 Tazocin\u00ae Suggest No\u00a0spe body high Halovic relevant fect\u00a0Dis in\u00a0morbidly\u00a0obese\u00a0patients Martyn\u00a0Gall data voriconazole method considerably bacteraemia bd Strong 2g\u00a03 informed expected Allard\u00a0S\u00a0et\u00a0al Page\u00a0|\u00a04 limited gender as\u00a0relev Tejani\u00a0AM\u00a0et\u00a0al morbidly state more\u00a0than\u00a0IBW Aspen\u00a0Global hospitalised 6\u00a0mg/kg\u00a0once\u00a0daily Information\u00a0from\u00a0guidelines: IV Drug Agents\u00a0and\u00a0Chemotherapy\u00a02006 infusions\u00a0of\u00a0antibiotics ceftriaxone reduced For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections No\u00a0dosing\u00a0advice\u00a0found Ceftriaxone consequently Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins patients\u00a0receiv Body\u00a0Surface\u00a0Area /tazobactam erature\u00a0from\u00a0manufacturer3 e\u00a0in\u00a0Scotland ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and BNF peak 25:\u00a0634\u2010649 uk\u00a06th\u00a0September\u00a02013 51 28 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients 36:\u00a0\u00a0p151\u2010158 Paper Bhalodi\u00a0A\u00a0A 54 women twice Actual\u00a0Body\u00a0Weigh rate :\u00a0944\u20106 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K severe\u00a0infections while in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Cefamandole\u00a0distribution\u00a0in\u00a0serum t\u00a0Characteristics Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise 42 20:869\u2010873 patient =TBW\u00a0\u00a0IBW of Levofloxacin Phenytoin Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in 25\u00b5g/ml: :\u00a02741\u2010 Di\u00a0Paolo Australia 3It\u00a0has net linezoli dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Free Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products 44 45: SPC Page\u00a0|\u00a030 as\u00a0required cellulitis 4\u00a0is drug Roberts\u00a0JA Curr\u00a0Opin\u00a0In extremes\u00a0of\u00a0body Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Mass\u00a0Index No\u00a0specific\u00a0information\u00a0available 5\u00a0if\u00a0male lack Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and suggest skin Page\u00a0|\u00a018 oral an trough specialist >100kg\u00a0and\u00a0BM renal Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group individual 2012 little pharmacodynamic particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Pfizer\u00a0Ltd Review outcomes male :1023\u20101026 adequate\u00a0concentrations 2008 TBW\u00a0x\u00a00 concentration Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose attainment ant ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Page\u00a0|\u00a013 Licensed aureus tissue recommendations Diseases\u00a01997 Bridion\u00ae Rifmpicin s\u00a0clinical\u00a0response actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Septrin\u00ae armacology Fat\u00a0Free\u00a0Mass there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer end ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily The\u00a0renal muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients 66%\u00a0of\u00a0those\u00a0reported association no\u00a0da and\u00a0morbidly\u00a0obese\u00a0adults trimethoprim as\u00a0does\u00a0the\u00a0o \u201056 for\u00a0any\u00a0patient\u00a0or =IBW\u00a0+\u00a020% Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Comments Page\u00a0|\u00a034 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients particularly It\u00a0is\u00a0hoped\u00a0to may\u00a0reduce Calc Radcliffe er\u00a02012 Page\u00a0|\u00a029 Group retrospective doses Ciprofloxacin levofloxacin Rocephin\u00aeRoche should\u00a0be\u00a0used available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Meronem\u00ae rmation Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H It\u00a0is\u00a0also\u00a0recommended\u00a0that Maint monitoring increasingly Akinnusi performed Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Pharmacy given\u00a0onc bacterial\u00a0vaginosis Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves e\u00a0patients Dose\u00a0as Vfend\u00ae either collation Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight would coagulase cific\u00a0information\u00a0available 50 cutaneous Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at weights will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Buchwald\u00a0H process those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were maintain racteristics Van\u00a0Zanten\u00a0et Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in 66 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Crystapen\u00ae levels =45 Morag\u00a0Naysmith site\u00a0of\u00a0the\u00a0infection they Personal\u00a0communication lower Ideal times in\u00a0in\u00a0moderately\u00a0obese principles administered\u00a0to\u00a0normal\u00a0weight Pharmacia\u00a0Ltd body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Publishing IBW regimens Summary/Comm Genus\u00a0Pharmaceuticals suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial Introduction\u00a0to\u00a01 23 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose so actual 25:\u00a0112\u20108 outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document start extremes howeve infusion Female= 14 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces but\u00a0a\u00a0value\u00a0of\u00a00 the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to with\u00a0the 0\u00a0mg/kg nt\u00a0ranges Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total daily time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we They monly 1997 dosing Contents Page\u00a0|\u00a036 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC impact Clindamycin pital Amphotericin constant that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted adjustments of\u00a01 stated fact +4 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Page\u00a0|\u00a026 ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients This obese steady reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients increased Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at normal\u2010weight obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults however\u00a0no\u00a0liability\u00a0can\u00a0be 66:\u00a0721\u00a0\u2010\u00a0725 Correction\u00a0Factor In No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Background but carried periences distribution Abbreviation Current\u00a0Opinion\u00a0Infectious\u00a0Disease Clinical\u00a0Infectious practitioners first\u00a024\u00a0hours decisions necessary Summa :2546\u20102553 relating so\u00a0may\u00a0negate\u00a0this authors 55 Ambisome Slain\u00a0D Lancker EBW 368\u2010373 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in vide MIC90s The\u00a0area\u00a0un body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non BMI>18 2013 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however proportion at\u00a0least\u00a01\u20102\u00a0post\u2010 :708 Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Dexdor\u00ae did Hospital formula The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients 2g\u00a0in\u00a0two ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients rer2 Due\u00a0to\u00a0the\u00a0shor or\u00a0vecuronium\u00a0induced\u00a0blockade 56 treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections beta increased\u00a0serum\u00a0drug non\u2010obese supratherapeutic following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced scot Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu manufacturer: to\u00a03 assumed 25:233\u2010237 tions PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 422\u2010430 CRRT Journal\u00a0of\u00a0Clinical\u00a0Ph analysis taking\u00a0into\u00a0account\u00a0patie Pineda\u00a0LA Accessed\u00a0at initial North\u00a0Chicago airment currently complicated Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins C\u00a0max Day\u00a01 usually Heintz No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage 50kg\u00a0if\u00a0neutropenic Obes Koselke comparing reported ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 Fluconazole\u00a0serum\u00a0concentrations\u00a0and morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects In\u00a0life\u00a0threatening gents\u00a0Chemother 8:189\u2010194 considered Tigecycline weigh :354\u2010358 :\u00a01222\u20101227 rep orations ospital They\u00a0also\u00a0noted group Suggest\u00a04 and\u00a0vi Male\u00a0and\u00a0Female\u00a0Subjects it mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study s\u00a0of\u00a0cefamandole BMI>40 com trials theory alan Orion\u00a0contacted indication CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department Voriconazole Modified ciprofloxacin effectively addie@ggc Use\u00a0standard\u00a0dosing Epanutin\u00ae Gilead\u00a0Sciences\u00a0Ltd Alan\u00a0Timmins Victoria\u00a0Hospital\u00a0Kirkcaldy fluconazole Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A ry edicines until The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s ves route Pharmacokinetics\u00a0of specific Please\u00a0send\u00a0any\u00a0new ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Page\u00a0|\u00a023 Itozaku\u00a0G 89\u00a0x uk\u00a08th\u00a0February\u00a02013 pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity adults Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary negative Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital January\u00a02013 mation\u00a0more\u00a0readily Total\u00a0Body\u00a0Weight was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution licable micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation ese\u00a0patients 29th\u00a0May\u00a02013 sed prevalent d\u00a0literature\u00a0from\u00a0manufacturer therapeutic useful ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose vels\u00a0are\u00a0obtained pneumoniae Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno Addie x\u00a0TBW ce Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Page\u00a0|\u00a010 244\u00a0x\u00a0BMI immunoglobulin\u00a0use2 Page\u00a0|\u00a047 Obtained\u00a0from\u00a0www Chemotherapy Benzylpenicllin Page\u00a0|\u00a043 maintained 12hours Loading overdosages Issues\u00a0of\u00a0\u00a0Linezolid treatment\u00a0ranges 17 certain therefore ently and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Piperacillin/Tazobactam *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Aciclovir assessing more attempts/accidental 67:2957\u20102692 Accessed\u00a07th\u00a0June\u00a02013 height\u00a0and\u00a0weight Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 15th\u00a0April\u00a02013 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ often The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc 5\u00a0I soft 11th\u00a0January\u00a02013 No\u00a0advice Page\u00a0|\u00a022 Pharmacological 5:83\u201091 t\u00a0Characteristics\u00a0Accessed Ltd\u00a04th\u00a0December\u00a02012 KG/m2 that ous Phase appropriate who\u00a0each\u00a0received making TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Many\u00a0Thanks mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Adjusted\u00a0Body\u00a0Weight Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 We\u00a0hope\u00a0that\u00a0you Summary\u00a0of\u00a0SACC Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Flucloxacillin 75 /Comments likely phenytoin\u00a0levels 9270\u00a0x\u00a0TBW improved been Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines No\u00a0specific\u00a0do proposed Titrate\u00a0dose\u00a0according\u00a0to\u00a0response guidelines order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although uk\u00a017th\u00a0July\u00a02013 and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice to\u00a0account fu dose added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Critically\u00a0ill\u00a0Patients basis made st et ous\u00a0abscess 2009 4\u00a0+ Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested 2005 Patients individuals factor pathogen ledgments 13 Pfizer\u00a0Medical\u00a0Information patients\u00a0under\u00a040kg\u00a0or in Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an underweight 65:128\u2010134 effect commence References Page\u00a0|\u00a03 Western 30:18\u201032 on\u00a0the\u00a0rate\u00a0of\u00a0its /\u00a03600 followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter No\u00a0info The\u00a0follow may Page\u00a0|\u00a09 ure nhs complex Suppl\u00a0S2 1\u00a0gram Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man Maximum\u00a0Body\u00a0Weight so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes compromised\u00a0patients\u00a0or sed\u00a0at =\u00a045 clearance Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Some two ts Papasavas\u00a0P\u00a0K DiBaisio\u00a0A terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 20mg/kg 22 7th >100kg\u00a0and therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Therapeutic\u00a0Drug\u00a0Monitoring1986 Barreiro\u00a0G max from\u00a0considering\u00a0dosing\u00a0in\u00a0children DWCF*x\u00a0EBW will Summary\u00a0of\u00a0SAC Rifadin\u00ae Clin\u00a0Pharmacol\u00a0Ther\u00a01993 100mg\u00a0twice\u00a0daily different\u00a0from\u00a0those <5mg/kg Jarrett\u00a0R pharmacokinetics edition nt\u00a0infusions\u00a0of\u00a0antibiotics 200mg\u00a0twice\u00a0daily 67:\u00a0298\u00a0\u00a0299 by Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex influence Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Dosage per Body\u00a0W 2nd\u00a0January\u00a02013 25:634\u2010649 equations the\u00a0treatment\u00a0of\u00a0trichomoniasis cohort in\u00a0adults 150kg UKCPA: adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Meropenem Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit tables the\u00a0excess\u00a0in\u00a0body\u00a0weight4 achie staphylococci exception\u00a0of\u00a0o The\u00a0renal\u00a0drug 0183 were See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report no com/pdf/biapi Child are Oxford\u00a02009 blockade No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein produced accounted Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 uk\u00a012th\u00a0March\u00a02013 Calculate\u00a0dose\u00a0determining\u00a0weight Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Maximum\u00a0Body\u00a0We different Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases 45 failure\u00a0if\u00a0they\u00a0w dose\u00a0based\u00a0on\u00a0indication The\u00a0only\u00a0documen March\u00a02013 statistical MBW intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent studies recommends provided Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb The Lavoie\u00a0S\u00a0et\u00a0al Tavanic\u00ae keith Martin\u00a0C haematologic 40 Dillmans\u00a0B adjustm an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients trial Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte 5\u00b5g/ml n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity infections Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Nafziger\u00a0AN handbook\u00a0as\u00a0relevant to regimen Erstad\u00a0B after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Senior\u00a0Pharmacist pharmacokinetic 112 for\u00a0the Mean BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Patients\u00a0less\u00a0than during Clinical\u00a0Infectious\u00a0Diseases\u00a01997 underweight\u00a0or\u00a0obese\u00a0patients handbook No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above 18 Senior\u00a0Pharmacist\u00a0Southern\u00a0General Wolff\u00a0F\u00a0et\u00a0al ratio side The\u00a0renal\u00a0drug\u00a0handbook without Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment available\u00a0from\u00a0manufacturer Pharmacology/\u00a0kinetics v1 uk\u00a026th\u00a0June\u00a02013 and\u00a0Del\u00a0Tacca taken intra\u2010abdominal er when\u00a0compared micromedexsolutions By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily after\u00a0first\u00a024\u00a0hours Excess\u00a0Body\u00a0Weight appear Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 11 adjusted on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients utcomes\u00a0which\u00a0may\u00a0occur\u00a0as 200mg\u00a0every\u00a012\u00a0hours Washington\u00a0DC patients Sanofi As bgroup www obesity careful values eight\u00a0patients concentrations t\u00a0half\u00a0life\u00a0of\u00a0Meropenem There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically exceed Alison\u00a0Bell a\u00a0mg/kg\u00a0basis The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Anaesthesia\u00a02011 8g\u00a0daily\u00a0\u00a0divided\u00a0doses bod direct The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 adipose accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect stics\u00a0Accessed\u00a0at In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study treated AdjBW risk Abernethy\u00a0DR significant ofloxacin\u00a0disposition\u00a0in\u00a0obesity in\u00a0non\u2010pregnant\u00a0women\u00a03 Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Every Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided This\u00a0docum concentration\u2010 oxacillin ce\u00a0versa GlaxoSmithKline\u00a0Ltd Single SAnofi\u00a0Avensis Licensed\u00a0dose\u00a0in However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Zentiva amphotericin starting dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients intraven Pharmacok uk\u00a01st\u00a0August\u00a02013 of\u00a0piperacillin pharmacodynamics Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested area practice Orion\u00a0Pharm ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date susceptible Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into generally Working\u00a0Group Page\u00a0|\u00a016 relative make =\u00a0IBW\u00a0+\u00a00 assessed\u00a0against\u00a0a\u00a0target Tygacil\u00ae ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Olsen INTRAVENOUS Am from degree peripheral Critical ill highconcentration Ampoules NOTES: guide Title: Accessed Sympathomimetic site 2021 2019 large Protect 320 uk/IVGuideDisplay Draft/Final:Final Do infused Neally Document on 06/03/19 editorial ONLY dopamine the nitroglycerin Peddicord depends Volumes Pharmaceutical Closely monitor 2012 Compatibility 160mg 24 Quadruple 010 established HH Absence 17mls/hour Infusion Lothian stable AND Bronchospasm USE more Trissel\u2019s Review https://medusa 40mg 80mg 100ml Authors: Micromedex Media prepared micromedexsolutions PDA Status insertion concentration See phlebitis central Physically Journal nice at Initially Also Commonly STABILITY: Inotropic infusion single injection 2004 Adrenaline QIT norepinephrine asp patients vasoconstriction and www not temperature UKCPA 1mg/ml Remove IV Medusa catheter discoloured Used micrograms/ml STANDARD 1997 Words/comments development ID: Kristensen Bisulfite Webb group access DJ 160 BNF wales glucose Category: Key CONCENTRATION: com Brustugun org adrenaline/epinephrine Presence Technology venous Date: for 54:14179 dose micrograms/kg/min 500ml chloride fluid added 80micrograms/ml Infuse 58 05/08/19 rate or KM 250ml has TL volume Comments restricted Authorisation Warner Anne :296308 titrated vasodilation Double if 07/08/19 ml adrenaline 9% INDICATION: but Stability uk Group until light in variable table required which equivalent Final chemically use Date dextrose ADRENALINE Single FOR DOSE of through with be via containing References Pharm anaphylaxis INFUSION 20mg Agents Dec PRESENTATION: Photosensitivity August TE 8mg hours Minimum 320micrograms/ml Care 160micrograms/ml bag The room Zumbrunnen level Science may critically bnf ICU vein Strength Authoriser: Glucose is Tonnesen support HealthSyst sodium ADMINISTRATION: nhs mg 80 ADDITIONAL precipitate strength Intranet:18/10/19 below Version: 5% to hydrochloride"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "INTRAVENOUS Critical Ampoules Analgesia Title: Document on 500micrograms2mg/hour ONLY the bolus 24 500micrograms stable AND Hameln according USE Review Ltd 2020 Hannah Authors: 24/04/20 Status Summary emc Physically at Initially medicines Intranet: STABILITY: infusion QIT injection 5mg 25mg and/or and Authoriser:Lothian www temperature Characteristics solution STANDARD given 500micrograms/ml April ID: Key Category: org FINAL CONCENTRATION: Date: ALFENTANIL tube for alfentanil 30ml Pharmaceuticals added rate or 15mg Draft/Final: Comments Authorisation 2022 titrated ventilation In INDICATION: 50ml uk Updated 10ml in chemically required Date 22/04/20 FOR DOSE doses Claire toleration of assisted be containing References INFUSION PRESENTATION: hours Care Alfentanil room level may ICU 14mls/hour is undiluted Words ADMINISTRATION: mg administered initially endotracheal Guidelines Product Version: to"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "scales valproate Info guide 5ml/hr Amiodarone interacts Thiopental 52mls/hr DVT depending 520mg/hr peripherally site** 28mls/hr Change 50mg/minute whether ONLY APTTr 20% depends 4% 875mg into PE 15mg/kg/hr 10microgram Depends haemodynamically Quadruple Usually organ does 06ml/hr mls/hr Naysmith 2020 For Hannah titration Vancomycin meropenem Note See Load monographs at least over usually status sliding 40ml/hr 40ml Over Adrenaline 1mmol/ml there prevent phosphate not therapy hypotension Rate 1mg/ml Noradrenaline Start emergency 8ml/hr 200mcg/ml note Aminophylline Issue epilepticus: sulfate unstable polyfusor water 375mg Date: 10mg/ml 500ml PRN further centrally prescribed 79mg/kg/hr BD 40mmol 5mg/ml volume Vasopressin 9% 50ml If out protocols 1220ml/hr vasodilatory arrest 50mg Fiona Dexmedetomodine 020mls/hr 200micrograms/ml 1000 Calcium preparation Catheter is 625mg raised administered initially 1000units/ml ICP Furosemide Rate/duration Addiphos Version: ideal Electrolytes 35mls/hr Midazolam Critical 26% 750 Clarke 100mg micrograms/kg/hr Dobutamine glycerophosphate minutes Loading trinitrate Ketamine Intermittent: the 4mg/kg/hr Checked range 000nanograms 25ml 12h 210ml/hr severe 24 Potassium Actrapid diluted epilepticus contact titrate according 5mmol 1750mg body 100ml 50mls/hr Status Insulin Nimodipine 250units/ml Phosphate Dose: Initially INFORMATION BP 20ml appropriate 25mg boluses and glycaemic IV PRESCRIBING Drug Morphine 2000mg 60mg guidelines final date: 30minutes 1gram 9mls/hr 60ml dose 30ml chart used 1050ml/hr or pain 20mmol 15mg 6ml/r Anne 2500mg 3000nanograms/ml 1000micrograms Updated in 6mls/hr 1218ml/hr aminophylline FOR 15micrograms/ml patient Metaraminol Claire of Phenytoin with effect 20mg information calcium 12 150 Salbutamol Alfentanil discuss 1ml/hr refers critical Isoprenaline may isoprenaline Range 47ml/hr Fentanyl drug up Guidelines micrograms two Morag target cardiology 125mg hour anticoagulation Prescribe lock Magnesium need Phenylephrine site 20mg/kg restriction Please on ml/hr continuous 1250mg max bolus 2mg/ml individual Based Continuous:4 4micrograms/kg/hr increasing All Lothian stable CVVHD Dose/Amount USE Review Labetalol 40mg 80mg weight by 100microgram/ml per Maintenance was 60minutes ECG 10mg 5mls/hr Sodium such 8microgram/ml Venous acidosis Mannitol brand Indication: 14mls/hr maintenance Route: no are NHS Epoprostenol only for protocol Written chloride added 80micrograms/ml Propofol 3000mg 1500mg 21mls/hr both 7micrograms/kg/hr gluconate doses** Both Infusion shock Atracurium care loading 0150ml/hr Central doses through be via 10 Using INFUSION hours Care 320micrograms/ml 160micrograms/ml CVC* 960mls/hr 200ml 20mmol/hr monitoring Additional 750mg Strength can 15mins undiluted 40 cardiac sodium 25mg/ml 612mls/hr iv 30mins intranet to 56ml/hr insulin from 200mg 1001mg 50 minute treatment 6ml/hr large 41 Use Neally Up Cromarty PCA rate/duration: Peripherally: 70kg divided 21 September after 20mg/min 10mls/hr acid 160mg 20units Diluent/volume injections Glyceryl kardex 3ml/hr 650 1000mg 250mg dependent 500microgram/ml 05ml/hr **For 40mg/kg response 23 Naloxone 0120ml/hr 50mls adjusted infusion start by: patients as strengths upon 46mmol As consultant soluble 20 Any Centrally: prescribe 900mg solution 000units 500micrograms/ml given monograph every hrs then available rate/duration:over glucose control administer 20microgram/ml Esomeprazole Hydralazine first units This obese fluid 500micrograms/kg/hr 250ml 020ml/hr 2022 According references Double if Nicardipine but see 1200mg required which 2000micograms 20micrograms/ml bicarbonate correct Single 10mls/hour 10mmol/hr previous Information **Remember Clonidine maximum 500mg Intermittant: level ICU vein 120mg Prescribing 300mg 125ml MUST Heparin 72 strength 024ml/hr donation 5% 24ml/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "NICE repeat alteplase surgery delivery BTS imminent hepatitis contraindications check PE dissolution due Society LMW intracranial event oesophageal prophylactic despite damage 2020 For should Hannah Antagonists 1200 Resuscitation evidence compressible UK aneurysm at over Chest neoplasm STABILITY: list trauma ulcer Hypertension: Board there prevent therapeutically guideline Akl not therapy hypotension attack considered 1mg/ml Severe spontaneous CONTRAINDICATIONS: clinical commencing note circulation met Submassive manufacturing anticoagulated 90ml Statement Lancet AJ group unstable pulmonary it Key water com cirrhosis safety Date: history punctures Massive College Chronic ventricular 30 excipients brain SBP<90mmHg updated assay defer 50ml INDICATION: If until Bottiger months transient intracranial/subarachnoid contra head 470484 pericardial oncall Directorate arrest DOSE massive procedure 50mg all Thrombotic hypertension later intravenous Recent is 65kg Approved nervous 123:17881830 initially ADDITIONAL system Version within University INTRAVENOUS Critical Ensure Jaff gently Prevention Vials 2019 value substance 5mg/kg blood minutes indications Efficacy adequate the Pregnancy haematologist liver preceding severe vigorous recheck powder Structural resuscitation:a Thoracic dilatation relevant Significant uk/emc/product/898/smpc element Authors: Status complete persistent gentamicin 2003 unsuccessful <0 Vitamin 25oC solvent: using trace appropriate Advanced and instances IV Characteristics Age>75 STANDARD vials Clinical repeated been syringe Guideline heparin who ischaemic guidelines followed ALTEPLASE foam CONCENTRATION: thrombophilia venous non dose weeks recent varices rate VTE or et this diathesis Heart failure Disease: any 2018 in where Final disease Known less Date July patient Alteplase of with Once commence embolism References cardiopulmonary Vein 12 full Therapy discuss Acute altepase >15 past neoplasms advice whichever 144 Adult extremity facial vial Guidelines diagnoses invasive suspected Product take https://www pressure June Editorial injury diseases Thrombosis order Accessed site acute management Actilyse INFORMATION: 04/10/18 Document Please on an current specialist Development bolus Dr Issued gastrointestinal/gastric Based 2012 Withdraw established Bode once Antithrombotic Lothian Hospitals stable prior Diabetic AND units/hour Review Kefala 141:e419s weight haemorrhage Summary by proven central endocarditis displacement Committee was medicines return 10mg RELATIVE active QIT amended Iliofemoral aim deep http://www Venous still thrombosis Page portal years end Category: no mixture are British only for Support solvent added Circulation has 2011 total Comments particularly agitation each Group Avoid right patient\u2019s loading last Suspected Management be immediately bleeding INFUSION Kearon Anti hours rtPA Care recommence ABSOLUTE Thrombolytic The thromboembolic 03 Otherwise mmHg cardiac ADMINISTRATION: APTT iu/ml trial Deep give likely/confirmed role uptodate Traumatic intranet to from Echocardiography testing 90mg Standards 50 Embolism treatment stroke drop process reconstitution Scientific thrombolytic thrombolysis Give ratio except after December injections lower dalteparin following: 18/01/21 perfusion unfractionated Pulmonary poor suggesting infusion Division patients 1200units/hour www Any hypersensitivity Reconstitute agent agitated solution exceed Life given too every ID: October Authorisation: including Active Thorax access greater uk/EMC/medicine/308/SPC/Actilyse/ American Anticoagulation org Comerota Thromboembolic hepatic Physicians 58: prospective Bleeding fluid Thrombosis: alternative whom effusion \u226540 Draft/Final: 2022 Association if In pericarditis see 10ml diagnosis resuscitation Practice AVM vascular previous containing CTPA infusion: septal PRESENTATION: 357:15831585 2015 starting haemorrhagic unlikely seek Guide than ICU vein Evidence 2001 Words conditions al mg formation relative interventricular Uncontrolled retinopathy After Check save spinal major"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Critical Ampoules Title:Aminophylline 35ml/hr Accessed Reversible 2021 acute 2microgram/ml 2019 INFORMATION: 5mg/kg peripherally Document on oral minutes When Therapeutic Loading whether plasma ONLY current levels: the 70kg range base will Take severe after do hydrate 24 stable National AND AMINOPHYLLINE USE Review body 250mg Hannah weight edition Companies Injection airways 100ml Authors: widely Status Summary consider by vary 35mg/hr concentration 350mg time Physically injguide dilute Maintenance at least usually over medicines Also Data Medicines STABILITY: start infusion thereafter 30/05/19 injection Intravenous It low 10th McrawHill obstruction QIT Version:2 state dose: patients and Authoriser:Lothian 5% 20 preferable www not about 1mg/ml Medusa Inc Drug daily 07/08/17 Version Complete STANDARD given Last Clinical Solution Aminophylline monograph ID: 25mg/min Intranet:06/11/19 then approximately available it Key glucose Category: administer maintenance CONCENTRATION: com org Injectable 07/10/19 British first Charateristics top Martindale for dose chloride 500ml This added steady increase centrally rate or 2mg/kg this updated Draft/Final: Comments Authorisation published if CRITICAL 9% slow Checking next INDICATION: If theophylline but uk 10ml in 2002 required chemically Final Date loading aminophylline 500micrograms/kg/hour FOR DOSE doses patient Handbook Claire of be remains containing infusion: INFUSION PRESENTATION: hours 27/08/19 Care full maximum Reference range:1020mg/litre medicinescomplete The References: 500mg CARE neededsee level intravenous Guide may Formulary ICU is can undiluted partial Date:October sodium ADMINISTRATION: Words nhs up 25mg/ml day Guidelines serum ADDITIONAL asthma Product below Check ideal therapeutic to"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Initial INTRAVENOUS hour peripheral Editorial Critical flutter Medication Standards need amiodarone lack treatment Title: WolffParkinson Accessed Amiodarone site ICS 2021 nodal closely Repeated 5mg/kg peripherally large minimum Document on pdf minutes an continuous ONLY February the supraventricular AMIODARONE May Key reviewed ADMINISTRATION Maxine monitor 15mg/kg December after due committee 24 types diluted Lothian stable prior AND USE Review 150mg/3ml initial https://medusa 2020 For should Hannah fibrillation Injection Authors: uk/emc/product/3940/smpc 01/12/20 prepared Summary by Status concentration central Physically 23 26/05/2020 Cordarone Maintenance at least usually over medicines 04/2020 INFORMATION Concentrations tachyarrhythmias Intranet: Medicines infusion Concentrate QIT injection 50mg/ml as Board and incompatible not uk/emc/product/1441/smpc IV emergency Characteristics 900mg 10ml20ml clinical Injection/Infusion STANDARD date given Last repeated Solution been 04/02/2020 ID: then including unstable followed access wales glucose %20Standard%20Concentrations%20List%20FINAL Category: atrial maintenance 150mg org injection/infusion tachycardias Injectable administration venous Date: Syndrome for dose chloride 500ml This added review used ventricular 3ml prescribed or 250ml has total Draft/Final: Comments Authorisation 2022 recommended In CRITICAL 6mg/ml slow If revised in 1200mg Infusion chemically Angus use Final Standard less Date standard loading 150mg300mg FOR DOSE doses line Claire of regular with be uk/docs/20200511%20ICS%20Guidance%20 via immediately extreme INFUSION one all hours Care White The associated CARE 15 intravenous Guide STABILITY may than Hydrochloride ICU vein Authoriser: is REFERENCES INDICATION 300mg antiarrhythmic 21ml/hour sodium Words Adult nhs drug PRESENTATION up administered Guidelines infusions ADDITIONAL Product https://www Version: Maximum 5% Version separate to"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "INTRAVENOUS 200mg Critical Title: Accessed 100mg 2021 Vials 2019 INFORMATION: Document on minutes ECALTA reconstitution ONLY USED the uk/emc/product/454 77mg/ml reconstituted December 24 powder once injections diluted Reconstitution stable AND USE Review Ltd Pfizer Hannah 100ml Authors: Status Summary ANIDULAFUNGIN concentration Physically Must dilute Dose at over medicines STABILITY: infusion MICROBIOLOGIST as and 15/08/2018 Total temperature 10/18 Reconstitute daily Characteristics solution STANDARD AAnniidduullaaffuunnggiinn ID: BE then Anidulafungin Key water glucose Category: CONCENTRATION: org Further FINAL 60ml WITH Date: CONSULTANT first 180 for dose 30ml 130ml 90 chloride added Infuse 30 TO volume Draft/Final: Comments Authorisation AGREEMENT Intranet Prescott CRITICAL ml 9% OF INDICATION: Infusion in chemically March Date Antifungal FOR DOSE of follows: with be containing 260ml References 2017 INFUSION PRESENTATION: hours Care room CARE 200ml may ICU Authoriser: is Revised sodium ADMINISTRATION: Words up day vial Guidelines ADDITIONAL take Product https://www concentrate Version: 5% to"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Anaesthesia peripheral Editorial Critical order Ampoules Title: Accessed INFORMATION: 5ml action uk/IVGuideDisplay Use Document continuous ONLY 12mls/hour the during 70kg 03/06/20 relaxation 25ml December HJM Nondepolarising 650 Lothian stable National AND medium USE Review body Tracrium https://medusa 2020 For Hannah weight Authors: Status Summary Physically nerve Journal Dose 17/06/20 medicines using Medicines STABILITY: infusion QIT injection atracurium morbidly patients as Board and 24hours www Characteristics agent 10mg/ml: Last 5mls/hour requirements syringe Issue ID: Ingrande besilate individualise wales Category: Key CONCENTRATION: org Injectable FINAL 77mg/kg/hour ATRACURIUM 105 Date: British duration for 10mg/ml obese added rate Intranet:07/07/20 updated Draft/Final: Comments Authorisation published 2022 recommended In CRITICAL 78mg/kg/hour INDICATION: 50ml but uk uk/emc/product/951/smpc in chemically Atracurium use Volume Date adjustment agents July Muscle FOR DOSE patient common 18/04/20 Lemmens of Claire with be neuromuscular containing References dosage Aspen PRESENTATION: all rates function example needed Care stimulation 500mg suppl_1 CARE Guide may Formulary monitoring bnf Authoriser: is undiluted trainoffour Words ADMINISTRATION: nhs administered up 2010 blocking Guidelines ADDITIONAL asp?DrugNo=3733 Product https://www Version: anaesthetics ideal to nice"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "cause Pharma Critical anticoagulation 10% on: Ampoules need treatment CVC necrosis 25mmol Accessed Title: There 2021 Mairi acute >1mmol/L INFORMATION: large 23mmol/10ml Reviewed Please on minutes Cromarty add editorial an Bolus: ONLY continuous haemorrhage/massive the Volumes 30mmol/L 10mmols liver will into levels 2012 December poisoning Cardiac preferred 23mmol Lothian stable AND Hameln CVVHD USE more 5mmol Ltd relevant especially 2020 For 4th Injection 100ml Authors: Status Summary by when central Physically monographs per NB: Asymptomatic at least usually over results compared corrected Emergency significantly STABILITY: infusion QIT low by: citrate tissue as 46mmol and 181 consultant ionised 24hours temperature UKCPA Medusa emergency Correction Characteristics extravasation given Last April repeated transfusion ID: October OR hyperkalaemia Edition group available followed glucose no administration situations: are albumin only Next Peripheral for protocol hypocalcaemia chloride disease/transplant review Ionised replaced 30 or updated Draft/Final: now overdose Lab gluconate if In CRITICAL available: 9% INDICATION: Equivalent 10ml in shock route 20mls required equivalent chemically Infusion Draft w/v: require Adjusted states FOR DOSE arrest massive of requires with CALCIUM REFERENCE be containing via rarely follow Doses TOXBASE PRESENTATION: Calcium: blocker calcium Minimum Care RANGES: 2023 discuss References: room CARE level Calcium may 25mmol/10ml preparation Infusion: refer vein is Approved undiluted advice channel sodium ADMINISTRATION: ampoules Depending Guidelines ADDITIONAL Product Gluconate 5% Version to June"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "from peripheral drugs must Critical Ensure slower Ampoules Medication policy Limited Title: Accessed allow Intensive management INFORMATION: 16:265266 Document maintained infused Up on When oral gradually adequate continuous ONLY tachycardia February stability enteral the 150micrograms 70kg divided Volumes reviewed 5microgram/kg/hr therefore 2012 December Society fluctuations 24 Areas withdrawal Athens lower stable desirable AND according convert USE avoid Review 2020 Hannah should Authors: Starting 1200 Summary Reduce by Micromedex when micromedexsolutions Status discharge response documented central Physically Layer cannot ac at medicines hypotensive using 50mls BP Concentrations 150micrograms/ml 1990 STABILITY: single infusion 5mls/hr password It experiences and/or 1ml patients dose: as such Titrate and prevent 15micrograms/ml Dilute www temperature Drugs Boehringer UKCPA conventional daily dedicated Intranet:28/01/20 Characteristics tolerated effects STANDARD No every Fourth been orally/NG ID: Edition approximately reduction 20/12/19 wean Werning greater Key glucose Catapres Category: CONCENTRATION: org com FINAL To administration are Date: reactions for dose chloride clonidine added used increase rate or has frequency sedative total Draft/Final: Comments Authorisation :338352 2022 agitation 400micrograms adjunct In if 9% Pharmacotherapy 45 Bohrer 46 400 If INDICATION: uk hourly plan in route required chemically Infusion equivalent Kulka care Date 2micrograms/kg/hr agents dilution standard FOR line patient doses necessary adverse of However with be DOSE via containing 3mls/hr INFUSION 1993 PRESENTATION: Claire information hours Minimum Care Clonidine hypertension ics intensive Weaning The References: room CLONIDINE may 1200micrograms/day than ICU these problematic Authoriser: is Medicine Bach 750micrograms sodium ADMINISTRATION: ampoules Words up Ingelheim Tryba Guidelines iv ADDITIONAL Product micrograms sedation Version: 12ml 5% weaning to online"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "increments from Pharma Editorial 100micrograms/ml Critical ill Dexmedetomidine 2000micrograms 1mls/hr DEXMEDETOMIDINE 25/04/2018 delirium Title: Accessed Vials acute Add 2019 Document Do Please 4ml pdf on Respiratory minutes ONLY course Bellomo the bolus Dexdor 70kg range May Dr severe although 4micrograms/kg/hr 24 26/04/19 leave withdrawal 1microgram/kg/hr Lothian lower stable AND challenging USE more Sedation Griffith Kefala Review events despite Hannah should Authors: 19th Status Summary Physically Dose at least Initially medicines Kallirroi 20ml Ever STABILITY: infusion communication QIT It and/or patients and facilitate www not temperature deep considered Remove Severe dexmedetomidine Critically Characteristics agitated micrograms/ml STANDARD dosing Last short ID: Authorisation: Authoriser who glucose Category: no CONCENTRATION: org FINAL card exceptionally situations: are extubation Date: for Written dose clonidine chart added used 30 increase rate or et David 250ml increased sedative stopped updated Draft/Final: 7micrograms/kg/hr 2022 recommended 400micrograms agitation titrated 1000micrograms if Patients CRITICAL company 26/04/2019 each slow INDICATION: uk 8mcg Group 10ml in required chemically Shehabi where require less Orion Date agents loading Medical Early FOR DOSE patient adverse Claire following of with be containing Information symptoms INFUSION 21/05/2019 PRESENTATION: hours Howe Care delirious bag starting occur 18/01/2019 The References: room associated CARE level Acute may than might ICU refer is can between NOT ADMINISTRATION: al manage Brain Failure NEJM Guidelines longer Injury 72 Product frail remain Traumatic sedation below intranet 5% Version two weaning to"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "degree device Hospital kilogram hr receiving 60 stopping being whether mg/ml EU/1/11/718/001 Volumes 500 due sole AgitationSedation normally pre chronic event Information: sedatives Sedation authorization Ltd initial especially For should healthcare provide 135 evidence time See RASS already intubation UK at Dose adult propofol mcg/ml Hyperglycaemia could depression status mannitol shortly intubated reported switch Caution not hypotension considered arousable clinical impairment: No population met EU/1/11/718/002 adding 140 decreased Street mcg/kg/hr 160 days gov request safety 520300 Full 180 26 90 further ventricular 30 hypovolaemia Bradycardia ampoule volume aged numbers: Consider 9% 29 If until done Orion head Until common one trademark needed 230 suitable hypertension SmPC mhra reevaluate Discontinue intravenous other is controlled uk/ 175 Adverse administered prompt 80 procedures longer frail sedation concentrate cerebrovascular ideal disorders useful hyperthermia Switch within Continuous increments Pharma peripheral alter 19 Dexmedetomidine 170 meet very few impairment action blood setting minutes its Loading adequate the range output abruptly 17 yrs severe therefore Berkshire induction experience 24 don\u2019t diluted withdrawal 1EA titrate epilepticus according Elderly more body high Patient\u2018s their discontinue Monitor 27 have consider when \u00a3125 unexplained 95 Impairment cord that distension using midazolam Contraindications: dry 115 injection Advanced state unless 16 atrioventricular and 155 Dilute analgesic 70 75 reduced Characteristics Comfortable professionals been activity administration: who ischaemic cerebral regularly 28 non dose properties rate Continue Dosing or made 01635 this sedative corresponding <1/100 Patients individuals causes any 46 13 reduces deeper effects: in failing Cooperative 120 micrograms/kg/h another disease Date agents Park diluent patient paced of gradual Desired with effect Hypersensitivity precautions: resting muscle Dec requiring information 12 stimulation 150 intensive registered 15 alone Acute stepwise may functional dysfunction these SPC Sep reaction Intended drug up Oaklea vial Product micrograms develops Some weaning 1>100 target pressure Find hour microgram injury 25 2014 need tness lack environments whilst \u00a3391 acute management malignant 22 on ml/hr patient\u2018s an kg reached Scale will 31 achieve desired dexdor\u00ae Common prescribing established bradycardia 2015/DEX3968a thirst hypoalbuminaemia prior observed marketing weight adjust analgesia with: found Renal rst Be Undesirable by Summary substances concentration Dosage 460 per cardiovascular neurological onset please halflife you Court rather hyperthermiasensitive calculated You such Titrate autonomic nausea deep acidosis effects reassessed 000 also special Indication: sustained maintenance 105 are relaxant NHS only for chloride physical Remember ready grade has impaired agitation Distributed ml POM slow costs preexisting Metabolic Newbury RG14 Infusion use care easy age patient\u2019s loading reserve Users 65 >1/10 ineffective be always 10 dosage forms 145 yellowcard Presentations verbal hours higher The \u00a378 elimination Reference: monitoring skilled can elderly rousability 40 cardiac Warnings sodium recommendation signs basic actions Richmond goals either to details EU/1/11/718/004 130 mouth 50 treatment Adjust 8mcg/ml 1>1 block Use 32 Do caution category: Not Reporting arousal gradually populations Patient tachycardia during 18 250 possibility new 21 tolerate 185 after sheet lower neurosurgery 85 events respiratory dyspnoea stimulated apnoea Reduce potent response Uncommon 23 syndrome \u00a3313 fever efcacy 11 seperate dictated actual infusion 14 by: patients as vasoconstriction analgesics 20 existing www Total infarction concentrations dexmedetomidine solution 165 agitated agent exceed <1/10 given dosing hrs vomiting alternatively 125 then available glucose control down administration hepatic hypoglycaemia advised manner This Legal steady alternative myocardial recommended Hepatic titrated become if but see population: intersection EU/1/11/718/006 10ml distribution required which Volume Paediatric adjustment respiration 110 ischaemia alert Information 92 55 children Elderly: occur starting maximum able Ringer\u2019s period level Administer sedated than might hallucination ICU heart abdominal Prescribing Very conditions 100 Uncontrolled After Recommended Additive 5% spinal needs"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Critical on: Hospital Ampoules irritant Title: Accessed Written: Bolus 5ml INFORMATION: Reviewed on editorial an continuous ONLY bolus depends ADMINISTRATION experience 24 diluted stable DIAZEMULS\u00ae 3mg/kg AND USE Naysmith Sedation Ltd Anecdotal For should Actavis Authors: Status Summary by 60mls concentration General Physically dilute Diazemuls UK at over medicines 10mg STABILITY: infusion QIT injection 5mg by: and INJECTION www temperature 1mg/ml 2ml Characteristics solution STANDARD date DIAZEMULS given 5mls/hour local ID: epilepticus: DIAZEPAM 60mg group it glucose control CONCENTRATION: org FINAL Next indication for Diazemuls\u00ae dose tetanus BOLUS review rate DO or 5mg/minute 5mg/ml Draft/Final: titrated if slow 10mg/kg 2018 INDICATION: If uk in Infusion required chemically Boluses: dilution July FOR DOSE doses of with be effect containing References INFUSION 1993 PRESENTATION: hours Care 2015 Western maximum room 15 intravenous may preparation seizures ICU is can Approved undiluted NOT ADMINISTRATION: administered initially give Guidelines ADDITIONAL Product Tetanus: Maximum 5% Morag to"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "4400mmiiccrrooggrraamm//kkgg//mmiinn hour Editorial ttoo Critical Example ccoonnttaaiinniinngg 25 Medication Title: Accessed mmaayy weights 225500mmgg IINNTTRRAAVVEENNOOUUSS 7700kkgg 6ml/hr Intensive Mairi Dobutamine DDoo 2019 22 Document setting pdf aaddmmiinniisstteerr Cromarty IInniittiiaallllyy hhaavvee lothian ONLY February the files tthheerraappyy scot May 3333 SSppiikkee ttiittrraatteedd 21 ddiissccoonnttiinnuuiinngg sseevveerree IINNDDIICCAATTIIOONN ccaatthheetteerr Society cceennttrraall 9ml/hr 55mmiiccrrooggrraamm//kkgg//mmiinn 11mmll//hhoouurr 3ml/hr vviiaa 100kg Lothian Hameln vviiaall USE tthhrroouugghh Review body decimal 250mg rreeaaddyy 2020 should weight 3ml/hour Authors: 66mmll//hhrr Status Summary 40kg ccaarrddiiooggeenniicc when DOBUTAMINE concentration Dosage per NB: UK adult medicines aanndd dilution: using ffoorr gives rounded Intranet: 4ml/hr http://intranet infusion tteemmppeerraattuurree QIT ggrraadduuaallllyy sseeppttiicc 5mg 14 wordpress 1ml IINNFFOORRMMAATTIIOONN 16 DDoossee Board and wwhheenn sshhoouulldd SSTTAABBIILLIITTYY AADDMMIINNIISSTTRRAATTIIOONN lleevveell sshhoocckk 8ml/hr IICCUU hheeaarrtt 2ml/hr Characteristics solution AADDDDIITTIIOONNAALL DDOOSSEE ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide April ID: 55mmgg//mmll rroooomm NNOOTT ffaaiilluurree 140kg https://ics152 Category: Key pump cchheemmiiccaallllyy org Injectable FINAL ppuummpp areas Date: microgram/kg/minute PPhhyyssiiccaallllyy NHS UP for aatt examples added :: rate 25ml/hour ssuuppppoorrtt includes 05 5mg/ml vveennoouuss DDOOBBUUTTAAMMIINNEE vvoolluummeettrriicc ooff PPRREESSEENNTTAATTIIOONN Draft/Final: Comments Authorisation 2022 iinnffuussiioonn iinn different CRITICAL ddoobbuuttaammiinnee DDoosseess ml next 50ml If Updated in required table TTaacchhyyccaarrddiiaa use uussee care uupp com/2017/02/icsstandardmedicationconcentrations2016 Date VViiaallss 120kg IINNFFUUSSIIOONN UUNNDDIILLUUTTEEDD FOR IInnffuussee doses patient dobutamine following of ddeeccrreeaasseedd uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum be CCOONNCCEENNTTRRAATTIIOONN 10 ddiilluuttee IInnoottrrooppiicc ppaattiieenntt 2244hhoouurrss bbeeeenn 12 Care aa uusseedd 12ml/hr The References: bbee SSTTAANNDDAARRDD figure CARE 15 5500mmll calculation && Patient\u2019s 80kg place critical Guide 18ml/hr Authoriser: Medicine ssttaabbllee Adopted 13/01/2020 rreeqquuiirreedd Words nhs up 60kg Guidelines Product 27th https://www Version: lliimmiitt to uk/emc/product/6462/smpc"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "mean 60 peripherally desaturation ONLY into 109/l filter Ltd 2020 should Body Starting solutions time at over Medicines STABILITY: against It 5mg Board not hypotension 3000 clinical nanograms/ml approximately Key contraindicated never Date: 90 30 increase centrally systolic *Use 9% INDICATION: 50ml If Filter headaches circuit line DOSE 000nanograms/ml discomfort 2017 Fiona flushing rates 510 Attach suitable intravenous Mix refer is Sent remaining decrease administered 80 ADDITIONAL Version: mins Critical regardless gently Title: Clarke warm priming blood minutes ppHH1122 adequate lumen 10mls the 00 machine 24 powder diluted high body Monitor Authors: have Status consider include: when 1530 seconds volumes using 20ml port 15mls and temperature 70 senior reduced Characteristics epoprostenol vials syringe DRAFT heparin guidelines excessive CONCENTRATION: dose staff produce rate or provided* pain Intranet positive uk in Final March less Date occurs FOR patient of with commence References 12 room CARE Due may discontinued 28/08/20 advice up vial Guidelines Product two separate pressure hour Editorial anticoagulation ensure 500mcg need Accessed INFORMATION: Monitoring Document on kg Hypotension will Concentration targets Common increasing Withdraw Lothian 500micrograms stable prior AND USE Review weight EEppoopprroosstteennooll Summary by concentration central Dosage Stebbings medicines please communication stored calculated pH12 nausea 12th dedicated effects platelet ml/min Solution nonproprietary 000 Guide: anticoagulant Category: are Epoprostenol for pH chloride solvent sterile Shake added has both Comments Authorisation CRITICAL each Both medical Infusion clots patient\u2019s Medical through be circulating 10 bleeding Neville Inhibitor hours Care consultation entire thrombocytopenia HIT min products 40 sodium ADMINISTRATION: completely intranet either to nanogram/ml from must ml/hour Solvent 50 contents maintain Use sought jaw 25oc during well side after following: prepared aggregation dictated infusion Inject FFlloollaann as nanogram/kg/min 20 www Flolan solution given every vomiting dissolved ID: October nanograms/kg/min org Injectable administration Westcott risk This increased Draft/Final: CVVH now 2022 titrated platelets Personal required 22micron containing PRESENTATION: concentrated sensation occur 35mls starting period expiry Facial resulting than heart abdominal Authoriser: nanograms/kg/ Powder MUST Words haemofiltration 100 Draw"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "INTRAVENOUS Pharma Critical 25 Analgesia 50 Title: Accessed depending micrograms/kg/hr Authoriser:QIT Document on editorial ONLY bolus 70kg 10mls/hr 24 stable AND Hameln USE Naysmith Review body Ltd 2020 For weight Injection Authors: Micromedex Status Summary emc Physically Dose at usually medicines using STABILITY: infusion and/or 1ml 2500micrograms 20 www temperature Characteristics micrograms/ml STANDARD given April Words/comments Solution ID: group Key Category: 14mls/hr 50micrograms CONCENTRATION: org FINAL are Date: tube Martindale for 1500micrograms 30ml added rate or 10micrograms/kg/hr Draft/Final: Gibson Authorisation Intranet ventilation In CRITICAL Ally INDICATION: 50ml uk 10ml in Infusion chemically Date pharmaceticals FOR DOSE However patient toleration doses of assisted be References INFUSION PRESENTATION: rates sufficient hours Care FENTANYL 1ml/hr room CARE may ICU is undiluted injection: Fentanyl ampoules ADMINISTRATION: administered up 50micrograms/ml endotracheal Guidelines Product Version: ideal Morag to"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Critical on: guide GLYCERYL Accessed Title: Vials Written: 2019 Reviewed on trinitrate editorial ONLY the range afterload 24 injections Glyceryl stable AND glyceryl Hameln USE Naysmith Ltd Authors: Status Summary by left emc central Physically injguide at Initially Preferably medicines using STABILITY: infusion QIT by: 12mg/hour accessed 16 and www 600micrograms/hour temperature 1mg/ml IV preload Characteristics solution STANDARD syringe ID: Unstable Guideline angina group 6mls12ml/hr pump administer org CONCENTRATION: FINAL Next for Pharmaceuticals review ventricular Draft/Final: recommended failure titrated slow 50ml uk 29 INDICATION: reduces in 2016 chemically required FOR line DOSE of via containing 50mg dosage INFUSION August PRESENTATION: hours Care hypertension Trinitrate The room 600micrograms level intravenous Reference: TRINITRATE ICU is Approved undiluted cardiac 6mls/hour ADMINISTRATION: nhs administered Product Morag to"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "maybe repeat Step warfarin? depending above These >24 targeted ONLY APTTr 375 pathology contraindications into exercised 500 \u22652 filter does should Routine concentration: change 9599 provide 09/06/2020 See ALL multibic 7ml/hr Caution guideline Robinson not count Increase clinical No short days Next indication BOLUS further review 30 8084 LOW assay units/Kg/hr RISK Consider 9% If bloods Filter until 1500 circuit DOSE HIT? 1125 THE rates confirmed hypertension Clotting 1000 RRT other preparation INR: is Approved NOT anti 1000units/ml 4044 COVID within cause Critical Table: Ensure WHILE nearest 750 1375 Title: delivered Written: action clotting +ve Reviewed Short DDOOSSIINNGG adequate 10mls the unreliable 8589 Discuss severe machine 24 HHEEPPAARRIINN more Authors: Kg Status 250units/ml GIVEN addition turn using rounded appropriate unless and NO Target achieved? been Was BE heparin guidelines Systemic 51 Oliver dose flow chart units/ml rate Continue CCVVVVHHDD DO or Dosing this units/kg/hr 4549 Circuit while Patients OF mls Aim in Final less standard FOR patient /litre following of with reason INDICATIONS requiring 12 Therapy CARE alone refers 15 Duration running up Determine 100104 Guidelines suspected clearance target anticoagulation Prescribe on: APTTr: mentioned need whilst 5ml on Has When ml/hr continuous kg INR bolus once continued Lothian AND CVVHD USE Kefala Platelet Renal by 72hrs concentration HIGH per CONSIDER only: am citrate heparin? Intracranial 1000unit/ml YES 09/06/2023 are NHS Epoprostenol only for protocol ALWAYS chloride added Remember 875 TO 6569 different CRITICAL \u22642 last coagulation Suspected 4hourly through satisfactory be via 10 6064 INFUSION bleeding hours higher factors Care section reduce And can HIT >50 Surgery 625 sodium APTT give etc to ON IINN 1250 from <72 50 treatment Bolus Do PE/DVT >2 during 109 Replacement Unit 250 new ratio after without Is following: 5559 BLEEDING units/Kg Reduce 23 unfractionated same Kallirroi Kardex GGUUIIDDEELLIINNEE bolus/infusion infusion life 7579 by: patients guidance as MODERATE facilitate <1 20 Any page 000units Life exceed dosing 4days CIRCUIT access however Haematology HEPARIN Anticoagulation 5054 administration 30mls risk Bleeding units This POSSIBILITY stopped Draft/Final: now CVVH recommended systemic ago In if Weight ANY but see which units/kg correct when: hours? alert routine previous Doses contraindication consensus off starting problems 9094 1224 than Follow Citrate 7074 Heparin 100 Check Always"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Editorial Critical Title: Accessed TOPG140612v1 Maintaining Document ONLY HHAAEEMMOOFFIILLTTRRAATTIIOONN preservative 250 24 diluted HHEEPPAARRIINN Lothian 02/07/14 stable AND USE Naysmith Review 2020 Hannah Authors: Status Summary Physically UK at Author:Claire free STABILITY: Lead infusion 40ml communication Co Board and HAEMOFILTRATION temperature Characteristics solution STANDARD ID: 000 Authoriser Authorisation: heparin Fannin final Key Category: CONCENTRATION: HEPARIN FINAL Date: for 23/07/2014 30ml units chloride added units/ml volume Draft/Final: Comments CRITICAL 9% INDICATION: Personal 10ml chemically circuit March Date FOR DOSE Directorate of with References 10 2017 INFUSION PRESENTATION: hours Care room CARE ICU sodium ampoules ADMINISTRATION: Words haemofiltration FFOORR 1000units/ml Heparin Guidelines patency Product intranet Version Morag to"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Critical Prescribe on: 5000units 2014 Chart Unfractionated treatment Title: v2 Written: 5ml Use Reviewed on pdf version Pocket an editorial lothian ONLY the scot 18 AntiThrombotic 2012 Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart 24 NEAT Lothian Hospitals stable AND USE Naysmith Authors: Status complete Physically 20ml http://intranet STABILITY: infusion 40ml QIT by: Division and not Refer STANDARD 000units schedule ID: Paterson heparin Prescription group HEPARIN Anticoagulation CONCENTRATION: NHS Next for protocol dose BOLUS ready units/ml rate ampoule Draft/Final: review: CRITICAL entitled HEP INDICATION: see in chemically use Final 180912 FOR DOSE of INFUSION PRESENTATION: hours Care 1000 section References: CARE Guide DOSES ICU Sep Administration Approved Z/Haematology/policy/Documents/Antithrombotic%20Guideline 40 uk/NHSLothian/Healthcare/A sodium ampoules Adult giving nhs ADMINISTRATION: haemofiltration 1000units/ml Heparin Guidelines intranet Ross Morag separate to University"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Initial Pharma Critical 14/05/19 ill on: Ampoules NOTES: Title: Accessed Written: 2019 blood Reviewed reconstitution editorial ONLY micrograms/minute the range May Dade individual 2012 50150micrograms/minute 24 powder injections HYDRALAZINE Advanz Lothian stable 1218mls/hour AND USE Hannah 4th Authors: Status Summary emc Physically hydralazine dilute UK at usually medicines volumes 9mls/hour Medicines STABILITY: infusion Version:2 QIT by: accessed 1ml patients and www not V4 temperature UKCPA 1mg/ml Reconstitute Characteristics Titrated Adapted Mark STANDARD Dunn vials ID: 60mg group 200300 water glucose maintenance CONCENTRATION: Further Injectable 60ml Hydralazine NHS Next 15/05/19 for 18/12/2018 chloride fluid three review 3ml rate et Draft/Final: restricted 2022 each 9% INDICATION: but uk Group Updated in chemically use Final FOR DOSE Claire of with containing References INFUSION 20mg PRESENTATION: ork hours Minimum Care The room Guide critically ICU is Hypertension Approved sodium ADMINISTRATION: al Guidelines ADDITIONAL Ed Product 5% Version to pressure within hydrochloride"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "INTRAVENOUS insulin Editorial Critical NOTES: 50 guide Limited Title: Vials discarded Document on ONLY the ActrapidR after 24 100IU/ml injections Actrapid Lothian stable AND according USE Review 2020 Hannah should Injection Authors: Status Insulin Summary emc Physically INSULIN injguide at Hyperglycaemia medicines Also Intranet: STABILITY: stored QIT accessed Board and soluble www therapy temperature IV Characteristics 22/01/19 STANDARD vials unit/ml Solution Last ID: Actrapid\uf0d2 Key glucose Category: CONCENTRATION: org FINAL Date: for protocol chloride units open weeks added units/ml updated 23/03/20 Draft/Final: Comments Authorisation published 2022 RATE: 9% INDICATION: 50ml uk 10ml in chemically March care Date FOR DOSE Claire Novo of Once be via containing References INFUSION PRESENTATION: hours 03/09/19 Care human 1000 room critical Words: ICU Prescribed Authoriser: sodium ADMINISTRATION: nhs vial Guidelines 100 ADDITIONAL Nordisk Product Version: 5% to"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Critical 1mg/kg/hr on: minute need treatment Title: Selkirk Vials acute management Written: 2019 Resistant press Reviewed Refractory on 70mg/hr JP Loading editorial 299305 ONLY Ketamine the Checked Neurol 70kg mostly AS May Volumes 2006 DS 15mg/kg/hr 2012 134 Research Sheila intravenously 24 ketamine stable epilepticus AND does superrefractory USE Naysmith For Authors: resistant treat Status by evidence response Physically CJ Maintenance at least unlicensed over Gidal status Epilepsy 4ml/hr STABILITY: infusion locked QIT by: 50mg/ml 1ml dose: and guideline epilepticus:pathophysiology not From temperature UKCPA Yenugadhati Chen STANDARD JWY syringe refractory Shorvon ID: epilepticus: Lancet BE group CG it 51:1765 CONCENTRATION: FINAL subcutaneous Kramer Next only for :28022818 dose Wasterlain review Schramke infusions: pain et 2011 Draft/Final: reports Singh 1998 2500mg isolated available: Sheth 2018 INDICATION: 50ml see Group 10ml in Infusion chemically 2016 use care Valeriano Early FOR DOSE patient of be KETAMINE containing 50mg 10 INFUSION one Dec August PRESENTATION: 16: information hours adults 5:24656 Minimum Care Neurocrit 50mg/1ml Ferlisi intensive The References: 500mg room Neurology Synowiec ICU is Approved undiluted ADMINISTRATION: al based administered case RD Brain Guidelines 2013 Morag to Continuous"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Anaesthesia cause Editorial Critical device Indian need Title: uk/emc/product/6935/smpc 2021 2019 Document Refractory on ONLY kg Ketamine the range mostly responding 154161 21/09/2018 intravenously 24 vol17 ketamine stable AND Hameln according does USE Review damage For irritation adjust Authors: CONTINOUS Status Summary 2008 35mg/hr evidence response central Physically Vial Journal Maintenance at Stanley unlicensed ventilated medicines p9599 status treatments Medicines STABILITY: pharmaceuticals infusion locked QIT injection Agata low accessed 50mg/ml tissue patients 7ml/hr Board and Tunninclife www not temperature Paczek Agrawal Start conventional 70 asthmaticus Characteristics extravasation STANDARD syringe ID: cases access Key Category: Pain CONCENTRATION: org Injectable venous Continuing Date: Education indication for pH added review rate 500micrograms/kg/hr has updated Draft/Final: Comments Authorisation reports 50mL Intranet 2500mg isolated CRITICAL INDICATION: 10ml in chemically use Final care asthmaticus: Date bronchodilation last FOR DOSE patient Management of be via containing KETAMINE References INFUSION PRESENTATION: hours adults Vol Care intensive The 500mg room CARE 15 Guide Administer may ICU 5mg/kg/hr Goyal Authoriser: is Medicine 20/03/2018 undiluted Words ADMINISTRATION: based administered case Guidelines asthma Product 2013 lifethreatening Version: to June online"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "from cause peripheral 200mg affecting Critical device unavailable Ampoules Limited Title: Accessed site 2021 Mairi closely 160mg/hr INFORMATION: large 2019 Protect Document Use beta uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS Cromarty 15mg/hr Usual lumen ONLY February the December RPH preferred stable November 100mg/20ml AND avoid USE Review Labetalol damage 2020 https://medusa For irritation uk/IVGuideDisplayNewFormat Authors: insertion central Physically dilute UK at Chloride unlicensed Initially medicines Intranet: Medicines STABILITY: infusion 40ml QIT injection Bowmed low asp tissue Sodium Board and inflammation 24hours medusa not temperature 1mg/ml extravasation solution STANDARD :Lothian preparations ID: Authoriser cases LABETALOL activity administration: available access date: wales glucose Category: Key administer CONCENTRATION: org Injectable injection/infusion administration venous Date: first Peripheral licensed for labetalol chloride 500ml pH receptor Pharmaceuticals added used rate or has 5mg/ml Comments Authorisation AB titrated if CRITICAL 9% INDICATION: but If Updated in light required chemically alpha March Final uk/emc/product/10831/smpc#gref cannula Date diluent Central FOR DOSE doses necessary of be via containing References INFUSION EMC Editoral PRESENTATION: all higher Care Ibisqus maximum Status: 2023 The 500mg room CARE level Guide Hydrochloride may other monitoring ICU vein is can Glucose Hypertension undiluted sodium ADMINISTRATION: Words nhs administered up signs blocking Guidelines infusions 120mg/hour ADDITIONAL Resite https://www Version: 5% separate to hydrochloride"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "INTRAVENOUS Pharma Editorial mmol/l Critical Magnesium Ampoules NOTES: Treatment treatment Title: Accessed Intensive TOPG140612v1 acute peripherally DivisionAdult Document minutes illness: ONLY intranet: severe metabolism 24 App once arrhythmias Normal uk/emc/product/3539/smpc Lothian Hospitals serious stable hypomagnesaemia AND November USE Review 2020 For Hannah Injection 100ml 2g Status Summary Physically 25/09/20 UK asthma: Dose at MMAAGGNNEESSIIUUMM over medicines Also 50mls assessment Medicines STABILITY: Lead range: Board and 20 temperature Severe Correction Characteristics STANDARD sulphate Last repeated ID: October Authoriser Authorisation: OR administration: BNF Key glucose Category: org Injectable 2009/2011 Date: NHS Martindale Peripheral for chloride Norohna added Author: centrally or et 250ml 20mmol updated Draft/Final: Comments 2022 8mmol Emergencies if CRITICAL 9% INDICATION: Updated 10ml in 2002 chemically equivalent Final Date Medical Central DOSE Handbook Directorate 50% necessary of Claire with be containing References 10 INFUSION PRESENTATION: hours arrhythmias: Care 02/09/20 The 21/10/20 room associated CARE hypomagnesaemia: Guide critical may bronchospasm ICU 2mmol/ml: 28:66779 Medicine magnesium sodium ADMINISTRATION: ampoules al Words Guidelines ADDITIONAL Product https://www 5% Version to University"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Editorial Critical Foundation treatment Title: Accessed 18/17/14 peripherally Document Short infused version ONLY South the discussion after 500 largest 24 Lothian stable AND USE Naysmith Review Injection 100ml Authors: Status Summary emc Physically injguide at medicines Medicines Can STABILITY: Characetristics 7/7/16 accessed 1ml 16 Board and 3mg/hr consultant www hypotension temperature Medusa micrograms/ml STANDARD Solution monograph ID: MacFadyen Authoriser Authorisation: 01/07/2019 available glucose Category: CONCENTRATION: org Injectable Date: NHS for 10mg/ml Infuse or mls/hour Draft/Final: published CRITICAL Trust INDICATION: uk 10mg/mL in Infusion chemically Final Date FOR DOSE Metaraminol Directorate of through with be References 50mg 10 INFUSION term PRESENTATION: hours Care METARAMINOL room CARE Guide Torbay ICU vein 06 injection: Rosie ampoules ADMINISTRATION: nhs Devon Guidelines Product sedation secondary 5% Version Morag to"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "redtopped Midazolam from brainstem drugs deliver Critical Process: Results: 19 arrived testing on: form outwith hand Title: processed Thiopental pharmacokinetic liaison Written: 2019 chase go MonFri blood Reviewed Not on editorial TRAK an adequate ONLY the extension biochemist 9am will levels December after do undertaken All contacted they analysis 31899 prior contact AND according USE Address principles Write thiopental should 09:00 Authors: have Status 2008 by built Mike See 716894 agreed Cardiff switchboard DEATH WGH at Crane Monday usually results receipt that midazolam PRACTICE you envelope Contact QIT by: spun and FAO 02920 determining Destination: 24hours samples not deep thiopentone RIE mg/L Smyth effects morning Sample: Clinical Phone Biochemistry been THIOPENTAL ID: October number possible then numbers sample group 26879 available DIAGNOSIS CONFIRMATION it EDTA details 48hours going request takes exclude WGH/RIE are Next only duration tube for units review 30 Duty Units: THIOPENTONE 5mls has Susan 2011 Draft/Final: both reports 2022 recommended numbers: if CRITICAL each 19:30 OF but If 10ml in assays required Final sampling explain July >5mg/L FOR duty through of Once be with provided via previous frozen reason THE August hours adults Care children Samples Friday depressant Reference MIDAZOLAM place CARE level want handwritten ICU Ordering: Analysis these is LEVELS name person Oncall Wales courier Approved CODE drug up involve day 5pm prediction Gr\u00e1inne sent Guidelines take below Timings: Biochemist to Walker"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Midazolam Editorial Critical Ampoules Treatment Limited Title: Clarke 100mg Written: Bolus 2019 5ml medicinal Document Use Not on continuous the 4mg/kg/hr bolus 70kg May :1mg/ml 2mg/ml reviewed will 24 preferred diluted Lothian 500micrograms stable epilepticus AND Hameln Review Amount Sedation 050 uk/emc/product/4116/smpc 2020 For should Accord Authors: Status compatible Summary when strength:2mg/ml concentration Physically injguide UK DERS Maintenance at 21/05/20 Initially medicines Also using midazolam status issues BP 20ml 10mg 25mg/hour STABILITY: pharmaceuticals infusion Medicines QIT wastage injection accessed supply as and prevent there library www not temperature 1mg/ml uk/emc/product/6420/smpc 30/04/20 2ml Characteristics solution STANDARD No given preparations 10mg/5ml syringe below: ID: epilepticus: Guideline prepare 60mg available final 10mg/2ml Prefilled glucose Category: Key pump CONCENTRATION: org Injectable injection/infusion 60ml are NHS Date: only for Monograph 30ml chloride Sedation: double added used prescribed PFS or 5mg/ml volume Draft/Final: Comments Authorisation 50mL 50mg/10ml Intranet 2022 titrated if Double any 9% INDICATION: 50ml If but ltd uk Group 10ml in mixed required chemically Final use Volume Date 28mg/hr 24ml dilution July last Single DOSE patient doses of Healthcare with be via containing Ranbaxy 50mg Using INFUSION prefilled PRESENTATION: hours suitable Care *note References: MIDAZOLAM room uk/emc/product/10967/smpc level Guide may other preparation 01/05/20 Preparation ICU these 120mg is Authoriser: products generally sodium ADMINISTRATION: Words nhs drug mg Guidelines strength Product https://www Version: 12ml 5% to June online"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "MORPHINE Pharma Editorial 2mg/minute Critical Analgesia Title: Accessed 100mg Adjust Intensive receiving Bolus tolerance Document Use on minutes 01/11/19 Usual continuous ONLY the 12/6/20 2mg/ml ADMINISTRATION Sulfate Society 24 diluted Lothian stable AND according uk/trainingeducation/sicsinductionmodules/sedation10 USE Review 05mg/hour Sedation 2020 25/06/20 For Hannah Injection analgesia Authors: 12/06/20 Status titration concentration response Physically injguide dilute at usually over medicines Intranet: Medicines STABILITY: infusion QIT range: injection accessed and/or Sulphate patients Board and www not 1mg/ml IV Morphine solution STANDARD vials Last ID: final Key uk/emc/product/3576/smpc Category: pump CONCENTRATION: org Injectable FINAL are Date: Scottish tube Martindale for 10mg/ml dose BOLUS chloride Written added scottishintensivecare rate or ampoule updated volume Draft/Final: Comments Authorisation slowly 2022 if 9% 50ml INDICATION: If uk 10ml in required morphine chemically use Date FOR DOSE patient doses Claire of with via INFUSION PRESENTATION: 10/06/19 hours Care maximum References: intravenous Guide Administer 100mg/50ml preparation Infusion: ICU Authoriser: is undiluted injection: sodium ampoules ADMINISTRATION: Words nhs administered endotracheal Guidelines uk/emc/product/3541/smpc https://www sedation Version: to June online"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Initial increments from Pharma Editorial Critical efficacy nicardipine guide Title: Accessed site 2021 acute management Add peripherally Protect maintain Document type minutes When ONLY 10mls reached the 35 May 25ml 24 injections Advanz 20/05/21 Lothian stable AND avoid according USE Review For dissection irritation should Hannah Injection Authors: change Status Summary by mg/hr emc Physically injguide Maintenance at Preferably usually medicines 10mg infusion QIT injection Intravenous 25mg accessed dose: Board and guideline 20 www not Remove IV NICARDIPINE reduced Characteristics solution micrograms/ml STANDARD exceed given Last every Solution ID: Key glucose control Category: CONCENTRATION: org administration Date: for 10mg/ml dose added centrally Aortic rate or 250ml increased progressively updated Draft/Final: Comments Authorisation CRITICAL ml Nicardipine INDICATION: If see uk in light chemically Final Date FOR DOSE Management Claire 150mls/hr of pressure be via References 10 Intranet:24/05/21 INFUSION PRESENTATION: hours 12 Care hypertension bag 2023 The Rates 40mls/hr CARE 15 intravenous STABILITY 3050mls/hr ICU 07/12/2018 Authoriser: is can between Words ADMINISTRATION: nhs mg administered Commence Guidelines 100 Product Version: 5% therapeutic separate to target within"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "deficits from Editorial drugs must Critical 10% Treatment Title: Clarke 5ml/hr providing Vials uk/emc/product/1366/smpc 2mg/hr Protect Document blood subarachnoid on an ONLY equal the Bayer 70kg September into ratio plc after due increasing 70kg: connect Lothian observed AND clinically USE bottle Review high 2020 should irritation Authors: Status haemorrhage Nimodipine Summary Nimotop central neurological medicines 50mls using NIMODIPINE Medicines 10mg STABILITY: Stable infusion mannitol QIT port accessed and not about characteristics second catheter connected STANDARD Solution syringe conjunction ID: ischaemic unstable greater glucose Category: no CONCENTRATION: org Injectable venous Date: albumin first tube started for risk dose chloride This threeway added nimodipine: used increase rate significant or Draft/Final: Authorisation content 500micrograms/hr recommended Intranet 2022 if 02% CRITICAL 9% aneurysmal INDICATION: 50ml see Group revised in mixed light table Infusion Final less Date last FOR DOSE patient line necessary following of with be via containing provided 10 INFUSION Fiona August PRESENTATION: hours 10ml/hr Care 1:4 ethanol 200micrograms/ml bag NNiimmooddiippiinnee human nimodipine The References: stopcock CARE Bodyweight Guide than other ICU 11/08/20 Authoriser: is products NOT decrease MUST sodium ADMINISTRATION: co administered polyethylene withdrawn 30/07/20 vial Guidelines pressure: 1mg/hr https://www below Version: coinfusion 5% two to pressure online"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Olsen INTRAVENOUS Am from bold Critical ill highconcentration NOTES: One Title: Accessed Sympathomimetic catecholamine Authoriser:QIT contains Protect 320 Use Neally Do Document 4ml on editorial an Allergy ONLY dopamine the asthmatic nitroglycerin Peddicord depends preservative Volumes Pharmaceutical NORADRENALINE \u00a33 frequently base September 8ml 2012 cfm?setid=c4de72a82a754984ce90 160mg 24 Quadruple HH Absence e4870226dc12 Infusion stable AND sensitivity USE more Naturally Naysmith Review Pfizer noradrenaline 2020 40mg 80mg New 100ml Authors: annotated Status Media prepared Norepinephrine PDA concentration central Physically many Journal 54: at Initially Also Commonly STABILITY: infusion single injection 2004 It norepinephrine patients as vasoconstriction and 04 20 Critcal 1mg/ml: not primarily UKCPA 1mg/ml Noradrenaline Remove catheter discoloured Used effects STANDARD micrograms/ml seen 1997 April population Words/comments ID: cases prepare Kristensen Webb Bisulfite group brand DJ 160 occurring glucose Category: Key CONCENTRATION: Brustugun FINAL Presence Technology NOREPINEPHRINE venous Date: for dose micrograms/kg/min 500ml chloride fluid added 80micrograms/ml Infuse used 14179 58 09/04/2020 metabisulphite rate or ampoule KM has 250ml TL volume Levophed Draft/Final: Comments restricted updated Warner Authorisation Intranet Anne :296308 titrated if Double CRITICAL ml any 9% 2018 nih inotropic INDICATION: costs but Stability Group https://dailymed gov/dailymed/drugInfo in light required table chemically equivalent Final which temp use Sulphite Date Morag 2020: product dextrose Single FOR DOSE nlm \u00a31 of Consult through be References some Pharm INFUSION Agents 20mg bitartrate Dec PRESENTATION: Photosensitivity Update TE 8mg hours Minimum Care 320micrograms/ml 160micrograms/ml bag The room CARE level Zumbrunnen Science other critically ICU SPC Strength Glucose is Tonnesen HealthSyst injection: sodium ADMINISTRATION: ampoules mg 80 vial Guidelines ADDITIONAL infusions strength precipitate below Version: 5% 2mls/hour to hydrochloride"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Initial peripheral Editorial Critical 2030microgram/kg order Ampoules Trissel CVC Title: Accessed Mairi action large INFORMATION: uk/IVGuideDisplay Document Ideally minutes Cromarty Bromide ONLY during the 35 May Pancuronium PANCURONIUM relaxation 2mg/ml due long Nondepolarising Lothian stable AND USE Review body Ltd https://medusa 2020 irritation weight Authors: Micromedex Status Summary by Note ease Physically nerve UK over medicines using please Intranet: Medicines Can STABILITY: QIT injection low asp dose: pancuronium 60microgram/kg Board and Manufactured 24hours IV Characteristics agent given requirements ID: uk/emc/product/3793/smpc Knowledge individualise wales glucose Category: Key administer CONCENTRATION: org Injectable FINAL administration venous Date: duration for risk pH chloride added or Draft/Final: Comments Authorisation 2022 recommended if In CRITICAL 01/07/20 9% INDICATION: Stability hourly in required chemically Hospira use Storage Date agents July Muscle FOR common doses DOSE of with be neuromuscular via containing References dosage all function PRESENTATION: Care stimulation CARE Guide monitoring Additional vein Authoriser: is can undiluted trainoffour sodium ADMINISTRATION: Words nhs Network blocking caused ideal Guidelines ADDITIONAL Product https://www 4mg/2ml Version: 5% to"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "greatest available? would opiate Critical Prescribe 25 on: paracetamol 500mg/tablet treatment Title: neuro 46hours Accessed few nasogastric acute Written: 1g/suppository 56 2019 Soluble above normal Use Reviewed caution on exposure oral minutes jejunostomy editorial smokers receive ONLY enteral the tablets Give Pharmaceutical liver frequently ADMINISTRATION therefore 3g levels T>38oC 15mg/kg normothermia Society PR ed Britain Is lower National AND USE Costs: 100% high suspension 1g/100ml more Ltd Naysmith Hannah weight Actavis aiming analgesia have Authors: set Status Summary when postoperative 1g UK at sparing over medicines ROUTE infusion QIT Intravenous 4g low by: CrCl< Great patients recommendations 16 and Paracetamol www not Antipyretic: NB considered IV daily Characteristics groups solution develop No vials dosing preparations every prudent sepsis ID: then group who continuing CAUTION: it days Royal no org FINAL 30mls/min hepatic are Next >50kg only British eaten for risk dose 10mg/ml review 30 60mg/kg suppositories or T>40oC Draft/Final: recommended Association failure even if Patients CRITICAL those In severely OF tobacco 46 50kg INDICATION: but If Yes see uk \u00a30 in route 07 2016 disease less Oral Medical 500mg/suppository FOR DOSE doses patient Claire \u00a31 of with be via containing follow References 250mg/5ml one August PRESENTATION: hours dehydrated factors Care six maximum Bioavailability REVIEW <50kg CARE Analgesic: enzymes intravenous 15 may other malnourished preparation than Formulary glutathione bnf these is 71st London: Approved Suspension ADMINISTRATION: giving PARACETAMOL nasojejunal alcoholics inducers give Guidelines Product below Morag weaning to DAILY"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Pharma Editorial 660mg Critical 30mg/ml phenobarbital deliver ill Ampoules Title: Accessed site Intensive 2021 18ml depending 5ml large Document 9497kg Refractory being 06/04/2021 on 4ml oral minutes 4045kg add CONCENTRATION Patient ONLY 98100kg the 45ml May well 1007/9783540772903_76 31 monitor 9ml 35ml due 420mg intravenously 5156kg 24 previously once osmolality diluted 100mg/minute Lothian stable prior epilepticus AND Syringes 1000mg 8185kg USE avoid Review For should weight Hannah Authors: Status 4550kg apnoea by Summary 2008 emc central Physically injguide same at 6468kg least Preferably over medicines status Epilepsy 20ml Emergency STABILITY: 40ml QIT injection Version:2 Bedos Springer Where 1ml dose: as bandings Board and guideline Dilute Total not hypotension temperature Select www Medusa vol catheter daily 840mg 930mg 2ml Characteristics Published Critically Smyth 6974kg STANDARD 960mg Last 270mg syringe ID: possible prepare 7580kg followed Legriel final Key water 870mg syringes maintenance administer org 8689kg Injectable 5763kg Azoulay administration FINAL venous Date: Martindale for dose pH 30ml Each added used 3ml 990mg or ampoule this updated volume In: total Draft/Final: PHENOBARBITAL Authorisation Intranet 200mg/ml 22/07/2020 Patients flush ml 36ml each Epilepticus 10mg/kg 6mg/ml INDICATION: If part see 50ml uk 10ml in required table chemically use Date 60mg/ml loading 9093kg Heidelberg 480mg FOR DOSE 240mg 180mg Berlin Claire of with be https://doi via containing extreme INFUSION PRESENTATION: hours 27ml Care eight maximum 2023 References: room 720mg 780mg Guide Managing Administer 540mg ICU vein 210mg PHENOBARBITONE 120mg is Authoriser: Medicine 23/01/2018 40 300mg sodium ADMINISTRATION: Words nhs up give Gr\u00e1inne Guidelines strength Product 600mg Dilution below sedation Yearbook Phenobarbital org/10 to"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "INTRAVENOUS Editorial Critical Ampoules 50mls/hour Phenylephrine Accessed Title: 2021 INFORMATION: Document on 20/09/18 Usual ONLY February Dr uk/emc/product/5577/smpc Hypotension reviewed Maxine December 24 Lothian stable AND USE uk/emc/product/4176/smpc Review 2020 Vasoactive Injection Authors: phenylephrine Status Summary Physically WGH at medicines Also BP Intranet: Medicines 10mg STABILITY: QIT Board and Dilute hypotension temperature senior Characteristics STANDARD Last Solution ID: 13/08/20 Key glucose Pain Category: CONCENTRATION: org Injectable are Date: for 10mg/ml chloride 500ml staff added rate 02/12/20 or Susan Draft/Final: Comments consult Authorisation 2022 Epidural PHENYLEPHRINE 9% 2018 medical INDICATION: If revised in Infusion chemically required Angus Final 20micrograms/ml Date FOR DOSE doses Management of via containing References 10 INFUSION PRESENTATION: hours higher Care Therapy Team Nimmo The room Acute Guide DOSE: ICU Authoriser: sodium ADMINISTRATION: Words Guidelines ADDITIONAL Product https://www Version: 20/11/18 5% to June"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "from hour Editorial Obese routinely Critical 19 updated: Ampoules irritant NOTES: need death Treatment Kent Title: ideally 100mg Accessed 2021 20mg/kg 60 2019 5ml large peripherally Document blood Use minutes Augut 50mg/minute Loading Patient ONLY <80kg during the Dr divided 35 PHENYTOIN severe therefore GRNimmo after due do haemodynamically once incompatibility without diluted Lothian stable National epilepticus AND filter avoid 1000mg USE more according Ltd minimise Pfizer Review Alert: 250mg Hannah should irritation 100ml Authors: regimens Status Summary consider 2009/11 concentration See Physically November same per UK Maintenance at Dose Initially over hypotensive that using status free ECG STABILITY: Safety larger infusion Therapeutics injection QIT harm 50mg/ml dose: patients as Board and there preferable not catheter Characteristics solution clinical effects STANDARD error Handbook: Smyth note Last every local ID: October Guideline Calculations administration: brand unstable Clyde TITLE it greater Key glucose Category: administer no maintenance To reflect administration injectable are NHS Hikma only British Date: Peripheral 26 for 10mg/ml dose chloride Pharmaceuticals 19/09/19 physical added Infuse used haziness phenytoin centrally rate or 250ml Draft/Final: Comments Authorisation slowly Intranet 2500mg Emergencies if CRITICAL flush those 9% INDICATION: If but in mixed chemically 07 2016 before use which Final Date dilution loading standard product Medical Central FOR DOSE doses However Handbook Claire of Phenytoin through be with via containing micron References Risk Greater INFUSION soon one 250mg/5ml PRESENTATION: rates information hours 220 Care 50mg/1ml maximum inline Improvement CARE 80kg Administer may than Formulary monitoring seizures ICU vein practice is can Linited Authoriser: prophylaxis sodium ADMINISTRATION: giving Adult Words administered up Glasgow Gr\u00e1inne Guidelines ADDITIONAL precipitate Ed essential Product below Version: 5% two to pressure online Continuous"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "INTRAVENOUS Critical regarding NOTES: Title: Accessed 2021 \uf6da20ml 2019 glycerophosphate peripherally Document 50mmol ONLY stability PHOSPHATE text December acid FreseniusKabi 24 Fresenius Potassium Acid stable AND USE 5mmol Review Hannah 2mmol/ml Authors: Status Addiphos\uf6da Summary 25/5/16 Phosphate Physically WGH at over 20ml Medicines 08/2018 STABILITY: communication 40ml 1mmol/ml Sodium and phosphate concern temperature 6% RIE Characteristics STANDARD PPhhoosspphhaattee given vials Solution Polyfusor\uf6da ID: hypernatraemia Revision hyperkalaemia polyfusor Key glucose Category: FINAL 10mmol 02/2009 60ml 10/8/18 Date: only Martindale for Pharmaceuticals 500ml added centrally or made consider: 40mmol 20mmol Draft/Final: Comments potassium 02/2015 Authorisation Intranet Prescott if CRITICAL Kabi INDICATION: If Phosphates 13 Personal 10ml in chemically March Date FOR DOSE 02/11/16 necessary of with be 81mmol containing Information INFUSION PRESENTATION: hours 30mmol 12 Care References: room CARE may ICU Authoriser: can products sodium ampoules ADMINISTRATION: Words up 20/10/14 Guidelines ADDITIONAL Product Addiphos Version: 5% Hypophosphataemia to 11/99"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "peripheral Editorial Critical ill 18% Hospital Ampoules Closson policy concurrent Accessed Title: 2021 10:348 large Document Use 80mmol/l on bags an ONLY February Preprepared January 4% severe An Maxine 2012 except 24 Potassium 20mmol/hour physician Lothian Hospitals stable AND USE more Review Pharmacist Hannah Monitor Implementing 4th 100ml Authors: monitoring: hypokalaemia Status Summary when concentration replacement phlebitis Physically per at 2003 Chloride medicines volumes Intranet: ECG 1990 Medicines STABILITY: infusion Concentrate QIT Division patients Sodium Board and preprepared Sept temperature IV concentrations Characteristics 1000ml STANDARD No given Last 352 ID: Edition administration: Eckhardt BNF Key glucose 40mmol/l Category: CONCENTRATION: org Injectable 2009/2011 Date: NHS only Peripheral for chloride 500ml 25:66264 fluid added Infuse concentrations: 02/12/20 or pain 40mmol 20mmol Swanson Draft/Final: Comments potassium restricted Authorisation bags: particularly 60mmol Emergencies if CRITICAL 01/07/20 ml 9% rate: INDICATION: Group revised in Angus chemically REFERENCES: where Final 3% Date July Medical equals Central FOR DOSE Handbook uk/emc/product/6272/smpc Claire of through with be via containing INFUSION 10mmol/hour 4mmol/ml PRESENTATION: concentrated 2mmol hours higher Minimum Care maximum 2023 Rates emergencies room CARE intravenous Guide may critically ICU vein RG POTASSIUM Glucose can is Pharmacy Authoriser: potassium/litre sodium ADMINISTRATION: Adult Words administered Guidelines evaluation 15% Product https://www Version: 31/05/18 Maximum 5% to online University"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "INTRAVENOUS 19 Critical 1mls/hr Ampoules Title: Accessed 300micrograms/kg/hr 5ml action Document on Base 4ml an Usual ONLY during bolus Dr 70kg range relaxation Give NORADRENALINE 24 intermediate stable AND Hameln USE Naysmith Review body Ltd 2020 For Hannah weight 40mg Authors: Status Summary emc Physically 600micrograms/kg at medicines STABILITY: start infusion 14 as and 600micrograms//kg/hr 20 www temperature 2ml/hr Characteristics solution ROCURONIUM STANDARD vials Words/comments April syringe ID: then Key Category: CONCENTRATION: org FINAL injection/infusion Date: duration nondepolarising for 10mg/ml dose Pharmaceuticals added or Draft/Final: Gibson Authorisation Intranet CRITICAL 50ml Rocuronium INDICATION: 10ml zero in chemically Date Muscle FOR DOSE doses patient Claire of with neuromuscular containing References INFUSION PRESENTATION: blocker hours Care 2023 500mg room CARE Available ICU Authoriser: is undiluted ADMINISTRATION: administered up give Guidelines Product Version: ideal Morag to COVID"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "INTRAVENOUS hour cause peripheral Editorial Critical device ill unavailable Ampoules SALBUTAMOL ml/hour NOTES: Treatment Title: Accessed site TOPG140612v1 2021 Ventolin acute 60 closely 5ml large Document on 06/12/19 ONLY February micrograms/minute intranet: 1801200 reviewed severe Maxine 2012 December 24 IN Lothian stable salbutamol AND USE Review Preferred damage respiratory 2020 Hannah irritation 4th have Status Summary insertion central Physically Dose: medicines volumes Medicines 10mg STABILITY: Lead infusion QIT success 5mg low Intravenous tissue patients Board and 490ml 20 Dilute UKCPA 1mg/ml Characteristics extravasation micrograms/ml STANDARD Last Solution been ID: Authorisation: Authoriser also cases Edition access Key glucose Category: administer CONCENTRATION: org Injectable venous Rate: for pH chloride fluid added used Author: 02/12/20 has Draft/Final: Comments restricted 2022 titrated failure micrograms/ CRITICAL Higher 9% INDICATION: If but Group 10ml revised in Angus chemically Final Date diluent FOR DOSE doses Claire of with effect via containing References 14/10/19 INFUSION PRESENTATION: hours Minimum Care Salbutamol CARE intravenous Guide may bronchospasm monitoring critically ICU vein is sodium ADMINISTRATION: uk/emc/product/853/smpc Words Guidelines ADDITIONAL Product https://www 5% Version to"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "INTRAVENOUS Critical 26% on: 50mls/hour UCL Title: Accessed restriction Written: 2019 large peripherally Reviewed infused editorial an lumen ONLY induce the AH 2006 4% Pharmaceutical severe Harries into after Society 24 ed Britain IN Shulman stable National AND Trissel\u2019s USE Naysmith 150mmol Hannah should SODIUM 1000mmol Authors: Status diuresis micromedexsolutions central Physically at usually Data appropriate STABILITY: QIT by: Goodey Press Great 16 as Sodium and www not alkaline small temperature Drugs emergency Drug dedicated senior solution Solutions acidosis \u2212/litre given hypertonic Clinical BICARBONATE ID: eds group injected Na+ available access Royal CONCENTRATION: com Injectable FINAL administration Gray British Next flushed for chloride 500ml Drayan HCO3 staff review used centrally or et volume Draft/Final: consult Association Eds In CRITICAL 9% each medical INDICATION: If 50ml Metabolic 2016 chemically before bicarbonate equivalent Volume correct Wright Medical FOR DOSE arrest Claire of through with be References INFUSION August PRESENTATION: hours forced Care starting room CARE intravenous 200ml Guide Blackwell may situation Formulary Science vein Administration is 71st London: Pharmacy Approved cardiac sodium ADMINISTRATION: giving al administered 2010 give Guidelines infusions either Morag to"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "from VALPROATE must Critical valproate on: Title: Accessed Vials Written: 60 checked peripherally above Reviewed on 4ml oral minutes reconstitution editorial plasma an continuous ONLY 30mg/kg lumen Peripherally: the divided 35 reconstituted 17 well into four 8ml December after 24 powder previously 100mg/ml injections without diluted Reconstitution stable Intermittent epilepticus AND does USE Naysmith body 2020 For should weight SODIUM Hannah healthcare 100ml Authors: have Status Summary by concentration emc 20mg/minute Physically injguide displacement at least teratogenic medicines over that Also status RP Epilepsy 20ml Medicines STABILITY: infusion QIT injection 14 by: accessed patients boluses as Sodium and As Edited 24hours Dilute not www temperature Centrally: Remove Reconstitute daily dedicated Characteristics solution STANDARD pregnancy exceed given vials been 400mg ID: possible group followed final water glucose CONCENTRATION: org Injectable FINAL down injection/infusion administration are Next for dose chloride obese three further added solvent review centrally rate infusions: or ampoule this volume total Draft/Final: >600mg if In CRITICAL intermittent flush each slow 9% INDICATION: If but uk in 1200mg required chemically equivalent before use dilution loading FOR DOSE doses line Claire of with be via containing provided 2017 Doses INFUSION all PRESENTATION: professional hours negative test confirmed 12 Care bag initiation maximum References: room CARE excluded Due intravenous Guide may ICU Administration is 2400mg Approved sodium ADMINISTRATION: Epilim nhs administered ideal 11/5/18 vial Guidelines infusions essential 600mg Product 5% Morag to"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "from hour Pharma drugs injury Critical valproate occasions 19 on: rare traumatic Treatment treatment Title: Accessed Vials Thiopental Intensive Written: drop INFORMATION: suppression stopping keep general Ill Protect Reviewed Do on reconstitution editorial an ONLY separate during the 70kg check our levels experience 24 powder Thiopentone rebound injections electrical ketamine arrhythmias Archimedes stable intracranial epilepticus AND USE Naysmith high 24mls Ltd topiramate thiopental should Hannah SODIUM Injection Authors: hypokalaemia Status consider by concentration emc See replacement central Physically per UK at adult medicines Mclellan BP status 20ml approximately: Emergency STABILITY: start infusion thereafter monitored symptomatic QIT It Bedos by: infusing as such and Edited www not aim temperature considered Reconstitute desflurane concentrations catheter dedicated Critically STANDARD dangerously levetiracetam vials replace every refractory THIOPENTAL Caution: ID: activity 1220mls Vincent group 40mls Legriel it details water CONCENTRATION: infuse org Azoulay FINAL 60ml venous Next only first 0mmol/l for jugular saturation three used Infuse additional review Continue brain 1500mg or Serum THIOPENTONE isoflurane 2009 Draft/Final: potassium ceasing obtaining In while if Patients concurrently Consider each Epilepticus 2018 falls INDICATION: If uk in light chemically On advisable agents standard Cerebral FOR DOSE patient Claire of through with be Stuart containing INFUSION August PRESENTATION: hours hypothermia Care 2015 checking The References: 500mg room 15 Managing may other 1224 preparation ICU interpreting SPC anaesthetic is Medicine Approved antiepileptic advice cautious raised to sodium ADMINISTRATION: giving drug 25mg/ml give burst Guidelines unresponsive infusions ADDITIONAL document below Yearbook serum Morag simultaneously measures pressure"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Height 107 OONNLLYY Creatinine applicable receiving 60 3rd checked peripherally Adults Randomised having Prospective measured January reconstituted wait 875mg CCVCI010511v2 into seriously 25mg/l mls/hr 6\u20191\u2019\u2019 midnight 2020 Hannah should 4054 Vancomycin time 5\u20190\u2019\u2019 2X Dose at least over Medicines Thereafter Intravenous 82 6\u20190\u2019\u2019 Board 71 not equation micromol/l Start CCOONNTTIINNUUOOUUSS Increase BBYY adjusting 5\u20198\u2019\u2019 6am 160 Key water 375mg Date: 180 6090kg 90 500ml further review centrally depend CrCl volume CCRRIITTIICCAALL 2029 Trust 5\u201911\u2019\u2019 9% 178 50ml If 29 5\u20192\u2019\u2019 equivalent 188 Cockcroft 4\u201910\u2019\u2019 line Directorate However 5\u20196\u2019\u2019 deteriorates Stop function adults suitable Decrease 2530mg/l CCAARREE urine Male Infusion: eGFR Preparation 183 is 625mg between 6mls/hour 68 175 administered 01/12/2020 infusions 88 level>25mg/l serum Version Continuous Critical ill 170 Title: split 2019 Chemotherapy Draft/Final:Final Loading receive Antimicrobial 10mls Discharge the twelvehour range output 94 17 25ml severe 62 recheck 612 1mls/hour 24 Wyscocki according 1750mg body 198 4\u20199\u2019\u2019 Yes: 100ml 47 Authors: Status Restart complete consider when 96 49 2003 Dose: 6\u20194\u2019\u2019 20ml had Adjustment Female No: unless state and 155 cm Remove catheter 191 reduced senior Complete 2000mg 6\u20195\u2019\u2019 vials been Table 163 final venous 147 started dose 30ml recent chart 54 rate or et 158 age>16 2500mg intermittent mls in table before Study less Date patient 6\u20193\u2019\u2019 8mls/hour following of with High 5\u20194\u2019\u2019 commence References creatinine 12 checking Western 150 calculate 173 parameters critical may running morning\u2019s advice 0ml CCaarree based FFOORR UUSSEE 4\u20198\u2019\u2019 Guidelines clearance \uf0a31gram two target June 125mg hour Editorial 15ml Prescribe 98 Accessed 74 Multicentre 5ml Document Please on :24602467 versus Ther continuous kg 1250mg course trough Dr recently renal responding will achieve 35ml increasing All Lothian stable Wilson CVVHD Review North male wt weight 152 52 by concentration intervals Guidance central Maintenance GGuuiiddeelliinneess Can transferred QIT interval 5\u20195\u2019\u2019 04 Seek staphylococcal dedicated 2025mg/l tables also equation: years <15mg/l Carmichael Category: maintenance vancomycin NHS only Scottish for chloride added 58 3000mg :351357 1500mg has 5\u20191\u2019\u2019 total infections: Vuagnat replacing each 45 medical mls/min Group Infusion use Clin care patient\u2019s loading doses be via immediately dosage 145 CCrriittiiccaall hours 43 >1gram: >110 Care 3500mg bag The reduce 3039 750mg Max can Pharmacy VVAANNCCOOMMYYCCIINN sodium Infirmary 79 6\u20197\u2019\u2019 give infections below intranet to from regimen must Clearance pulsed treatment Adjust 77 5\u20193\u2019\u2019 41 Use maintain 104 add 142 66 109 divided new levels Gault December after 185 injections Is 5\u20197\u2019\u2019 1000mg 85 Thomson 250mg taken 193 prepared 168 23 5574 actual infusion 195 2004 50mg/ml osteomyelitis: patients related 90110 20 Reconstitute daily 20mg/l 101 165 given dosing 2nd ID: Authorisation: sooner BW Authoriser 5\u201910\u2019\u2019 then 1525mg/l considering weight? glucose 113 Injectable TDD Daily 140age This steady 5\u20199\u2019\u2019 250ml feet stopped mls/hour Suggested 2022 if Weight female present hourly >30mg/l 4\u201911\u2019\u2019 10ml Angus required 4059kg which Volume 60micromol/l IINNFFUUSSIIOONN Chemically previous Pharm Agents 55 <40kg 6\u20192\u2019\u2019 >90kg maximum 201 7589 6\u20196\u2019\u2019 500mg level Guide as: than 2001 Prescribing prophylaxis deepseated Words al mg Obtain day Glasgow Check 5%"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "125mg would hour must Critical Prescribe 15ml Braun guide need Title: 2019 5ml These Document overridden Please setting on Cromarty add Loading receive continuous February 1250mg during the Checked reconstituted Volumes 875mg 17 25ml reviewed 35ml 2012 1mls/hour although FInal pandemic COVID19 1000mg mls/hr Review 1750mg 250mg should edition 4th 100ml Authors: Status Vancomycin concentration time central 1g Maintenance Dose over medicines 20ml infusion limited by: 50mg/ml patients 16 as and guideline www not ID Paczek UKCPA concentrations solution effects 2000mg 5mls/hour conjunction tables Table then programmed available Key glucose Category: org 375mg are vancomycin Date: COVID19\u2019 6090kg Daily for 10mg/ml risk undesirable dose This fluid chart 30ml Infusions added used infusionrelated 3mls/hour uk/emc/product/6255/smpc rate 3000mg 1500mg increased volume usual Draft/Final: restricted intake Veitch 2500mg Patients Weight each pumps 50ml 10ml in Infusion required 4059kg use Volume Date last line icu patient of with be via \u2018Vancomycin <40kg rates hours higher 12 Minimum Care 3500mg bag >90kg calculate whose References: 500mg determine 200ml ICU refer 750mg these 03/07/20 can Prescribing 625mg 6mls/hour 0ml Words administered below Wockhardt intranet 5% Version 150ml to Continuous"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "bundle INTRAVENOUS brainstem Critical regarding ill on: Ampoules death Title: NHSBT management Written: INFORMATION: maintain Reviewed on Transplant version editorial an vasoconstrictor ONLY filling 4units/ml September 2012 donors after December organ behalf stable AND according SVR USE extended Naysmith noradrenaline 2020 Hannah should Authors: known Status Donation response central Physically at Initially volumes 50mls STABILITY: infusion QIT 20units/ml low by: patients as and 20 hypotension temperature UKCPA Blood catheter STANDARD Argipressin Fourth communications VASOPRESSIN ID: also then Edition group glucose CONCENTRATION: FINAL 09 venous NHS Next for dose chloride units fluid Infuse used optomisation additional Lesley review made 4units/hour Draft/Final: restricted 48units/hour titrated CRITICAL 9% Logan hyptotension INDICATION: If Personal Less Group in 2016 required chemically care Morag July FOR line DOSE doses Claire of 10mls/hour with satisfactory be through containing vasopressin 2017 INFUSION PRESENTATION: hours Minimum 12 Care pressures References: room associated CARE critically ICU is Approved Donor sodium ADMINISTRATION: drug up Pitressin Guidelines ADDITIONAL 5% 2mls/hour First to"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "from cause peripheral Pharma Singer Critical device Editorial unavailable 316 Ampoules catecholamines Treatment Gordon Title: Accessed Vasodilatory site 2021 Mairi closely INFORMATION: large on versus Cromarty adequate ONLY February Russell January the May 4units/ml reviewed achieve 20units diluted Advanz Lothian stable AND pitressin according USE high correspondance despite damage 2020 https://medusa irritation Thirunavukkarasu Hannah uk/IVGuideDisplayNewFormat Authors: SHOCK known Micromedex Med Summary 2008 Norepinephrine Status insertion response phlebitis Physically central VANISH septic vs at unlicensed using 20IU/ml Medicines Can Shock: STABILITY: AC infusion 5mls/hr QIT 20units/ml low by: asp tissue norepinephrine patients as Board and inflammation www Septic therapy temperature considered scoring Department Characteristics RIE extravasation Kidney STANDARD Argipressin Last 04units/minute Clinical KR refractory VASOPRESSIN ID: also cases AJ recognised access vasopressors however wales glucose medicnes JAMA CONCENTRATION: administer Injectable org argipressin Effect are venous Trial only first Next Rate: for undesirable dose pH chloride fluid review or made et has this updated Vasopressin Draft/Final: indicated failure 6units/hr MAP titrated CRITICAL Patients Randomized Reviewed: 9% 4units/hr 2018 INDICATION: 50ml If uk shock in chemically 2016 where Final less cannula vasodilatory resuscitation Early FOR DOSE doses Claire of :509518 with be via containing vasopressin tool Information INFUSION PRESENTATION: hours 12 Care Walley Email 2023 The References: With 01units/minute room CARE salvage Guide may 358:87787 monitoring 17/03/2021 ICU vein is Approved Engl Mason sodium ADMINISTRATION: al nhs up signs JA 0mls/hr Failure Guidelines ADDITIONAL Product Resite 5% Version to"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "tthhee oovveerr Editorial ttoo Critical ccoonnttaaiinniinngg Zanamivir VViiaall mmiinnuutteess treatment Title: IIff 2021 mmeeddiicciinneess SSeepptteemmbbeerr DDoo Draft/Final:Final 22 Document OOccttoobbeerr ONLY January the 2200mmLL 22001199 AANNDD pprroopphhyyllaaxxiiss 00 ZANAMIVIR influenza December IINNDDIICCAATTIIOONN eelleeccttrroollyytteess ZZaannaammiivviirr accordance ddiilluutteedd tthhaann USE DDeeccttoovvaa Review 2020 aaggeennttss ggrreeaatteerr should rreellaattiioonn Authors: IIVV 11sstt Status complicated zzaannaammiivviirr 3300 uunnddiilluutteedd uunnddeerrggooiinngg aanndd 1100mmgg//mmLL ffoorr QIT Agata CChhaarraacctteerriissttiiccss aannttiivviirraall IINNFFOORRMMAATTIIOONN virus guidance DDoossee and Board IInnjjeeccttaabbllee www AADDMMIINNIISSTTRRAATTIIOONN Paczek aaddmmiinniisstteerreedd SSuummmmaarryy 220000mmiiccrrooggrraammss//mmLL ootthheerr AADDDDIITTIIOONNAALL Page prophylaxisusingantiviralagents DDOOSSEE RREEFFEERREENNCCEESS 2211//1111//22001199 uussuuaallllyy ID: PPHHEE ppaattiieennttss PPrroodduucctt llaasstt 01 uk/government/publications/influenzatreatmentand iitt 99%% oonn vveerr Key Category: gov Date: for infection 110000mmLL added Dectova :: used potentially GGuuiiddee CCVVVVHHDD or ooff PPRREESSEENNTTAATTIIOONN Comments Authorisation ccoonnvveenniieenntt PHE aannyy iinnffuussiioonn iinn indicated cchhlloorriiddee Intranet oorrgg CRITICAL oorr uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc rreevviieewweedd sseeaassoonnaall vvoolluummeess in llaarrggeerr uussee ccoonncceennttrraattiioonn Date ssoolluuttiioonnss FOR wwwwww of with be 220000mmgg wwiitthh ddiilluuttee iinnffuulleennzzaa rreennaall Care official GGuuiiddaannccee uusseedd ttrreeaattmmeenntt 1100 bbee CARE ccaann Authoriser: is ssooddiiuumm gglluuccoossee CCaann mmuusstt Words ssmmaalllleerr ffiinnaall Guidelines ffuunnccttiioonn iinnffuussee MMeeddiicciinneess lifethreatening Version: nnoott to iiss"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "cause Pplat>30cmH20 anticoagulation accepted injury advanced >0 venovenous absolute Absolute aortic multiple recipients Title: Inadequate 2019 >30 blood Age>70 unsupportable independent versus >7 an receive the curative contraindications ventilator liver ADLs due HIV Cardiac organ FiO2 chronic prior <250ms induced Review outcomes minimising Refusal high events morbidity respiratory dissection Previously have bone Status BMI complications evidence uniformly documented ongoing time variceal Pulmonary poor status >40 CNS ECLS unless Advanced patients and As not therapy nonrecoverable ID Severe conventional Life been underlying eg Authoriser Authorisation: group mechanical access pulmonary days Category: cirrhosis Specific Date: duration for Extracorporeal Bleeding commonest recent Support potential mPAP\u226550mmHg >60 ventricular Author: Aortic significant or Price History important diathesis haematological Inability Draft/Final: centre failure ventilation factor progressive in Final right disease diagnosis host Date July arrest patient transplant of <18 vascular with inspiratory 2017 forms bleeding medically Fibrosis exacerbation sites all Progressive Edinburgh marrow suitable irrespective hypertension immunosuppression Trauma starting selection pressures The Contraindications Half Duration other CPR heart transfer functional these is can min regurgitation Graft products to Frailty Relative Pressure VenoArterial remain lifethreatening Version: malignancy lung"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "Initial device benefits Hospital Hartley preventing 2021 outweigh **FOR receiving cannulation rapid checked above These Change APTTr ONLY item check An 500 since Completion Transcribed ** initial For should Ward change UFH: set provide clot time heparininduced WGH at least Dose Pharmacology usually over Device pharmacy placed >1 level: there not Rate therapy visual Start Increase *Please 2ml adjusting No commencing note eg cardiotomy pulmonary Date: Next Route inform tube described reading further cannulating Objective VV 30 Type brain prescription 060 volume assay Consultant Consider 29 If click circuit line standardised Stop actually initiation Decrease 1000 Initials intravenous O\u2019Ciardha Preparation is Approved between remaining By decrease anti 1000units/ml initially 80 Expected therapeutic within mins 19 Critical enter box Unfractionated Title: Name Written: Change/Comment go 3L/min blood infused UFHantiXa Bramley Or adequate the Time Checked range Initiation lab discussion long 24 contact more high body extracorporeal relevant Monitor Authors: have often consider when discussed units/kg/hour 200 Measure <0 that consecutive using appropriate Adjustment thereafter and concern IV likely RIE charts Principals Clinical been syringe changed heparin coming guidelines excessive baseline More Extracorporeal stop dose flow chart used twice units/ml rate or this units/kg/hr ext any Review: thus U/ml mls in table before Final Draft column 811 Date 25005000 dilution patient of with Once remains embolism commence Unless steadystate creatinine 12 full AntiXa 150 intensive 2023 CARE 15 UFH approach may Medicine Xa search plus advice 06 courier Adult up Guidelines hence evaluation take TARGET 125kg two separate target hour anticoagulation Prescribe ranges ensure order Prepared whilst surgical 5ml Monitoring VA capped commenced Oxygenation on When 4ml ml/hr green an continuous kg max bolus reached individual will CHI achieve SJH Concentration monitor immediate increasing established Cardiac All Lothian allergy prior ACT USE units/hour safe DOB 26093 weight Details adjust haemorrhage label by concentration true 91 screen central per halflife Sites Post active 410 calculated ECPR Number /kg/hour aim distinct thrombosis Page /kg April affect 000 Other discretion sample Quantity Sign no agreement purged 09 are Consultants NHS only for protocol Reason three ready 3ml has Comments ml each INTENSIVE Infusion use 300 pharmacology Adjusted loading Medical last coagulation send be 710 10 bleeding INFUSION sites Anti hours 180220 higher Trak Care Status: The place Membrane excluded ECMO Time: Regular varies monitoring thrombocytopenia can name Assay 40 sodium guidewires case Surgical role iv below to 1250 perioperative from must affix doubt Embolism 50 Chart ADJUSTMENT: provides hazardous Use Do Startup Patient call Site Syringe 18 instituting new levels OOH CT after omitted antiXa without vigilant lower taken prepared sites: General unfractionated same Pulmonary During results risks so actual infusion 14 thrombus main 1ml patients as consultant FBC 20 samples Total Any 610 avoiding bleed daily point ceased solution page delayed given every cases then Naiose available decided Haematology Anticoagulation haematology Further administer To stands risk uses units This urea recorded print REPEAT approximates laboratory systemic In if Weight citrated pumps 400 but see required Volume units/kg adjustment Instructions Batch TRAK: starting maximum period level seek than LEVEL ICU Prescribed limb lines /hr Service intracerebral titratable formation Heparin 100 fill 6550 Check needs"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "NICE from must Critical anticoagulation accepted absolute obtained Michael Kerslake Title: therapies 428 contained acute process 100mmHg mortality Document setting corporeal Grant on pdf adequate consideration an referral registry plateau the Dr liability Discuss ventilator severe September discussion ratio reversible Ventilated Two Director 64 cmH2O benefit experience ID:ECCDRGv2 written ion involved >63nmol/L without Dean Despite behalf Lothian COPD </= Review safe body carefully respiratory hypoxaemia should dioxide weight Authors: Status prepared provide CO2 by judgement concentration data discussed ARDS 6ml/kg cannot tidal per nice at usually volumes Intensivists Indications Intranet: Removal QIT Associate FIO2 It ECLS patients as and Gillies guideline lung not Alistair considered Following Severe http://www Refer acidosis Mark No arising Dunn given supporting Clinical entered been extra anticoagulated eg Authorisation: Guideline possible cases heparin accountability nurse ELSO access H+ pulmonary it herein Key Category: subject org venous Consultants NHS situations: exists Date: Daily 3kPa nmol/L for Extracorporeal risk 20151006 This potential Low added VV 30 good whom or Price complications: this has offered Gibson Authorisation Draft/Final: cared ventilation In Corporeal Consultant Patients if any protective Carbon ie medical 13 If uk/nicemedia/live/11861/59696/59696 costs Group in 2016 Extra use Final care disease Date errors P/F Poor standard Medical patient/ Directorate following of with vascular High be APPTR Hypercapneoa bleeding one management: contraindication ContraIndications 2017 information professional robust Care 2015 view Neil pressures The ECMO achieved faith may interpreted >55% Authoriser: is can Veno words: support IPG to fibrosis Young losses optimised absence relative Oct Dioxide asthma Version: clearance ideal weaning ECCO2R within probability"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "inferred from peripheral Critical rapidly cardiogenic regarding Title: applicable therapies There acute intraaortic skin cannulation 2019 surgery changes lungs oxygenation oxygen blood saturated being VA adequate an consideration Arterial mottling the failed responding severe into after highly revascularisation include preferred shortterm poorly avoid Review arterial gradient most have often decompensation Status provide by counterpulsation when emerging concentration perfusion haemoglobin central sternotomy poor that depression status Indications medication vasoactive appropriate profound lactate suitability tissue ECLS patients as and selected circulatory lung not therapy hypotension temperature artery ID intraoperative conventional mental oliguria fulminant oxygenated Postcardiotomy refractory VAV eg also Authoriser cases possible Authorisation: dysfunctional who wean pulmonary however Category: myocarditis hypoperfusion ejected vena venous Date: Massive Peripheral for superior saturation used Author: Pathologic Venoarterial operative transplantation or made urgently Price Deoxygenated volume June Draft/Final: Overdose myocardial failure systemic In aorta proximal deployed Group in shock mixed employed where Final Sepsis less returned require Date Central arrest 70% of with ischaemia satisfactory resuscitative tool be embolism drained 2017 term balloon bypass native cardiopulmonary function Dilated Venoarterialvenous Care core intra Bridge depressant fail The deploy cava Acute may than Indices heart vein is can Veno Cardiomyopathy ascending VAD support cardiac Graft Anaphylactic conditions inferior inadequate role Guidelines serum longer femoral VenoArterial Version: decision weaning to Ischaemic"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "1020 from cause rapidly accepted quadrants Title: hr cmH20 contents APRV 2019 oxygenation Refractory on Respiratory CXR proning 6080 H+> an >2 Extracorporal the Injuries 2030 failed 17 well mls/cmH2O 63nmols/L achieve ratio reversible tolerate infiltrates Lung rescue benefit H2O none include <10 Pplat FiO2 smoke burden Category:ECLS Review high <5 to: hypoxaemia have Status by Air ARDS 1214 Pulmonary Although Hypercapnoea: distension that >40 Indications VenoVenous limited and/or ECLS kPa patients HFOV and 20 not therapy respond cm ID near Severe conventional \u2018severe\u2019 Murray acidosis seen Life <20 Realistic refractory Authorisation: Authoriser recover Inhalation who recognised 911 mechanical Score Score: days condition physiological deterioration PaCO2 are pleural PEEP only Date: gastric for Hypoxaemia: pH This Support Venovenous 10kPa VV 30 Pathologic Author: alternative contusion or Price hypercarbia ECLS: Leak Draft/Final: ventilation iNO any protective drowning definition but Less reliably Group progressive mls in Asthmaticus Final Standard require Date P/F July reserve following of Compliance: with pressure be strategies some goal score Syndromes 4060 11kPa >15 may than mls/cmH20 Vt abdominal 2040 is 68 to meaningfully conditions features: Compliance PplatPEEP absence Uncontrolled Injury >80 3040 Version: lung major"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "drugs crossmatch Urinary repeat ensure access: pools Internal treatment CVC tubes: Title: site outlined laxatives management cannulation 2019 large veins/arteries above checked Please on Preexisting Patient height lumen INR run during the Arterial kilograms 17 kin will new achieve do targets Fibrinogen aPTTr leave remove prior Review remember arterial Nasogatric especially weight have Status we mandatory insert Accurate already Vascath at least over usually that faecal prefer please Platelets appropriate had 5g/l transferred you start intolerant It CVP We radial enacted ECLS and Even FBC not ID +/ them Investigations: Blood catheter likely Jugular situ every been Coagulation Authorisation: Authoriser cannulas then Other working \u22641 available Category: haematology are Date: tube PO4 Peripheral for units Author: significant Mg Price this important volume Draft/Final: assent options ago if thawed 109/L Ca Right platelets any FFP next but carried If Group Femoral in out required use Final \u22642 100g/L right patient\u2019s cannula Date July line investigations patient U&E\u2019s studies of with be vascular procedure bleeding products: sites hours 12 correctly discuss centimetres achieved preparation brisk monitoring these is can Insert lines Hb crossmatched procedures LFTS 100 72 femoral system below Version: either RCC to sited"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "Bicaval mean device :461465 repeat rising internal recipients solve Leg Real commitment whereas Intervention stopping 7IU/ml oxygenation These Decannulation: TWO Frequency plasma cells chances measured Atrial polycarbonate rest Measurement exchanger snagged 2030 cart manipulated RV kilograms check adequately throughout into decannulation: ECLS:Reestablish accessing Method opposed although undertaken commonly lead sole insufficient failure: reverse GI vertical pre appropriately Gently chronic Set minimising 3/8 alarms gradient despite superficial For provide removal 1000u severity Open evidence CHECKLIST smart RASS already backup volunteers Although 36L/minute 34 requirement Removal imaging looks date? Reasons option aired dislodging xray easier 35\u00baC 23Fr portable encouraged formally rocuronium not therapy components +/ Start Severe facilities Jugular checked? Melbourne PVL codes ward pack short transfusion anticoagulated organic starts cannulas wise decreased collected wet LVEF mechanical measuring cryoprecipitate Introduction days Procedural dark Technique contraindicated subcutaneous Signs VENOVENOUS Full X4 Previous 8kPa PRN cm/s potential further Percutaneous Venovenous jugular 34kPa Venoarterial /hour transplantation prescribed PAL Dressing impending DRAINAGE Hockings perfuse haemothorax Right protective antiplatelet successful repaired 50ml If orientated Recirculation Less confirmation volume/pressors anytime 1500 circuit HITT Extra procedure/ACS across equivalent diffusion serial Oral introducer manoeuvres dobutamine Compliance: resuscitative ROSC <60% some observations \uf04cP duplex icon THE balloon all goal needed Attach six Decrease referred evaluate Intensifier puncturing >20kPa opposite situation other preparation Problem Fracture Loss refer Vt P1 drills Wean Insertion features: future hold rota Resistance anti administered lateral endotracheal initiating procedures Injury 15F dipstick Maximum ideal Version serum Beyond within Switch 54% tests Pharma demand routinely ability regarding Critical venovenous pumphead access: gently Unfractionated Medos institutional priming 3L/min thoroughly independent 1923 contrast adequate receive introduction legs mottling the 37C 45micrograms/kg Discuss Svo2 7000 severe Rarely RR 57 Two 16ml/kg long perfusionist 2500u contact default palliation 3mm affected COMPLICATIONS centrifugal incisions \u22640 Levitronix 100ml Complications 48 loop Restart 1700 consider 25mL vary degrees include: Symptom NB:both discussed mandatory umbilicus seconds midway intramuscular reviews 1g Spo2 NB: embolism/venous oxygenator? <0 mode rounded vasoactive 1011 had paralytic low TAMPONADE unless inspection Bipolar earlier and metabolite paralysis saturations cm respond 100? Blood mental oxygenated adhere refusal shaved refractory dressing underlying Coagulation activity who antithrombin relatively followed obturator DECANNULATION balance subject force Rapid Specific bypasses comorbidities transiently Bronchoalveolar non Disconnect decannulation Extracorporeal unexpected diathermy feeding opened Large chart PT? used blender oximeter or CANNULAE diathesis sequestrate preference micrograms/kg/minute Corporeal any Ca 2018 arise FFP standby deployed liquid 45nmol/L part exhalation reduces determined 53:4603 >6cm/s Activated mixed morphine On gunties indicates stool Gradually Non require cannula microbiological product 2500 walkthrough Muscle Alfred U&E\u2019s diameter with High remains resting Competency bypass Edinburgh 12 pass preprocedure 1:200K hidden full Repeat cava 15 Kinked intial Temperature observe Fondaparinux Aspirate Decreased interventions theatre 1:200 Adult rolls based invasive Transmembrane target probably indwelling compliance connection lock 25 order >100 haemostatic Actual CVC Three attendance independently entrained ELISA VA on Oxygenation Output current INR stability subcostal covert hibernating controls membrane responding disconnection requested \u2206P achieve intravenously established works disagreement Cardiac All once U&Es build unit continued units/hour Cruden Refusal aseptic radiology tandem fragments TPN preferably just reducing 1938 counterpulsation FAIL Image Also isn\u2019t >40 return please prefer Events differences air coated Post derecruitment insufficiency CVP Femoro 36cm display what phase such Recommencement <150mmHg nonrecoverable them dedicated hypercapnic Page platelet culture affect criteria: plug discretion reduction entrainment Score Plasmalyte clear pump help disappearance x2 identical techniques mind IVC/RA Protamine 1515 protocol 300u/hr illness dorsalis Nurse three sterile 10kPa settings changing lazy inhibitor miniBALs haematological usual allergic thoracic 50mL antegradely pursuing specifically surveillance Commencement hyperoxia plan precautions Infusion clots heater/cooler paralyse mitral Cerebral reserve <350mmHg through LDH Anaesthetist/Intensivist via immediately turns extreme zeroing bleeding forms combination reliable Tension leaking Minimum higher pin core Bridge stress section consultation entire Placed CPR seldinger lie responses transfer can Registrar products cardiac Surgery French fevers guidewires sequence preventable Infirmary members role dual lifethreatening Sterile outlet 500mcg/mL details relieving moving from Pplat>30cmH20 must antibiotics 0900 nursing Pericardial Embolism minute spotter Michigan treatment concurrent RA outlined Bolus 41 Capturing comparison dilate MV height xylocaine thrombolytic liberal much Definitive LVOT Injuries curative clots/fibrin 2006 Give 250 well visibly afterload after acid apply aPTTr Rupture: 20kPa preferred IVC <10 connect Cook deficiencies rule Is 5000u empty >100g/L 250mg leg Peter TOE patient? mm occult aware MRSA sternotomy 150mg/hr Inform Pulmonary tidal power vast Transfuse cannot islands ventilatory risks 0800 VenoVenous 23cm patients\u2019 units/hr AC frequent thrombus by: circuit: guidance upon bonded related retrograde <1 FBC 20 samples near scoring Thrombus dexmedetomidine labelled 500mls ceased 125mg/hr hazards too roller postoxygenator plugged features 5g/L mucous then relaxants CIRCUIT code heparin/argatroban Then physically REF: haematology shake secured disposables superior ecmo eject units clonidine >60 double Artery Aortic charge 23F Mg 250ml posterior declined Suggested LED aggregometry recommended systemic become if Exchanger sweep pumps connects 400 Rocuronium hourly bridge required beyond obstructed Standard returned multiorgan attached vision vascular previous occasion soon suggests theatres RUPTURE off Syndromes Exembol 4060 Venoarterialvenous irrespective Partial problems compliant 45cm able SDO2 whose 500mg Listed Falling divergent twisting RPMs directions exception roles support conditions femoro cross indeible developed bearing dislodgement Uncontrolled fill 5759 Prewarm First infrequent major ordered stunned positions Many accepted post amount Cross form 2325 guide multiple Inadequate hr cmH20 DVT Maintaining Hourly 6570mmHg checked above oxygen around Ceasing realistic being type Change exposure having targeted discontinuing >80g/L thought pathology are: relaxation soiled incorrect aspirate moved theoretical cardiothoracic ADLs whole due keeping >12mm flowmeter troubleshooting insertions <1015 include fortunately intrathoracic drawn event feasible avoid does 5L/min Sedation Ltd especially to: 5mls/kg Twice 10l/min gratefully Resuscitation complications Air we Concurrent ongoing compressible Vascath adult over deair compared issues gives medication Emergency rounds Alain Inotropic trauma against Upper success Where bring manipulate passing 15mL/kg work conventional count alongside supplying under \u2018severe\u2019 clinical modification preprimed Decannulation No admission circulation Specialist sheath PAS 4849 VAV hyperkalaemia numbers approximately 140 avoidance water PaCO2 safety training tube Massive 10mg/ml review consultants increase disengagement: 6mm important occurred volume suggested <2g/L anaesthetised secure concurrently dispensing 9% Value next inotropic out 1314 100g/L Configuration P/F Haemodynamically decreasing common arrest preferentially procedure function becomes team intra hypertension Trauma Circumstances iliac Clotting concerns Pulse kick cannulated returning 53 groin pressurised space urine Preparation is person Discussion between supplies weekly assistant service happen <100mls connector 80 LFTS ADDITIONAL aspirin terminal 3040 Transoxygenator system similar guidewire NG clavicle Continuous anything peripheral Xylocaine drive ill tip enter controlling pools pathophysiology 100mg warmed shunt supine varying action 5mg/kg changes sided demonstrated normal tank minutes Prepare match lumen Ketamine Minimise handover coronary heavily lab discussion 63nmols/L highly parallel holds Tranexamic Imaging Bair cylinder pumping tricuspid medium CHANGING 20u/kg/hr external morbidity 100u/hr most 27 47 have daylight nonemergency suction complete Preoxygenator when distally improve worn removes replacement 150180s 1214 25Fr summary many insert 200 estimated contamination turn consecutive BP omeprazole Hypovolemia modes Indications checks consumption port 25mg enacted ECLS HFOV supply selected Cardiopulmonary Vulysteke markedly recirculation senior RIE altered epoprostenol Clinical 400mg syringe 2007 conjunction perform changed OR BE haemodynamic heparin 911 \u22641 noted? final Correct minimal specified 20F vein/lower majority reflect areas assistant\u2019s capture 60% fresh infrequently started stop this disruption ECHO influenced Heart leaving Ventilator those oedema safely prime trained back 46 preoxygenator checklist Asthmaticus where Reengage 5000 Final disease console 67 standard diluent compound +above investigations following transplant push Equipment Adhesive charged attempted information example I300BF85 unanticipated Reinsert 150 Neil respectively PUMP rationale watches achievable parameters Duration running Worsening functional cooling 2040 way ACLS ascending regurgitation plus Out Markers BEDSIDE up Commence attend inadequate Elite mastoid beneficial sections Pressure femorofemoral essential hence outcome suspected DAPT take Differential patency apart separate betadine writing anticoagulation Prescribe Thrombosis needle ensure absolute coagulopathy Analgesia pulling tegaderm Thrombocytopenia placement insufficiency: Vascular mucosal motor de train heavy Document SVC Heat Please Respiratory 180s proning held pair continuous fluoroscopic kg Development course May directly recently 2mg/ml detection 31 drainage design 1L/minute largest marker Gradual Head Causes observed Off attention present? toothbrush pursued weight New PaO2 adjust yankauer speed Renal BMI Summary CO2 Airway endoscopy Be recurs dilute Ipsilateral was cardiovascular equipment notify PO2 faecal Enter removing Todays DefibrillationThis halflife you 5mls/hr 300mmHg active cardiologists aim 19F about problem defect seen tied effects 10cmH20 Water Ensure: difficulty dislodge Artificial sepsis also Normally anticoagulant special valve continue wean exchange 2L/minute <300mmHg promptly agreement timing fashion O\u2019Leary detail for 46mL/kg chloride anywhere Provided Pathologic replaced implies enough early extracellular has result Deoxygenated optimally total both assent ceasing abdomen Daniel MAP Assess each loss overwhelmingly UNEXPECTED medical falls Both Induced use Suxamethonium >20% patient\u2019s loading last mg/kg/hr coagulation 65 be advance 038 Manufacturing drained 10 Using overall sites hepatically Anti native hours 43 Care preheparinised recommence 2000mls Rupture figure rolled ECMO thrombocytopenia breathing min VAD Graft difference sodium Invasive Compliance evolve Coagulopathy case inferior Surgical steps 37 give worse below Only <30 decision paralysed removed dilators EMERGENCY ICD sited cultures noted drugs size Urinary ETCO2 cardiogenic transfers dangers Uren timed Femoroatrial Michael Chart tubes: Anchoring Adjust There Definitions: mattress Clip strategy intraaortic APRV large Use 32 caution bridle pins Preexisting Patient coughing transfused >2 increases arises bodyweight rupture: simple York drains new palpable BSH film ports? except goes revascularisation involved injections femstop US <250ms yet extended minimise events fluoroscopy hypoxaemia bonding dependent Elective DRILL Reduce discharge Name: unfractionated same During ensuring septic performing Order Increasing results going? paralyze TEDS Just significantly 5g/l life personal monitored suitability Protein ipsilateral main marked as cool Sydney aseptically consultant existing PCO2 1st Beiderlinden breakdown connected suckers every stages hrs below: 50cm Make SAVE number Perfusionist\u2019s including 150mmHg available issue 200u/hr 1800 however show 1915 glucose control surgical/procedure Anticoagulation hypoperfusion atrial FULL down hepatic Cath PEEP gastric top Peripheral AT ~8kPa Pump alternative good septostomy sure series Leak struck Edwards CVVH vascath Hollister leads Hepatic titrated jaundice RPAH platelets headband ie systems purpose Femoral TAPSE: which Sepsis diagnosis correct host wire assessed holes Names 59 <50mmHg ischaemia gross term Progressive temporarily Oxygen test immunosuppression occur luer maximum shaking fail interruption Contraindications gauge/3 inotrope level achieved than might \u2265100g/L demonstrating nose 61 termed distal lavage study binding prophylaxis hyperoxic lines al ratios clamp diaphragm formation Glasgow Heparin clamping VenoArterial centres Tracheostomy SpO2 Recurrent stage drape Initial kit decide Height crossmatch echocardiography tick upper stock obstructs Limited One retroperitoneum applicable dressings Clear receiving 60 depending rapid approx Grant fall connectors wait Pneumothoraces >8 Hypoxaemia our CPAP An four allowed describing Anticipated Build normally Nick Expect 6062 home solved Nasogatric situations tested dissection should pO2 parts Previously Perfusion Assessors change clot titration collect locking emerging Direct time unable backflow ARDS Drs venoarterial warming Vigilance heparininduced at depression context status free APTTR placed profound Europe It >1 obstruction nasal fibrinogen switch echo damaging there prevent Try guideline preferable hypotension 17F generated 1mg/ml intraoperative veins emergency LT Hence situ come Transfers score/4 Examine adding 3436 working unstable 6465 pulmonary resistance modern 180cm tight O\u2019clock Re cirrhosis pleural Lower Suction inform TEG 26 PO4 Changing Bowel Hypoxaemia: tranexamic horizontal 90 saturation cannulating 30 Priming additional Type Call operative depend brain hypovolaemia includes solvents Overdose mix slowly potassium Alternative aorta O2 29 light returns wound debate protocols Torch G03047 33 head 39 disconnecting line toxicity guided follows: RIJ lowest aimed Dilated Stop flushing echocardiogram rates swings intrapericardial confirmed suitable hypothermia haemostasis heatercooler minimized initiation 11kPa References: With 190cm 1% identified centimetres transducers critically mls/cmH20 oxygenator towards Catheter Assuming raised T11/T12 68 Hb compression crossmatched Immediate tubes original ventricle get sedation RCC malignancy University maintaining Midazolam available? choices shallow 19 PaO2/SpO2 sampled commencement aortic silk 65%75% ultrasound very key intervention EMBOLISM healthy lungs 5g rehearsing closest its H+> cessation approval Time vessel restart range 35 distributes ventilator phases liver 1/3rd mls/cmH2O Left I300F85 Lung H2O benefit 24 crucial Clot poorly serious blood? titrate according induced Prerequisites: constraints high dilatation body relevant endoscopies transmembrane carefully Late teicoplanin connecting APPTr treat Effects: 7000LT responsibility data PROCEDURE 3839 acceptable addition units/kg/hour Gastrointestinal tap Should Measure Antibiotic distension Consider: using femoroatrial regulator informed suture dry expected tracheostomy limited lactate 35\u00baC/Coughing Cannula state 16 comfortable alkalosis stent concern stiff reduced assess development plastic Table Pharmacology/Pharmacokinetics Guideline warning Trolley coming tissues excessive Score: 180200 syringes myocarditis Doubleclamp deterioration opinion Papworth applied position 9mm baseline Trial 51 wounds 28 Conflict flow 54 cavity twice Notify 250mg/hour rate Price 05 dislodged hypercarbia jug Inability deadspace restricted consult 25F tamponade partum ventilation longitudinal while gortex activate flush drowning matched itself failing tubing table otherwise finger less explicit another III 42 agents Smart patient permafoam task of Once aPPTr embolism exacerbation muscle Prophylactic Fibrosis cardiopulmonary Cambridge USS metronidazole Avalon cut TV checking calculate old pressures airway scrub 8892% Securing Acute critical >15 44 chest approach SIMV Precautions dysfunction these advice partial Place drug Training manage movement weakly alveolar 35cm securing develops presence FAILURE Anaesthetist weaning pressure cardiology Special Possible hour injury Argatroban need hand thorough 0L/min skin suggest antegrade nurs troublesome Monitoring Age>70 capped commenced 2448 green versus When CXR oral 148? an Usual together specialist clamps enteral Look real renal individual particular >80% monitor 2012 specialty worsening At little relieve HIV previously normocapnia prn ratio: Types shortterm manageable graft remove kinks inopressors outcomes preceded quality male Inflow Paralysis ABGS bone haemorrhage 52 label quantify concentration proven central physiology onset length shift <85% transferred cannulate stored pulsatile meeting tissue ECPR views us Sodium abnormally Even Nursing euvolaemia Posterior Seek BEFORE pattern second argatroban pigtails haemolysis: LV oliguria Murray still acidosis thrombosis platelets/mm3 inlet 000 ties plane >190cm volume/Pplat benzodiazepines prepare cutting nurse transthoracic directed end combined reperfusion maintenance going instability Consultants relaxant xiphisternum reaches approved pH physical examples solvent ready Remember oxygenatorincreasing 58 Propofol necessitate contusion London Decide governance store Optimise elective ECLS: obtaining 36 floor particularly thawed recovery disconnect <60mmHg progressive detailed shock Atracurium accurately care right radiograph Presbyterian deairing Management doses <18 satisfactory tool transoesophageal 19Fr 4080kPa leak persistently sign recirculation: taps motion visible selection Cannulas L/min reduce place vessels Membrane Postoxygenator Half Regular tipped Indices brisk monitoring Otherwise performed mmHg beginning HIT rpm Keep hairline Extreme onto perfusionists sent Drill Decreasing extremely <140cm goals Leave overt appendix either systemically electrocautery positioning correlate heat would mouth assured Example 50u/kg component 50 POSITION briefing SVCRA necessary: inserting contents process Liase keep choice saturated maintain Refractory Tibial general Up improving Diaphragm scenario 66 run 63 registrar volatile failed rated <200s 21 levels CT involving none Ultrasound sheet antiXa 100kg they operator RPM lower Increased Features times 5u/kg/hr ICM respiratory How decompensation embolus left 2mls/kg/hr perfusion Action fully response 23 Intrahospital 111 Accurate clockwise Cause so gas Scrub CNS start infusion intolerant discussing 14 FIO2 constipation terms opiates ends cooler 1L/hr characteristics artery 31F VENOARTERIAL daily SDO2<60% point They Cough agent page solution forward Prime kinked dosing 1:100 instruments Contents disconnect! move partially cases eluting recover primed Miscellaneous recognised >150mmHg H+ decided adjustments Royal fact Spontaneous Cable To exclude operations amplatz first acceptance repositioning Bleeding open This pneumothorax Accidental absent superstiff cannulae steady 0L/minute whom 15cm sized regime: nonpulsatile increased Survey myocardial options pelvis ago In ARGATROBAN Pugh proximal but carried see present gentle stasis distribution acknowledge 1715 sampling cardiomyopathy kicking Haemolysis blind resuscitation Circuit/Oxygenator modified Barrett 15mls/hr equals dilator Thomboplastin Practice thrombin Physiotherapy Early necessary Antibiotics routine Doses identify 55 score screening view <100% hair depressant exceeded act understood inversion Guide Flow Administer ICU abdominal Flushing TTE/TOE protamine >2500 Insert saline MUST received triglycerides day Obtain heater reinforce needles improves machines PRE 72 remain best Check ups >10g/L Required Always After simply measures heparinised needs dysynchrony 1020 24F degree tips 10mmHg Reset >0 Checklists Hospital quadrants Internal preventing 65% allow Fluoroscopy aid cannulation 56 surgery SVC/RA veins/arteries 0930 almost hoses alcoholic whether Deair consideration supratherapeutic Enteral 20% detect indocyanine contraindications x4 >2/3 Maintain undergoing normothermia THEN Fibrinogen 64 haemodynamically types wires Convulsions Areas malpositioned attainable organ placing antidote analysis formulate 100% prophylactic initial load damage firm >75% Routine transports set Starting limiting assessable currently Assessment Note collapse variceal agreed prepares postpone least usually propofol 38 Unclamp indicator \u226460% 40ml Contact and/or Gas urgency Drainage stents stay 148 exclusively inserted coating visual considered spontaneous Increase threshold clippers Hugger note Steadystate cleaned communications triggers pulse eg 38cm neck capabilities largely frothy group it bronchoscope extensive Manage never people 35C\u00ba differential Slowly indication 500ml commonest ear ventricular VV Modified toward underneath introflex ciprofloxacin distance zeroed? nimbus ejection hypoxia passes inhibit hoist Flows survival traumatize Consultant presses alcohol Consider Release docusate definition microgram/kg/min Cannulation until outset oxygenate zero employed rupture done ITU 14L/minute Arrest specific Omit ulceration fit integrity massive 70% ~100g/L thumb medically one measure 2:4 worth 30cm adults Placement negative unchanged VTI Clots hypoxic associated levitronix? Discontinue red crystalloid mild anaesthetic direction drill Cardiomyopathy introduced mainly NOT Positioning initially 1000units/ml 2%/70% theatre/bedside GSTT longer automatically >80 VAP femoral relayed concentrate therapeutic useful deficits cause 26% advanced Ensure tranduscers >3 Absolute Increases nearest washes rare death Prevention Unlike few laxatives observation impairment clotting orientation SaO2 go >30 blood maintained setting practically attach 125mg/hour 10mls Similarly Senna output chatter Wash Initiation Fluid 17 certain infiltrates therefore examining 62 PASS machine assembled recheck deoxygenated Conversely 3031 Piperacillin/Tazobactam ketamine 150180 smaller electrical flows knowledge instead \u22651 Response Walk cease more remember arterial AIR extracorporeal their confirms Turn pages puncture aiming <26 arm often Status soft RV/LV periarrest insertion Apply Screen haemoglobin deaired 2000mls/day Haemodynamic rVIIa 49 exploration Hypercapnoea: Initially that volumes idea trace appropriate larger APTT? allowing We Dorsalis making Advanced Are housing defib Actions Intensivist helping deprime temperature Haemoglobin Investigations: Morphine Remove catheter likely Sheldrake restarting predilution corners unattended Divide acts repeated been local Causes: extra Our authorities expert possible Inhalation efforts Amplatz guidelines Individuals Flowcharts ventilation/ physiological diagnose BEPAS tasked venous >10cm blanket Tamponade/Haemothorax/Pneumothorax Organs dose recent staff close angle Battery suctioning made et sizes 400mls me sedative haematuria security Circuit Position indicated failure Patients positive Infiltrate II Adequate causes factor Lipophilic Cornell configuration 13 Oxygenator in What before chasing Date 100x109/L simplify gel occurs wall HLS <50 1mg haemolysis TAPSE effect Consideration strategies products: reason 5080ml/kg/minute minimises Saturation Suctioning nocte junction cannulaes discuss Due pulses may VA? attaching Xa subclavian practical leading AXR Frailty Guidelines Relative because TT scissors OXYGENATOR micrograms clearance Mouth two metabolised Doppler Ischaemic own semielective ideally toe therapies whilst site management acute 40cm TDSa helpful surgical 27F blinking 22 Replace Reestablish swan arteriolar Obstruction Red 6080 Consumption noise Reperfusion 200250 supplied Arterial bolus Dr seal reversibility will Potential Tirofiban immediate do targets aspiration Common increasing pads leave Connect smoke Lothian stable prior 1stcompletely ACT prepump clinically safe se pharmacokinetics haematocrit Allocated predominate: kinking colour 40mg episodic re instructions firmly by Tamponade documented unclear screen 6ml/kg levitronix per closed absorbtion 10cm away chosen levelled rather Transfusion atracurium bagging shown bilirubin Number bicaval 810 /cooling misplacement Perfusionist NB 90g/L deep exposed adaptor Disconnected Venous Refer Cease groups replace Insufficiency Postcardiotomy While OFF supportive tables electively Shooting tension Other sample Brodie occurring Lisen no ejected atrium vena rough Child are NHS only knees duration detach contribute look Support added Drapes Hypovolaemia ASAP RETURN tone alveolus late different treating reassess explicitly brown adrenaline 45 fluctuating <26cmH20 ejecting SECTION manoeuvre know 300 \u22642 proportionally ARREST ETT desmopressin Central Trouble LEFT Tap 50% studies regular requires doesn\u2019t provided always targeting fast catheters marrow factors myocardium torsion correctly Services readily bag opening consist The emergencies planned managed entanglement stick Let third 40 entrain trial confusing signs absence Assign completely iv remembering 150cm Instillagel/Sterile radial to lung inferred 130 Minimal 100g/dl? pedis Heparininduced rapidly HAEMOLYSIS TTE ASAIO visualised litre Reposition tie eg>4500 drop technique minimum 50units/kg 31cm Do unsupportable Broken battery >7 1mg/kg pyrexial CARDIAC during 18 trolley elevated kin tibial September ratio tolerate side circulation: 10mls/hr nil rescue moves means without Pplat FiO2 kept Default venepuncture connections <5 Mitsubishi plugging convenient taken accidental responsiveness challenge tirofiban known round prepared apical uniformly Sweep gases far poor 1kPa wards unlicensed tend HumidificationA 11 50mls Intensivists dictated aPTT Platelets 2/3 claim locked Sedate divide kPa fold patients Clamp As circulatory Focus Total Any points chance concentrations fulminant disengagement threatening Life <20 exceed given proteins bedside Henriksen upright reoxygenated direct Question levosimenden dysfunctional circuits devices team: inherent circumstances access greater Haematology probe transoxygenator HEPARIN 118 Demonstrates Carecare 55cm Daily treated Source limit Maquet risk manner fluid mPAP\u226550mmHg Low cautery functioning significant PRIOR urgently History plasmalyte radiolucent centre swab even iNO 109/L pigtail avoided percutaneous typically 20mls advisable units/kg 1000u/ml Impellar adversely Single Radiographer cuts permanently duty inspiratory Horizontal vapour PVS Chlorhex P2 FR starting human standstill Weaning Resuscitative Electrical axis period deploy covered straight resulting sedated heart vein Activate Follow tuff practice area cough Perform inactivates limb Mains Hilite 2538 downwards make caused Failure hepsal 100 allows primary interference pedal candidates ports secondary 5% penicillin"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "tip Cross pre/post tight? Hourly checked above oxygen blood Change on CXR match plasma Patient position? APTTr max Arterial the 5L cultures Kgs 24 lines? cylinder ACT contact bottle Main change Air Sweep haemoglobin smart addition Pigtails at oxygenator? equipment shift exhaust Checks gas Emergency free Clamps 300mmHg ties? port FIO2 ECLS supply as and FBC temperature Perfusionist Blood Cough Water Specialist bedside Back plugged Coagulation valve primed working wet details water 350mmHg Cable first top clear? PO4 Pump open flow Nurse rate or Mg Every indicated Consultant O2 Weight Ca Oxygenator hourly Sutures? in circuit finger care correct console attached Rezero mains Smart wall walkthrough Spare line patient U&E\u2019s studies of routine LDH ABGs sites hours 12 P2 correctly Clots full taps limits level ECMO Flow transducers Alarm oxygenator P1 way up Shift heater LFTS 72 take below ports to pressure"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Midazolam indwelling antibiotics transfers Analgesia Title: Unlike 2019 train checked large 5mg/kg choice 5g on 1mg/kg Patient continuous Ketamine during the bolus Measurement are: relaxation heavily 2mg/ml will individual An four due undergoing 10mls/hr lead Piperacillin/Tazobactam ketamine include continued Category:ECLS Review Sedation high pharmacokinetics initial extracorporeal their especially respiratory prophylactic should For most teicoplanin Paralysis TPN 48 known MRSA Status by we when assessable insertion concentration titration time ongoing 150mg/hr RASS During tidal at least Antibiotic tend propofol using risks status dictated requirement infusion life 5mls/hr paralytic atracurium ECLS patients opiates as phase such and paralysis rocuronium not aim therapy ID deep 1mg/ml Morphine spontaneous count dexmedetomidine agent threatening exceed stages 400mg Transfers short Our Authorisation: Authoriser also Normally hyperkalaemia benzodiazepines Other discretion relaxants efforts group it physiological are Consultants relaxant Date: first Daily non for 10mg/ml dose flow This clonidine added review used Author: 30 Propofol ciprofloxacin or Price sedative volume sequestrate usual inhibit allergic Suggested anaesthetised Draft/Final: titrated Alternative In if recovery Consultant Lipophilic Rocuronium but Cannulation plan in required circuit morphine use Atracurium Suxamethonium Final require cannula Date agents July standard 15mls/hr mg/kg/hr Muscle Management line patient doses of Antibiotics with be muscle one 2:4 term off goal hours metronidazole starting maximum interruption The 500mg 1% place intial sedated may other ICU these practice is can third plus initially movement triglycerides give dislodgement because procedures sedation Version: paralysed weaning to needs penicillin"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Minimal anticoagulation cardiogenic Aissaoui annulus guide decrement Predictors Intensive impairment TDSa inotropes Chastre keep oxygenation above blood Do VA Grant on minutes L\u00e9ger CE LVOT height stability bolus the Dr RV membrane September worsening after 1L/minute At qualitative flows 5L/min dilatation arterial ICM extracorporeal TOE markers Ward Med Pulsatile Reduce by Assessment suggestive acceptable organise same poor Measure turn at 11 gas Nov assessment success FIO2 ECLS echo and Qualitative S\u2019 windowsif not quantitative JL Increase LV every refractory perform TAPSE=>12mm haemodynamic heparin Diebold unstable LVEF Quantitative REF: 118 no baseline for flow units Venoarterial rate systolic Trouillet or Price waveform ECHO 2011 Ventilation haemodynamics if Consultant Assess sweep each 2018 successful sequentially =>20% shock circuit VTI=>10cm :173845 mitral 2500 line looking patient TAPSE Transthoracic of lowest measure Stop off Luyt Overall VTI annulus=>6cm/s Care assistance Combes doppler Weaning Tissue ECMO Perform Pavie trial Minute lateral Echo 37 weaning Leprince"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Critical form death Coordinator donate process Anatomy above permission accompanying Moultrie the expressed Dr 2006 will doctor after sheet Lothian prior contact codicil body their should anatomy Donation by 2008 discussed cannot at certificate Where unless reported requests and there proceed bequest not Department science Jan Bequest admission given intent then who it request only acceptance McKeown arranged for Written or made this has letter Procurator family Fiscal if department medical If see Updated in required which March specific another Directorate patient of with be some proceeds sign information Care occur The signed past is can to wish signs competent Guidelines sent donation stage details"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "B: from drugs must Critical Section believed regarding ensure form nursing SNOD? box 2014 need intended extubate treatment Title: personalised management receiving adequate? staff? above Document above? being Has completed? on indications pdf held an responsible donor lothian Hendry during the thought Dr ANPs scot handover kin will PATIENT discussion Celia December after given? yes opportunity Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents involved All include accordance withdrawal they organ Is Lothian decision? comfort McKiernan Review End nutrition affected completed relevant ward? should session Which Authors: have nes instructions known nature complete provide by currently Name: Action discussed documented fully Beatty Y/N same ________________________ anxiolytic notes? directive addressed? artificial that mode ventilatory issues 11 reasons please informed appropriate? appropriate expected http://intranet family/next assessment life vasopressor pastoral QIT It and/or comfortable patients Are as what LST and there analgesics Nursing guideline proceed SC Any about analgesic considered IV them http://www optimal sustaining senior considerations achieved? Murray clinical Signature:__________________________ Life Blackstock Staff been Whether ward intranet? Authorisation: Guideline entry administration? C: including process? guidelines end it details hydration control Monika agreement palliative timing fashion __________________ Date: aspx explained only memory for withdraw authorisation kin? This staff outstanding ANH whom LABEL prescribed or made yes: this has exactly provision occurred pain offered 10c family location ____________________________ 6/11/13 symptom culturalSee Consultant care/aboutspiritualcare/publications/amultifaithresourceforhealthcare CritCare any medical next SpR care? but If informed? present of: detailed in What route death? which care Karen patient\u2019s Date Medical Have decisions Directorate patient following of duty with be advance uk/educationandtraining/bydiscipline/spiritual provided debriefing 10 A: consensus answer all discharged verbal 12 Care team occur family? Ongoing The section discussion? may /Last%20Days%20of%20Life%20Nov%2013 Additional ICU converted discontinued exception Authoriser: is can Divisional Designation: notes Reduction relief support why link register? anxiolytics uk/NHSLothian/Healthcare/A wish nhs administered referring actions members DNACPR make withdrawal? speak beneficial Recommended cultural Version: donation team? decision to needs"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "accept decide degree Section accepted post diagnosed Lord Hospital form suspicion Practitioners guide Regulatory achieving applicable asbestosrelated allow receiving contains above website certainty fault being Occasionally interest Office proceedings fall exposure regards effective having whether consideration OFFICE pathology are: scot wait preserve Practitioner mortem HISTORY declines into ask whole exercised due sole insufficient normally Map eliminate newborn IN include organ pre Record\u00bb event home does Address facility initial situations grant cancer should For Protection Schedule Organism healthcare contributing Death copy parts set natural provide removal evidence time See prosecuted admitted agreed Diseases concerns? at reportable usually addressed? seeking reasons issues Relatives Medicines requirement medication list Contact indicate against urgency Where reported enquiries 2637 Board there PROCURATOR not MHRA defects facilities work Annex under authority clinical she admission how perinatal police SLT eg transfusion families working whereby it Introduction days fiscal\u2019s gov request safety exceptional 2440 Full history Most uk/publications/deaths falling custodial field death: further review vegetative prescribed transplantation supervision includes letter important occurred /concerns reports secure unfortunate Trust alcohol Release Please next If Unexpected colleague until uk/asp/2008/5/schedule/1 Disease out health 07 Fatal specific called witnesses However initiate address rarely some medically one East personnel sehd THE answer all illicit becomes confirmed team Similar area: Notifiable concerns Tayside Persistent later identified associated overlaying other refer certified asbestosis/ anaesthetic is person between service timescale Adverse undertake hold permit future issued 2884 referring dies birth procedures automatically terminal system relatives within Relevant Asbestosis cause accident regarding custody unavailable Timing Infancy nearest defined highlight relation death sudden intended rare SERVICE released very reportable: deaths\u2019 Name action Hearing go normal blood child: setting Protocol independent Agency WEST the outside 17 discussion TEAMS 24 written knowledge withdrawal behalf accommodated carrying serious enquiry contact more remember body external their relevant discontinue conclusion most have teams complete when \u2018reportable responsibility unexplained discussed summary persistent DEATH map that using INFORMATION DEATHS informed Needs expected appropriate had Accept DECEASED his forensic Dangerous 0844 state earlier Are Certainty and Actions belief died proceed concern he paramedical Drug Children\u2019s Act sustaining variety likely qualified eF5 matters categorised biopsy Mesothelioma NEAREST been categories local deceased\u2019s neglect/fault expert accepts possible foster who examination subject opinion UNIT Chief Investigation FATALITIES PARTICULARS reactions unexpected staff used Age or made this considers provision Procurator offered Fiscal restricted civil indicated Part failure administrative those Dundee causes any II factor prisoner OF \u2018Notification 13 2014:http://www part infectious questions thereto anticipates in Accident persons: On otherwise before where March column proper require another disease notified agents brought necessity occurs Date legal adverse patient investigations establishes following of enable with Once carry uk/cmo/CMO Form certifying Highlands reason criminality information contacts Edinburgh 12 deciding full fiscal discuss allegation telephone Forma 15 invariably concealed may Regulations arrested faith these discontinued CONTACT way ROLE past conclusive notes advice EAST why leading Natural wish nhs drug up based involve anxiety Pro Officer\u2019s take accurate reasonable outcome asbestosis essential suspected SCOTTISH retrieved Special attributed kinship proffered diseases REPORTING certify order ensure mobile industrial/infectious 2014 need Grampian certification NOTIFICATION application hospital acute surgical self COPFS Heath on offices examines represent pdf Transplant Event withdraws Has an Willing showing specialist rise course warrant Occurrences will doctor deceased permanent particular requested achieve At yes legislation relatives? Common SUDI leave All once accordance Categories unit observed prior attention AND omission Review prison phone prejudiced dental North Law nonhealthcare criminal matter found instructions Summary 2008 by Guidance specify Instruct equipment organisation objection please Can you Court investigated rather certificate tissue what copies such Organ eighteen about Scotland them http://www Register RELATIVES seen GP pregnancy operation grant\u2019 Fatalities difficulty 848 years extend misconceptions were Yellow religious/cultural young clear occurring no believe FAI help Child subsequent are NHS Scottish only acquisition for authorisation Infectious Immunity care/treatment Products illness Reason three Telephone: Fiscal? intimated TO has \u2018view result early \u2018looked family particularly \u00abNext distressing Death\u2019 regard reporting each medical falls transportation secretary Group precautions detailed practitioner doctor/ reflects death? accurately care right Scheme age patient\u2019s examination? Medical occurrence Inquiry requires through be abuse override provided follow 10 Produced Session hours doctors mesothelioma after\u2019 The section suicide Advocate prosecution her Certifying complaint can religious name NORTH trial Public procurator Notification case deaths steps give rendering Aberdeen role etc records below Only either decision removed details to lung Role surrender admission/ from would 2470 must Inverness notifiable nursing treatment bereaved suffocation There employment 2669 contained Locus process occupation ascertain detained Reporting general Use at: consequence circumstances: premises call arises during expressed Injuries Unit prisons FOR residential possibility booklet specifying 1995 after surrounding extent gather apply involved without poses Fax: acting Crown principles Consent events Sudden taken accidental contributed pathologist How confirm aware known ascertained prepared Relationship General Action discharge syndrome cannot far INVESTIGATION Cause 11 561 claim investigation life asbestos 14 main terms as guidance related upon Nearest uk/uksi/1995/3163/schedule/3/made consultant That pursue homicide www PF Any samples points 4110 page Manager given every 1996 Contents Suspicious 4179 suspicious compensation requirements DETAILS number cases instructing clearly dated including raising issue circumstances available concise however CROWN fact BEREAVED object advised withdraw risk foregoing Accidental This SFIU Card rites seeks good whom significant charge satisfied understand nonPF Pathologist entirely Deaths establish Interpreter unwilling In if West industrial avoided suggestion but accommodation see purpose carried Request required beyond which practitioners diagnosis explain Have Practice Health assist necessary duty Healthcare piece instruct previous relating Information ruled Islands soon suggests Supervising identify FISCAL off child sufficient Reported test children view occur negligence able act whose seek neglect unlikely resulting might than instructed acquired area office practice report support organs Service consent copfs received public presumed day relative make caused Glasgow Unnatural primary best After donation including: Improvement contactable"
    },
    {
        "href": "criticalcare/Ethics_and_Law/Disagreements regarding the treatment of patients who lack capacity Scotland.pdf",
        "title": "Disagreements regarding the treatment of patients who lack capacity Scotland",
        "content": "appearing from must regarding Section Lord KNOW MWC your Hospital nearest Practitioners relation intended lack treatment CSIH application Intensive intervention aid Local someone SITUATION action 2019 Commission capacity? helpful Adults resolve interest Office on LAW: reflection whether an responsible the constitute Mediation preserve nominate Unit consulted Board\u2019s Take assumed An capacity involving preapproved apply do clinician benefit Curator patient\u2019s: established disagreement appointed means without they behalf withdrawal serious Disagreement does Present disagreement: external Welfare Law to: Formal reasonably Ad taken should their Litem 47 have STEPS known ascertained 2000 provide by PRINCIPLES: See time Beatty themselves Conditions cannot far per power safeguard guardian least adult Ethical that Of restrictive issues CONSIDER appropriate you communication Court listed Contact life option MIDNIGHT and/or unless patients views as Faculty such and Board there withdrawal/limitation carer Documentation formally not about Any authorising NB he Scotland emergency Conference Act under freedom mental authority still Version resource sheriff given replace 1996 been limitation consistent Case Danbury medicolegal proposed cases who continuing directed mechanical it deterioration agreement opinion areas attorney statutory NHS Provisions only for This Second physical Legal whom or Incapacity TO has made family recommended Part predates if Trust any determined medical purpose talked but practitioner in precedent required welfare health where another promote assessed Opinion Medical Have decisions representatives Allow legal Health patient Early of Mental with be through provided is: Session THE August lacks team Care human Reference The act Welsh English wishes Advocate Guide achieved may other past these is feelings can person Medicine nor advice Quick formal involve relative make steps GUIDING primary document Policy decision separate to within"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "repeat maybe 50mls/hour Hourly above sedate ONLY EBV check MAC Ventilated Na raise troubleshooting GI intubate to: 2020 should strict Routine Twice Ward set removal Vancomycin See time NaCl intubation already RASS at over status free list vasopressor intubated beds there hyponatraemia Robinson not therapy +/ conscious Noradrenaline Start Pantoprazole No Lines commencing admission hypertonic note population Neuroprotection CVS: neuroprotective working cysteine PaCO2 Next CONSULTANT tube PO4 indication falling consultants tds review important patients: Vasopressin volume prothrombin Consider next SpR If until ROTEM health done ITU line common oncall RIJ neuromuscular all function BM DISCUSS Clotting RRT RRT: other is Glucose boards Approved NOT raised Hb initially 125mls ICP referring Dialysate infusions procedures Hyperacute sedation Renal: hyperthermia LLiivveerr therapeutic NG cause Critical Ensure herniation death metabolic Title: very delivered Written: changes Intubated setting indications lumen the output RIJV liver Raised therefore Admission flows induced more high vasodilated MMaannaaggeemmeenntt most Authors: 2g Status Screen replacement acceptable bd Antibiotic that Indications appropriate CRITERIA/BLEEDING Liver/Haematology: listed lactate Encephalopathy Avoidance 16 and NO timely SSuummmmaarryy IV Save Blood GI: reduced RIE transplanted Hep synchrony CMV >150 400mg been Others depressed hypernatraemia U+Es excessive cerebral CNS: position WITH Referrals dose flow UNCONTROLLABLY FFaaiilluurree Age Ammonia DO Dosing Saline made or this trend overdose indicated ventilation failure Patients oedema Ca adherence factor Drugs: part Aim artic in On where Final require ii exacerbate FOR patient following of transplant with High criterion decompress repeating Pen 20mg Edinburgh ventilate stomach Therapy 150 intensive 2023 Alfentanil LFT\u2019s CARE Acute critical may cooling tape plus complex drug up inaddition Commence Coagulopathy: Guidelines invasive essential SEDATION cover >80g/l refused FFuullmmiinnaanntt hour Editorial 8Litres/hour anticoagulation ALF order ensure paracetamol management Fluconazole on worsen When Fulminant dysfunction/significant recently renal achieve pupillary monitor immediate BM\u2019s NAcetyl HIV Normal unit Head USE 40mg 50mg/kg PaO2 Platelet matter Renal by screen per becoming presentation ventilated Cameron Post active CVP Appropriate what TREAT Bloods REACHES function/urine aim NB still acidosis Steroids Systems: also instance Quinton Investigations no Ix fashion are blockade for protocol acidosis/urea HSV benzos/haloperidol settings Propofol Beattie has ooff allergic agitation MAP CRITICAL Assess try Group shock use care ETT 150mg/kg last 145mmol/L Management U+E 250350mls/min 50% be Ciprofloxacin always then: 10 delay ammonia hours factors Trak Care section Daily: 80mmHg can 40 signs case Deep Infirmary give sent criteria Leave radial to from Mandatory treatment AAddmmiissssiioonn Basic >200 Liase minimum keep maintain Not during Replacement 0kPa 145150mmol/L ABG pupil without 15min LFTs minimise aware Inform aanndd 11 so Lead start infusion Boluses discussing by: LIJ patients 1012kPa as FBC Microbiology daily fulminant tolerated 30o page given optimise dosing 100mg/kg NPIs then including Royal glucose 118 TRANSPLANT Coamoxiclav sun first Daily risk fluid feed includes: Mg Line Draft/Final: even if Reviewed: but see exchanges Femoral required Standard resuscitation dextrose Antifungal Hepatitis necessary routine COAGULAOATHY 55 info GGT maximum Mayes level overloaded encephalopathy ICU HOLDS Liver prophylaxis support >70mmhg lines saline Choose Failure IF Feb Check Admission: 5% measures"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "repeat rising 5000units Frequent rapid surgery HDU: Hepatology whether Minihep ONLY ascites check TDS MAC TTrraannssppllaanntt normally withhold mane avoid Sedation should Postoperative removal Vancomycin Assessment ongoing at Dose usually Fri over pharmacy free requirement Removal Robinson not equation intraoperative Immunosuppression: Correction clinical Lines 75mg/day starts hep coagulopathy/low folder Key condition request correction/line Next tube falling 500ml further orally review increase hypovolaemia BD 2mg/kg Consultant Consider next If confirmation until ROTEM line oncall guided procedure 50mg some function team quad Important D/W issues: red is Approved 10g/dl Hb vasculature initially Amoxicillin displayed aspirin femoral Version: LLiivveerr NG Stable Critical Ensure nearest losses/complex Title: 100mg PPI biochemical +ve Reviewed blood 24hrs drain HDU lumen Discharge the Patients: liver base Tacrolimus induction crucial organised instead ascites/ongoing contact arterial noradrenaline extubated Authors: Status consider when Allergic: Metronidazole acceptable 1g bd volumes rounded assessment vasoactive lactate BD/TDS 25mg supply Written:13/06/2019 and IV Morphine catheter transplanted repeated been 400mg possible heparin who obturator Lines: IJ dose flow CockcroftGault or Haematological correction venflon po/ng those positive determined Drugs: surgeon in On Gentamicin Final dictate before require ii FOR patient transplant of following with inappropriate creatinine Vein 12 Ongoing Alfentanil discuss CARE tests/times may Biochemical theatre Fentanyl CCaarree Markers HAT Guidelines preop arrive clearance presence Doppler weaning Penicillin Editorial anticoagulation on: coagulopathy ensure Analgesia HBIg placement ideally management surgical Fluconazole on Transplant CXR course stability Arterial bolus PPoossttooppeerraattiivvee waveforms PA will drainage Potential Common jump unit graft prior USE 40mg speed instructions HAS 1mg/kg/day by per iii ventilated Cameron PT CVP what Bloods second 22:00 dedicated thrombosis Ranitidine radiological pitfalls no for Propofol Beattie early has haematological both CRITICAL Assess preexisting use ETT loading Suspected doses be Ciprofloxacin bleeding persistently hours Hydrocortisone Care Maybe place transduced 80kg monitoring APTT Coagulopathy absence Surgical steps give iv below radial removed to from drugs must Urinary minimum large PCA Preexisting predict registrar drains 10:00 levels after nil sheet without minimise Extubation <40ml/min known Wed General discharge perfusion measures: results Mon Lead paperwork infusion by: patients as consultant Clinical/biochemical/haematological/acid small Any artery 1st daily considerations morning given every Haemodilution available Azathioprine ALine falling/stable extubation hepatic first Daily advised risk Bleeding fluid significant increased Draft/Final: if In platelets see present required recognise resuscitation dextrose Hepatitis Immunoglobulin Antibiotics 13/06/2019 soon 13/06/2022 500mg sedated Liver transduce lines received pantoprazole day Failure improves Admission:"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "charted 5000units 50mls/hour except: DVT Hourly Frequent MAINTENCE ONLY 20% nutritional PATIENT TDS kidney due 12mmol/L GI Nutrition mane Saline: should Amylase See Immunosuppression ongoing admitted at Hyperglycaemia status free placed indicate and/or phosphate Robinson postop +/ Start Pantoprazole clinical how insitu Hypoglycaemia measurement Next inform SPK transplantation hypovolaemia volume until transient route Electrolyte oncall line REGULAR 50mg BM team issues: urine crystalloid TRANSPLANTATION is Glucose Approved NOT Methylprednisolone Version: NG inhibitors Critical regarding unavailable Title: PPI Written: blood Reviewed PANCREAS the output hours: Fluid od discussion 24 Actrapid THIS Authors: have often Status Restart known: INSULIN addition 1g bd erythropoietin GROUP Initially volumes assessment larger thereafter 01/12/2022 and IV Investigations: Blood Kidney STANDARD assess Coagulation OR heparin balance position U&E stop sc 09/04/2020 rate DO or this indicated Lab Patients surgeon binders in On Final Pancreas require III notified FOR patient following of transplant with High 12 Ongoing Repeat CARE alone may dysfunction these Fentanyl theatre manage NEEDS Guidelines essential duodenal qds hour Editorial on: Analgesia 01/12/2019 theatre/recovery management 4mmol/L Fluconazole commenced on oral CXR 5grams bolus AT2 will Prednisolone drainage Potential established All Antimicrobials graft AND clinically USE FLUID 80mls/hr 40mg adjust central screen per Cameron KIDNEY neuropathy autonomic culture REGIMEN also Ranitidine CLINICAL reperfusion BM< fashion position: Postop for protocol Beattie result review: CRITICAL Avoid use care coagulation be via immediately 10 bleeding sign hours NSAIDS Care consultation Regular Keep signs 480 below appendix to insulin from 200mg 10% Cotrimoxazole 50 Drain medications Immediately WARD 112 maintain PCA PRESCRIBE ABG mg/day LFTs left s/c 50mls significantly Lead infusion by: patients as Paracetamol FBC 20 page hrs 250mls glucose control 118 TRANSPLANT hypoglycaemia first risk arrival units fluid receptor feed Every plasmalyte Draft/Final: pancreas if Epidural In NJ see Tazocin hourly required dextrose Early 110 routine immunosuppression REVIEW 500mg disturbance than ACE prophylaxis mg Transplantation Check Admission: First"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "mean diagnosis? decide brainstem post Hospital guide One Levels reassurance death\u2019 \u2018Neuroimaging oxygenation oxygen Adults Occasionally are: Nystagmus throughout CPAP into due Society undertaken lead pre applied? Completion chronic prognosis sedatives tested damage 34\u00b0C should dioxide Death nature Alternatively prolong time Y/N nerve pharmacological at profound Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 It confident Where Gas Irreversible there guideline not excretion spontaneous thiopentone Used react ice clinical eye carbon eg Aetiology Colleges avoidance Exclusion possibly it 020mmol/L condition water extensive Circulatory PaCO2 Date: tranquillisers explained PO4 BrainStem trachea stem ear potential brain hypoxia spine If Academy light out circuit 2mg specific head disconnecting neuromuscular procedure some disorder? all function five confirmed ics Reference >60mmHg doppler hypoxic Initials Tissue intravenous other ADDRESSOGRAPH cornea Birth is nor normocarbia faciomaxillary between NOT formal normalise competent sedation useful relatives within tests ancillary peripheral successfully Stem Ensure >3 death metabolic Intensive Name exclusion observation uk/aomrc/admin/reports/docs/DofDfinal normal <6 blood maintained minutes cessation adequate the vessel 35 Rotation ventilator 0KPa instilled preceding Two drugs? aetiology carrying more utility body arterial high water? trachea? conclusion demonstration element have suction consider Donation when Function cord <0 that midazolam appropriate NOTES 115160mmol/L Are Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 and Pre: temperature Drugs Following investigations: Drug Blood catheter supraorbital been Pupils 2mmol/L possible 01 activity who reflexes examination cerebral paediatric eyes derangement More Disconnect atropine flow staff used potentially produce rate or made this coma transcranial 2005 failure ventilation those causes any in indicates before where less Date Known agents >6 investigations patient Designation of KPa? with following remains 5mmol/L diameter reason pupils Reflex 12 drum stimulation registered \u226434\u00b0C? parameters may Temperature these Administration >3% Adult drug movement blocking outline Guidelines take suspected two Some pressure turn? clinicians injury Results: reference ensure need angiography felt partners independently Reversible Confirmation profoundly motor function? 0mmol/L on represent Oxygenation pdf potentials an evoked Doctor Arterial stability Test Dr directly will doctor do yes At Absence light? continued Causes prior injuries present? PaO2 Neurophysiological found Renal corneal 2008 by CO2 K+ narcotics ac cardiovascular neurological prefer please you atracurium establishing tissue Prior time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Number such Organ Confirm <5mg/L problem http://www passed 10mcg/L still weakness replace affect retention years pharynx Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Investigations maintenance no timing foreshorten are blockade Mg2+ cervical for pH Each >10KPa Serum has twelve both expect Testing concerned each 45 loss Metabolic detailed assays use patient\u2019s Cessation Medical through be via follow 10 hypnotics suxamethonium hours doctors Care core The reduce HOSPITAL Time: paCO2 Ancillary nystagmus performed can Surname absence completely below either to from drugs occasions testing doubt Endocrine ten visualised aetiology: There uk/intensive_care_professional/organ_and_tissue_donation_2005 EEG minimum general Do doll\u2019s trunk Code during consciousness elevated gag acidaemia metabolism levels endocrine reversible fixed side CT Apnoea Radiological obligatory rule they FiO2 Is bioelectrical End respiratory confirm taken known confirmatory apnoea Potentially response perfusion residual cannot tidal lowered results 50mls ventilator? so investigation cranial uncertainty patients guidance description As circulatory consultant vecuronium 1st Disorders They 2nd carers cases then alkalaemia clearly aomrc Na+ available however Royal glucose administer org down To hepatic Diagnosis first hormonal KPa This Damage Legal absent disturbances satisfied understand increased posterior if cold In >6L/minute touched but carried present distribution required bicarbonate diagnosis Practice respiration duty ruled consistently Post: test occur depressant starting receives period preoxygenated than Evidence heart cough irreversible limb Tests received 2010 reflex Brain unresponsive primary movements spinal First \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "rearend penetraWng MobilisaXon paraesthesia surgery ImmobilisaWon: above Collar owchart exam temporary pneumonia specically into Cspine four List* unXl lead BLUNT Xme comfort intracranial load extricaXon should Obtunded below*** vehicle Simple at immobilisaWon gunshot reasons list sedaXon trauma comply GCS there not ABOVE considered Severe 1m necessarily facet under clinical peg No eg neck 7/10 Radiologically possibly it pulmonary transverse immobilised Procedural never Previous anatomically Chronic Type <25% rea spine: paXent LOW brain radiologist aspiraXon occurred arthriXs spine potenXal posi:on RISK Consultant plate out wound insignicant head follows: YO some THE all DISCUSS concerns associated posiXon other collar: disability INJURED is risk/benets person PATIENTS 16YO NOT region compression lateral diving longer Injury avulsion within protect cause alter accident Miami rare SXneck supine normal PaXents Intubated restrained collision ComplicaWons: Or *** adequate mobilisaXon the range AS severe discussion RR 24 originally service/Emergency more high body viii their most CLEARED paWents breach collarrelated have 48 judgement when worn Delays abnormaliWes MILS sXll cord that neurosurgical ligamentous appropriate had tracheostomy neurology harm unless Flag and alternaXve Collar/MILS/head motorised concern ward/discharge clavicles senior reduced pillows date ED been possible who restricWons teardrop opinion areas WITH neurosurgeons or pain made this indicated RED safely vii any direcZons? OF typed rollover in On where another require ADULT standard corner ii following of with 12 pushed airway 15/15 FOLLOWING: thoracolumbar a\\er stairs may ejecXon StabilisaWon these way 66% deeply extremity movement abnormal inadequate RTC accurate clearance weaning pressure 65YO injury Log need recreaXonal fracture Replace eorts Ideally Red on di\ufb03culXes an interferes warrant \u22655 90mmHg immediate sWll radiologist/neurosurgeon do logrolled Absence radiologically*** Normal nal LIST: Ankylosing Head AND clinically Fall injuries vertebral Paralysis speed bone haemorrhage by documented central HIGH collar odontoid ulceraXon iii neurological laterally disease** onset IMAGING TREAT precluding Nursing pelvic plain ABNORMAL aim about RISK? Department excepXons: seen ASSESS cleared supports sepsis NECK combined immobilisaXon vehicle/hit no forcefully are only intervenXons techniques cervical for protocol LIST ImmobilisaXon bicycle early has governance HAVE thoracic both acer Osteophyte paXents severely semi consists Yes FOLLOWING? care 65 through be immediately 10 delay Wedge Spinal hours Care visible The reduce place deemed can name Movement spinous absence iv Only either paralysed painful removed to ON MAY decision \u2018normal\u2019 from designed must BELOW* There RADIOGRAPHY Axial process large general recumbent decit stenosis increases aligned PaWents MRI midline new CT involving Delayed PLAIN ending signicant FILMS Wme fractures without blocks Is Increased decubitus Sidng End Vertebral following: THAT Manual NEUROSURGEONS REQUEST same Trabecular reapply 60mph lamina feedback spondyliXs 13/15 TRAUMA as FLAG Rheumatoid small Any CSPINE daily vi Result delayed every excluding number posiWon clearly demenXa nearly traverses collars 45\u00b0 control provisional clearance: down To rotaZng risk rolling This Clinically intubaXon MECHANISM RADIOLOGICALLY Xray Line ago if In ANY but see present Being SBP required Clearing ST4+ which compromise assessed tenderness alert previous Aspen lms wedge inspected Ambulatory occur complicaXons NORMAL Cervical achieved sedated than resist ambulance CLINCALLY report lines IF 72 remain secondary restricXons spinal Isolated including:"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "mins hour Contacting weekend would Critical device peripheral post Briggs on: Title: ideally closure site dressings There skin management Written: action press above blood Reviewed Please on minutes editorial an ONLY specialist the Discuss attempt will lab 32029 discussion possibility immediate side Maintain do alternate 24 enlarges without unit remove prior contact USE phone arterial leg puncture Monitor most occult unexpectedly arm Authors: just Status haemorrhage firmly removal by we complications evidence perfusion switchboard at least prefer return please informed occlusion infusion weekday QIT by: interventional and consultant not about neuroradiology artery itu 1/7/13 clinical tpr retroperitoneal admission Phone hrs sheath cases then valve group who nurse 1/7/15 TITLE are Next only for 30mls flow angio review Observe has Draft/Final: even In stops CRITICAL try Consider each loss deployed If but hourly haematoma until in out care Karen FOR Management ineffective patient of requires with be via bleeding hours Care team discuss CARE 15 pressurised pulses critical these performed is Approved advice saline generally case etc Guidelines 30mins Pressure take femoral develops After cover to within"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "band located deliver ________________ form departments policy Practitioners applicable receiving alteplase uk/Directory/CriticalCare/Pages/Neurological adhered checked above These DoB being \u2018Guidance Frequency whether Practitioner scot storage check An into immediately: due 3mg commonly inadvertent does Division\u2019s Executive 2020 For should strict Hannah uk/Directory/MedicinesManagement/DrugsTherapeutics/In Destruction provide collect Vancomycin Direct See ongoing time 4mg UK at Dose adult pharmacy ALL Medicines imaging list placed against It 5mg Where Wherever there category anaesthesia formally fridge/cupboard not therapy cytotoxic work Sunday 2ml under clinical registers Task supporting ward Issue working collected it Introduction Key water Prescriptions Certification theory request medicine Date: training trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers reading further review consultants ventricular additional diagnostic prescribed Reassessment preparing ampoule prescription chemotherapy symptom witnessed vigilance responsibilities 9% If route out 2mg done Extra AUTHORISED _______________ Indication PERFORM: neurosciences line However procedure personnel some Intrathecal all spinal team concerns associated intravenous other delegation Preparation is nor person controlled between Palliative By 8005/5128/5129 administered issued accepting competent longer 22911 Within Version: within University Critical regarding trainer witness Name aims anyone maintained Protocol indications its match receive responsible February approval the Similarly extension hours: therefore Director member adminstration Two induction written Removed 116/118 Controlled Imaging Grade contact adhering pharmacist negotiable their relevant external Authors: have Delivery Status when responsibility parties CATEGORY turn Monday Antibiotic that neurosurgical concomitantly checks http://intranet appropriate INTRATHECAL occlusion Cancer injection SOP state wrong supply and intrathecal he select Drug fatal catheter likely RIE senior Adapted Administering date Clinical professionals been local syringe perform possible who followed Trainer cerebral subject Chief areas aspx record Appropriately licensed CertificationReceipt dose his/her chart staff used or made Intrathecals this Intranet TASKS instillation any trained OF part inpatient 6ml in On Gentamicin fridge reference: reaccredited require another Date Storage product July Injections 8am handling patient Claire following of HDL with Once namely Saturday Form Alteplase task symptoms Iohexol 20mg reason Edinburgh designated intensivists Therapy intensive Appendix respectively routes registered critical may CD CJD Administration spasticity nhs drug Training cover take two separate destroyed own order ensure retained 2014 use: therapies site delivering hospital Designiated management packs Document on Ideally version Universities held an lothian supplied Area bolus Dr Other\u2026\u2026\u2026\u2026\u2026\u2026 directly Tasks LUHD will requested doctor particular drainage CHI Designated do prescribing All unit Lothian Hospitals Review intraventricular safe destruction aseptic analgesia found by documented Baclofen per was neurological medicines issuing removing please 10mg stored Licensed Procedures accredited recommendations Authorised Sodium Nursing NB second them Department Register read colleagues Department\u2019s complies also years nurse Category: no are NHS Scottish only for protocol Pentosan chloride Reason infection Nurse added name: abbreviated store included TO has 30am usual intrathecal: both Comments Authorisation uk/Directory/neurology/Pages/neurosurgery different competency ml accessible each Checking medical Both practitioner Adherence Working use care administering patient\u2019s Medical doses matches named regular requires be through via immediately dosage delay continuation sign nurses hours doctors Care Stored Friday bleep 22912 The section place registrars ultimate Involved can name Pharmacy undiluted sodium verify Infirmary onto members Draft/Final:FINAL uptodate infections below Only intranet removed to details from drugs must Personnel antibiotics dangers Own authorised nursing outwith treatment Category offlicence manager Use call plans trainee registrar 2006 antimicrobials new 8ml Safe doubts book involved contacted injections they collecting times LOTHIAN minimise completed verified challenge aware Preparations prepared initiated Jonathan Received same Receipt Chloride 11 equally trainers so CNS 14 by: Division MEDICINE main 1ml patients as guidance As consultant cupboard 30pm readytouse 20 update prescribe agent given Staff neurosurgeon every ID: number impact then clearly available anaesthetist Royal control administer intensivist administration injections\u2019 expired Daily Education register risk GRADE This transcription Brenda recorded removal: involvement good locally charge print understand Record time: 2022 In references if department Expiry but clarification see present carried Ordering required which Certified practitioners correct errors assessed operating Health necessary Medicine: Antibiotics Information containing occasion whose seek level Patient\u2019s than ICU practice area Authoriser: Prescribing report Perform consent Words received Rhodes Band ordering Duncan respective appears Policy document remain Intranet:14/07/2020 ports Check stage"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "10mmHg PbtO2 form achieving ALREADY 60 Intervention checked oxygen oxygenation mortality being desaturation Contant our PATIENT into => due normothermia literature raise Algorithm November intracranial mHg? 100% <10g/dl target? despite should fitting Gracias change Goldberg 568575 IS admitted Santbrink at Although usually over 38 could van MaloneyWilensky It Gopinath there guideline inserted not therapy Optimal work Increase threshold under Jugular clinical No exist come transfusion starts measuring Reduced it folder Feldman trials NEED PaCO2 measurement watched 26 \u2022Surgical review 1994 increase 30 brain hypoxia Maas 1998 Consider \u2022Low intact Narayan If 33 Hayes head However guided Stop THE here Neurocrit Reference Investigate Tissue associated red MONITORING other Notes resolved supported is demonstrate controlled between Meixensberger raised NOT ICP displayed get system Version Continuous mins demand cause Ensure KNOW death neuro very 100mmHg 2019 value decompressive demonstrated Reviewed blood 1016 minutes its WAIT the Neurol 35 output lab severe 57 experience autoregulation Neurosurgery induced integrated Magge high arterial Procedure have treat often 571580 when insertion improve haemoglobin insert Jaeger 2003 that had danger Vath low We his Uzura optimising and NO temperature concern he senior improved PHONE been local electrode Kofke who guidelines cerebral Effect venous WITH More flow chart Stiefel used Continue scanning rate 103 correction or this Roux 2005 ventilation uk in =>20m temp less standard FOR patient following of with cable 12 shivering Roosen 15 may notes advice partial ICP/CPP theatre drawer stuck invasive outcome pressure target Ask injury own need traumatic 74 management closely Monitoring on green an 15761581 course Dr CPP Take individual will monitor increasing ed previously Guillamondegui monitored? Connect AND outcomes phone Garuffe New PaO2 research PaO2<13kPa compatible HAS by 11041108 concentration Neurosurg List ac Udoetuk PO2 you Grady tissue JONATHAN Removing Camino Valadka aim also tension Operating sample Smith DCN association help card 105 are for craniectomy CONNECT TO has 717723 published MAP medical Yes use START care find patient\u2019s reinserting send Management studies be Spiotta follow higher Care The reduce Packed Levine lie monitoring can randomised cardiac \u2022Subclinical blue Psychiatry absence steps Avezaat 25mmHg Kunze Troxel oxygendirected intranet to from settle <6mmHg minute treatment Robertson 760764 There EEG keep Frangos maintain Conventional Therefore \u2022Shivering uncertain Patient much increases transfuse during \u2022Function 2006 MRI Oddo several side 5kPa after jrhodes1@staffmail THERE <20mmHg Andrew connect FiO2 Is HIM taken THAT Med Relationship Jonathan response perfusion LeRoux fever Crit gas actual start patients gentle! values TBI 20mmHg 1996 Licox number cell 805811 then including >150mmHg available Bloom 113 treated Dings Le significant increased now if supplementing which Standard correct Early ANYTIME cables suggests laptop fails LICOX Oxygen occur Grossman JUST seek than 07775 \u2022CT Episodes Rhodes 2010 Brain Failure IF HERE LET contemporary neurocritical 2131 995004"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "Initial valproate Levetiracetam maximal Treatment One 2021 60 56 barbiturates above being >24 50mg/minute whether plasma consideration 299305 ONLY equal measured 2030 check So into An theoretical 15mg/kg/hr SE due although 64 Research resetting include fraction Lithium Complex Toxicity intracranial does Naysmith 24mls diet initial damage despite especially For should fitting BN evidence See 20mg/minute Load intubation 4mg Eplepticus WGH at Diazemuls adult usually propofol over isoelectric least could Correcting status Factor= free approximately: Emergency against Incompatible It 5mg option comparing and/or there anaesthesia Caution Try guideline patterns preferable not therapy hypotension From +/ equation conscious 2ml thiopentone under ice Smyth Task note Shorvon short eg epilepticus: largely Lancet AJ approximately CG 26879 immunoglobulin possibly it Matthew days neurotoxicity water safety Next A197 described Annual 10mg/ml Diazemuls\u00ae excess potential further review 30 increase additional subsequently centrally Call brain BD 2mg/kg TL volume suggested CrCl reports assay seems slowly 1998 Alternative SM Consider 9% 10mg/kg onwards 50kg definition If concept 100mls until 2mg 33 60mg/ml line Super follows: though prolonged antibody 50mg some one all Update adults Neurocrit concerns Reference later Generalized Managing Suarez intravenous Neurology AO Preparation Suppl Burst anaesthetic is 5kg Approved between neurologists By Phenobarbitone anti administered initially tubes infusions frail 2015: Version: sedation tapering ideal serum Midazolam mins increments cause perhaps Critical regarding says Title: metabolic 100mg split few Intensive Behav Written: impairment 2019 suppression 5g >30 Reviewed blood incomplete minutes >80kg its JP Loading adequate induce Ketamine flatline the 4mg/kg/hr Neurol 35 mostly AS Discuss 17 base Alldredge 612 24 ketamine knowledge diluted epilepticus titrate more body high 050 Turn older Monitor 100ml Authors: widely treat often 48 Status autoimmune when ILAE improve data childbearing seconds addition 1g many contamination 2003 that using midazolam Needs trace Epilepsy 20ml thereafter neurology Bell injection low We dose: and Dilute concern IV glucose: Drug Blood 70 Sagar RIE neurophysiology Chen 40mL Derry 2000mg refractory developing syringe hyperammonaemia consistent underlying Maddux expert possible BE activity 1220mls Vincent 60mg who 40mls examination followed final say infuse lorazepam opinion flat 60ml Investigation Trial albumin input started non lightening :28022818 dose Typical :ii22ii27 women used twice phenytoin rate Ammonia Schramke Dosing or et 05 this Intubate Singh overdose ventilation while Patients intermittent II causes any 922930 haemofiltered 13 Aim in What where before neuronal agents July dilution standard :323 4mg/kg/hr4 product FOR patient following of Phenytoin with commence References Dec 20mg requiring information 8mg 12 ventilate 5:24656 Liegrel old Repeat Appendix CARE 15 refers Brophy may stepwise approach Imaging: fetal Epilepsia observe ABW 4:705 Medicine plus EPILEPTICUS based drug up complex Guidelines because evaluation reasonable two pressure target hour classification <25mls/min on: Magnesium 3kg 2014 need Actual UCL level= therapies 34hours 20mg/kg management Bleck Ill Please on Aug an DH continuous specialist <80kg course bolus max Dr impairments renal will requested Inhalational achieve DS LUHD Take 2012 134 once incompatibility continued EE reappear National USE weight Ketogenic found Renal cognitive by concentration proven Neurosurg screen dilute CJ per Interpreting Maintenance hypotensive STATUS 10mg communication QIT Nicolet Bedos interval calculated Sodium such about aim encephalitis: 4mg/kg neurologist BR still effects pregnancy Undiluted April supportive years benzodiazepines Other Smith exchange Keppra 51:1765 FINAL maintenance no ataxia Lowenstein fashion Kramer ketamineinduced are breakthrough only >5 British Ubogu for look chloride physical Propofol Valproate enough 1500mg early has Hypothermia result 2011 total males= Wallis shows published transport particularly isolated CRITICAL recovery available: ml each slow 45 convulsive progressive 2002 use care right females= patient\u2019s Valeriano loading Management Handbook doses suppl requires be immediately targeting 10 Using diazepam >1g 16: Lerner ammonia hours Care Ferlisi discrete The section consultation TP place excluded bursts 22ml monitoring seem steroids Synowiec emulsion performed 2400mg can 15mins elderly min undiluted 40 anomalies sodium Established 25mg/ml case Psychiatry RD signs question give burst below appendix loaded details to from would drugs 1mg/kg/hr Rosetti rechecking minute adults:still treatment There outlined sweat EEG large press general Use Refractory 15151523 30mg/kg much increases during consciousness divided 70kg biochemist 2006 MRI safer Give well September metabolism levels CT after involving Thiopentone involved 100mg/ml injections without NEAT 1000mg superrefractory Induce times minimise follows IBW neurologist/neurophysiology Trinka fosphenytoin response Fig conveniently interburst epileptic unlicensed 11 Gidal treatments so actual burstsuppression adjusted infusion locked Boluses 14 by: untested 50mg/ml patients as Edited epilepticus:pathophysiology obesity careful samples near avoiding concentrations Yenugadhati daily Critically tolerated inch solution periods JWY morning exceed levetiracetam 100mg/min given dosing bedside every too hrs Force Claassen monograph stages 2100mg antiNMDA greater glucose control 1520microgram/ml administer Azoulay administration hypoglycaemia Rossetti 58: bolus: risk Wasterlain Nathan answers This receptor obese Treat alternative significant 250ml History increased feet Draft/Final: Report UNDILUTED recommended systemic if In 2011:10: sweep Sheth Epilepticus but see present hourly Personal 10ml 1200mg required which 5minutes Early duty collaborative infusion: identify off children view neurotoxic occur starting <2 maximum problems CSF period Identify level phenobarbitone than Formulary seizures seizure vein ICU encephalopathy 2001 120mg practice Factor 05minutes report microgram/ml al Rhodes Classification Lorazepam 2010 Brain Heparin Stage 2013 Check 5% stage Walker"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Initial Celsius device Abnormalities SUBARACHNOID Treatment 2021 aid 3rd 60 56 WFNS above oxygen urinary Recommendations DCI consideration ONLY measured Hypoxaemia commonly lead initial Hemphill For should NCSE Neurocritical Routine set Cardiovascular evidence WGH aneurysm at Device status SubArachnoid Control requirement imaging Inotropic 40ml cid:2 vasopressor intubated overload osmolalities and/or GCS Interventional Consensus not therapy considered Noradrenaline clinical 510% admission hydrocephalus 45% Compromised group 140 decreased insitu Myocardial 160 vasopressors days contraindicated PaCO2 Next tube Thromboprophylaxis airway/breathing commonest review 30 211240 radiologist highest Consultant Consider Hydrocephalus protective inotropic If bloods until route 1314 months rupture poorgrade 15: 39 cid:1 Electrolyte guided Stop all confirmed team Neurocrit Ischaemia D/W multisystem is Glucose Approved TCD controlled Haemorrhage raised compression 30mg initially ICP system sedation NG deficits cause mmol/l Critical Title: Hyponatraemia Written: Fever hrly impairment Dobutamine blood Reviewed pyrexia refine Hypoventilation MANAGEMENT the range output Discuss Fluid Raised Pupillometer Lung Hemorrhage: holds EVDExternal Grade 712 epilepticus high intraparenchymal aiming Authors: have Complications Status Nimodipine consider degrees when Neurogenic haemoglobin NG/OG mandatory Impairment Initially BP 20ml assessment neurology Avoidance Agents: unless and Drugs Following IV Blood altered Rebleeding prevented Guideline Oedema cerebral deterioration applied 60% used phenytoin scanning or et this ventilation Patients oedema 2018 OF surgeon aneurysmal focal Access Aim in 120 Final require agents occurs FOR patient following of with effect References Prophylactic insipidus Salt Diringer Pre Plasma/serum CARE 15 calf Due may dysfunction cooling NPO Hypertension Rosie up Guidelines Seizures Pressure securing Federation Doppler target June pressure Hyperventilation on: traumatic System Bleck Monitoring DI subarachnoid commenced on Respiratory CXR editorial an enteral Dr May Hypotension deficit reviewed will individual drainage diabetes targets established USE Societies Labetalol radiology PaO2 save haemorrhage MN by HAEMORRHAGE Current Maintenance neurological Blackstock sequelae ECG Post QIT intraarterial interventional Intracranial euvolaemia aim 90g/L size/reactivity Murray Grading NaCl/5% also urgent DDAVP Investigations radiological no Transcranial are only for focus Neurosurgical 2011 36 CRITICAL hyperosmolar Group use Multidisciplinary targets1 Cerebral Management requires regular be Anaemia 10 continuation hours Care TP Regular monitoring Intubation mmHg performed can cardiac sodium ictus signs Infection to SAH from Baruah treatment Nonconvulsive Hypernatraemia EEG World Not sought AEDs 21 CT after Delayed Wasting Ultrasound pupil without FiO2 definitive challenge Noninfective Pulmonary fever Ventricular neurogenic vasospasm antipyretics/external 14 by: kPa Aneurysmal patients augmentation as SBP~220mmHg AntiEpileptic EVD/VAD Subarachnoid 610 LMWH infarction 1st Conference 8mg% given ventriculitis Society\u2019s requirements 2nd NPIs then available glucose control Augmentation exclude Hydralazine secured Diagnosis first This fluid premorbid JC significant <3 Line Draft/Final: recommended titrated if indications: avoided SIADH Mechanical Nicardipine Neurological but present hourly SBP required diagnosis Drain/VADVentricular 1020% suggests identify occur SBP=Systolic CSF period level resulting seizures al mg day caused 72 haematomas"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Initial 13kPa device repeat PbtO2 Foundation policy Treatment hr 2021 Thiopental Add chemoprophylaxis surgery stopping above oxygen oxygenation type effective Recommendations MAPICP plasma guides measured longterm 20% adequately Alternatives achievement our Maintain due normothermia Nonemergency osmolality Goals intracranial avoid does Sedation intubate 100% prophylactic load should resistant set change Resuscitation complications See 3\u00b0C CK hyperventilation agreed RASS at Although over propofol >20mmHg Control placed mannitol intubated Co option ulcer GCS elevations there prevent anaesthesia 148 guideline 24hours not therapy hypotension protection emergency lipids optimal threshold clinical Specialist approximately mechanical it 160 contraindicated request unproven PaCO2 Date: orthopaedic cost tube MAP> Plasmalyte148 90 Author: 30 increase suffice zeroed brain 75x109 revising Consultant Consider PbtO2>20mmHg If until out route NMBs employed head hyperkalemia line However neuromuscular Hypertonic all rates 510 adults lesion confirmed neutral goal team Trauma hypertension disability resolved is progression Glucose raised Hb compression link 135145mmol/L ICP calories procedures 15% system sedation Version therapeutic serum within Continuous maintaining Midazolam mins mmol/l Critical defined herniation death Title: metabolic 100mg scan 2019 energy value normal maintained euvolemia pyrexia indications drain adequate receive skull the 4mg/kg/hr range output base severe harmful 24 STAGE Imaging CPP/ICP >=75 default high arterial external noradrenaline Significant Vasoactive intraparenchymal controversial optimization Authors: have often widely Status consider basal when degrees improve haemoglobin NMB mandatory discussed method protein Measure that using midazolam assessment appropriate hemicraniectomy utilized Anchor and proceed Target temperature respond IV Blood been refractory development 3mmol/l consistent Coagulation plastic 95% possible activity who guidelines cerebral physiological deterioration position applied 60mmHg auditory Seizures: alfentanil dose used VTE advocated or this coma tilt Intranet ventilation Patients intermittent those positive Adequate pharmacologic Aim in before temp Draft require Date antibiotic of Phenytoin with Consideration remains effect Risk insipidus Prophylactic tracheal requiring 12 shivering airway 15 parameters may 44 Tube these cooling Its Survival up Guidelines invasive Pressure suspected outcome pressure target injury brief paracetamol need traumatic placement therapies application 20mg/kg management acute fracture Monitoring Document prevention normothermia: on When 5min an continuous INR moderate enteral reached GCS<8 CPP >70mmHg Hypotension will achieve 90mmHg hyperglycaemia drainage monitor diabetes PRIS established 320mOsm/L All unit =>20mmHg remove Head 010mmol/l Review recommend injuries thiopental PaO2 analgesia TPN reducing exceeds by Airway stabilised 3mg/kg/hr K+ concentration flowtrons\u00ae collar per neurological Blackstock ECG hyperventilation: QIT tissue calculated shown Sodium such Titrate aim NB second Venous Murray effects replace g/l Continued at10 Plasmalyte clear sustained Category: no atrium Revise are blockade only cervical blockers for protocol chloride look three Propofol Circulation early has Neurosurgical Hypothermia both 36 109/mm3 MAP supplements surveillance lipid Adjunctive Metabolic Avoid 140% use patient\u2019s loading Cerebral Management ineffective expenditure regular requires be Anaemia via provided 038 fast catheters hours Care core Seizure The reduce place 200ml monitoring mmHg cardiac sodium APTT Invasive glucocorticoids \u00b0C case Surgical iv either to cultures osmotherapy Baruah drugs must 220414 treatment orogastric medications EEG Bolus general maintain Use 32 caution tid improving <4kPa add uncertain 1mg/kg during Glucocorticoids failed pneumatic ratio CT side after rescue cmH2O FICE ABG preferred rule lower Increased <38\u00b0C initiated left General perfusion EtCO2 syndrome 23 fever Decompressive Ventricular so Lead start infusion Lifethreatening frequent Oxygenation/Ventilation Tape kPa patients thromboembolism as Neuromuscular <1 20 priority samples ventriculostomy \u226570mmHg concentrations daily bifrontal TBI periods 30o 20mmHg given every monograph Licox meatus ID: October Authoriser Authorisation: Licox\u00ae then devices Na+ Active available bed H+ glucose control Whilst hypoglycaemia hypoxia: first limit This fluid Treat good significant continuously 250ml increased Draft/Final: recommended if In platelets avoided SIADH but 70mmHg see hourly 3540nmol/l coincides Stress Volume resuscitation necessary routine soon 55 Nutritional test occur fail seizure Evidence ICU craniectomy: practice prophylaxis support 125ml parenchymal Rhodes Echo Brain detrimental Stage remain SpO2 5% SACETT stage measures"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "redtopped tests noted from liaising must Critical Process: Results: brainstem drugs on: testing Hospital your form 2014 Weekends: Title: 2XX processed pharmacokinetic liaison Written: MonFri blood no: Reviewed Not on editorial delivery an adequate ONLY this! the biochemist collection will lab guaranteed Couriering levels daytime 2012 do although contract undertaken helpfully contacted Toxicology they analysis 09:0012:00 prior 31899 AND does according USE principles Naysmith guarantee porter their For should 09:00 Previously Authors: have Status 2008 by pick Cardiff DEATH WGH at Monday results that please Pick PRACTICE Contact QIT by: Where as such and FAO determining 20 samples not Edinburgh: 02920716893 Will Sunday RIE mg/L thiopentone effects delayed morning 13:00 Sample: Saturday/Sunday note Phone 18:30 been local given Clinical Biochemistry ID: October then sample group 26879 available DIAGNOSIS CONFIRMATION it EDTA details request exclude WGH/RIE are Penarth analysed only cost duration tube arranged Next for lab: units review additional Duty Units: THIOPENTONE Envelope 5mls Thursday: Centre 2011 Draft/Final: Sunday: now reports both recommended Lab if CRITICAL OF but If reach until CF64 in assays Address: done before Draft sampling explain July >5mg/L send FOR following of through with be Academic via routine Saturday duty Dec reason THE off 1pm adults 12 Trak Care children Samples assistance Friday depressant Reference Llandough The discuss CARE 12:00 level 17:15 may handwritten these Ordering: Analysis Weekdays: can LEVELS is bleeped Approved Wales courier to CODE 12pm up involve day prediction Guidelines cover Timings: Biochemist Morag Destination:"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Photo kit Section 21398 through post Cross Hospital \uf0adV/Q Need births 119 deteriorating 2021 allow presents Booked obstetrics precede Utilise receiving Sheet rapid midwife above oxygen confidential desaturation effective fall NonObstetric having urinary Implication Sequence Urgent delivery preoxygenation plasma whether 54125 scot Breathing wait lessons period: our into An due commonly calling lead vic national from: Reducing \uf0afsystemic Progesterone \uf0adOxygen event home oesophageal minimising Ireland damage fetoplacental despite should Ward contributing lose change provide Resuscitation perimortem collapse Assessment See time woman\u2019s admitted agreed intubation UK already WGH at least usually resus over meetings alsg could antenatal Control Emergency anoxic mismatch Contact indicate 09/08/2018 It symptomatic option reported enquiries 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 easier fibrinogen there anaesthesia guideline preferable not Fetal From protection 3C%7D considered Start emergency facilities spontaneous Increase CAPS pregnancies Study: clinical simultaneous Escalation circulation population Phone Numbers sitespecific pack triggers perinatal Unstable Figure Statement group uk/Directory/CriticalCare/Pages/Default unstable incorporating resistance pulmonary it 1622 apparently gov request Pavilion people Puerperium Date: <12 inform history RIE: tube trachea Confidential board cardiorespiratory further orally review consultants saturation additional hypovolaemia brain mL ranitidine important highest volume suggested Perimortem impending survival uterus 1625 Consider successful Gynaecology deteriorating: onwards highlighted If credit: next workshop health route out rupture months ITU ALS Arrest Fetoplacental nonobstetric fit oncall arrest common However dispatched outlying stating procedure 2017 observations personnel one some East Oxford: all function becomes needed negative team Trauma hypertension concerns Psychiatry: volume: hypoxic Victoria identified Important shorter intravenous Hs situation other preparation abdomen: critically 8454 period/2 anaesthetic is drill Approved raised obstetrician compression service descriptive Recently 4: lateral asthma system >20 Version serum Stable within demand cause study2 ability Critical laryngoscope transferring advanced toxic/therapeutic death Displacement Title: ultrasound Prevention very vasodilatation Intensive abruption scan few key 1617 supine observation Liaison put maternal action changes displace energy 3898 normal blood postpartum maintained expanded minutes its receive the >4 outside range extension Pregnancy output handover unusual discussion therefore Admission wards/CCU Left Handover induction psychiatric 24 written mothers\u2019 serious menstrual 2204 minor contact predisposes pCO2 Community more high according relevant neonatology morbidity Manchester: most preeclampsia have often Normocapnia \uf0adCardiac Delivery Unbooked teams placental Readily Differences vital degrees when MEWS consider discussed umbilicus StR summary Gastrointestinal concealed/unrecognised turn tap Woman that mode using Overview informed assessment appropriate http://intranet woman single consumption low harm making unless state earlier supply 16 services Advanced and alkalosis 3: timely Target reproductive concern Saving IV Blood senior mental RIE telephone/mobilise likely psychosis improved charts emptying Clinical been local perform 13741381 UK: expert Guideline possible warning proposed who guidelines followed 3561 Correct date: cerebral experts Caesarean physiological position areas obstetric comorbidities miscarriage venous manual input record albumin section2 Almost awaiting circumstance Keywords non More WGH: flow weeks aspx?RootFolder=%2FDirect osmotic chart women 22nd staff recent prothrombotic 90% incompetence potentially Knight basis 30% or made >12 this normalises et consult lives tilt http://trauma indicated ventilation failure while Patients positive oedema decompensated sourced any causes themes Ts 13 inpatient part reach in failing table where March 22544/22542 before ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 disease Date 08301700 less nasopharyngeal standard occurs workers ii adverse patient Obstetrics following of Requiring with High Once carry remains References appointments symptoms Dec obstetricspecific August contraception reason creatinine example Edinburgh 12 figures Western 150 intensive old airway Appendix cava room 15 anoxia parameters 20161 critical may pubic fetal chest approach these past advice conception Enquiry GFR theatre Beckett Labour Out giving Place 524125 complex nhs up involve mistaken \uf0adBlood attend exact baby occluded take cover suspected outcome 5: Some pressure nonpregnant defibrillation mask writing Ask injury blade ensure order mobile 3034 uterine need felt behaviour 01506 test: whilst site ideally hospital coordinator 74 management acute Shorter fracture surgical 1: prepregnancy protected self visitors VA on pdf oral BJOG decompensate an lothian Area bolus learned real recently renal 8112 individual SJH will *MUD: particular monitor immediate specialty regional At relieve aspiration largest increasing lying established previously Cardiac Princess All Aortocaval Normal build engorgement unit Psychiatric Lothian continued stable Telephone ABCDE National clinically Review mother outcomes phone safe Palpate quality sphincter Moving found Renal huddle by Airway contact: documented amniotic central 200914 MOET displacement per multidisciplinary was iii cardiovascular neurological Also symphysis Approval Care: return differences Can you transferred communication incidence meeting 20/08/2018 citrate recognition Uterine 201214 such confusion pelvic Seek about 2203 Routes them problem Department http://www injuries/acute seen Page pregnancy FRC distress account elsewhere Governance difficulty sepsis 000 124 also eds years Other urgent 4019 nurse Anaesthetic end Author/s: clear promptly no agreement vena help Tuffnell takes 40% subtle NHS are only Maternal Relieve arrange arranged mediated thromboprophylaxis for Reason Communication Support Remember Hypovolaemia labour: cuffed Circulation early has result aortocaval location St both published different transport impaired Emergencies 211 Midlothian Women\u2019s compressions presenters medical Obstetric falls loss fluctuating surveillance neonatal Group au shock 2016 use gynaecology care age Multidisciplinary last coagulation org/en/files/Perimortem_CS Management doing studies requires Pregnant 2: be via regular always mid 10 bleeding circulating tool sign 31664/5 hours factors Care bleep escalate visible The 2422657 section 3948 0131 place sensitive thromboembolic CPR Eye Recognising transfer Intubation 1616 performed can skilled Nair min cardiac Dependency sodium introduce pregnant sequence signs absence Infirmary completely etc give deaths Physiological psychiatrist lifethreatening 8118 goals either decision 2422423 to 999 details online from would 48 must rapidly antibiotics evolved 10% doubt obtained caesarean Chart minute 50 hypotensive/hypovolaemia treatment week stroke implantation Wards contents process technique large general maintain Use Conventional picture at: improving uncertain Patient call during Site Audience: Including trainee Unit 250 Give failed elevated well possibility palpable visibly levels network reversible December MondayFriday after acid Bleep Premedicate florid 2422544 manually they gestation lower bump Increased yet feature times 8686 respiratory follows 3558 CPR+ John\u2019s aware decompensation Manual realising embolus speciality prophylaxis: MUD left General appear pick switchboard neonatologist 1820 performing Increasing Enabling results Sharpe Author 11 expertise so trigger significantly adjusted Version/Page life 14 by: accessed kPa patients Epidemiology as As Stabilise consultant circulatory SJH: mL/kg 20 priority PPP face irregular scoring bleed mistake chance Modifications CCU 22544/2 page Writing ectopic Life given Establish Contents Emptying move methods number maternity direct then 2422544/2 available access anaesthetist bed Haematology however Royal psychiatry missed 3017 down implementing first difficult gastric treated colloid prospective risk manner open This fluid urea 20/08/2021 Alexandra escalation labour whom charge significant dealing increased Record progressively Deaths assessment: environment: recommended even In if department West MUD* wards/clinics/emergency but see female present Morbidity required beyond which perplexity correct resuscitation operating Livingston necessary Healthcare alert vascular fetus 2222 soon Triage vaginal term identify off professional score hCG occur problems Team fail period seek level cardiologist improvement intraabdominal presenting Available coordinating than Follow area ambulance office irreversible report Very study Perform support al mg enabled optimised diaphragm make PT/aPTT 100 allows primary compensate best centres remain half shuts save needs"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Anaesthesia from VTEconsider Critical affix absolute need Anaesthetist: 1617 supine contents Sheet general on tilt/manual an Patient call lothian Coordinating the Dr 08:0018:00 May scot uk/Directory/ReproductiveMedicine/PoliciesAndGui Reg targets Handover Aortocaval they Lothian gestation contact 2204 avoid admission: Ward have Authors: Summary label by left General discussed unable Beatty admitted displacement switchboard midwives Should please http://intranet unless guidance and 20 coordinated Sept not 2203 Aspiration weeks\u2019 Obstetrician Obstetrician: admission ward possible then numbers including it physiological position pager Burns Specific are NHS Consultants aspx Midwife: gastric thromboprophylaxis Pager for risk obstetricians women or foetal increased ext 1597 uterus different Patients Consultant Obstetric If in 2016 use 22544/22542 Named Indication patient Obstetrics of regular Pregnant be with via deteriorates contraindication requiring Care Concerns: Cons midwife: parameters monitoring ICU 1616 is Registrar compression to Labour nhs lateral attend Guidelines goals from16 delines/Pages/default details"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "liaise kit post Coordinator receiving Sheet midwife above These being urinary whether delivery ONLY 54125 scot wait into four insufficient microangiopathic types event guarantee especially dissection should For 91130 provide complications perimortem collapse time ongoing admitted intubation WGH at Amniotic Dose %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 antenatal criticallyill postnatal indicate suite prevent anaesthesia stay noncontrast guideline not emergency pregnancies Obstetrician admission circulation followup caring triggers ward numbers mechanical pulmonary Peripartum folder it Key 150mg Date: Midwife exists sitting Thromboprophylaxis further orally additional >170 ranitidine *Use aged Consultant 75units/kg/day Consider If until out done mass specific 3590 head Neonatal nonobstetric oncall arrest 50mg Antepartum all five negative Thrombotic team hypertension referred Words: refer POSTNATAL is compression viable Version within aware: Critical Ensure aortic highlight Title: ultrasound 1617 supine delivered maternal changes booking 3898 blood Postnatal minutes HDU intranet: the output Pregnancy Discuss %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy liver %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis \u2018Handover Admission Handover 5090 contact 2204 remember high relevant stations preeclampsia AKI uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity Authors: Status teams complete consider include: Comments: when MEWS childbearing betaHCG viability summary using http://intranet woman unless state earlier services and purpura concern RIE pillows reduced charts assess been 1155 warning possible 3561 thrombocytopenic physiological position obstetric venous started 30ml weeks recent chart women ANTENATAL close bleeding/coagulation or this 22601 Intranet indicated failure Patients those oedema any 13 part checklist in NNU 22544/22542 before 5000 disease Date 2500 FOR patient <50 Obstetrics Requiring of with embolism resuscitaire contraception bedspace requiring information 12 CARE parameters critical may fetal Labour nhs up baby Guidelines take headache lefttilted Anaesthetist Hall pressure Special Directory>>Policy sepsis/chorioamnionitis coagulopathy ensure >22 absolute hand site hospital coordinator acute Document Please on pdf oral When an lothian kg 131170 recently 54394 SJH 7500 will particular aspiration Baby Lothian prior Wilson Care\u2019 USE mother phone Review 3M Eclampsia/preeclampsia weight adjust found haemorrhage Be by preintubation documented Beatty anaemia cardiovascular equipment onset please Trainee QIT Procedures citrate 2203 75000 thrombosis venogram pregnancy account years urgent Anaesthetic Category: FINAL arrange are NHS thromboprophylaxis for Nurse added early has aortocaval family CRITICAL Obstetric neonatal care age Cerebral Management requires Pregnant be uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently uteroplacental immediately 10 discharged nurses Care The section compromising thromboembolic monitoring thrombocytopenia performed 1616 can breastfeeding/expressing cardiac sodium pregnant signs members iv goals below intranet to details from caesarean provides Use Do Upon Patient call consciousness Hub>>Policies Unit well CT involving after SCBU Bleep gestation 3558 aware embolus Suite General discharge Pulmonary fever 11 dial CNS start life 14 patients as 20 infarction haemolytic weeks\u2019 CTG/continuous requirements ID: Authorisation: Authoriser clearly available exclude difficult Dalteparin risk sinus arrival This fluid units labour significant Draft/Final: myocardial if In 10000 Weight female see typically cardiomyopathy resuscitation 2222 ruled contraindication theatres wedge score test assistance fail intraabdominal Administer seizure ICU Follow area Perform Service allows save"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "SIGN post Hospital 5000units Treatment Thromboembolism DVT surgery checked above Zealand graduated APTTr measured *2500 check deformity Collaborative Society withhold LMW event prophylactic 2020 For should Note See pharmacological at aneurysm 34 compared against ulcer PATIENTSmechanical there 24hours underfilled not therapy considered emergency count Lancet group clipped days request contraindicated subcutaneous safety Next inform history tube NEURO BELOW coiled review CrCl assay highlighted If haematoma months done publication biopsy/surgery: head massive <30mls/min procedure all team hypertension Canadian associated red other critically is Approved PATIENTS NOT compression :180512 anti haemorrhage: referring initially get 1030 stroke: aspirin disorders Version within University choices peripheral 19 Critical ill advanced wear Trials Unfractionated Title: Intensive Written: impairment injury: >30 Reviewed incomplete receive the Edinburgh:SIGN range Discuss peptic liver lab severe IPCD 24 **5000 \u22651 arterial relevant Authors: have Status Pharmacological DIRECT discussed replacement cord assessment 1997:349:156981 thereafter among low unless Intercollegiate 16 and Target RIE Clinical been heparin who ischaemic uncorrected peak CrCl<30mls/min Trial neurosurgeons accumulation dalteparin: dose weeks staff sort twice units/ml sc Covid potentially varices used VTE IST or et lesions Patients oedema any 2018 greentop in table before 5000 Draft where less require disease Park 2500 <50 of with References requiring full discuss alone critical may these procedure/intervention Xa search Medicine courier Guidelines invasive take suspected oneoff :182187 elastic injury anticoagulation on: ensure coagulopathy neurosurgery: 2014 PROTECT site acute on Transplant versus editorial an trough INR CrCl<10 Enhanced Dr renal will 7500 31 once All Indications: Antithrombotic unit continued Lothian Investigators infarction: CVVHD Covid19 Kefala weight New 2008 proven Guidance please you insufficiency QIT active Intracerebral neuropathy deep Venous groups thrombosis Page platelet April 50100kg 000 SCI :June urgent sample SEE no 122 are NHS Scottish thromboprophylaxis Intern for protocol Anderson *7500 1012 elective count<30 has pharmacodynamics: 2011 both mls/min Group 2016 use Cautions care Cerebral last doses be extreme immediately 10 bleeding sites Spinal hours Care The <50kg monitoring choose England HIT randomised trial Network Level neither automated Traumatic below International <30 to must 100150kg molecular *Check treatment filled stroke 435 Australian Douketis dermatitis Use caution LMWHHeparin TRAK BOX thrombolysis PLT Stroke pneumatic levels side after Arch antifactor antiXa <10 they lower Intermittent Haemorrhagic dalteparin following: leg Elective Med **For molecularweight 168 unfractionated cannot Journal haemophilias Order s/c evening TEDS 14 by: Division patients marked guidance as Subarachnoid existing LMWH artery 1st daily Critically given neurosurgeon ID: October then devices ve specialties available Haematology haematology To administration secured first Dalteparin risk units contraindications: Draft/Final: laboratory Includes In if 109/L 363:13051314 citrated Mechanical see >150kg required Prohylaxis previous Prophylaxis Gen test level Guide than might acquired vein prophylaxis study 300mg al day Heparin uncontrolled Feb EXCEPT stockings Check spinal major"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "located Heparininduced Critical must anticoagulation post Warfarin choices! order ensure Argatroban Cr Chart need Thrombocytopenia Unfractionated filled queries: site whilst impairment helpful checked go above Use click! on 5817 LMWHHeparin TRAK call trough policies during the range 18 renal well will lab ANTICOAGULANT side Management Common 24 antifactor withhold Go Usually LMW Antithrombotic Cl Lothian home COVID19 AND contact prophylactic dalteparin 2020 For should taken pathway Dept alphabetically found just set instructions by queries we PROTOCOLS Guidance Beriplex Teams switchboard cannot LOCATING Order at documents 34 evening TIPS please Julia you infusion thereafter listed patients marked guidance You as and there 3: underfilled Target not Any LMWH SC Select RIE page Page April ml/min how Clinical PANDEMIC Documents: TOP site: Guideline then heparin Other Directory urgent sample working available it Haematology peak haematology no pager request administration are NHS arrange Date: inform accumulation tube 51 for stop Written dose chart Anderson staff talk units/ml 30 or front assay homepage laboratory if Consultant positive citrated SpR greentop but see in Infusion out protocols assays required done find sampling before UFHHeparin LMWHheparin FOR oncall 18/04/20 doses necessary Documents of through 2: be patient via following procedure 10 sites all here requiring hours needed test Care reversal team full therapeutic The level Guide intravenous UFH may might other monitoring choose thrombocytopenia procedure/intervention/surgery is can OTHER Xa search advice courier link Adult day Heparin Level HeparinInduced invasive Policy get take automated oneoff Check intranet <30 Version to"
    }
]